<SEC-DOCUMENT>0001193125-20-126152.txt : 20200429
<SEC-HEADER>0001193125-20-126152.hdr.sgml : 20200429
<ACCEPTANCE-DATETIME>20200429161114
ACCESSION NUMBER:		0001193125-20-126152
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20200617
FILED AS OF DATE:		20200429
DATE AS OF CHANGE:		20200429
EFFECTIVENESS DATE:		20200429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEKTAR THERAPEUTICS
		CENTRAL INDEX KEY:			0000906709
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				943134940
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-24006
		FILM NUMBER:		20830398

	BUSINESS ADDRESS:	
		STREET 1:		455 MISSION BAY BOULEVARD SOUTH
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158
		BUSINESS PHONE:		4154825300

	MAIL ADDRESS:	
		STREET 1:		455 MISSION BAY BOULEVARD SOUTH
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INHALE THERAPEUTIC SYSTEMS INC
		DATE OF NAME CHANGE:	19980723

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INHALE THERAPEUTIC SYSTEMS
		DATE OF NAME CHANGE:	19940303
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d910899ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section 14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No. &nbsp;&nbsp;&nbsp;&nbsp;) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Filed by a Party other than the
Registrant&nbsp;&nbsp;&#9744;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Soliciting Material Pursuant to &#167;240.14a-12</TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>Nektar
Therapeutics </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
</B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">No fee required.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of each class of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aggregate number of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proposed maximum aggregate value of transaction:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fee paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amount Previously Paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Form, Schedule or Registration Statement No.:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing Party:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date Filed:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g910899g36i66.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">NEKTAR THERAPEUTICS </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">455 Mission Bay Boulevard South </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">San Francisco, California 94158 </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">TO BE HELD ON JUNE&nbsp;17, 2020 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">AT 2:00 P.M. PACIFIC TIME </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Dear Stockholder: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You are cordially invited to attend the 2020 Annual Meeting of
Stockholders of Nektar Therapeutics, a Delaware corporation which will be held by live webcast only. The 2020 Annual Meeting will be held on Wednesday, June&nbsp;17, 2020, at 2:00 p.m. solely by webcast for the following purposes: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To elect three directors with terms to expire at the 2023 Annual Meeting of Stockholders. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To approve an amendment of our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common stock
authorized for issuance under the plan by 10,000,000 shares. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To approve an amendment and restatement of our Amended and Restated Employee Stock Purchase Plan to increase the aggregate number of shares of
common stock authorized for issuance under the plan by 1,000,000 shares. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To ratify the selection of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending
December&nbsp;31, 2020. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To approve a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory resolution regarding our executive compensation (a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-pay&#148;</FONT></FONT> vote). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To conduct any other business properly brought before the 2020 Annual Meeting. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">These items of business are more fully described in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. The
record date for the 2020 Annual Meeting is April&nbsp;20, 2020. Only stockholders of record at the close of business on that date are entitled to notice of, and to vote at, the 2020 Annual Meeting or any adjournment thereof. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Due to the public health and travel concerns our stockholders may have related to the coronavirus
<FONT STYLE="white-space:nowrap">(COVID-19)</FONT> and the protocols that federal, state, and local governments may impose, we have elected to hold the Annual Meeting of Stockholders solely by means of remote communication. The webcast of the Annual
Meeting will begin promptly at 2:00 p.m. Pacific Time. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>To participate in the live webcast, please visit
www.virtualshareholdermeeting.com/NKTR2020. You will need the control number included on your Notice, proxy card, or voting instruction form. We encourage you to access the meeting prior to the start time. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Your vote is very important. Whether or not you participate in the 2020 Annual Meeting which will be held by live webcast on the day of
the meeting, it is important that your shares be represented. You may vote your proxy on the Internet, by phone or by mail in accordance with the instructions in the Notice of Availability of Proxy Materials. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On behalf of the Board of Directors, thank you for your participation in this important annual process. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:55%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:55%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Mark A. Wilson </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:55%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mark A. Wilson </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:55%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Senior Vice President, General Counsel and
Secretary </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">San Francisco, California </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">April&nbsp;29, 2020 </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">YOU ARE CORDIALLY INVITED TO ATTEND THE ANNUAL MEETING IN
VIA LIVE WEBCAST ON THE DAY OF THE MEETING. WHETHER OR NOT YOU EXPECT TO ATTEND THE ANNUAL MEETING, PLEASE VOTE ON THE INTERNET, BY PHONE OR BY MAIL AS INSTRUCTED IN THE NOTICE OF AVAILABILITY OF PROXY MATERIALS, AS PROMPTLY AS POSSIBLE IN ORDER TO
ENSURE YOUR REPRESENTATION AT THE MEETING. EVEN IF YOU HAVE VOTED BY PROXY, YOU MAY STILL VOTE DURING THE LIVE WEBCAST IF YOU ATTEND THE ANNUAL MEETING. PLEASE NOTE, HOWEVER, THAT IF YOUR SHARES ARE HELD OF RECORD BY A BROKER, BANK OR OTHER NOMINEE
AND YOU WISH TO VOTE AT THE ANNUAL MEETING, YOU MUST OBTAIN A PROXY ISSUED IN YOUR NAME FROM THAT RECORD HOLDER. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_1">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING PROCEDURES</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_2">PROPOSAL 1: ELECTION OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_3">PROPOSAL 2: APPROVAL OF AN AMENDMENT TO OUR AMENDED AND RESTATED 2017 PERFORMANCE INCENTIVE
PLAN</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_4">PROPOSAL 3: APPROVAL OF AN AMENDMENT AND RESTATEMENT OF OUR AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN
</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_5">PROPOSAL 4: RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></FONT></P></TD>

<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_6">PROPOSAL 5: ADVISORY VOTE ON EXECUTIVE COMPENSATION</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_7">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_8">DELINQUENT SECTION 16(A) REPORTS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_9">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_10">INFORMATION ABOUT THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_11">THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_12">DIRECTORS CONTINUING IN OFFICE UNTIL THE 2021 ANNUAL MEETING</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_13">DIRECTORS CONTINUING IN OFFICE UNTIL THE 2022 ANNUAL MEETING</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_14">CURRENT DIRECTORS NOMINATED FOR REELECTION TO SERVE UNTIL THE 2023 ANNUAL MEETING</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_15">MEETINGS OF THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_16">CORPORATE GOVERNANCE</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_17">BOARD LEADERSHIP STRUCTURE</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_17a">LEAD INDEPENDENT DIRECTOR</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_18">RISK OVERSIGHT</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_19">INDEPENDENCE OF THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_20">INFORMATION REGARDING THE COMMITTEES OF THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">36</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_21">STOCKHOLDER COMMUNICATIONS WITH THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">42</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_22">CODE OF BUSINESS CONDUCT AND ETHICS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_23">ORGANIZATION AND COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_24">DIRECTOR COMPENSATION TABLE</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">44</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_25">COMPENSATION DISCUSSION AND ANALYSIS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_26">COMPENSATION COMMITTEE REPORT</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">64</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_27">SUMMARY COMPENSATION TABLE&#151;FISCAL 2017-2019</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_28">DESCRIPTION OF EMPLOYMENT AGREEMENTS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">66</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_29">GRANTS OF PLAN BASED AWARDS IN 2019</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">67</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_30">OUTSTANDING EQUITY AWARDS AT FISCAL <FONT STYLE="white-space:nowrap">YEAR-END</FONT> FOR
2019</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">70</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_31">OPTION EXERCISES AND STOCK VESTED IN 2019</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">72</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_32">POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE OF CONTROL</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">72</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_33">INFORMATION ABOUT OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">77</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_34"><FONT STYLE="white-space:nowrap">PRE-APPROVAL</FONT> POLICIES AND PROCEDURES</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">77</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_35">REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">77</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_36">OTHER MATTERS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc910899_37">ADDITIONAL INFORMATION</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g910899g36i66.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">NEKTAR THERAPEUTICS </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">455 Mission Bay Boulevard South </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">San Francisco, California 94158 </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">TO BE HELD ON JUNE&nbsp;17, 2020 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">AT 2:00 P.M. PACIFIC TIME </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_1"></A>QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING PROCEDURES </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Due to the public health and travel concerns our stockholders may have related to the coronavirus <FONT STYLE="white-space:nowrap">(COVID-19)</FONT> and the protocols that federal, state, and local
governments may impose, we have elected to hold the Annual Meeting of Stockholders solely by means of remote communication. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HY</SMALL> <SMALL>AM</SMALL> I <SMALL>RECEIVING</SMALL> <SMALL>THESE</SMALL> <SMALL>MATERIALS</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We sent you a Notice of Availability of Proxy Materials (the &#147;Notice&#148;) because the board of directors of Nektar Therapeutics, a
Delaware corporation (&#147;Nektar,&#148; the &#147;Company,&#148; &#147;we&#148; or &#147;us&#148;), is soliciting your proxy to vote at our 2020 annual meeting of stockholders (the &#147;Annual Meeting&#148;) to be solely by live webcast on
June&nbsp;17, 2020 at 2:00 p.m. There will be no <FONT STYLE="white-space:nowrap">in-person</FONT> meeting. We invite you to attend the Annual Meeting by live webcast to vote on the proposals described in this proxy statement. However, you do not
need to attend the live webcast meeting to vote your shares. Instead, you may vote by proxy over the Internet or by phone by following the instructions provided in the Notice or, if you request printed copies of the proxy materials by mail, you may
vote by mail. Please visit our website at www.nektar.com for updated information related to the Annual Meeting. As always, we encourage you to vote your shares prior to the Annual Meeting. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The webcast of the Annual Meeting will begin promptly at 2:00 p.m. Pacific Time. To participate in the live webcast, <B>please visit
www.virtualshareholdermeeting.com/NKTR2020. </B>You will need the control number included on your Notice, proxy card, or voting instruction form. We encourage you to access the meeting prior to the start time. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Notice was first sent or made available on or about April&nbsp;29, 2020 to all stockholders of record entitled to vote at the Annual
Meeting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HO</SMALL> <SMALL>CAN</SMALL> <SMALL>VOTE</SMALL> <SMALL>AT</SMALL> <SMALL>THE</SMALL> <SMALL>ANNUAL</SMALL>
<SMALL>MEETING</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Only stockholders of record at the close of business on April&nbsp;20, 2020 will be entitled to
vote at the Annual Meeting. On this record date, there were 177,914,327 shares of common stock outstanding and entitled to vote. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Stockholder of Record: Shares Registered in Your Name </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If, on
April&nbsp;20, 2020, your shares were registered directly in your name with our transfer agent, Computershare Inc., then you are a stockholder of record. The Notice will be sent to you by mail directly by us. As a stockholder of record, you may vote
remotely at the Annual Meeting or vote by proxy. Whether or not you plan to attend the Annual Meeting remotely, we urge you to vote on the Internet or by phone as instructed in the Notice or by proxy by mail by requesting a paper copy of the proxy
materials as instructed in the Notice to ensure your vote is counted. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Agent
</I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If, on April&nbsp;20, 2020, your shares were held in an account at a brokerage firm, bank or other agent, then you are the
beneficial owner of shares held in &#147;street name&#148; and the Notice is being forwarded to you by that organization. The organization holding your account is considered the stockholder of record for purposes of voting at the Annual Meeting. As
a beneficial owner, you have the right to direct your broker, bank or other agent on how to vote the shares in your account. Your brokerage firm, bank or other agent will not be able to vote in the election of directors unless they have your voting
instructions, so it is very important that you indicate your voting instructions to the institution holding your shares. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You
are also invited to attend the Annual Meeting by live webcast. However, since you are not the stockholder of record, you may not vote your shares remotely at the Annual Meeting by live webcast unless you request and obtain a valid proxy from your
broker, bank or other agent. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HAT</SMALL> <SMALL>AM</SMALL> I <SMALL>VOTING</SMALL> <SMALL>ON</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">There are five matters scheduled for a vote: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 1: To elect three directors with terms to expire at the 2023 Annual Meeting of Stockholders. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 2: To approve an amendment of our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common
stock authorized for issuance under the plan by 10,000,000 shares. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 3: To approve an amendment and restatement of our Amended and Restated Employee Stock Purchase Plan to increase the aggregate number of shares
of common stock authorized for issuance under the plan by 1,000,000 shares. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 4: To ratify the selection of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for our fiscal year ending
December&nbsp;31, 2020. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 5: To approve a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory resolution regarding our executive compensation (a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-pay&#148;</FONT></FONT> vote). </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OW</SMALL> <SMALL>ARE</SMALL> <SMALL>PROXY</SMALL> <SMALL>MATERIALS</SMALL> <SMALL>DISTRIBUTED</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under rules adopted by the Securities and Exchange Commission (&#147;SEC&#148;), we are sending the Notice to our stockholders of record
and beneficial owners as of April&nbsp;20, 2020. Stockholders will have the ability to access the proxy materials, including this proxy statement and our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended
December&nbsp;31, 2019, on the Internet at <I>www.nektar.com</I> or to request a printed or electronic set of the proxy materials at no charge. Instructions on how to access the proxy materials over the Internet and how to request a printed copy may
be found on the Notice. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, any stockholder may request to receive proxy materials in printed form by mail or
electronically by email on an ongoing basis. Choosing to receive future proxy materials by email will save us the cost of printing and mailing documents to stockholders and will reduce the impact of annual meetings on the environment. A stockholder
who chooses to receive future proxy materials by email will receive an email prior to next year&#146;s annual meeting with instructions containing a link to those materials and a link to the proxy voting website. A stockholder&#146;s election to
receive proxy materials by email will remain in effect until the stockholder terminates it. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OW</SMALL> <SMALL>DO</SMALL> I <SMALL>VOTE</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may either vote &#147;For&#148; or &#147;Against&#148; or abstain from voting with respect to each nominee to the board of directors.
For Proposals 2, 3, 4 and 5, you may vote &#147;For&#148; or &#147;Against&#148; or abstain from voting. The procedures for voting are: </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Stockholder of Record: Shares Registered in Your Name </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a
stockholder of record as of April&nbsp;20, 2020, you may vote remotely at the Annual Meeting by live webcast, vote by proxy over the Internet or by phone by following the instructions provided in the Notice or, if you request printed copies of the
proxy materials by mail, you may vote by mail. If your proxy is properly executed in time to be voted at the Annual Meeting, the shares represented by the proxy will be voted in accordance with the instructions you provide. Whether or not you plan
to attend the Annual Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the Annual Meeting and vote remotely if you have already voted by proxy. </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote during the meeting, attend the Annual Meeting which will be held by live webcast. To attend the live meeting go to
<B><U>www.virtualshareholdermeeting.com/NKTR2020</U></B><B> </B>on the day and time of the meeting. You will need the control number included on your Notice, proxy card, or voting instruction form. We encourage you to access the meeting prior to the
start time. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote on the Internet prior to the Annual Meeting, go to www.proxyvote.com to complete an electronic proxy card. You will be asked to
provide the <FONT STYLE="white-space:nowrap">16-digit</FONT> control number from the Notice and follow the instructions. Your vote must be received by 11:59 p.m. Eastern Time on June&nbsp;16, 2020 to be counted. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote by phone, request a paper or email copy of the proxy materials by following the instructions on the Notice and call the number
provided with the proxy materials to transmit your voting instructions. Your vote must be received by 11:59 p.m. Eastern Time on June&nbsp;16, 2020 to be counted. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote by mail, request a paper copy of the proxy materials by following the instructions on the Notice and complete, sign and date the proxy
card enclosed with the paper copy of the proxy materials and return it promptly in the envelope provided. If you return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Agent </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you should have received a Notice and
voting instructions from that organization rather than from us. Simply follow the instructions to ensure that your vote is counted. To vote by live webcast at the Annual Meeting, you must obtain a valid proxy from your broker, bank or other agent.
Follow the instructions from your broker, bank or other agent included with the Notice, or contact your broker, bank or other agent. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>We provide Internet proxy voting to allow you to vote your shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions. However, please be aware
that you must bear any costs associated with your Internet access, such as usage charges from Internet access providers and telephone companies. </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OW</SMALL> <SMALL>MANY</SMALL> <SMALL>VOTES</SMALL> <SMALL>DO</SMALL> I <SMALL>HAVE</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">On each matter to be voted upon, you have one vote for each share of common stock you owned as of April&nbsp;20, 2020. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HAT</SMALL> <SMALL>IS</SMALL> <SMALL>THE</SMALL> <SMALL>QUORUM</SMALL>
<SMALL>REQUIREMENT</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A quorum of stockholders is necessary to take any action during the meeting (other than to
adjourn the meeting). The presence, by live webcast, or by proxy duly authorized, of the holders of a majority of the outstanding shares of stock entitled to vote will constitute a quorum. On April&nbsp;20, 2020, there were 177,914,327 shares
outstanding and entitled to vote. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Your shares will be counted towards the quorum only if you submit a valid proxy or vote
during the live webcast at the Annual Meeting. Even if your valid proxy card indicates that you abstain from voting or if a broker indicates on a proxy that it lacks discretionary authority to vote your shares on a particular matter, commonly
referred to as &#147;broker <FONT STYLE="white-space:nowrap">non-votes,&#148;</FONT> your shares will still be counted for purposes of determining the presence of a quorum at the Annual Meeting. If there is no quorum, the chairman of the Annual
Meeting or a majority of the votes present at the Annual Meeting may adjourn the Annual Meeting to another date. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HAT</SMALL>
<SMALL>IF</SMALL> I <SMALL>RETURN</SMALL> <SMALL>A</SMALL> <SMALL>PROXY</SMALL> <SMALL>CARD</SMALL> <SMALL>BUT</SMALL> <SMALL>DO</SMALL> <SMALL>NOT</SMALL> <SMALL>MAKE</SMALL> <SMALL>SPECIFIC</SMALL> <SMALL>CHOICES</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a stockholder of record and you return a proxy card without marking any voting selections, your shares will be voted:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 1: &#147;For&#148; election of the three nominees for director. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 2: &#147;For&#148; the approval of an amendment to the Amended and Restated 2017 Performance Incentive Plan to increase the aggregate
number of shares of common stock authorized for issuance under the plan by 10,000,000 shares. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 3: &#147;For&#148; the approval of an amendment and restatement of our Amended and Restated Employee Stock Purchase Plan to increase
the aggregate number of shares of common stock authorized for issuance under the plan by 1,000,000 shares.</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 4: &#147;For&#148; the ratification of the Audit Committee&#146;s selection of Ernst&nbsp;&amp; Young LLP as our independent
registered public accounting firm for our fiscal year ending December&nbsp;31, 2020. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 5: &#147;For&#148; the approval of a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory resolution regarding our executive
compensation (a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-pay&#148;</FONT></FONT> vote). </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If any other matter is properly presented at the meeting, your proxy (one of the individuals named on your proxy card) will vote your shares using his best judgment. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, your shares are held by your broker,
bank or other agent as your nominee (that is, in &#147;street name&#148;) and you will need to obtain a proxy form from the organization that holds your shares and follow the instructions included on that form regarding how to instruct the
organization to vote your shares. If you do not give instructions to your broker, bank or other agent, it can vote your shares with respect to &#147;discretionary&#148; items but not with respect to
<FONT STYLE="white-space:nowrap">&#147;non-discretionary&#148;</FONT> items. Discretionary items are proposals considered routine under the rules of various national securities exchanges, and, in the absence of your voting instructions, your broker,
bank or other agent may vote your shares held in street name on such proposals. <FONT STYLE="white-space:nowrap">Non-discretionary</FONT> items are proposals considered <FONT STYLE="white-space:nowrap">non-routine</FONT> under the rules of various
national securities exchanges, and, in the absence of your voting instructions, your broker, bank or other agent may not vote your shares held in street name on such proposals and the shares will be treated as broker
<FONT STYLE="white-space:nowrap">non-votes.</FONT> Proposals 1, 2, 3 and 5 are matters considered <FONT STYLE="white-space:nowrap">non-routine</FONT> under the applicable rules. If you do not give your broker specific instructions, the broker will
not vote your shares on Proposals 1, 2, 3, and 5 and your shares will constitute broker <FONT STYLE="white-space:nowrap">non-votes</FONT> which will be counted for purposes of determining whether a quorum exists but will not affect the outcome of
these proposals. Proposal 4 involves a matter we believe to be routine and thus if you do not give instructions to your broker, the broker may vote your shares in its discretion on Proposal 4 and therefore no broker
<FONT STYLE="white-space:nowrap">non-votes</FONT> are expected to exist in connection with Proposal 4. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OW</SMALL> <SMALL>ARE</SMALL> <SMALL>VOTES</SMALL> <SMALL>COUNTED</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Votes will be counted by the inspector of election appointed for the Annual Meeting, with respect to Proposal 1, &#147;For&#148; votes,
&#147;Against&#148; votes, abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> for each nominee, with respect to Proposal 2, 3 and 5, &#147;For&#148; votes, &#147;Against&#148; votes, abstentions and broker <FONT
STYLE="white-space:nowrap">non-votes,</FONT> and with respect to Proposal 4, &#147;For&#148; votes, &#147;Against&#148; votes and abstentions.&nbsp;&nbsp;&nbsp;&nbsp; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HO</SMALL> <SMALL>WILL</SMALL> <SMALL>SERVE</SMALL> <SMALL>AS</SMALL> <SMALL>INSPECTOR</SMALL> <SMALL>OF</SMALL> <SMALL>ELECTIONS</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A representative of Broadridge Financial Solutions, Inc. will serve as the inspector of elections. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OW</SMALL> <SMALL>MANY</SMALL> <SMALL>VOTES</SMALL> <SMALL>ARE</SMALL> <SMALL>NEEDED</SMALL> <SMALL>TO</SMALL> <SMALL>APPROVE</SMALL>
<SMALL>EACH</SMALL> <SMALL>PROPOSAL</SMALL>? </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Proposal 1 electing three members of the board of directors, each director must receive a &#147;For&#148; vote from a majority of the votes cast
during the live webcast or by proxy at the Annual Meeting on the election of the director. A majority of the votes cast shall mean that the number of shares voted &#147;For&#148; a director&#146;s election exceeds fifty percent (50%)&nbsp;of the
number of the votes cast with respect to that director&#146;s election. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Proposal 2 approving an amendment to our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common
stock authorized for issuance under the plan, the proposal must receive a &#147;For&#148; vote from a majority of the votes cast either during the live webcast or by proxy at the Annual Meeting. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Proposal 3 approving an amendment and restatement of our Amended and Restated Employee Stock Purchase Plan to increase the aggregate number of
shares of common stock available for issuance under the plan. The proposal must receive a &#147;For&#148; vote from a majority of the votes cast either during the live webcast or by proxy at the Annual Meeting. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Proposal 4 ratifying the Audit Committee&#146;s selection of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for
our fiscal year ending December&nbsp;31, 2020, the proposal must receive a &#147;For&#148; vote from a majority of the votes cast either during the live webcast or by proxy at the Annual Meeting. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Proposal 5 approving the resolution regarding executive compensation, the proposal must receive a &#147;For&#148; vote from a majority of the votes
cast either during the live webcast or by proxy at the Annual Meeting. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For purposes of all proposals above,
votes cast shall include any shares voted &#147;Against&#148; and shall exclude abstentions and, to the extent applicable, broker <FONT STYLE="white-space:nowrap">non-votes.</FONT> </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HO</SMALL> <SMALL>IS</SMALL> <SMALL>PAYING</SMALL> <SMALL>FOR</SMALL> <SMALL>THIS</SMALL> <SMALL>PROXY</SMALL> <SMALL>SOLICITATION</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will pay for the entire cost of soliciting proxies. In addition to the Notice and the proxy materials, our directors and employees may
also solicit proxies during the live webcast, by telephone or by other means of communication. We have retained Georgeson LLC to assist in the distribution of proxy materials and the solicitation of proxies from brokerage firms, fiduciaries,
custodians, and other similar organizations representing beneficial owners of shares for the Annual Meeting. We have agreed to pay Georgeson a fee of approximately $14,795 plus customary costs and expenses for these services. We will not pay our
directors and employees any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents for the cost of forwarding the Notice and any other proxy materials to beneficial owners. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HAT</SMALL> <SMALL>DOES</SMALL> <SMALL>IT</SMALL> <SMALL>MEAN</SMALL> <SMALL>IF</SMALL> I <SMALL>RECEIVE</SMALL> <SMALL>MORE</SMALL>
<SMALL>THAN</SMALL> <SMALL>ONE</SMALL> <SMALL>NOTICE</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you receive more than one Notice, your shares are
registered in more than one name or are registered in different accounts. Please vote by proxy according to each Notice to ensure that all of your shares are voted. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>AN</SMALL> I <SMALL>CHANGE</SMALL> <SMALL>MY</SMALL> <SMALL>VOTE</SMALL>
<SMALL>AFTER</SMALL> <SMALL>SUBMITTING</SMALL> <SMALL>MY</SMALL> <SMALL>PROXY</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yes, you can revoke your proxy at
any time before the final vote at the Annual Meeting. If you are a stockholder of record, you may revoke your proxy in any one of three ways: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">A duly executed proxy card with a later date or time than the previously submitted proxy; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">A written notice that you are revoking your proxy to our Secretary, care of Nektar Therapeutics, at 455&nbsp;Mission Bay Boulevard South, San
Francisco, California 94158; or </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">A later-dated vote on the Internet or by phone or a ballot cast during the live webcast at the Annual Meeting (simply attending the Annual
Meeting will not, by itself, revoke your proxy). </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a beneficial owner, you may revoke your proxy
by submitting new instructions to your broker, bank or other agent, or if you have received a proxy from your broker, bank or other agent giving you the right to vote your shares at the Annual Meeting, by attending the meeting and voting during the
live webcast. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HEN</SMALL> <SMALL>ARE</SMALL> <SMALL>STOCKHOLDER</SMALL> <SMALL>PROPOSALS</SMALL> <SMALL>DUE</SMALL>
<SMALL>FOR</SMALL> <SMALL>NEXT</SMALL> <SMALL>YEAR</SMALL>&#146;<SMALL>S</SMALL> <SMALL>ANNUAL</SMALL> <SMALL>MEETING</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> under the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), some stockholder proposals may be eligible for
inclusion in our 2021 proxy statement. Any such proposal must be submitted in writing by December&nbsp;30, 2020, to our Secretary, care of Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, California 94158. If we change the date
of our 2021 annual meeting by more than 30 days from the date of the previous year&#146;s annual meeting, the deadline shall be a reasonable time before we begin to print and send our proxy materials. Stockholders interested in submitting such a
proposal are advised to contact knowledgeable counsel with regard to the detailed requirements of the applicable securities laws and our bylaws. The submission of a stockholder proposal does not guarantee that it will be included in our proxy
statement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Alternatively, under our bylaws, if you wish to submit a proposal that is not to be included in next year&#146;s
proxy statement or nominate a director, you must provide specific information to us no earlier than March&nbsp;19, 2021 and no later than the close of business on April&nbsp;18, 2021. If we change the date of our 2021 annual meeting by more than 30
days from the date of the previous year&#146;s annual meeting, the deadline shall be changed to not later than the sixtieth day prior to such annual meeting and no earlier than the close of business on the ninetieth day prior to such annual meeting.
The public announcement of an adjournment or postponement of the 2021 annual meeting does not commence a new time period (or extend any time period) for the giving of a stockholder&#146;s notice as described in this proxy statement. You are advised
to review our bylaws, which contain additional requirements with respect to advance notice of stockholder proposals and director nominees. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">A stockholder&#146;s submission must include certain specific information concerning the proposal or nominee, as the case may be, and information as to the stockholder&#146;s ownership of our common
stock. Proposals or nominations not meeting these requirements will not be entertained at any annual meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In relation to
stockholder proposals and nominations, in certain instances we may exercise discretionary voting authority under proxies held by the board of directors. For instance, if we do not receive a stockholder proposal by April&nbsp;18, 2021, we may
exercise discretionary voting authority under proxies held by the board of directors on such stockholder proposal. If we change the date of our 2021 annual meeting by more than 30 days from the date of the previous year&#146;s annual meeting, the
deadline will change to a reasonable time before we begin to print and send our proxy materials. In addition, even if we are notified of a stockholder proposal within the time requirements discussed above, if the stockholder does not comply with
certain requirements of the Exchange Act, we may exercise discretionary voting authority under proxies held by the board of directors on such stockholder proposal if we include advice in our proxy statement on the nature of the matter and how we
intend to exercise our discretion to vote on the matter. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HAT</SMALL> <SMALL>IS</SMALL> &#147;<SMALL>HOUSEHOLDING</SMALL>&#148; <SMALL>AND</SMALL>
<SMALL>HOW</SMALL> <SMALL>DOES</SMALL> <SMALL>IT</SMALL> <SMALL>AFFECT</SMALL> <SMALL>ME</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have adopted a
procedure approved by the SEC called &#147;householding.&#148; Under this procedure, stockholders who have the same address may receive only one copy of the Notice, unless one or more of these stockholders notifies us that they wish to receive
individual copies of the Notice and, if requested, other proxy materials. This process potentially means extra convenience for stockholders and cost savings for companies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If you are a beneficial owner of our common stock, once you receive notice from your broker, bank or other agent that they will be householding communications to your address, householding will continue
until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in householding and would prefer to receive separate Notices or other proxy materials, please notify your broker, bank or other
agent, direct your written request to Nektar Therapeutics, Secretary, 455 Mission Bay Boulevard South, San Francisco, California 94158 or contact our Secretary at <FONT STYLE="white-space:nowrap">(415)&nbsp;482-5300.</FONT> Stockholders who
currently receive multiple copies of the Notice or other proxy materials at their address and would like to request householding of their communications should contact their broker, bank or other agent. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OW</SMALL> <SMALL>CAN</SMALL> I <SMALL>FIND</SMALL> <SMALL>OUT</SMALL> <SMALL>THE</SMALL> <SMALL>RESULTS</SMALL> <SMALL>OF</SMALL>
<SMALL>THE</SMALL> <SMALL>VOTING</SMALL> <SMALL>AT</SMALL> <SMALL>THE</SMALL> <SMALL>ANNUAL</SMALL> <SMALL>MEETING</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preliminary voting results will be announced at the Annual Meeting. Final voting results will be published in a Current Report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> filed with the SEC within four business days following the Annual Meeting. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_2"></A>PROPOSAL 1 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ELECTION OF DIRECTORS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our board of directors is presently comprised of eight (8)&nbsp;directors and is divided into three (3)&nbsp;classes. Class&nbsp;III currently consists of two directors, and each of Classes I and II
currently consists of three directors. Each class has a three (3)&nbsp;year term. The three (3)&nbsp;current directors in Class&nbsp;I are Howard W. Robin, Karin Eastham, and Myriam J. Curet, M.D., whose term expires in 2020. Each of the current
directors in Class&nbsp;I have been nominated for reelection at the Annual Meeting. Mr.&nbsp;Robin was previously elected by the stockholders. Ms.&nbsp;Eastham was appointed to our board of directors in September 2018 and Dr.&nbsp;Curet was
appointed to our board of directors in December 2019.&nbsp;&nbsp;&nbsp;&nbsp; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vacancies on the board, including vacancies
created by an increase in the number of directors, are filled only by persons elected by a majority of the remaining directors. A director elected by the board to fill a vacancy in a class serves until the earliest of the end of the remaining term
of that class, the election and qualification of his or her successor or such director&#146;s death, resignation or removal. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Directors are elected by a majority of the votes cast at the Annual Meeting on the election of directors. A majority of votes cast shall
mean that the number of shares voted &#147;For&#148; a director&#146;s election exceeds fifty percent (50%)&nbsp;of the number of votes cast with respect to that director&#146;s election, with votes cast including votes &#147;Against&#148; in each
case but excluding abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> with respect to that director&#146;s election. Shares represented by executed proxies by stockholders of record will be voted for the election of the
three&nbsp;nominees named below, unless the &#147;Against&#148; or &#147;Abstain&#148; voting selection has been marked on the proxy card. Neither abstentions nor broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have an effect on the
outcome of the vote. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If any nominee becomes unavailable for election as a result of an unexpected occurrence, shares that
would otherwise be voted for such nominee will be voted for the election of a substitute nominee proposed by the Nominating and Corporate Governance Committee and nominated by the board of directors. Each person nominated for election has agreed to
serve if elected. Our management has no reason to believe that any nominee will be unable to serve. If elected at the Annual Meeting, each of the nominees will serve until the earliest of the 2023 annual meeting of our stockholders, the election and
qualification of his or her successor or his or her death, resignation or removal. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following is a brief biography of each
nominee. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Karin Eastham </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Karin Eastham</I>, age 70, was appointed to serve as a member of our board of directors in September 2018. Ms.&nbsp;Eastham currently serves on the boards of directors of several life sciences
companies. Ms.&nbsp;Eastham has served on the board of directors of Geron Corporation since March 2009, Veracyte, Inc. since December 2012, and Personalis, Inc. since November 2019. Ms.&nbsp;Eastham served as a member of the board of directors of
Ilumina Inc. from August 2004 to May 2019, MorphoSys AG from May 2012 to May 2017, Amylin Pharmaceuticals, Inc. from September 2005 until its acquisition in August 2012, Genoptix, Inc. from July 2008 until its acquisition in March 2011, Tercica,
Inc. from December 2003 until its acquisition in October 2008, and Trius Therapeutics, Inc. from February 2007 until its acquisition in September 2013. From May 2004 to September 2008, Ms.&nbsp;Eastham served as Executive Vice President and Chief
Operating Officer, and as a member of the Board of Trustees, of the Burnham Institute for Medical Research (now Sanford Burnham Prebys Medical Discovery Institute), a <FONT STYLE="white-space:nowrap">non-profit</FONT> corporation engaged in
biomedical research. From April 1999 to May 2004, Ms.&nbsp;Eastham served as Senior Vice President, Chief Financial Officer and Secretary of Diversa Corporation, a biotechnology company. Ms.&nbsp;Eastham previously held similar positions with
CombiChem, Inc., a computational chemistry company, and Cytel Corporation, a biopharmaceutical company. Ms.&nbsp;Eastham also held several positions, including Vice President, Finance, at Boehringer Mannheim Diagnostics, from 1976 to 1988.
Ms.&nbsp;Eastham received a B.S. in Accounting and an M.B.A. from Indiana University and is a Certified Public Accountant. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Myriam J. Curet, M.D. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Myriam J. Curet, M.D., age 63,</I> was appointed to serve as a member of our board of directors in December 2019. Dr.&nbsp;Curet
currently serves as the Executive Vice President and Chief Medical Officer of Intuitive Surgical, Inc. Prior to being promoted as Executive Vice President and Chief Medical Officer in November 2017, Dr.&nbsp;Curet served as the Chief Medical Advisor
for Intuitive Surgical from December 2005 to February 2014 and as Intuitive Surgical&#146;s Senior Vice President and Chief Medical Officer from February 2014 to November 2017. Dr.&nbsp;Curet also has a faculty position as Professor of Surgery at
Stanford University School of Medicine. Since October 2010, she has served as a Consulting Professor of Surgery at Stanford University with a part time clinical appointment at the Palo Alto Veteran&#146;s Administration Medical Center. She was also
on the faculty at the University of New Mexico for six years prior to joining Stanford University in 2000. Dr.&nbsp;Curet received her M.D. from Harvard Medical School and completed her general surgery residency program at the University of Chicago
and her Surgical Endoscopy fellowship at the University of New Mexico. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Howard W. Robin </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Howard W. Robin, age 67, </I>has served as our President and Chief Executive Officer since January 2007 and has served as a member of
our board of directors since February 2007. Mr.&nbsp;Robin served as Chief Executive Officer, President and a director of Sirna Therapeutics, Inc., a biotechnology company, from July 2001 to November 2006 and from January 2001 to June 2001, served
as their Chief Operating Officer, President and as a director. From 1991 to 2001, Mr.&nbsp;Robin was Corporate Vice President and General Manager at Berlex Laboratories, Inc. (&#147;Berlex&#148;), a pharmaceutical products company that is a
subsidiary of Schering, AG, and from 1987 to 1991 he served as Vice President of Finance and Business Development and Chief Financial Officer. From 1984 to 1987, Mr.&nbsp;Robin was Director of Business Planning and Development at Berlex. He was a
Senior Associate with Arthur Andersen&nbsp;&amp; Co. prior to joining Berlex. He received his B.S. in Accounting and Finance from Fairleigh Dickinson University and serves as a member of its Board of Trustees.<I> </I> </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; THE ELECTION OF EACH NAMED NOMINEE. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_3"></A>PROPOSAL 2 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>APPROVAL OF AN AMENDMENT TO OUR AMENDED AND RESTATED 2017 PERFORMANCE INCENTIVE PLAN </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">At the Annual Meeting, our stockholders will be asked to approve an amendment to the Nektar Therapeutics Amended and
Restated 2017 Performance Incentive Plan (the &#147;2017 Plan&#148; and as amended, the &#147;A&amp;R 2017 Plan&#148;) to increase the authorized shares under the A&amp;R 2017 Plan by 10,000,000 shares.</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"> </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">The 2017 Plan was approved by our board of directors on March&nbsp;28,
2017, subject to stockholder approval which was received on June&nbsp;14, 2017, and was previously amended on June&nbsp;26, 2018. Our board of directors approved the A&amp;R 2017 Plan on March&nbsp;31, 2020, subject to stockholder approval at the
Annual Meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prior to the adoption of the 2017 Plan, the Company maintained the Nektar Therapeutics 2012 Plan, as amended
(the &#147;2012 Plan&#148;), the Nektar Therapeutics 2008 Equity Incentive Plan, as amended (the &#147;2008 Plan&#148;), the Nektar Therapeutics 2000 Equity Incentive Plan, as amended (the &#147;2000 Plan&#148;), and the Nektar therapeutics 2000 <FONT
STYLE="white-space:nowrap">Non-Officer</FONT> Equity Incentive Plan, as amended (the (&#147;2000 <FONT STYLE="white-space:nowrap">Non-Officer</FONT> Plan&#148;). The 2000 <FONT STYLE="white-space:nowrap">Non-Officer</FONT> Plan together with the
2012 Plan, the 2008 Plan and 2000 Plan, are referred to as the &#147;Prior Plans.&#148; Following stockholder approval of the 2017 Plan, no further awards were made under the Prior Plans. As of April&nbsp;1, 2020, 10,465,708 shares were subject to
outstanding stock options and restricted stock units granted under the 2017 Plan and 5,038,066 shares remained available for future grants. In addition, under the terms of the 2017 Plan, the reserve pool under the 2017 Plan may be increased by
shares subject to awards granted under the Prior Plans that were outstanding as of December&nbsp;31, 2017 in the event that such awards expire, or for any reason are cancelled or terminated, without being exercised. As of April&nbsp;1, 2020
7,219,813 shares remained subject to outstanding stock options and restricted stock units granted under the Prior Plans. If stockholders approve the amendment to the 2017 Plan, as of April&nbsp;1, 2020, the number of shares available for future
awards under the A&amp;R 2017 Plan will increase by 10,000,000 shares to 14,932,121 shares. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Additional Information on Outstanding Awards
and Available Shares under the 2017 Plan and the Prior Plans </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following provides additional information on the total
equity compensation awards outstanding and available shares. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8px">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="4" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Shares Outstanding and Available for Grant under the 2017 Plan and the Prior Plans</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>As&nbsp;of&nbsp;April&nbsp;1,&nbsp;2020</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total shares subject to outstanding stock options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,251,260</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total shares subject to outstanding deferred restricted stock, restricted
stock units, and performance restricted stock units</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,434.261</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Weighted-average exercise price of outstanding stock options under all
stock incentive plans</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25.35</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Weighted-average remaining term of outstanding stock options
(years)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.05</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total shares available for grant under all stock incentive plans but not
yet granted&nbsp;</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,038,066</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:2.00em; text-indent:-2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)&#8194;&#8201;&#8202;Excludes shares available for purchase under the ESPP (573,266)</FONT></P></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px">
<P STYLE="margin-left:0em; text-indent:0em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#8194;&#8201;&#8202;&nbsp;</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based solely on the closing price of our common stock as reported by the NASDAQ Global Select Market on
April&nbsp;1, 2020 and the maximum number of shares that would have been available for awards as of such date, taking into account the proposed increase described herein, the maximum aggregate market value of the common stock that could potentially
be issued under the A&amp;R 2017 Plan is $262,506,687. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Given the limited number of shares that currently remain available
under the 2017 Plan, our board of directors and management believe it is important that this amendment be approved in order to maintain the Company&#146;s ability to grant stock-based awards to retain employees and continue to provide them with
strong </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
incentives to contribute to the Company&#146;s future success. The Company believes that incentives and stock-based awards focus employees on the objective of creating stockholder value and
promoting the success of the Company, and that incentive compensation plans like the 2017 Plan are an important attraction, retention and motivation tool for participants in the plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">All members of the board of directors and all of the Company&#146;s executive officers will be eligible for awards under the A&amp;R 2017
Plan and thus have a personal interest in the approval of the amendment to the 2017 Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholders are requested in this
Proposal 2 to approve the amendment to the 2017 Plan. Approval of the amendment to the 2017 Plan requires the affirmative vote of a majority of the votes cast, in person during the live webcast or by proxy, and entitled to vote at the Annual
Meeting. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes,</FONT> to the extent applicable, are not included in the tabulation of the voting results and therefore will not have an effect on the outcome of the vote. If stockholders
do not approve this amendment, the 2017 Plan will continue in accordance with its current terms. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS
RECOMMENDS A VOTE IN FAVOR OF PROPOSAL 2. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The essential features of the 2017 Plan, as proposed to be amended, are
outlined below: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The principal terms of the A&amp;R 2017 Plan are summarized below. The following summary is qualified in its
entirety by the full text of the A&amp;R 2017 Plan, which appears as Exhibit A to this proxy statement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Summary of the A&amp;R 2017 Plan
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Purpose</I></B>. The purpose of the A&amp;R 2017 Plan is to promote the success of the Company and the interests of
our stockholders by providing an additional means for us to attract, motivate, retain and reward directors, officers, employees and other eligible persons through the grant of awards. Equity-based awards are also intended to further align the
interests of award recipients and our stockholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Administration</I></B><B>.</B> Our board of directors or one or
more committees appointed by our board of directors will administer the A&amp;R 2017 Plan. Our board of directors has delegated general administrative authority for the A&amp;R 2017 Plan to the organization and compensation committee of our board of
directors. The organization and compensation committee may delegate some or all of its authority with respect to the A&amp;R 2017 Plan to another committee of directors, and certain limited authority to grant awards to employees may be delegated to
one or more officers of the Company. (The appropriate acting body, be it the board of directors, a committee within its delegated authority, or an officer within his or her delegated authority, is referred to in this proposal as the
&#147;Administrator&#148;). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Administrator has broad authority under the A&amp;R 2017 Plan with respect to award grants
including, without limitation, the authority: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to select participants and determine the type(s) of award(s) that they are to receive; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to determine the number of shares that are to be subject to awards and the terms and conditions of awards, including the price (if any) to be paid for
the shares or the award; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to cancel, modify, or waive the Company&#146;s rights with respect to, or modify, discontinue, suspend, or terminate any or all outstanding awards,
subject to any required consents; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to accelerate or extend the vesting or exercisability or extend the term of any or all outstanding awards; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">subject to the other provisions of the A&amp;R 2017 Plan, to make certain adjustments to an outstanding award and to authorize the termination,
conversion, succession or substitution of an award; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to allow the purchase price of an award or shares of the Company&#146;s common stock to be paid in the form of cash, check, or electronic funds
transfer, by the delivery of already-owned shares of the </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2">
Company&#146;s common stock or by a reduction of the number of shares deliverable pursuant to the award, by services rendered by the recipient of the award, by notice and third party payment or
cashless exercise on such terms as the Administrator may authorize, or any other form permitted by law. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>No Repricing.</I></B> In no case (except due to an adjustment to reflect a stock split or other events referred to under
&#147;Adjustments&#148; below, or any repricing that may be approved by stockholders) will the Administrator (1)&nbsp;amend an outstanding stock option or stock appreciation right to reduce the exercise price or base price of the award,
(2)&nbsp;cancel, exchange, or surrender an outstanding stock option or stock appreciation right in exchange for cash or other awards for the purpose of repricing the award, or (3)&nbsp;cancel, exchange, or surrender an outstanding stock option or
stock appreciation right in exchange for an option or stock appreciation right with an exercise or base price that is less than the exercise or base price of the original award. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Eligibility.</I></B> Persons eligible to receive awards under the A&amp;R 2017 Plan include officers or employees of the Company or
any of its subsidiaries, directors of the Company or any of its subsidiaries, and certain consultants and advisors to the Company or any of its subsidiaries. As of April&nbsp;1, 2020, approximately 652 employees (including executive officers) and
seven <FONT STYLE="white-space:nowrap">non-employee</FONT> directors would be eligible to participate in the 2017 Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Authorized Shares; Limits on Awards</I></B><B>.</B> Subject to the adjustment provisions included in the 2017 Plan, the maximum
number of shares of the Company&#146;s common stock initially available for issuance pursuant to awards under the 2017 Plan equaled 8,300,000 shares of the Company&#146;s common stock (reduced by the number of shares of common stock subject to
awards granted under the 2012 Plan on or after March&nbsp;31, 2017 and prior to the adoption of the 2017 Plan), which was increased to 19,200,000 by stockholder approval in June 2018. The proposed amendment to the 2017 Plan would increase the
available shares to 29,200,000 Shares issued in respect of any &#147;full-value award&#148; granted under the A&amp;R 2017 Plan will be counted against the share limit described in the preceding sentence as 1.50 shares for every one share actually
issued in connection with the award. For example, if the Company granted 100 restricted stock units under the A&amp;R 2017 Plan, 150 shares would be charged against the share limit with respect to that award. For this purpose, a &#147;full-value
award&#148; generally means any award granted under the plan other than a stock option or stock appreciation right. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
following other limits are also contained in the A&amp;R 2017 Plan: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The maximum number of shares that may be delivered pursuant to options qualified as incentive stock options granted under the plan is 29,200,000.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The maximum number of shares subject to options and stock appreciation rights that are granted during any calendar year to any individual under the
plan is 3,000,000<B> </B>shares. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;Performance-based awards&#148; under Section&nbsp;5.2 of the A&amp;R 2017 Plan granted to a participant in any one calendar year will not provide
for payment of more than (1)&nbsp;in the case of awards payable only in cash and not related to shares, $5,000,000, and (2)&nbsp;in the case of awards related to shares (and in addition to options and stock appreciation rights which are subject to
the limit referred to above), 3,000,000 shares. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The aggregate value of cash compensation and the grant date fair value (computed in accordance with generally accepted accounting principles) of shares
of common stock that may be paid or granted during any calendar year to any <FONT STYLE="white-space:nowrap">non-employee</FONT> director shall not exceed $1,200,000 for existing <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and
$2,200,000 for new <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Except as described in
the next sentence, shares that are subject to or underlie awards which expire or for any reason are cancelled or terminated, are forfeited, fail to vest, or for any other reason are not paid or delivered under the A&amp;R 2017 Plan or the Prior
Plans will again be available for subsequent awards under the A&amp;R 2017 Plan (with any such shares subject to full-value awards increasing the A&amp;R 2017 Plan&#146;s share limit based on the full-value award ratio described above or, in the
case of an award granted under a Prior Plan, the full-value award ratio set forth in such Prior Plan). Shares that are exchanged by a participant or withheld by the Company to pay </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
the exercise price of an award granted under the A&amp;R 2017 Plan, as well as any shares exchanged or withheld to satisfy the tax withholding obligations related to any award, will not be
available for subsequent awards under the A&amp;R 2017 Plan. To the extent that an award granted under the A&amp;R 2017 Plan or a Prior Plan is settled in cash or a form other than shares, the shares that would have been delivered had there been no
such cash or other settlement will again be available for subsequent awards under the A&amp;R 2017 Plan (with any such shares subject to full-value awards increasing the A&amp;R 2017 Plan&#146;s share limit based on the full-value award ratio
described above or, in the case of an award granted under a Prior Plan, the full-value award ratio set forth in such Prior Plan). In the event that shares are delivered in respect of a dividend equivalent right, the actual number of shares delivered
with respect to the award shall be counted against the share limits of the A&amp;R 2017 Plan. (For purposes of clarity, if 1,000 dividend equivalent rights are granted and outstanding when the Company pays a dividend, and 50 shares are delivered in
payment of those rights with respect to that dividend, 75 shares (after adjustment for the full-value award share counting ratio described above) shall be counted against the share limits of the plan.) To the extent that shares are delivered
pursuant to the exercise of a stock appreciation right or stock option, the number of underlying shares as to which the exercise related shall be counted against the applicable share limits, as opposed to only counting the shares issued. (For
purposes of clarity, if a stock appreciation right relates to 100,000 shares and is exercised at a time when the payment due to the participant is 15,000 shares, 100,000 shares shall be charged against the applicable share limits with respect to
such exercise.) In addition, the A&amp;R 2017 Plan generally provides that shares issued in connection with awards that are granted by or become obligations of the Company through the assumption of awards (or in substitution for awards) in
connection with an acquisition of another company will not count against the shares available for issuance under the A&amp;R 2017 Plan. The Company may not increase the applicable share limits of the A&amp;R 2017 Plan by repurchasing shares of
common stock on the market (by using cash received through the exercise of stock options or otherwise). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Types of
Awards</I></B><B>.</B> The A&amp;R 2017 Plan authorizes stock options, stock appreciation rights, stock bonuses, restricted stock, performance stock, stock units, phantom stock or similar rights to purchase or acquire shares, whether at a fixed or
variable price or ratio related to the common stock, upon the passage of time, the occurrence of one or more events or the satisfaction of performance criteria or other conditions, awards of any similar securities with a value derived from the value
of or related to the common stock and/or returns thereon, or cash awards. The A&amp;R 2017 Plan retains flexibility to offer competitive incentives and to tailor benefits to specific needs and circumstances. Awards granted under the A&amp;R 2017
Plan will be subject to such terms and conditions as established by the Administrator and set forth in the underlying award agreement, including terms relating to the treatment of an award upon a termination of employment. Any award may be paid or
settled in cash. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A stock option is the right to purchase shares of the Company&#146;s common stock at a future date at a
specified price per share (the &#147;exercise price&#148;). The per share exercise price of an option may not be less than the fair market value of a share of the Company&#146;s common stock on the date of grant. The maximum term of an option is
eight years from the date of grant. An option may either be an incentive stock option or a nonqualified stock option. Incentive stock option benefits are taxed differently from nonqualified stock options, as described under &#147;Federal Income Tax
Consequences of Awards Under the A&amp;R 2017 Plan&#148; below. Incentive stock options are also subject to more restrictive terms and are limited in amount by the U.S. Internal Revenue Code of 1986, as amended (the &#147;Code&#148;) and the A&amp;R
2017 Plan. Incentive stock options may only be granted to employees of the Company or a subsidiary. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A stock appreciation
right is the right to receive payment of an amount equal to the excess of the fair market value of share of the Company&#146;s common stock on the date of exercise of the stock appreciation right over the base price of the stock appreciation right.
The base price will be established by the Administrator at the time of grant of the stock appreciation right and may not be less than the fair market value of a share of the Company&#146;s common stock on the date of grant. Stock appreciation rights
may be granted in connection with other awards or independently. The maximum term of a stock appreciation right is eight years from the date of grant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Performance-Based Awards</I></B><B>.</B> The Administrator may grant performance-based awards under the A&amp;R 2017 Plan.&nbsp;&nbsp;&nbsp;&nbsp;Performance-based awards are in addition to any of
the other types of awards that may be granted under </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
the A&amp;R 2017 Plan. Performance-based awards may be in the form of restricted stock, performance stock, stock units, other rights, or cash bonus opportunities. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The vesting or payment of performance-based awards may depend on the absolute or relative performance of the Company on a consolidated,
subsidiary, segment, division, or business unit basis. The Administrator will establish the criterion or criteria and target(s) on which performance will be measured.&nbsp;&nbsp;&nbsp;&nbsp;The criteria that the Administrator may use for this
purpose may include, without limitation, any one or more of the following: earnings per share; cash flow (which means cash and cash equivalents derived from either net cash flow from operations or net cash flow from operations, financing and
investing activities); working capital; stock price; total stockholder return; revenue; gross profit; operating income; net earnings (before or after interest, taxes, depreciation and/or amortization); gross margin; operating margin; net margin;
return on equity or on assets or on net investment; cost containment or reduction; regulatory submissions or approvals; manufacturing production; completion of strategic partnerships; research milestones; any other measure selected by the
Administrator or any combination thereof.&nbsp;&nbsp;&nbsp;&nbsp;As applicable, these terms are used as applied under generally accepted accounting principles or in the financial reporting of the Company or of its subsidiaries. The applicable
performance goals may be applied on a <FONT STYLE="white-space:nowrap">pre-</FONT> or <FONT STYLE="white-space:nowrap">post-tax</FONT> basis and may be adjusted to include or exclude determinable components of any performance goal, including,
without limitation, foreign exchange gains and losses, asset write-downs, acquisitions and divestitures, change in fiscal year, unbudgeted capital expenditures, special charges such as restructuring or impairment charges, debt refinancing costs,
extraordinary or noncash items, unusual, infrequently occurring, nonrecurring or <FONT STYLE="white-space:nowrap">one-time</FONT> events affecting the Company or its financial statements or changes in law or accounting principles. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The performance measurement period with respect to an award may range from three months to ten years. Performance-based awards may be
paid in stock or in cash (in either case, subject to the limits described under the heading &#147;Authorized Shares; Limits on Awards&#148; above). The Administrator has discretion to determine the performance target or targets and any other
restrictions or other limitations of performance-based awards and may reserve discretion to reduce payments below maximum award limits. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Dividend Equivalents; Deferrals</I></B><B>.</B>&nbsp;The Administrator may provide for the deferred payment of awards, and may determine the other terms applicable to deferrals.&nbsp;The
Administrator may provide that awards under the A&amp;R 2017 Plan (other than options or stock appreciation rights), and/or deferrals, earn dividends or dividend equivalents based on the amount of dividends paid on outstanding shares of common
stock, provided that as to any dividends or dividend equivalent rights granted in connection with an award granted under the A&amp;R 2017 Plan that is subject to vesting requirements, no dividends or dividend equivalent payments will be made unless
the related vesting conditions of the award are satisfied. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Award Agreements. </I></B>Each award shall be evidenced by
either (1)&nbsp;a written award agreement in a form approved by the Administrator and executed by the Company by an officer duly authorized to act on its behalf, or (2)&nbsp;an electronic notice of award grant in a form approved by the
Administrator. The award agreement shall set forth the material terms and conditions of the award as established by the Administrator consistent with the express limitations of the A&amp;R 2017 Plan. Notwithstanding anything in the A&amp;R 2017 Plan
to the contrary, the Administrator may approve an award agreement that, upon the termination of a participant&#146;s employment or service, provides that, or may, in its sole discretion based on a review of all relevant facts and circumstances,
otherwise take action regarding an award agreement such that (i)&nbsp;any or all outstanding stock options and stock appreciation rights will become exercisable in part or in full, (ii)&nbsp;all or a portion of the restriction or vesting period
applicable to any outstanding award will lapse, (iii)&nbsp;all or a portion of the performance measurement period applicable to any outstanding award will lapse and (iv)&nbsp;the performance goals applicable to any outstanding award (if any) will be
deemed to be satisfied at the target, maximum or any other interim level. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Assumption and Termination of
Awards</I></B><B>.</B> Generally, and subject to limited exceptions set forth in the A&amp;R 2017 Plan, upon the occurrence of a &#147;change in control,&#148; as defined in the A&amp;R 2017 Plan, the Administrator may provide for the cash payment
in settlement of, or for the termination, assumption, substitution or exchange </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
of any or all outstanding awards granted under the A&amp;R 2017 Plan. To the extent the administrator does not provide for the assumption, substitution or other continuation of the awards, then
all awards then-outstanding under the A&amp;R 2017 Plan will become fully vested or paid, as applicable, and will terminate or be terminated in such circumstances, provided that the holder of a stock option or stock appreciation right would be given
reasonable advance (but no more than ten days&#146;) notice of the impending termination and a reasonable opportunity to exercise his or her vested stock option or stock appreciation right (after giving effect to any accelerated vesting required in
the circumstances) in accordance with their terms before the termination of such awards. The Administrator also has the discretion to establish other change in control provisions with respect to awards granted under the A&amp;R 2017 Plan. For
example, the Administrator could provide for the acceleration of vesting or payment of an award in connection with a change in control and provide that any such acceleration shall be automatic upon the occurrence of any such event, including a
termination of employment within a limited period of time following a corporate transaction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Transfer
Restrictions</I></B><B>.</B> Subject to certain exceptions contained in the A&amp;R 2017 Plan, awards under the A&amp;R 2017 Plan generally are not transferable by the recipient other than by will or the laws of descent and distribution and are
generally exercisable, during the recipient&#146;s lifetime, only by the recipient. Any amounts payable or shares issuable pursuant to an award generally will be paid only to the recipient or the recipient&#146;s beneficiary or representative. The
Administrator has discretion, however, to establish written conditions and procedures for the transfer of awards to other persons or entities, provided that such transfers comply with applicable federal and state securities laws and are not made for
value (other than nominal consideration, settlement of marital property rights, or for interests in an entity in which more than 50% of the voting securities are held by the award recipient or by the recipient&#146;s family members). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Adjustments</I></B><B>.</B> As is customary in incentive plans of this nature, each share limit and the number and kind of shares
available under the A&amp;R 2017 Plan and any outstanding awards, as well as the exercise or purchase prices of awards, and performance targets under certain types of performance-based awards, are subject to adjustment in the event of certain
reorganizations, mergers, combinations, recapitalizations, stock splits, stock dividends, or other similar events that change the number or kind of shares outstanding, and extraordinary dividends or distributions of property to the stockholders.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>No Limit on Other Authority</I></B><B>.</B> The A&amp;R 2017 Plan does not limit the authority of the board of
directors or any committee to grant awards or authorize any other compensation, with or without reference to the Company&#146;s common stock, under any other plan or authority. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Termination of or Changes to the A&amp;R 2017 Plan</I></B><B>.</B> The board of directors may amend or terminate the A&amp;R 2017
Plan at any time and in any manner. Stockholder approval for an amendment will be required only to the extent then required by applicable law or any applicable listing agency or required under Sections 422 or 424 of the Code to preserve the intended
tax consequences of the plan. Unless terminated earlier by the board of directors, the authority to grant new awards under the 2017 Plan will terminate on March&nbsp;27, 2027. Outstanding awards, as well as the Administrator&#146;s authority with
respect thereto, generally will continue following the expiration or termination of the plan. Generally speaking, outstanding awards may be amended by the Administrator (except for a repricing), but the consent of the award holder is required if the
amendment (or any plan amendment) materially and adversely affects the holder. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Clawback Policy. </I></B>The awards
under the A&amp;R 2017 Plan are subject to the terms of the Company&#146;s clawback policy as it may be in effect from time to time. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Federal Income Tax Consequences of Awards under the A&amp;R 2017 Plan </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The U.S. federal income tax consequences of the A&amp;R 2017 Plan under current federal law, which is subject to change, are summarized in the following discussion of the general tax principles applicable
to the A&amp;R 2017 Plan. This summary is not intended to be exhaustive and, among other considerations, does not </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
describe the deferred compensation provisions of Section&nbsp;409A of the Code to the extent an award is subject to and does not satisfy those rules, nor does it describe state, local, or
international tax consequences. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">With respect to nonqualified stock options, the Company is generally entitled to deduct,
except to the extent limited by Section&nbsp;162(m) of the Code, and the participant recognizes taxable income in an amount equal to the difference between the option exercise price and the fair market value of the shares at the time of exercise.
With respect to incentive stock options, the Company is generally not entitled to a deduction nor does the participant recognize income at the time of exercise, although if the participant is subject to the U.S. federal alternative minimum tax, the
difference between the option exercise price and the fair market value of the shares at the time of exercise is includible for purposes of such alternative minimum tax. If the shares acquired by exercise of an incentive stock option are held for at
least two years from the date the option was granted and one year from the date it was exercised, any gain or loss arising from a subsequent disposition of those shares will be taxed as long-term capital gain or loss, and the Company will not be
entitled to any deduction. If, however, such shares are disposed of within the above-described period, then in the year of that disposition the participant will recognize compensation taxable as ordinary income equal to the excess of the lesser of
(i)&nbsp;the amount realized upon that disposition and (ii)&nbsp;the excess of the fair market value of those shares on the date of exercise over the purchase price, and the Company will be entitled to a corresponding deduction, except to the extent
limited by Section&nbsp;162(m) of the Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The current federal income tax consequences of other awards authorized under the
A&amp;R 2017 Plan generally follow certain basic patterns: nontransferable restricted stock subject to a substantial risk of forfeiture results in income recognition equal to the excess of the fair market value over the price paid (if any) only at
the time the restrictions constituting a substantial risk of forfeiture lapse (unless the recipient elects to accelerate recognition as of the date of grant); bonuses, restricted stock units, stock appreciation rights, cash and stock-based
performance awards, dividend equivalents, stock units, and other types of awards are generally subject to tax at the time of payment; and compensation otherwise effectively deferred is taxed when paid. In each of the foregoing cases, the Company
will generally have a corresponding deduction at the time the participant recognizes income, except to the extent limited by Section&nbsp;162(m) of the Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If an award is accelerated under the A&amp;R 2017 Plan in connection with a &#147;change in control&#148; (as defined in the A&amp;R 2017 Plan), the Company may not be permitted to deduct the portion of
the compensation attributable to the acceleration (&#147;parachute payments&#148;) if it exceeds certain threshold limits under Section&nbsp;280G of the Code (and certain related excise taxes may be triggered). Furthermore, Section&nbsp;162(m) of
the Code limits to $1&nbsp;million the amount that a publicly held corporation is allowed each year to deduct for compensation paid to the corporation&#146;s &#147;covered employees.&#148; &#147;Covered employees&#148; include the corporation&#146;s
chief executive officer, chief financial officer and three next most highly compensated executive officers. If an individual is determined to be a covered employee for any year beginning after December&nbsp;31, 2016, then that individual will
continue to be a covered employee for future years, regardless of changes in the individual&#146;s compensation or position. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">16 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>New Plan Benefits </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company has not approved any awards that are conditioned upon stockholder approval of the amendment to the 2017 Plan. The Administrator has the discretion to grant awards under the A&amp;R 2017 Plan
and, therefore, it is not possible as of the date of this proxy statement to determine future awards that will be received by the Company&#146;s named executive officers or others under the A&amp;R 2017 Plan. Accordingly, in lieu of providing
information regarding benefits that will be received under the A&amp;R Plan, the following table provides information concerning the benefits that were received by the following persons and groups during 2019: each named executive officer; all
current executive officers, as a group; all current directors who are not executive officers, as a group; and all current employees who are not executive officers, as a group. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8px">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="8" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="8" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Position</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Options</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Restricted Stock Units</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="4" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Shares</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(#)</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Average<BR>Exercise<BR>Price</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Units</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(#)</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Dollar
Value<BR>($)<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Chief Executive Officer</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">379,900</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21.79</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">188,200</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,100,859</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President, Chief Operating Officer and Chief Financial Officer</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">322,100</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20.23</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">155,300</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,131,971</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Northcott</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President and Chief Commerical Officer</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">200,000</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19.48</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">200,000</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,895,980</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jillian B Thomsen</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President and Chief Accounting Officer</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65,000</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21.79</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">29,800</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">649,339</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jonathan Zalevsky, Ph.D.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Research and Development Officer</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">313,200</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20.18</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">155,300</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,131,971</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">All executive officers (5 persons)</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,280,200</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20.64</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">728,600</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,910,121</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;
</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">All <FONT STYLE="white-space:nowrap">non-executive</FONT> directors (7 persons other than
Mr.&nbsp;Robin)</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">101,400</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19.49</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,700</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">988,138</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;
</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">All employees (other than current executive officers) (approximately 647
persons)*</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">460,193</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25.78</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,409,497</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">58,960,820</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;
</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">As of April&nbsp;1, 2020 </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">The valuation of stock awards is based on the grant date fair value computed in accordance with FASB ASC Topic 718. For a discussion of the
assumptions used in calculating these values, see Note&nbsp;11 to our consolidated financial statements in our annual report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the fiscal year ended December&nbsp;31, 2019.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents the weighted average exercise price for the group. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents the aggregate grant date fair value for the group. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">17 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Equity Compensation Plan Information </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table presents aggregate summary information as of December&nbsp;31, 2019, regarding the common stock that may be issued
upon the exercise of options and rights under all of our existing equity compensation plans: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000 ; display:table-cell;"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Plan Category</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of
Securities<BR>to&nbsp;be&nbsp;Issued&nbsp;Upon<BR>Exercise&nbsp;of&nbsp;Outstanding</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Options &amp; Vesting
of<BR>RSUs</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B><FONT STYLE="white-space:nowrap">Weighted-Average</FONT></B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise Price</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>of Outstanding</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Options</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;
Securities</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Remaining&nbsp;Available&nbsp;for</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Issuance&nbsp;Under Equity</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Compensation&nbsp;Plans</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Excluding Securities</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Reflected in
Column(a)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity compensation plans approved by security holders</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,809</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25.24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,145</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity compensation plans not approved by security holders</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,817</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25.23</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,145</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE IN FAVOR OF PROPOSAL 2 FOR APPROVAL OF THE AMENDMENT TO OUR
AMENDED AND RESTATED 2017 PERFORMANCE INCENTIVE PLAN AS DESCRIBED ABOVE AND SET FORTH IN EXHIBIT A HERETO. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">18 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_4"></A>PROPOSAL 3 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>APPROVAL OF AN AMENDMENT AND RESTATEMENT OF OUR AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In February 1994, our board of directors adopted, and our stockholders subsequently approved, our Amended and Restated Employee Stock
Purchase Plan (the &#147;Purchase Plan&#148;).&nbsp;The Purchase Plan was amended and restated in May 2002, and an amended and restated version of the Purchase Plan was approved by our stockholders in June 2002. In June 2014, an amended and restated
version of the Purchase Plan was approved by our stockholders. On March&nbsp;31, 2020, subject to stockholder approval, our board of directors amended the Purchase Plan to increase the number of shares of common stock available for issuance under
the Purchase Plan&nbsp;by an additional 1,000,000 shares. Our board of directors adopted this amendment in order to ensure that a sufficient reserve of shares of common stock remains available for the grant of purchase rights under the Purchase Plan
at levels determined appropriate by the board of directors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Currently, 2,500,000 shares of common stock are authorized for
issuance under the Purchase Plan.&nbsp;As of April&nbsp;1, 2020, 573,266 shares of common stock remain available for future grant under the Purchase Plan.&nbsp;If stockholders approve the amendment and restatement to the Purchase Plan, the maximum
number of shares authorized for issuance under the Purchase Plan will increase from 2,500,000 shares to 3,500,000 shares.&nbsp;If approved, the additional 1,000,000 shares would bring the total number of shares currently available for grant under
the Purchase Plan to 1,573,266 shares.&nbsp;&nbsp;&nbsp;&nbsp; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The additional shares that are proposed to be reserved under
the amended and restated Purchase Plan have an aggregate value of $175,800,000, based on the April&nbsp;1, 2020 closing price of our common stock, as reported on the NASDAQ Global Select Market, of $17.58 per share. We believe that the proposed
share reserve increase to the Purchase Plan is reasonable, appropriate, and in the best interest of our stockholders. Stockholders are requested in this Proposal 3 to approve the amendment and restatement to the Purchase Plan. The affirmative vote
of the holders of a majority of the shares present during the live webcast or represented by proxy at the Annual Meeting and cast on this proposal will be required to approve the amendment and restatement to the Purchase Plan. Abstentions and broker
<FONT STYLE="white-space:nowrap">non-votes,</FONT> to the extent applicable, are not included in the tabulation of the voting results and therefore will not have an effect on the outcome of the vote. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE IN FAVOR OF PROPOSAL 3. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The essential features of the Purchase Plan, as amended and restated (the &#147;A&amp;R Purchase Plan&#148;), are outlined below:
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Summary of the A&amp;R Purchase Plan </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The principal terms of the Purchase Plan, as proposed to be amended and restated, are summarized below. The following summary is qualified in its entirety by the full text of the A&amp;R Purchase Plan,
which appears as Exhibit B to this proxy statement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Purpose. </I></B>The purpose of the A&amp;R Purchase Plan is
(i)&nbsp;to provide a means by which our employees (and employees of any of our subsidiaries designated by the board of directors to participate in the A&amp;R Purchase Plan) may be given an opportunity to purchase our common stock through payroll
deductions, (ii)&nbsp;to assist us in retaining the services of our employees and secure and retain the services of new employees, and (iii)&nbsp;to provide incentives for such persons to exert maximum efforts for our success. All of our employees
are eligible to participate in the A&amp;R Purchase Plan provided that they satisfy the eligibility requirements described below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The rights to purchase common stock granted under the A&amp;R Purchase Plan are intended to qualify as options issued under an &#147;employee stock purchase plan&#148; as that term is defined in
Section&nbsp;423(b) of the Code. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">19 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Administration</I></B>. The board of directors will administer the A&amp;R
Purchase Plan and has the final power to construe and interpret both the A&amp;R Purchase Plan and the rights granted under it. The board of directors has the power, subject to the provisions of the A&amp;R Purchase Plan, to determine when and how
rights to purchase common stock will be granted, the provisions of each offering of such rights (which need not be identical), and whether employees of any of our subsidiaries will be eligible to participate in the A&amp;R Purchase Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The board of directors has the power, which it has not yet exercised, to delegate administration of the A&amp;R Purchase Plan to a
committee composed of not fewer than two members of the board of directors. As used herein with respect to the A&amp;R Purchase Plan, the &#147;board of directors&#148; refers to any committee the board of directors appoints and to the board of
directors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Stock Subject to Purchase Plan</I></B>. Currently, a maximum of 2,500,000 shares of common stock are
authorized for issuance under the Purchase Plan.&nbsp;If stockholders approve the amendment and restatement to the Purchase Plan, the maximum number of shares authorized for issuance under the A&amp;R Purchase Plan will increase from 2,500,000
shares to 3,500,000 shares (an increase of 1,000,000 shares). If rights granted under the A&amp;R Purchase Plan expire, lapse or otherwise terminate without being exercised, the shares of common stock not purchased under such rights again become
available for issuance under the A&amp;R Purchase Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Offerings</I></B>. The A&amp;R Purchase Plan is implemented by
offerings of rights to all eligible employees from time to time by the board of directors. The maximum length for an offering under the A&amp;R Purchase Plan is twenty-seven months. Currently, under the Purchase Plan, each offering is twenty-four
months long and is divided into four shorter &#147;purchase periods&#148; approximately six months long. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Eligibility</I></B>. Unless otherwise determined by the board of directors in accordance with the terms of the A&amp;R Purchase
Plan, any person who is customarily employed at least twenty hours per week and five months per calendar year by us (or by any of our parent or subsidiary designated by the board of directors) on the first day of an offering is eligible to
participate in that offering, provided that such employee has been continuously employed by us or the designated parent or subsidiary corporation for at least six months preceding the first day of the offering. Officers who are &#147;highly
compensated&#148; as defined in the Code may be eligible to participate in the A&amp;R Purchase Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">However, no employee is
eligible to participate in the A&amp;R Purchase Plan if, immediately after the grant of purchase rights, the employee would own, directly or indirectly, stock possessing 5% or more of the total combined voting power or value of all classes of our
stock or of any parent or subsidiary (including any stock which such employee may purchase under all outstanding rights and options). In addition, no employee may purchase more than $25,000 worth of common stock (determined at the fair market value
of the shares at the time such rights are granted) under all of our employee stock purchase plans and the employee stock purchase plans of any of our parent or subsidiary corporations in any calendar year. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of April&nbsp;1, 2020, approximately 652 individuals employed by the Company and participating subsidiaries are eligible to
participate in the Purchase Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Participation</I></B>. Eligible employees enroll in the A&amp;R Purchase Plan by
delivering to us, prior to the date selected by the board of directors for the offering, an agreement authorizing payroll deductions of up to 15% of such employees&#146; total compensation during the offering. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Purchase Price</I></B>. The purchase price per share at which shares of common stock are sold in an offering under the A&amp;R
Purchase Plan is no less than the lower of (i) 85% of the fair market value of a share of common stock on first day of the offering or (ii) 85% of the fair market value of a share of common stock on the applicable purchase dates. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Payment of Purchase Price; Payroll Deductions</I></B>. The purchase price of the shares is accumulated by payroll deductions over
the offering. At any time during the offering, a participant may reduce or terminate his or </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
her payroll deductions as the board of directors provides in the offering. A participant may increase or decrease such payroll deductions after the beginning of the offering as the board of
directors provides in the offering. Further, in the case of an employee who first becomes eligible to participate as of a date specified during the offering, such employee may make payroll deductions after the beginning of the offering. All payroll
deductions made for a participant are credited to his or her account under the A&amp;R Purchase Plan and deposited with our general funds. A participant may not currently make additional payments into such account. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Purchase of Stock</I></B>. Upon execution of an agreement to participate in the A&amp;R Purchase Plan by an employee, shares of
common stock are automatically purchased on the employee&#146;s behalf under the A&amp;R Purchase Plan. In connection with offerings made under the A&amp;R Purchase Plan, the board of directors specifies a maximum number of shares of common stock an
employee may be granted the right to purchase and the maximum aggregate number of shares of common stock that may be purchased pursuant to such offering by all participants. If the aggregate number of shares to be purchased upon exercise of rights
granted in the offering would exceed the maximum aggregate number of shares of common stock available, the board of directors would make a pro rata allocation of available shares in a uniform and equitable manner. Unless the employee&#146;s
participation is discontinued, his or her right to purchase shares is exercised automatically at the end of the offering at the applicable price. See &#147;Withdrawal&#148; below. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Withdrawal</I></B>. While each participant in the A&amp;R Purchase Plan is required to sign an agreement authorizing payroll
deductions, the participant may withdraw from a given offering by terminating his or her payroll deductions and by delivering to us a notice of withdrawal from the A&amp;R Purchase Plan. Such withdrawal may be elected at any time prior to the end of
the applicable offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Upon any withdrawal from an offering by the employee, we will distribute to the employee his or her
accumulated payroll deductions without interest, less any accumulated deductions previously applied to the purchase of shares of common stock on the employee&#146;s behalf during such offering, and such employee&#146;s interest in the offering will
be automatically terminated. The employee is not entitled to again participate in that offering. However, an employee&#146;s withdrawal from an offering will not have any effect upon such employee&#146;s eligibility to participate in subsequent
offerings under the A&amp;R Purchase Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Termination of Employment</I></B>. Rights granted pursuant to any offering
under the A&amp;R Purchase Plan terminate immediately upon cessation of an employee&#146;s employment for any reason, and we will distribute to such employee all of his or her accumulated payroll deductions, without interest. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Restrictions on Transfer</I></B>. Rights granted under the A&amp;R Purchase Plan are not transferable, other than by will or the
laws of descent and distribution or by a beneficiary designation by the employee in the event of the employee&#146;s death, and may be exercised only by the person to whom such rights are granted. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Adjustment</I></B>. In the event of any change in the shares of common stock subject to the A&amp;R Purchase Plan or subject to any
purchase right thereunder through a transaction not involving receipt of consideration by us, such as a merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, stock split,
liquidating dividend, combination of shares, exchange of shares, or change in corporate structure, the A&amp;R Purchase Plan will be appropriately adjusted in the type(s), class(es) and maximum number of shares subject to the A&amp;R Purchase Plan
and the outstanding purchase rights granted under the A&amp;R Purchase Plan will be appropriately adjusted in the type(s), class(es), number of shares and purchase limits of such purchase rights. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Effect of Certain Corporate Transactions</I></B>. In the event of a &#147;corporate transaction,&#148; as defined in the A&amp;R
Purchase Plan, any surviving or acquiring corporation may continue&nbsp;or assume rights outstanding under the A&amp;R Purchase Plan or may substitute similar rights. If any surviving or acquiring corporation does not continue or assume such rights
or substitute similar rights, then the participants&#146; accumulated payroll deductions will be used to purchase shares of common stock within ten days prior to the corporate transaction under the ongoing offering and the participants&#146; rights
under the ongoing offering will terminate immediately after such purchase. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">21 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Duration, Amendment, and Termination</I></B>. The board of directors may suspend
or terminate the A&amp;R Purchase Plan at any time. Unless terminated earlier, the A&amp;R Purchase Plan will terminate at the time that all of the shares of common stock reserved for issuance under the A&amp;R Purchase Plan, as increased and/or
adjusted from time to time, have been issued under the terms of the A&amp;R Purchase Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The board of directors may amend
the A&amp;R Purchase Plan at any time. Any amendment of the A&amp;R Purchase Plan must be approved by the stockholders if the amendment is necessary for the A&amp;R Purchase Plan to satisfy Section&nbsp;423 of the Code or other applicable laws and
regulations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rights granted before amendment or termination of the A&amp;R Purchase Plan will not be altered or impaired by
any amendment or termination of the A&amp;R Purchase Plan without consent of the employee to whom such rights were granted. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>New Plan
Benefits. </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">No purchase rights have been granted, and no shares have been issued, on the basis of the 1,000,000 share
increase, which is the subject of this proposal. Because benefits under the A&amp;R Purchase Plan will depend on employees&#146; elections to participate and the fair market value of our common stock at various future dates, it is not possible to
determine the benefits that will be received by executive officers and other employees if the A&amp;R Purchase Plan is approved by the stockholders. <FONT STYLE="white-space:nowrap">Non-employee</FONT> directors are not eligible to participate in
the A&amp;R Plan.</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Federal Income Tax Information</B> Following is a general summary of the current federal income tax
principles applicable to the A&amp;R Purchase Plan. The following summary is not intended to be exhaustive and does not describe state, local or international tax consequences. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The A&amp;R Purchase Plan is intended to qualify as an &#147;employee stock purchase plan&#148; under Section&nbsp;423 of the Code.
Participant contributions to the A&amp;R Purchase Plan are made on an <FONT STYLE="white-space:nowrap">after-tax</FONT> basis. That is, a participant&#146;s A&amp;R Purchase Plan contributions are deducted from compensation that is taxable to the
participant and for which the Company is generally entitled to a tax deduction. Generally, no taxable income is recognized by a participant with respect to either the grant or exercise of his or her A&amp;R Purchase Plan option. The Company will
have no tax deduction with respect to either of those events. A participant will generally recognize income (or loss) only upon a sale or disposition of any shares that the participant acquires under the A&amp;R Purchase Plan. The particular tax
consequences of a sale of shares acquired under the A&amp;R Purchase Plan depends on whether the participant has held the shares for a &#147;Required Holding Period&#148; before selling or disposing of the shares. The Required Holding Period starts
on the date that the participant acquires the shares under the A&amp;R Purchase Plan and ends on the later of (1)&nbsp;two years after the grant date of the offering period in which the participant acquired the shares, or (2)&nbsp;one year after the
exercise date on which the participant acquired the shares. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the participant holds the shares for the Required Holding
Period and then sells the shares at a price in excess of the purchase price paid for the shares, the gain on the sale of the shares will be taxed as ordinary income to the participant to the extent of the lesser of (1)&nbsp;the amount by which the
fair market value of the shares on the grant date of the offering period in which the participant acquired the shares exceeded the purchase price of the shares (calculated as though the shares had been purchased on the grant date), or (2)&nbsp;the
gain on the sale of the shares. Any portion of the participant&#146;s gain on the sale of the shares not taxed as ordinary income will be taxed as long-term capital gain. If the participant holds the shares for the Required Holding Period and then
sells the shares at a price less than the purchase price paid for the shares, the loss on the sale will be treated as a long-term capital loss to the participant. The Company will not be entitled to a tax deduction with respect to any shares held by
the participant for the Required Holding Period, regardless of whether the shares are eventually sold at a gain or a loss. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">22 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The participant has a &#147;Disqualifying Disposition&#148; if the participant disposes
of the shares before the participant has held the shares for the Required Holding Period. If the participant sells the shares in a Disqualifying Disposition, the participant will realize ordinary income in an amount equal to the difference between
the purchase price paid for the shares and the fair market value of the shares on the exercise date on which the participant acquired the shares, and the Company generally will be entitled to a corresponding tax deduction. In addition, if the
participant makes a Disqualifying Disposition of the shares at a price in excess of the fair market value of the shares on the exercise date, the participant will realize capital gain in an amount equal to the difference between the selling price of
the shares and the fair market value of the shares on the exercise date. Alternatively, if the participant makes a Disqualifying Disposition of the shares at a price less than the fair market value of the shares on the Exercise Date, the participant
will realize a capital loss in an amount equal to the difference between the fair market value of the shares on the exercise date and the selling price of the shares. The Company will not be entitled to a tax deduction with respect to any capital
gain realized by a participant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Securities Underlying Awards </B>The closing price of a share of the Company&#146;s common
stock as of April&nbsp;20, 2020 was $20.11 per share. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE IN FAVOR OF PROPOSAL 3 TO
APPROVE THE AMENDMENT AND RESTATEMENT TO OUR AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN AS DESCRIBED ABOVE AND SET FORTH IN EXHIBIT B HERETO. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">23 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_5"></A>PROPOSAL 4 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee of the board of directors has selected Ernst&nbsp;&amp; Young LLP as our independent registered public accounting
firm for the fiscal year ending December&nbsp;31, 2020, and has further directed that management submit the selection of our independent registered public accounting firm for ratification by the stockholders at the Annual Meeting. Ernst&nbsp;&amp;
Young LLP has audited our consolidated financial statements since our inception. Representatives of Ernst&nbsp;&amp; Young LLP are expected to be present at the Annual Meeting. They will have an opportunity to make a statement if they so desire and
will be available to respond to appropriate questions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Neither our bylaws nor other governing documents or law require
stockholder ratification of the selection of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm. However, the Audit Committee is submitting the selection of Ernst&nbsp;&amp; Young LLP to the stockholders for ratification
as a matter of good corporate practice. If the stockholders fail to ratify the selection, the Audit Committee will reconsider whether or not to retain Ernst&nbsp;&amp; Young LLP. Even if the selection is ratified, the Audit Committee, in its
discretion, may direct the appointment of a different independent registered public accounting firm at any time during the year if the committee determines that such a change would be in our best interests and our stockholders&#146; best interest.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The affirmative vote of the holders of a majority of the votes cast during the live webcast or by proxy at the Annual Meeting
will be required to ratify the selection of Ernst&nbsp;&amp; Young LLP for our fiscal year ending December&nbsp;31, 2020. Abstentions are treated as shares represented during the live webcast or by proxy and entitled to vote at the Annual Meeting
and, therefore, will have the effect of a vote against the ratification of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm. No broker <FONT STYLE="white-space:nowrap">non-votes</FONT> are expected to exist in
connection with this proposal. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE IN FAVOR OF PROPOSAL 4. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">24 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_6"></A>PROPOSAL 5 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ADVISORY VOTE ON EXECUTIVE COMPENSATION </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The board of directors is committed to excellence in governance and is aware of the significant interest in executive compensation matters by investors and the general public. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have designed our executive compensation program to attract, motivate, reward and retain the senior management talent required to
achieve our corporate objectives and increase stockholder value. We believe that our compensation policies and procedures are centered on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance</FONT></FONT> principles
and are strongly aligned with the long-term interests of our stockholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We urge you to carefully review the Compensation
Discussion and Analysis section of this proxy statement for details on our executive compensation, including our compensation philosophy and objectives and the 2019 compensation of the named executive officers (&#147;NEOs&#148;) described in the
section titled &#147;Compensation Program Objectives and Philosophy.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are presenting this proposal, which gives you
as a stockholder the opportunity to endorse or not endorse our compensation program for the NEOs by voting for or against the following resolution (a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-pay&#148;</FONT></FONT> vote), as required pursuant to Section&nbsp;14A of the Exchange Act: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&#147;RESOLVED, that the compensation paid to the Company&#146;s NEOs, as disclosed pursuant to Item&nbsp;402 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated by the SEC, including
the Compensation Discussion and Analysis, compensation tables and related narrative discussion contained in the proxy statement for the Company&#146;s 2020 Annual Meeting is hereby APPROVED.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">While the vote on the resolution is advisory in nature and therefore will not bind us to take any particular action, our board of
directors and our Organization and Compensation Committee intend to carefully consider the stockholder vote resulting from the proposal in making future decisions regarding our compensation program. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The affirmative vote of a majority of the votes cast by holders of the shares of common stock present during the live webcast or
represented by proxy at the Annual Meeting is required (on a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory basis) for approval of this proposal. Abstentions are treated as shares represented during the live webcast or by proxy and
entitled to vote at the Annual Meeting and, therefore, will have the effect of a vote against this proposal. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the outcome of the vote. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE IN FAVOR OF PROPOSAL 5. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_7"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth certain information regarding the ownership of our common stock as of
April&nbsp;20, 2020, by: (i)&nbsp;each director and nominee for director; (ii)&nbsp;each of our NEOs; (iii)&nbsp;all of our executive officers and directors as a group; and (iv)&nbsp;all those known by us to be beneficial owners of more than five
percent of our common stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unless otherwise noted below, the address of each beneficial owner listed in the table is c/o
Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, California 94158. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Beneficial&nbsp;Ownership&nbsp;**</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000 ; display:table-cell;"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Beneficial&nbsp;Owner</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent&nbsp;of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Invesco Ltd.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1) </SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31,629,134</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17.78</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">PRIMECAP Management Company</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2) </SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,080,348</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11.29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">FMR LLC</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3) </SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,698,403</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">BlackRock, Inc. and certain subsidiaries</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4) </SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,417,535</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Wellington Management Group LLP</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5) </SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,198,179</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Vanguard Group</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6) </SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,157,611</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.08</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jeff Ajer</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7) </SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">82,041</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert B. Chess</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8) </SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">444,639</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Myriam J. Curet, M.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,900</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Karin Eastham</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10) </SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,110</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(11) </SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">343,249</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lutz Lingnau</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(12) </SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">178,366</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(13) </SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,152,486</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roy A. Whitfield</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(14) </SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">399,916</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(15) </SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">837,104</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Northcott</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(16) </SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jillian B. Thomsen</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(17) </SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">471,768</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jonathan Zalevsky, Ph.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(18)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">403,708</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All executive officers and directors as a group (12 persons)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,335,287</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.99</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Denotes ownership percentage less than 1%. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">**</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">This table is based upon information supplied by officers, directors and principal stockholders and Schedules 13G filed with the SEC. Unless
otherwise indicated in the footnotes to this table, and subject to community property laws where applicable, we believe that each of the stockholders named in the table has sole voting and investment power with respect to the shares indicated as
beneficially owned. Applicable percentages are based on 177,914,327 shares outstanding on April&nbsp;20, 2020, adjusted as required by rules promulgated by the SEC. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based solely on the Schedule 13G/A (Amendment No.&nbsp;2) filed with the SEC on February&nbsp;7, 2020 by Invesco Ltd. a registered investment
adviser in accordance with Rule <FONT STYLE="white-space:nowrap">240.13d-1(b)(1)(ii)(E).</FONT> Invesco Ltd. has the sole voting power with respect to 31,629,134 shares of our common stock and sole dispositive power with respect 31,629,134 shares of
our common stock. The address of Invesco Ltd. is 1555 Peachtree Street NE, Suite 1800, Atlanta, GA 30309. Investco Advisers, Inc. is a subsidiary of Invesco Ltd. and it advises the Invesco Oppenheimer Global Opportunities Fund which owns 17.79% of
the security reported herein. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based solely on the Schedule 13G/A (Amendment No.&nbsp;9) filed with the SEC on February&nbsp;12, 2020 by PRIMECAP Management Company, a
registered investment adviser in accordance with Rule <FONT STYLE="white-space:nowrap">240.13d-1(b)(1)(ii)(E).</FONT> PRIMECAP Management Company has the sole voting power with respect to 20,010,429 shares of our common stock and sole dispositive
power with respect 20,080,348 shares of our common stock. The address of PRIMECAP Management Company is 177 East Colorado Blvd., 11th floor, Pasadena, CA 91105. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">26 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based solely on the Schedule 13G/A (Amendment No.&nbsp;5) filed with the SEC on March 10. 2020 by FMR LLC, a parent holding company in
accordance with Rule <FONT STYLE="white-space:nowrap">240.13d-1(b)(1)(ii)(G).</FONT> FMR LLC has the sole voting power with respect to 4,181,758 shares of our common stock and the sole dispositive power with respect to 18,698,403 shares of our
common stock. The address of FMR LLC is 245 Summer Street, Boston, Massachusetts 02210. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based solely on the Schedule 13G/A (Amendment No.&nbsp;11) filed with the SEC on February&nbsp;4, 2020 by BlackRock, Inc., a parent holding
company or control person in accordance with Rule <FONT STYLE="white-space:nowrap">13d-1(b)(1)(ii)(G).</FONT> BlackRock, Inc. has the sole voting power with respect to 17,766,330 shares of our common stock and the sole dispositive power with respect
to 18,417,535 shares of our common stock. The address of BlackRock, Inc. is 55 East 52nd Street, New York, NY 10055. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based solely on the Schedule 13G/A (Amendment No.1) jointly filed with the SEC on February&nbsp;12, 2019 by Wellington Management Group, LLP,
Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP, and Wellington Management Company LLP. Wellington Management Group LLP has the shared voting power with respect to 15,900,223 shares of our common stock and the shared
dispositive power with respect to 16,198,179 shares of our common stock. Wellington Group Holdings LLP has the shared voting power with respect to 15,900,223 shares of our common stock and the shared dispositive power with respect to 16,198,179
shares of our common stock. Wellington Investment Advisors Holdings LLP has the shared voting power with respect to 15,900,223 shares of our common stock and shared dispositive power with respect to 16,198,179 shares of our common stock. Wellington
Management Company LLP has the shared voting power with respect to 15,692,729 shares of our common stock and shared dispositive power with respect to 15,809,703 shares of our common stock. Each of Wellington Management Group LLP, Wellington Group
Holdings LLP and Wellington Investment Advisors Holdings LLP is a parent holding company or control person in accordance with Rule <FONT STYLE="white-space:nowrap">240.13d-1(b)(1)(ii)(G)</FONT> and Wellington Management Company LLP is an investment
advisor in accordance with Rule <FONT STYLE="white-space:nowrap">240.13d-1(b)(1)(ii)(E).</FONT> The shares of our common stock as to which the Schedule 13G/A was filed by Wellington Management Group LLP, as parent holding company of certain holding
companies, and the Wellington Investment Advisers, are owned of record by clients of the Wellington Investment Advisers. Wellington Investment Advisors Holdings LLP controls directly, or indirectly through Wellington Management Global Holdings,
Ltd., the Wellington Investment Advisers. Wellington Investment Advisors Holdings LLP is owned by Wellington Group Holdings LLP. Wellington Group Holdings LLP is owned by Wellington Management Group LLP. Company LLP, Wellington Management Canada
LLC, Wellington Management Singapore Pte Ltd, Wellington Management Hong Kong Ltd, Wellington Management International Ltd, Wellington Management Japan Pte Ltd and Wellington Management Australia Pty Ltd (collectively the &#147;Wellington Investment
Advisers&#148;) are owned of record by clients of the Wellington Investment Advisers. Wellington Investment Advisors Holdings LLP controls directly or indirectly through Wellington Management Global Holdings Ltd, the Wellington Investment Advisers.
Wellington Investment Advisors Holdings LLP is owned by Wellington Group Holdings LLP, Wellington Group Holdings LLP is owned by Wellington Management Group LLP. The address of Wellington Management Group LLP, Wellington Group Holdings LLP,
Wellington Investment Advisors Holdings LLP and Wellington Management Company LLP is c/o Wellington Management Company LLP, 280 Congress Street, Boston, MA 02210. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based solely on the Schedule 13G/A (Amendment No.&nbsp;7) filed with the SEC on February&nbsp;11, 2019 by The Vanguard Group Inc., a
registered investment adviser in accordance with Rule <FONT STYLE="white-space:nowrap">240.13d-1(b)(1)(ii)(E).</FONT> The Vanguard Group has the sole voting power with respect to 208,599 shares of our common stock, shared voting power with respect
to 36,535 shares of our common stock, sole dispositive power with respect to 18,068,697 shares of our common stock and shared dispositive power with respect to 235,834 shares of our common stock. Vanguard Fiduciary Trust Company, a wholly-owned
subsidiary of The Vanguard Group, Inc., is the beneficial owner of 155,899 shares as a result of its serving as investment manager of collective trust accounts. Vanguard Investments Australia, Ltd., a wholly-owned subsidiary of The Vanguard Group,
Inc., is the beneficial owner of 132,635 shares as a result of its serving as investment manager of Australian investment offerings. The address of The Vanguard Group is 100 Vanguard Blvd., Malvern, PA 19355. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 70,666 shares issuable upon exercise of stock options exercisable within 60 days of April&nbsp;20, 2020.
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">27 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 174,166 shares issuable upon exercise of stock options exercisable within 60 days of April&nbsp;20, 2020.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 3,900 shares issuable upon exercise of stock options exercisable within 60 days of April&nbsp;20, 2020. </FONT></P></TD></TR></TABLE>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 18,110 shares issuable upon exercise of stock options exercisable within 60 days of April&nbsp;20, 2020.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(11)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 198,166 shares issuable upon exercise of stock options exercisable within 60 days of April&nbsp;20, 2020.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(12)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 158,166 shares issuable upon exercise of stock options exercisable within 60 days of April&nbsp;20, 2020.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(13)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i) 1,940,598 shares issuable upon exercise of stock options exercisable within 60 days of April&nbsp;20, 2020, (ii) and 23,629
shares from RSU awards that are scheduled to vest and be released within 60 days of April&nbsp;20, 2020 and (iii) 410 shares owned by Mr.&nbsp;Robin&#146;s wife. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(14)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i) 188,166 shares issuable upon exercise of stock options exercisable within 60 days of April&nbsp;20, 2020 and (ii) 20,000 shares
held in trust for Mr.&nbsp;Whitfield&#146;s children under which Mr.&nbsp;Whitfield is the sole trustee. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(15)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i) 834,395 shares issuable upon exercise of stock options exercisable within 60 days of April&nbsp;20, 2020, (ii) 16,324 shares from
RSU awards that are scheduled to vest and be released within 60 days of April&nbsp;20, 2020, (iii) 4,218 shares issued pursuant to our Amended and Restated Employee Stock Purchase Plan and (iv) 997 shares issued pursuant to our 401(k) Retirement
Plan. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(16)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Northcott was hired in December of 2019 and does not yet have shares issuable upon exercise of stock options exercisable within 60
days of April&nbsp;20, 2020 and (ii)&nbsp;does not yet have shares from RSU awards that are scheduled to vest and be released within 60 days of April&nbsp;20, 2020. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(17)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i) 409,042 shares issuable upon exercise of stock options exercisable within 60 days of April&nbsp;20, 2020, (ii) 3,887 shares from
RSU awards that are scheduled to vest and be released within 60 days of April&nbsp;20, 2020, (iii) 988 shares pursuant to our 401(k) Retirement Plan and(iv) 4,809 shares issued pursuant to our Amended and Restated Employee Stock Purchase Plan.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(18)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i) 362,939 shares issuable upon exercise of stock options exercisable within 60 days of April&nbsp;20, 2020 and (ii) 12,992 shares
from RSU awards that are scheduled to vest and be released within 60 days of April&nbsp;20, 2020. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_8"></A>D<SMALL>ELINQUENT</SMALL> S<SMALL>ECTION</SMALL>&nbsp;16(<SMALL>A</SMALL>) R<SMALL>EPORTS</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section&nbsp;16(a) of the Exchange Act requires our directors and executive officers, and persons who beneficially own more than ten
percent of a registered class of our equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of our common stock and other equity securities. Officers, directors and greater than ten percent
beneficial owners are required by SEC regulations to furnish us with copies of all Section&nbsp;16(a) forms they file. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To our
knowledge, based solely on our review of Forms 3, 4 and 5, and any amendments thereto, furnished to us or written representations that no Form 5 was required, we believe that during the fiscal year ended December&nbsp;31, 2019, all filing
requirements applicable to our executive officers and directors under the Exchange Act were met in a timely manner except for one Form 4 for Mr.&nbsp;Lingnau that was filed one day late on October&nbsp;2, 2019 in connection with the sale of 3,000
shares of common stock on September&nbsp;27, 2019 pursuant to a <FONT STYLE="white-space:nowrap">10b5-1</FONT> trading plan.</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">28 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_9"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We review all relationships and transactions between us and (i)&nbsp;any of our directors or executive officers,
(ii)&nbsp;any nominee for election as a director, (iii)&nbsp;any security holder who is known to us to own beneficially or of record more than five percent of our common stock or (iv)&nbsp;any member of the immediate family of any of the foregoing.
Our legal staff is primarily responsible for the development and implementation of processes and controls to obtain information with respect to related person transactions and for then determining, based on the facts and circumstances, whether the
Company or a related person has a direct or indirect material interest in the transaction. In addition, the Audit Committee reviews and approves or ratifies any related person transaction that is required to be disclosed. In the course of its review
and approval or ratification of a disclosable related party transaction, the committee considers: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the nature of the related person&#146;s interest in the transaction; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the material terms of the transaction, including, without limitation, the dollar amount and type of transaction; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the importance of the transaction to the related person; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the importance of the transaction to the Company; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">whether the transaction would impair the judgment of a director or executive officer to act in the best interest of the Company; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any other matters the committee deems appropriate. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Any member of the Audit Committee who is a related person with respect to a transaction under review may not participate in the deliberations or vote respecting approval or ratification of the
transaction; however, such director may be counted in determining the presence of a quorum at a meeting where the Audit Committee reviews the transaction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As required under SEC rules, related party transactions that are determined to be directly or indirectly material to us or the related party are disclosed in our proxy statement. Historically, we have not
entered into transactions with related parties. Michael Robin, the son of Howard W. Robin, our President and Chief Executive Officer, is employed by the Company in a <FONT STYLE="white-space:nowrap">non-executive</FONT> officer capacity as a
vice-president in our project management group.&nbsp;During 2019, Michael Robin&#146;s total compensation was approximately $723,778 including base salary, bonus, spot awards, RSUs and benefits. Michael Robin&#146;s 2019 compensation is comprised of
43% equity-based compensation. Michael Robin&#146;s compensation was established by the Company in accordance with its compensation practices applicable to employees with equivalent qualifications and responsibilities and holding similar positions,
without the direct involvement of Howard W. Robin. During the 2019 fiscal year, there were no other relationships or transactions between us and any related party for which disclosure is required under the rules of the SEC. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">29 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_10"></A>INFORMATION ABOUT THE BOARD OF DIRECTORS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following is a brief biography of each current director, including each nominee for reelection at the Annual Meeting to a new term of
office and each director whose current term of office continues through the Annual Meeting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_11"></A>THE BOARD OF
DIRECTORS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_12"></A>D<SMALL>IRECTORS</SMALL> C<SMALL>ONTINUING</SMALL> <SMALL>IN</SMALL> O<SMALL>FFICE</SMALL>
U<SMALL>NTIL</SMALL> <SMALL>THE</SMALL> 2021 A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Jeff Ajer </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Jeff Ajer</I>, age 57,<I> </I>was appointed to the board of directors of in September 2017. Mr.&nbsp;Ajer currently serves as Executive
Vice President and Chief Commercial Officer at BioMarin Pharmaceutical Inc. (&#147;BioMarin&#148;), a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders.
From October 2012 to January 2014, Mr.&nbsp;Ajer served as Senior Vice President and Chief Commercial Officer of BioMarin. From April 2009 to October 2012, Mr.&nbsp;Ajer served as BioMarin&#146;s Vice President, Commercial Operations, The Americas,
where he had responsibility for commercial operations throughout the Americas and led product marketing, reimbursement, and sales operations for BioMarin. Prior to joining BioMarin, Mr.&nbsp;Ajer served in various roles at Genzyme Corporation
(&#147;Genzyme&#148;) beginning in November 2003, most recently as Vice President, Global Transplant Operations from December 2004 to August 2005. Mr.&nbsp;Ajer&#146;s experience prior to Genzyme includes roles in sales, marketing and operations at
SangStat Medical Corporation and ICN Pharmaceuticals. Mr.&nbsp;Ajer also served on the board of directors of True North Therapeutics. Mr.&nbsp;Ajer received both a B.S. in chemistry and an M.B.A. from the University of California, Irvine.<I> </I>
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Robert B. Chess </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Robert B. Chess</I>, age 63, is the Chairman of our board of directors and has served as a director since May 1992. From March 2006 until January 2007, Mr.&nbsp;Chess served as our Acting President and
Chief Executive Officer, and from April 1999 to January 2007, served as Executive Chairman.&nbsp;He also served as our <FONT STYLE="white-space:nowrap">Co-Chief</FONT> Executive Officer from August 1998 to April 2000, as President from December 1991
to August 1998, and as Chief Executive Officer from May 1992 to August 1998. Mr.&nbsp;Chess was previously the <FONT STYLE="white-space:nowrap">co-founder</FONT> and President of Penederm, Inc., a publicly-traded dermatological pharmaceutical
company that was sold to Mylan Laboratories. He has held management positions at Intel Corporation and Metaphor Computer Systems (now part of IBM), and was a member of the first President Bush&#146;s White House staff as a White House Fellow and
Associate Director of the White House Office of Economic and Domestic Policy.&nbsp;From 1997 until his retirement in 2009, Mr.&nbsp;Chess served on the board of directors of the Biotechnology Industry Organization
(&#147;BIO&#148;).&nbsp;Mr.&nbsp;Chess served as Chairman of BIO&#146;s Emerging Companies Section&nbsp;and <FONT STYLE="white-space:nowrap">Co-Chairman</FONT> of BIO&#146;s Intellectual Property Committee. Mr.&nbsp;Chess was the initial Chairman of
Bio Ventures for Global Health and continues to serve on its board.&nbsp;He also serves on the Board of Trustees of the California Institute of Technology where he chairs the Technology Transfer Committee. Mr.&nbsp;Chess is the <FONT
STYLE="white-space:nowrap">co-founder</FONT> and a member of the board of directors of Biota Technology, a private company developing applications of <FONT STYLE="white-space:nowrap">DNA-sequencing</FONT> for the energy industry, and also serves on
the board of directors and is a lead director of Twist Biosciences, a publicly-traded company in the synthetic DNA production field. He is currently a member of the faculty of the Stanford Graduate School of Business, where he teaches courses in the
MBA program on starting technology-based businesses and the healthcare industry.&nbsp;Mr.&nbsp;Chess received his B.S. degree in Engineering with honors from the California Institute of Technology and an M.B.A. from Harvard University. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Roy A. Whitfield </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Roy A. Whitfield</I>, age 66, has served as our director since August 2000 and as Lead Independent Director since January 2019. Mr.&nbsp;Whitfield is the former Chairman of the Board and Chief
Executive Officer of Incyte Corporation (&#147;Incyte&#148;), a drug discovery and development company he <FONT STYLE="white-space:nowrap">co-founded</FONT> in 1991. From January 1993 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">30 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
to November 2001, Mr.&nbsp;Whitfield served as its Chief Executive Officer and from November 2001 until June 2003 as its Chairman. He also served as a director of Incyte from 1991 to January
2014. From 1984 to 1989, Mr.&nbsp;Whitfield held senior operating and business development positions with Technicon Instruments Corporation (&#147;Technicon&#148;), a medical instrumentation company, and its predecessor company, Cooper Biomedical,
Inc., a biotechnology and medical diagnostics company. Prior to his work at Technicon, Mr.&nbsp;Whitfield spent seven years with the Boston Consulting Group&#146;s international consulting practice. He currently serves as a director of Station X,
Inc. a private company. Mr.&nbsp;Whitfield previously served as the Executive Chairman of the board of directors of Bioseek and as member of the board of directors of Illumina, Inc. Mr.&nbsp;Whitfield received a B.S. in mathematics from Oxford
University and an M.B.A. from Stanford University. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_13"></A>D<SMALL>IRECTORS</SMALL> C<SMALL>ONTINUING</SMALL>
<SMALL>IN</SMALL> O<SMALL>FFICE</SMALL> <SMALL>UNTIL</SMALL> <SMALL>THE</SMALL> 2022 A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>R. Scott Greer </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>R. Scott Greer, age 61, </I>has served as our director
since February 2010. Mr.&nbsp;Greer currently serves as Managing Director of Numenor Ventures, LLC, a venture capital firm. In 1996, Mr.&nbsp;Greer <FONT STYLE="white-space:nowrap">co-founded</FONT> Abgenix, Inc., a company that specialized in the
discovery, development and manufacture of human therapeutic antibodies, and from June 1996 through May 2002, he served as its Chief Executive Officer. He also served as a director of Abgenix from 1996 and Chairman of the board of directors from 2000
until the acquisition of Abgenix by Amgen, Inc. in April 2006. Prior to Abgenix&#146;s formation, Mr.&nbsp;Greer held senior management positions at Cell Genesys, Inc., a biotechnology company, initially as Chief Financial Officer and Vice President
of Corporate Development and later as Senior Vice President of Corporate Development, and various positions at Genetics Institute, Inc., a biotechnology research and development company. He currently serves as a member of the board of directors of
Inogen, Inc., a medical device company that develops and markets oxygen therapy products. Mr.&nbsp;Greer served as a member of the board of directors of Sientra, Inc., a medical aesthetics company from 2014-2018, Versartis, Inc., an endocrine
focused biopharmaceutical company from 2014-2018, Auspex Pharmaceuticals, a biopharmaceutical company developing drugs for patients with movement disorders and other rare diseases from 2014-2015, Sirna Therapeutics, Inc., a biotechnology company,
from 2003, and as its Chairman of the board of directors from 2005, through the closing of the acquisition of Sirna by Merck&nbsp;&amp; Co., Inc. in December 2006. From 2001 to 2005, Mr.&nbsp;Greer served as a member of the board of directors of
Illumina, Inc., a provider of integrated systems for the analysis of genetic variation and biological function; and from 2001 to 2004, he served as member of the board of directors of CV Therapeutics, Inc., a biotechnology company. Mr.&nbsp;Greer
also served as a member of the board of directors of StemCells, Inc., a biopharmaceutical company focused on stem cell therapeutics from 2010 to 2016 and additionally from 2010-2016 was Chairman of the board of Ablexis, an antibody technology
company. Mr.&nbsp;Greer received a B.A. in Economics from Whitman College and an M.B.A. degree from Harvard University. He also was a certified public accountant. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Lutz Lingnau </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Lutz Lingnau</I>, age 77, has served as our director since
August 2007. Mr.&nbsp;Lingnau retired from Schering AG Group, Germany, in December 2005 as a member of Schering AG&#146;s Executive Board and as Vice Chairman, President and Chief Executive Officer of Schering Berlin, Inc., a United States
subsidiary. Prior to his retirement, Mr.&nbsp;Lingnau was responsible for Schering AG&#146;s worldwide specialized therapeutics and dermatology businesses. He joined Schering AG&#146;s business trainee program in 1966. Throughout his career at
Schering AG, he served in various capacities and in a number of subsidiaries in South America and the United States, including his roles as President of Berlex Laboratories, Inc., from 1983 to 1985, as the Head of Worldwide Sales and Marketing in
the Pharmaceutical Division of Schering AG, from 1985 to 1989, and as Chairman of Berlex Laboratories, Inc. from 1985 to 2005. Mr.&nbsp;Lingnau was a member of the Supervisory Board of LANXESS AG, a specialty chemicals company listed on the
Frankfurt Stock Exchange from 2005 to May 2010. From December 2006 through September 2009, he served as Chairman of the board of directors of Micropharma Limited, a private biotechnology company, and was a member of the board of directors of Sirna
Therapeutics, Inc., a biotechnology company, from February 2006 through the closing of the acquisition of Sirna by Merck&nbsp;&amp; Co., Inc. in December 2006. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">31 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_14"></A>C<SMALL>URRENT</SMALL> D<SMALL>IRECTORS</SMALL> N<SMALL>OMINATED</SMALL>
<SMALL>FOR</SMALL> R<SMALL>EELECTION</SMALL> <SMALL>TO</SMALL> S<SMALL>ERVE</SMALL> U<SMALL>NTIL</SMALL> <SMALL>THE</SMALL> 2023 A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Myriam J. Curet, M.D. </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Myriam J. Curet</I>, <I>M.D.</I>, age 63, was apponted to serve as a member of our board of directors in December 2019. Dr.&nbsp;Curet currently serves as the Executive Vice President and Chief Medical
Officer of Intuitive Surgical, Inc. Prior to being promoted as Executive Vice President and Chief Medical Officer in November 2017, Dr.&nbsp;Curet served as the Chief Medical Advisor for Intuitive Surgical from December 2005 to February 2014 and as
Intuitive Surgical&#146;s Senior Vice President and Chief Medical Officer from February 2014 to November 2017. Dr.&nbsp;Curet also has a faculty position as Professor of Surgery at Stanford University School of Medicine. Since October 2010, she has
served as a Consulting Professor of Surgery at Stanford University with a part time clinical appointment at the Palo Alto Veteran&#146;s Administration Medical Center. She was also on the faculty at the University of New Mexico for six years prior
to joining the Stanford University in 2000. Dr.&nbsp;Curet received her M.D. from Harvard Medical School and completed her general surgery residency program at the University of Chicago and completed her Surgical Endoscopy fellowship at the
University of New Mexico. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Karin Eastham </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Karin Eastham</I>, age 70, was appointed to serve as a member of our board of directors in September 2018. Ms.&nbsp;Eastham currently serves on the boards of directors of several life sciences
companies. Ms.&nbsp;Eastham has served on the board of directors of Geron Corporation since March 2009, Veracyte, Inc. since December 2012, and Personalis, Inc. since November 2019. Ms.&nbsp;Eastham served as a member of the board of directors of
Ilumina Inc. from August 2004 to May 2019, MorphoSys AG from May 2012 to May 2017, Amylin Pharmaceuticals, Inc. from September 2005 until its acquisition in August 2012, Genoptix, Inc. from July 2008 until its acquisition in March 2011, Tercica,
Inc. from December 2003 until its acquisition in October 2008, and Trius Therapeutics, Inc. from February 2007 until its acquisition in September 2013. From May 2004 to September 2008, Ms.&nbsp;Eastham served as Executive Vice President and Chief
Operating Officer, and as a member of the Board of Trustees, of the Burnham Institute for Medical Research (now Sanford Burnham Prebys Medical Discovery Institute), a <FONT STYLE="white-space:nowrap">non-profit</FONT> corporation engaged in
biomedical research. From April 1999 to May 2004, Ms.&nbsp;Eastham served as Senior Vice President, Chief Financial Officer and Secretary of Diversa Corporation, a biotechnology company. Ms.&nbsp;Eastham previously held similar positions with
CombiChem, Inc., a computational chemistry company, and Cytel Corporation, a biopharmaceutical company. Ms.&nbsp;Eastham also held several positions, including Vice President, Finance, at Boehringer Mannheim Diagnostics, from 1976 to 1988.
Ms.&nbsp;Eastham received a B.S. in Accounting and an M.B.A. from Indiana University and is a Certified Public Accountant. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Howard W. Robin </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Howard W. Robin, age 67, </I>has served as our President and Chief Executive Officer since January 2007 and has served as a member of our board of directors since February 2007. Mr.&nbsp;Robin served
as Chief Executive Officer, President and a director of Sirna Therapeutics, Inc., a biotechnology company, from July 2001 to November 2006 and from January 2001 to June 2001, served as their Chief Operating Officer, President and as a director. From
1991 to 2001, Mr.&nbsp;Robin was Corporate Vice President and General Manager at Berlex Laboratories, Inc. (&#147;Berlex&#148;), a pharmaceutical products company that is a subsidiary of Schering, AG, and from 1987 to 1991 he served as Vice
President of Finance and Business Development and Chief Financial Officer. From 1984 to 1987, Mr.&nbsp;Robin was Director of Business Planning and Development at Berlex. He was a Senior Associate with Arthur Andersen&nbsp;&amp; Co. prior to joining
Berlex. He received his B.S. in Accounting and Finance from Fairleigh Dickinson University and serves as a member of its Board of Trustees.<I> </I> </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_15"></A>M<SMALL>EETINGS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The board of directors met thirteen (13)&nbsp;times during 2019. For the term of service during which he or she was a director in fiscal
year 2019, each board member attended 75% or more of the aggregate of the board meetings and key committee meetings. All of our directors on our board, except Dr.&nbsp;Myriam&nbsp;J. Curet (who was appointed to the board effective as of
December&nbsp;12, 2019), attended our 2019 annual meeting of stockholders. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">32 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_16"></A>C<SMALL>ORPORATE</SMALL> G<SMALL>OVERNANCE</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The board of directors has documented our governance practices in our Corporate Governance Policy Statement to assure that the board will
have the necessary authority and practices in place to review and evaluate our business operations as needed and to make decisions that are independent of our management. The guidelines are also intended to align the interests of directors and
management with those of our stockholders. The Corporate Governance Policy Statement sets forth certain practices the board will follow with respect to board composition, board committees, board nomination, director qualifications and evaluation of
the board and committees. The Corporate Governandce Policy Statement also provides that the board of directors will include qualified candidates when filling positions for Chief Executive Officer vacancies and board membership from a variety of
backgrounds and experiences, including candidates of gender, age and racial/ethnic diversity. In any retained search for Chief Executive Officer and board candidates, the board of directors will direct the third party search firm to identify and
include candidates with gender and racial/ethnic diversity as part of the retained search. The Corporate Governance Policy Statement, as well as the charters for each committee of the board, may be viewed at <I>www.nektar.com</I>. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_17"></A>B<SMALL>OARD</SMALL> L<SMALL>EADERSHIP</SMALL> S<SMALL>TRUCTURE</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The positions of Chief Executive Officer and Chairman of the board of directors are currently held by Howard W. Robin and Robert B. Chess,
respectively. The board of directors believes at this time having a separate chairman provides a more effective channel for the board of directors to express its views on management, by enhancing the board&#146;s oversight of, and independence from,
management, and allows the Chief Executive Officer to focus more on the strategy and operations of the Company. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_17a"></A>Lead Independent Director </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Roy A. Whitfield serves as our Lead Independent Director. The board of directors believes that a robust Lead Independent Director role facilitates independent board oversight of management. In accordance
with the Company&#146;s revised Corporate Governance Policy Statement approved by the Board on February&nbsp;4, 2019, the Lead Independent Director shall, among other things, (i)&nbsp;have authority to call meetings of the independent directors;
(ii)&nbsp;chair meetings of the independent directors in the event the Chairman of the board of directors is not independent; (iii)&nbsp;serve as a liaison between the Chairman of the board and the independent directors; (iv)&nbsp;approve
information sent to the board; (v)&nbsp;approve meeting agendas for the board; (vi)&nbsp;approve meeting schedules for the board to assure that there is sufficient time for discussion of all agenda items; and (vii)&nbsp;have such other duties and
responsibilities as may be assigned by the board from time to time. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_18"></A>R<SMALL>ISK</SMALL>
O<SMALL>VERSIGHT</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The board of directors monitors and assesses key business risks directly through deliberations of
the board of directors and also by way of delegation of certain risk oversight functions to be performed by committees of the board of directors.&nbsp;The board of directors regularly reviews and assesses, among other matters, the following
important areas that present both opportunities and risk to the Company&#146;s business: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Review and approval of the Company&#146;s annual operating and capital spending plan and review of management&#146;s updates as to the progress against
the plan and any related risks and uncertainties. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Periodic consideration of the balance of risk and opportunities presented by the Company&#146;s medium to long-term strategic plan and the potential
implications of success and failure in one or more of the Company&#146;s key drug development programs. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Regular consideration of the risks and uncertainties presented by alternative clinical development strategies. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Periodic review and oversight of information technology (IT) risks and opportunities. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">33 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Regular review of the progress and results of the Company&#146;s clinical development programs and early research efforts including but not limited to
the strengths, weaknesses, opportunities and threats for these programs. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Periodic review and oversight of material outstanding litigation or threatened litigation. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Review and approval of material collaboration partnerships for the further development and commercial exploitation of the Company&#146;s proprietary
drug development programs and technologies. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Regular review and approval of the annual corporate goals and an assessment of the Company&#146;s level of achievement against these established goals.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Regular review of the Company&#146;s financial position relative to the risk and opportunities for the Company&#146;s business.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Periodic review of the Company&#146;s intellectual property estate. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Periodic&nbsp;review and assessment of CEO succession planning. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Periodic&nbsp;review of the Company&#146;s compensation programs. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The discussion above of risk oversight matters reviewed by the board of directors is intended to be illustrative only and not a complete
list of all important matters reviewed and considered by the board of directors in providing oversight and direction for the Company&#146;s senior management and business. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The risk oversight function of the board of directors is also administered through various board committees.&nbsp;The Audit Committee oversees the management of financial, accounting, internal controls,
disclosure controls and the engagement arrangement and regular oversight of the independent auditors.&nbsp;The Audit Committee also periodically reviews the Company&#146;s investment policy for its cash reserves, corporate insurance policies,
information technology infrastructure and general fraud monitoring practices and procedures, including the maintenance and monitoring of a whistleblower hotline and the segregation of duties and access controls across various functions.&nbsp;To
assist the Audit Committee in its risk management oversight function, the internal auditor has a direct reporting relationship to the Audit Committee.&nbsp;The Company&#146;s internal audit function is focused on internal control monitoring and
activities in support of the Audit Committee&#146;s risk oversight function. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Organization and Compensation Committee is
responsible for the design and oversight of the Company&#146;s compensation programs as well as succession planning for the chief executive officer position and other key executive positions. The Organization and Compensation Committee regularly
considers whether the Company&#146;s compensation policies and practices create risks that could have a material adverse impact on the Company and has concluded that they do not based on several design features of our compensation program that we
believe reduces the likelihood of excessive risk-taking, including the following: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The compensation plan design provides a mix of base salary, short-term incentive compensation opportunity and equity compensation earned over
multiple-year periods. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The determination of the corporate performance rating under the annual bonus plan is based on our achievement of a diversified mix of development,
research, organizational and financial objectives. Thus, the achievement of any single corporate objective does not have a disproportionate impact on the aggregate annual bonus awarded. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each employee&#146;s annual cash bonus is determined by a combination of the corporate performance rating and a subjective determination of individual
performance. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The maximum payout levels for annual incentive bonuses are capped at 200% of each employee&#146;s annual target bonus. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">A substantial portion of each executive&#146;s compensation opportunity is in the form of long-term equity incentives, which help to further align the
long-term interests of our executives with those of our stockholders. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">34 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">All employees are subject to our security trading policy which prohibits trading in derivative securities (i.e., puts or calls), short selling, and any
trading in the Company&#146;s securities on margin. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each executive officer is subject to our claw-back policy which provides that any compensation received by an executive officer based upon the
achievement of financial results that are subsequently revised is subject to cancellation or a reimbursement obligation. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Nominating and Corporate Governance Committee periodically reviews the Company&#146;s corporate governance practices, including certain risks that those practices are intended to address.&nbsp;This
committee periodically reviews the composition of the board of directors to help ensure that a diversity of skills and experiences is represented by the members of the board of directors taking into account the stage of growth of the Company and its
strategic direction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In carrying out their risk oversight functions, the board of directors and its committees routinely
request and review management updates, reports from the independent auditors and legal and regulatory advice from outside experts, as appropriate, to assist in discerning and managing important risks that may be faced by the Company.&nbsp;The board
of directors is committed to continuing to ensure and evolve its risk oversight practices as appropriate given the stage of the Company&#146;s evolution as a research-based development stage biopharmaceutical company and the fast-paced changes in
the biopharmaceutical industry. In that regard, in 2019 the Company maintained a risk management committee composed of senior managers in charge of important functional areas that regularly reported to the board of directors or one of its designated
committees. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_19"></A>I<SMALL>NDEPENDENCE</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL>
O<SMALL>F</SMALL> D<SMALL>IRECTORS</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As required under the NASDAQ Global Select Market listing standards, a majority
of the members of a listed company&#146;s board of directors must qualify as &#147;independent,&#148; as affirmatively determined by the board of directors. Our board consults with counsel to ensure that its determinations are consistent with all
relevant securities and other laws and regulations regarding the definition of &#147;independent,&#148; including those set forth in pertinent NASDAQ listing standards, as in effect from time to time. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consistent with these standards, after review of all relevant transactions (if any) or relationships between each director, or any of his
or her family members, and us, our senior management and our independent registered public accounting firm, the board has affirmatively determined that all of our directors are independent directors within the meaning of the applicable NASDAQ
listing standards, except for Mr.&nbsp;Robin, our President and Chief Executive Officer. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As required under applicable NASDAQ
listing standards, in the 2019 fiscal year, our independent directors met at least four times in regularly scheduled executive sessions. The Chairman of the board presided over such sessions at which only independent directors were present.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">35 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_20"></A>I<SMALL>NFORMATION</SMALL> R<SMALL>EGARDING</SMALL> <SMALL>THE</SMALL>
C<SMALL>OMMITTEES</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The board of directors has three regularly constituted committees: an Audit Committee, an Organization and Compensation Committee, and a Nominating and Corporate Governance Committee. The following table
provides membership and meeting information as of December&nbsp;31, 2019, for each of the board committees: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000 ; display:table-cell;"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Audit</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Organization&nbsp;
and</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Compensation</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Nominating</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>and</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Corporate</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Governance</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jeff Ajer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert B. Chess</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Myriam J. Curet, M.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"> (1)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Karin Eastham</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lutz Lingnau</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roy A. Whitfield</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"> </SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Total meetings in the 2019 fiscal year</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Curet was appointed to the board of directors effective as of December&nbsp;12, 2019. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Committee Chairperson. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Below is a description of each committee of the board of directors. The board of directors has determined that each member of each committee meets the applicable rules and regulations regarding
&#147;independence&#148; and that each member is free of any relationship that would interfere with his or her individual exercise of independent judgment with regard to us. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>AUDIT COMMITTEE </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee of the board of directors
oversees our corporate accounting and financial reporting process. For this purpose, the Audit Committee performs several functions. The Audit Committee: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">evaluates the performance of and assesses the qualifications of our independent registered public accounting firm; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">determines whether to retain or terminate our independent registered public accounting firm or to appoint and engage a new independent registered
public accounting firm; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and determines the engagement of the independent auditors, including the overall scope and plans for their respective audits, the adequacy of
staffing and compensation, and negotiates and executes, on behalf of the Company, engagement letters with the independent auditors; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">establishes guidelines and procedures with respect to the rotation of the lead or coordinating audit partners having primary responsibility for the
audit and the audit partner responsible for reviewing the audit; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and approves the retention of the independent registered public accounting firm for any permissible
<FONT STYLE="white-space:nowrap">non-audit</FONT> services and, at least annually, discusses with our independent registered public accounting firm, and reviews, that firm&#146;s independence; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">obtains and reviews, at least annually, a formal written statement prepared by the independent registered public accounting firm delineating all
relationships between the independent registered public accounting firm and the Company and discusses with the independent registered public accounting firm, and reviews, its independence from management and the Company;
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">36 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews with the independent registered public accounting firm any management or internal control letter issued or, to the extent practicable, proposed
to be issued by the independent registered public accounting firm and management&#146;s response; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews with management and the independent registered public accounting firm the scope, adequacy and effectiveness of our financial reporting
controls; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and discusses with management, the Company&#146;s risk management committee, the internal auditor and the independent registered public
accounting firm, as appropriate, the Company&#146;s major financial risks, the Company&#146;s policies for assessment and management of such risks, and the steps to be taken to control such risks; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and evaluates the Company&#146;s information technology processes and risks; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">establishes and maintains procedures for the receipt, retention and treatment of complaints regarding accounting, internal accounting controls or
auditing matters, including procedures for the confidential and anonymous submission by employees of concerns regarding questionable accounting or auditing matters; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">investigates and resolves any disagreements between our management and the independent registered public accounting firm regarding our financial
reporting, accounting practices or accounting policies and reviews with the independent registered public accounting firm any other problems or difficulties it may have encountered during the course of the audit work; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">meets with senior management and the independent registered public accounting firm in separate executive sessions; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews the consolidated financial statements to be included in our quarterly reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and our
annual reports on Form <FONT STYLE="white-space:nowrap">10-K;</FONT> </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">discusses with management and the independent registered public accounting firm the results of the independent registered public accounting firm&#146;s
review of our quarterly consolidated financial statements and the results of our annual audit and the disclosures contained under the caption &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; in
our periodic reports; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and discusses with management and the independent registered public accounting firm any material financial arrangements of the Company which do
not appear on the financial statements of the Company and any significant transactions or courses of dealing with parties related to the Company; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews with management and the independent registered public accounting firm significant issues that arise regarding accounting principles and
financial statement presentation; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">oversees the Company&#146;s internal audit function; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">discusses with management and the independent registered public accounting firm any correspondence from or with regulators or governmental agencies,
any employee complaints or any published reports that raise material issues regarding the Company&#146;s consolidated financial statements, financial reporting process or accounting policies; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">oversees the preparation of the Audit Committee report to be included in the Company&#146;s annual report or proxy statement; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews the Company&#146;s investment policy for its cash reserves, corporate insurance policies, information technology infrastructure and general
fraud monitoring practices and procedures, including the maintenance and monitoring of a whistleblower hotline and the segregation of duties and access controls across various functions. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">37 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has the authority to retain special legal, accounting or other
professional advisors to advise the committee as it deems necessary, at our expense, to carry out its duties and to determine the compensation of any such advisors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Greer serves as the Chairman of the Audit Committee. The board of directors annually reviews the NASDAQ listing standards definition of independence for Audit Committee members and has determined
that all members of our Audit Committee are independent. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">During the 2019 fiscal year, the board of directors determined that
Mr.&nbsp;Greer qualified as an &#147;Audit Committee financial expert&#148; as defined in applicable SEC rules. The board of directors made a qualitative assessment of Mr.&nbsp;Greer&#146;s level of knowledge and experience based on a number of
factors, including his formal education and experience as a Chief Executive Officer at a public reporting company, a Chief Financial Officer, and the chairman of public company Audit Committees. In addition to our Audit Committee, Mr.&nbsp;Greer
also serves as the chair of the Audit Committee of Inogen, Inc. (NASDAQ: INGN). The board of directors does not believe that such simultaneous service impairs Mr.&nbsp;Greer&#146;s ability to effectively serve as Chairman of our Audit Committee. The
board of directors has also determined that Ms.&nbsp;Eastham also qualifies as an &#147;Audit Committee financial expert&#148; as defined in applicable SEC rules. The board of directors made a qualitative assessment of Ms.&nbsp;Eastham&#146;s level
of knowledge and experience based on a number of factors, including her formal education and experience as a Chief Financial Officer of a public reporting company. In addition to our Audit Committee, Ms.&nbsp;Eastham also serves on the Audit
Committees of Illumina, Inc. (NASDAQ: ILMN), Geron Corporation (NASDAQ: GERN) and Veracyte, Inc. (NASDAQ: VCYT). The board of directors does not believe that such simultaneous service impairs Ms.&nbsp;Eastham&#146;s ability to effectively serve on
our Audit Committee. The Audit Committee has adopted a written Audit Committee charter that is available on our corporate website at <I>www.nektar.com</I>. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>ORGANIZATION AND COMPENSATION COMMITTEE </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Organization and
Compensation Committee of the board of directors administers the variable compensation programs and reviews management&#146;s recommendations for organization structure and development of the Company. Additionally, the Organization and Compensation
Committee reviews and in some cases approves the type and level of cash and equity-based compensation for officers, employees and consultants of the Company, and recommends certain compensation actions to the board of directors for review and
approval. The Organization and Compensation Committee: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and approves the structure and guidelines for various incentive compensation and benefit plans; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">grants equity awards under the various equity incentive compensation and benefit plans and an inducement plan established under NASDAQ Listing Rule
5635(c)(4) and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">IM-5635-1;</FONT></FONT> </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">approves the compensation for the executive officers of the Company, including the President and Chief Executive Officer, and those vice-president
level employees that report directly to the President and Chief Executive Officer, including, but not limited to, annual salary, bonus, equity compensation and other&nbsp;benefits; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">recommends the compensation levels for the members of the board of directors who are not employed by us or our subsidiaries <FONT
STYLE="white-space:nowrap">(&#147;non-employee</FONT> directors&#148;) for approval by the independent members of the board of directors; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews the operation of the Company&#146;s executive compensation programs to determine whether they remain supportive of the Company&#146;s business
objectives and are competitive relative to comparable companies and establishes and periodically reviews policies for the administration of executive compensation programs; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">38 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews the Company&#146;s executive compensation arrangements to evaluate whether incentive and other forms of compensation do not encourage
inappropriate or excessive risk taking and reviews and discusses, at least annually, the relationship between risk management policies and practices, corporate strategy and the Company&#146;s executive compensation arrangements;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and discusses with management and the Company&#146;s risk management committee, as appropriate, the Company&#146;s major risks relating to the
purview of the Organization and Compensation Committee, the Company&#146;s policies for assessment and management of such risks, and the steps to be taken to control such risks; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">oversees the preparation of the Organization and Compensation Committee report to be included in the Company&#146;s annual proxy statement and Annual
Report on Form <FONT STYLE="white-space:nowrap">10-K;</FONT> </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and reassess the adequacy of the Organization and Compensation Committee charter on at least an annual basis; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews management recommendations on organization structure and development, including succession planning; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews performance of the executive officers and vice-president level employees that report directly to the Chief Executive Officer.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Organization and Compensation Committee takes into account our President and Chief Executive
Officer&#146;s recommendations regarding the compensatory arrangements for our executive officers, although our President and Chief Executive Officer does not participate in the deliberations or determinations of his own compensation. In particular,
the Organization and Compensation Committee considered our President and Chief Executive Officer&#146;s recommendations for 2019 regarding the increase in annual base compensation, award of annual performance-based bonus compensation and the equity
granted to our executive officers excluding himself. While the Organization and Compensation Committee considers and appreciates the input and expertise of management in making its decisions, it does ensure that an executive session where no
management is present is included in the agenda for every committee meeting.&nbsp;The Organization and Compensation Committee&#146;s charter gives the committee the sole authority to retain independent counsel, compensation and benefits consultants
or other outside experts or advisors that it believes to be necessary or appropriate. During 2019, the Organization and Compensation Committee retained Radford, part of the Rewards Solutions practice of Aon plc, a nationally recognized executive
compensation consulting firm that performs compensation benchmarking, analysis and design services.&nbsp;Radford was engaged in 2019 to provide regulatory, legislative updates and market trend analysis, to provide analysis on our compensation
programs, to provide recommendations and advice on the structure, elements and amounts of compensation provided to our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors, to provide recommendations and advice on Nektar peer companies, to
review the Compensation Discussion and Analysis, and to provide executive compensation analysis as needed.&nbsp;Radford provides compensation survey services to the company in addition to the executive and director compensation services it performs
at the request of the Organization and Compensation Committee. In 2019, we paid Radford $31,282 for provision of survey services. After consideration of such services and other factors prescribed by the SEC for purposes of assessing the independence
of compensation consultants, we have determined that no conflicts of interest exist between the Company and Radford (or any individuals providing such services to the committee on Radford&#146;s behalf). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Organization and Compensation Committee may delegate to its subcommittees such authority as it deems appropriate, except for the
authority the committee is required to exercise by applicable law or regulation. The Organization and Compensation Committee has delegated certain limited authority to grant stock option awards under our stock incentive plan to a committee comprised
of management representatives, and with respect to certain limited authority to grant restricted stock unit awards (RSUs), to a committee of the board of directors, with Mr.&nbsp;Robin serving as the sole member of that committee. These committees
may not approve award grants to anyone serving as an executive officer or director of the Company. Other than the authority delegated to these committees, the Organization and Compensation Committee has no current intention to delegate any of its
authority to any other committee or subcommittee. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">39 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The current members of the Organization and Compensation Committee are
Mr.&nbsp;Lingnau, who chairs the committee, and Messrs. Ajer, and Greer, and Ms.&nbsp;Eastham. The board of directors annually reviews the NASDAQ listing standards definition of independence for Organization and Compensation Committee members and
has determined that all members of our Organization and Compensation Committee are independent. The Organization and Compensation Committee charter can be found on our corporate website at <I>www.nektar.com</I>. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>NOMINATING AND CORPORATE GOVERNANCE COMMITTEE </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Nominating and Corporate Governance Committee: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">establishes criteria for board membership, including standards for independence, and considers and assesses the independence of the directors;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">evaluates board composition and performance; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">identifies, reviews and recommends the board&#146;s selected candidates to serve as directors; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">considers stockholder recommendations for director nominations and other proposals submitted by stockholders; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews the adequacy of, and compliance with, our Code of Business Conduct and Ethics; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">administers and oversees all aspects of our corporate governance functions on behalf of the board; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">monitors regulatory and legislative developments in corporate governance, as well as trends in corporate governance practices, and makes
recommendations to the board regarding the same; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and discusses with management and the Company&#146;s risk management committee, as appropriate, the Company&#146;s major risks relating to the
purview of the nominating and corporate government committee, the Company&#146;s policies for assessment and management of such risks, and the steps to be taken to control such risks; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">establishes and oversees procedures for the receipt, retention and treatment of complaints received by the Company with respect to legal and regulatory
compliance (except for compliance relating to accounting, internal accounting controls, auditing matters and financial disclosure and reporting); and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">provides recommendations to the board of directors to establish such special committees as may be desirable or necessary from time to time in order to
address ethical, legal, business or other matters that may arise. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Nominating and Corporate Governance
Committee believes that candidates for director should possess the highest personal and professional ethics, integrity and values, be committed to represent our long-term interests and those of our stockholders, possess diverse experience at
policy-making levels in business, science and technology, possess key personal characteristics such as strategic thinking, objectivity, independent judgment, intellect and the courage to speak out and actively participate in meetings, as well as
have sufficient time to carry out the duties and responsibilities of a board member effectively. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The current members of the
Nominating and Corporate Governance Committee comprise Mr.&nbsp;Whitfield, who chairs the committee, and Messrs. Greer and Lingnau. The board of directors annually reviews the NASDAQ listing standards definition of independence for the Nominating
and Corporate Governance Committee and has determined that all members of our Nominating and Corporate Governance Committee are independent. The Nominating and Corporate Governance Committee charter can be found on our corporate website at
<I>www.nektar.com</I>. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The current members of our board of directors represent a desirable mix of backgrounds, skills and
experiences, and are all believed to share the key personal characteristics described above.&nbsp;Below are some of the specific experiences and skills of our directors. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">40 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Jeff Ajer </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Ajer, has more than 25 years of biotechnology industry experience within rare disease and specialty medicine. Mr.&nbsp;Ajer
currently serves as Executive Vice President and Chief Commercial Officer at BioMarin Pharmaceutical Inc. Mr.&nbsp;Ajer recently served on the board of directors of True North Therapeutics. Mr.&nbsp;Ajer has extensive knowledge and expertise of the
biotechnology industry. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Robert B. Chess </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Chess is our Chairman and former President and Chief Executive Officer and has a deep understanding of our business. Having founded and led private and public companies, Mr.&nbsp;Chess has strong
experience leading growing companies in our industry. Due to his long association with the Company as a director and senior executive leader at various times, he possesses significant knowledge and perspective on the history and development of the
Company. Mr.&nbsp;Chess is a prominent participant in our industry, was a long-time member of the board of our industry association, and is on the board of trustees and faculty of leading academic institutions. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Myriam J. Curet, M.D. </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Curet<I> </I>has over 20 years of expierence in the biopharmaceutical industry and faculty positions, and currently serves as the Executive Vice President and Chief Medical Officer of Intuitive
Surgical. Dr.&nbsp;Curet has held senior executive positons and has served as Vice President and Chief Medical Officer in November 2017, as the Chief Medical Advisor for Intuitive Surgical from December 2005 to February 2014 and as Intuitive
Surgical&#146;s Senior Vice President and Chief Medical Officer from February 2014 to November 2017. Dr.&nbsp;Curet also has a faculty position as Professor of Surgery at Stanford University School of Medicine. Since October 2010, she has served as
a Consulting Professor of Surgery at Stanford University with a part time clinical appointment at the Palo Alto Veteran&#146;s Administration Medical Center. She was also on the faculty at the University of New Mexico for six years prior to joining
the Stanford University in 2000. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Karin Eastham </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Eastham has held senior executive and finance positions in the biopharmaceutical industry and brings more than 35 years of
experience as both an executive and independent director with significant experience in life sciences with particular expertise in both finance and operations. Ms.&nbsp;Eastham currently serves as a director of several other companies. As a result
of her extensive experience, she brings strong expertise in finance, accounting, operations management, business development, and corporate governance. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>R. Scott Greer </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Greer has a proven track record as an entrepreneur
and senior executive with extensive experience in the biotechnology industry, most recently with Abgenix, Inc., until its acquisition by Amgen, Inc. in 2006. Mr.&nbsp;Greer has held senior executive and finance positions at other companies in our
industry and currently serves as a director of several other companies in the biopharmaceutical and medical device industries and has served as the Chairman of the Board of several companies. He possesses strong expertise in biotech industry
strategy, business models, and finance and has served on compensation, governance and audit committees. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Lutz Lingnau
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Lingnau has a strong management background in the pharmaceutical industry as a senior executive and member of the
executive board of Schering AG Group. He has international sales and operations experience as former head of worldwide sales and marketing in the pharmaceutical division of Schering, and in operational roles in South America and the U.S., and also
as a member of the supervisory board of a German specialty chemicals company. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">41 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Howard W. Robin </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Robin is our President and Chief Executive Officer. Mr.&nbsp;Robin has over 25 years of experience in the pharmaceutical and
biotechnology industries in a variety of roles of increasing responsibility and, prior to becoming our chief executive officer, was the chief executive officer and president and a director of Sirna Therapeutics, a development stage biotechnology
company. The board of directors has determined that Mr.&nbsp;Robin&#146;s position as president and chief executive officer provides him with important insight into the Company&#146;s opportunities, risks, strengths and weaknesses, as well as its
organizational and operational capabilities, which is valuable to the board of directors in making strategic decisions and performing its oversight responsibilities. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Roy A. Whitfield </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Whitfield has a strong strategy development and
leadership background in the biotechnology and medical industries. He is a former strategy consultant from a major consulting firm, was the founder and chief executive officer of a public biotechnology company and has held executive positions in
various segments of the health care industry. He has extensive corporate governance experience through his service on other public company boards in the pharmaceutical and life sciences industries. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Candidates for director nominees are reviewed in the context of the current composition of the board, our operating requirements and the
long-term interests of stockholders. In conducting this assessment, the committee considers diversity, age, skills and such other factors as it deems appropriate given our current needs and those of our board to maintain a balance of knowledge,
experience and capability. The Nominating and Corporate Governance Committee also periodically reviews the overall effectiveness of the board, including board attendance, level of participation, quality of performance, self-assessment reviews and
any relationships or transactions that might impair director independence. In the case of new director candidates, the Nominating and Corporate Governance Committee also determines whether the nominee must be independent for NASDAQ purposes, which
determination is based upon applicable NASDAQ listing standards, applicable SEC rules and regulations and the advice of counsel, if necessary. The committee then uses its network of contacts to compile a list of potential candidates, but may also
engage, if it deems appropriate, a professional search firm. The committee conducts any appropriate and necessary inquiries into the backgrounds and qualifications of possible candidates after considering the function and needs of the board. The
Nominating and Corporate Governance Committee meets to discuss and consider such candidates&#146; qualifications and then selects a nominee for recommendation to the board by majority vote. We have paid fees to third party search firms in the past
to assist in our process of identifying or evaluating director candidates. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Nominating and Corporate Governance Committee
of our board of directors will consider for nomination any qualified director candidates recommended by our stockholders. Any stockholder who wishes to recommend a director candidate is directed to submit in writing the candidate&#146;s name,
biographical information, relevant qualifications and other information required by our bylaws to our Secretary at our principal executive offices before the deadline set forth in our bylaws. All written submissions received from our stockholders
will be reviewed by the Nominating and Corporate Governance Committee at the next appropriate meeting. The Nominating and Corporate Governance Committee will evaluate any suggested director candidates received from our stockholders in the same
manner as recommendations received from management, committee members or members of our board. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_21"></A>S<SMALL>TOCKHOLDER</SMALL> C<SMALL>OMMUNICATIONS</SMALL> <SMALL>WITH</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL>
<SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The board of directors will consider any written or electronic communication
from our stockholders to the board, a committee of the board or any individual director. Any stockholder who wishes to communicate to the board of directors, a committee of the board or any individual director should submit written or electronic
communications to our Secretary at our principal executive offices, which shall include contact information for such stockholder. All communications from stockholders received will be forwarded by our Secretary to the
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">42 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
board of directors, a committee of the board or an individual director, as appropriate, on a periodic basis, but in any event no later than the board of directors&#146; next scheduled meeting.
The board of directors, a committee of the board, or individual directors, as appropriate, will consider and review carefully any communications from stockholders forwarded by our Secretary. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_22"></A>C<SMALL>ODE</SMALL> <SMALL>OF</SMALL> B<SMALL>USINESS</SMALL> C<SMALL>ONDUCT</SMALL> <SMALL>AND</SMALL> E<SMALL>THICS</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have adopted a code of business conduct and ethics that applies to all employees, including our principal executive officer, principal
financial officer, principal accounting officer or controller, or persons performing similar functions. The code of business conduct and ethics is available on our website at <I>www.nektar.com</I>. Amendments to, and waivers from, the code of
business conduct and ethics that apply to any director, executive officer or persons performing similar functions will be disclosed at the website address provided above and, to the extent required by applicable regulations, on a Current Report on
Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_23"></A>O<SMALL>RGANIZATION</SMALL>
<SMALL>AND</SMALL> C<SMALL>OMPENSATION</SMALL> C<SMALL>OMMITTEE</SMALL> I<SMALL>NTERLOCKS</SMALL> <SMALL>AND</SMALL> I<SMALL>NSIDER</SMALL> P<SMALL>ARTICIPATION</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">During 2019, the Organization and Compensation Committee consisted of four independent directors: Messrs. Ajer, Greer and Lingnau and Ms.&nbsp;Eastham. No director who served on the Organization and
Compensation Committee in 2019 was, or has been, an officer or employee of us, nor has any director had any relationships requiring disclosure under the SEC rules regarding certain relationships and related-party transactions. None of our executive
officers served on the board of directors or the Organization and Compensation Committee (or other board committee performing equivalent functions) of another entity, one of whose executive officers served on our board of directors or Organization
and Compensation Committee. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">43 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_24"></A>D<SMALL>IRECTOR</SMALL> C<SMALL>OMPENSATION</SMALL>
T<SMALL>ABLE</SMALL>&#151;F<SMALL>ISCAL</SMALL> 2019 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each of our <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors participates in our Amended and Restated Compensation Plan for <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors (the &#147;Director Plan&#148;). Only our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors are
eligible to participate in the Director Plan. The following table shows compensation awarded or paid to our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors for the fiscal year ended December&nbsp;31, 2019. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name (1)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000 ; display:table-cell;"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fees&nbsp;Earned<BR>or&nbsp;Paid&nbsp;in<BR>Cash&nbsp;($)<BR>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock<BR>Awards<BR>($)(2)<BR>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Awards<BR>($)(3)<BR>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All Other<BR>Compensation<BR>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total ($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(f)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Jeff Ajer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">90,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">122,199</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">139,029</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">351,478</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Robert B. Chess</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">124,700</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">122,199</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">139,029</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">385,928</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Myriam J. Curet, M.D.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">254,942</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">293,165</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">548,107</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Karin Eastham</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">91,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">122,199</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">139,029</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">352,728</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>R. Scott Greer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">118,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">122,199</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">139,029</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">379,228</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Lutz Lingnau</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">122,199</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">139,029</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">361,228</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Roy A. Whitfield</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">123,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">122,199</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">139,029</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">384,228</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Robin, our President and Chief Executive Officer, is not included in this table as he was an employee of the Company in 2019 and
received no additional compensation for his services in his capacity as a director. Please see the &#147;Summary Compensation Table &#150; Fiscal 2017-2019&#148; for information regarding the compensation Mr.&nbsp;Robin received as our President and
Chief Executive Officer. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts reported represent the aggregate grant date fair value of RSU awards computed in accordance with Financial Accounting Standards Board
Accounting Standards Codification Topic 718, Compensation-Stock Compensation (&#147;FASB ASC Topic 718&#148;), based on the closing price of the Company&#146;s common stock on the grant date and excluding the effects of estimated forfeitures. As of
December&nbsp;31, 2019, each of our then-serving <FONT STYLE="white-space:nowrap">non-employee</FONT> directors had 6,500 outstanding RSUs. Dr.&nbsp;Curet had an additional 5,200 outstanding RSUs as part of her initial grant upon being appointed to
the board of directors in December 2019. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts reported represent the aggregate grant date fair value of option awards computed in accordance with FASB ASC Topic 718, which excludes
the effects of estimated forfeitures. For a complete description of the assumptions made in determining the valuation, please refer to Note 11 (Stock-Based Compensation) to our audited financial statements in our annual report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2019. Each of our then-serving <FONT STYLE="white-space:nowrap">non-employee</FONT> directors received a stock option for 13,000 shares for their annual stock option
grant on September&nbsp;25, 2019. Dr.&nbsp;Curet received an additional stock option for 10,400 shares as part of her initial grant upon being appointed to the Board in December, 2019. As of December&nbsp;31, 2019, each of our <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors had stock options outstanding the following number of shares: Mr.&nbsp;Ajer: 78,750; Mr.&nbsp;Chess: 202,500; Dr.&nbsp;Curet 23,400; Ms.&nbsp;Eastham: 30,000; Mr.&nbsp;Greer: 202,500;
Mr.&nbsp;Lingnau: 162,500; and Mr.&nbsp;Whitfield: 192,500. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The 2019 compensation for the Company&#146;s <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors was recommended by the Organization and Compensation Committee to the Board following the receipt of a report from our independent compensation consultant, which in 2019 was Radford, part of
the Rewards Solutions practice of Aon plc, which contained an analysis of prevailing market practices regarding levels and types of <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation, including the <FONT
STYLE="white-space:nowrap">non-employee</FONT> director compensation practices of our 2019 peer group set forth below in the section entitled &#147;Compensation Discussion and Analysis&#148;, and a comparative assessment of our <FONT
STYLE="white-space:nowrap">non-employee</FONT> director compensation to such peers and market practices.&nbsp;On at least an annual basis, qualified experts deliver a presentation to the Organization and Compensation Committee about recent
developments and best practices related to <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Effective January&nbsp;1, 2019 the annual retainer for <FONT STYLE="white-space:nowrap">non-employee</FONT> directors was $65,000
(&#147;Annual Retainer&#148;) for up to 13 board meetings in each calendar year, after which each member received compensation in the amount of $2,000 for attendance at each subsequent <FONT STYLE="white-space:nowrap">in-person</FONT> or telephonic
Board Meeting, and $1,000 for each <FONT STYLE="white-space:nowrap">in-person</FONT> Board Meeting attended via conference telephone. In addition to the Annual Retainer, the Chairperson </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">44 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">
or Lead Director of the Board of Directors received an additional annual retainer of $50,000 for a total of $115,000 for the annual retainer for Chair of the Board of Directors. The annual
retainer amount was $33,000 for the Chair of the Audit Committee and $13,000 for members other than the Chair for up to 9 Audit Committee meetings in each calendar year, after which each member received compensation in the amount of $1,750 for
attendance at each subsequent <FONT STYLE="white-space:nowrap">in-person</FONT> or telephonic Audit Committee meeting and $875 for each <FONT STYLE="white-space:nowrap">in-person</FONT> Audit Committee meeting who attended via conference telephone
in the calendar year, $26,000 for the Chair of the Compensation Committee and $11,000 for members other than the Chair of the Compensation Committee for up to 8 Compensation Committee meetings in each calendar year, after which each member received
compensation in the amount of $1,750 for attendance at each subsequent <FONT STYLE="white-space:nowrap">in-person</FONT> or telephonic Compensation Committee meeting and $875 for each <FONT STYLE="white-space:nowrap">in-person</FONT> Compensation
Committee meeting who attended via conference telephone in the calendar year, $20,000 for the Chair of the Governance Committee and $9,000 for members other than the Chair of the Governance Committee for up to 6 Governance Committee meetings in each
calendar year, after which each member received compensation in the amount of $1,750 for attendance at each subsequent <FONT STYLE="white-space:nowrap">in-person</FONT> or telephonic Governance Committee meeting and $875 for each <FONT
STYLE="white-space:nowrap">in-person</FONT> Governance Committee meeting attended via conference telephone in the calendar year. The Chair of any new committee of the board of directors received an additional annual retainer of $5,000.</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"> </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In September of each year, each <FONT STYLE="white-space:nowrap">non-employee</FONT> director is eligible to receive an equity award
consisting of either all stock options or a combination of stock options and RSUs, as determined by the board of directors. These equity awards vest over a period of one year (monthly for stock options and upon the anniversary date for RSUs) and
include a number of shares as determined annually by the board of directors. In September 2019 our then-serving <FONT STYLE="white-space:nowrap">non-employee</FONT> directors received 13,000 stock options and 6,500 RSUs. Upon initial appointment to
the board of directors, each <FONT STYLE="white-space:nowrap">non-employee</FONT> director is eligible to receive an equity award consisting of either all stock options or a combination of stock options and RSUs. These initial equity awards vest
over a period of three years from the date of appointment and will be at a level based on 180% of the most recent annual equity compensation grant to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors, as determined annually by the board
of directors. The exercise price of stock options granted is equal to the closing price of the Company&#146;s common stock on the grant date. Following completion of a <FONT STYLE="white-space:nowrap">non-employee</FONT> director&#146;s service on
the board of directors, his or her stock options will remain exercisable for a period of eighteen months (or, if earlier, the end of the maximum term of the option). The term of stock options granted to
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors is eight years. In the event of a change of control, the vesting of each option or RSU award held by each <FONT STYLE="white-space:nowrap">non-employee</FONT> director will accelerate in
full as of the closing of such transaction. In the event of death or disability, each RSU of the <FONT STYLE="white-space:nowrap">non-employee</FONT> director will vest immediately. In the event a <FONT STYLE="white-space:nowrap">non-employee</FONT>
director retires from the Board at the next annual stockholder&#146;s meeting, their RSU awards vest on a <FONT STYLE="white-space:nowrap">pro-rata</FONT> basis. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Director Plan includes ownership guidelines for <FONT STYLE="white-space:nowrap">non-employee</FONT> directors stating that each <FONT STYLE="white-space:nowrap">non-employee</FONT> director should
own shares of our common stock equal to at least three times the value of the annual board cash retainer. The minimum stock ownership level was to be achieved by each <FONT STYLE="white-space:nowrap">non-employee</FONT> director within five years of
the date of his or her first appointment to the board of directors. As of December&nbsp;31, 2019, each <FONT STYLE="white-space:nowrap">non-employee</FONT> director met the minimum stock ownership guidelines or was within the five-year grace period
provided by the plan. Our 2017 Plan also limits the aggregate value of cash compensation and the grant date fair value (computed in accordance with generally accepted accounting principles) of shares of Common Stock that may be paid or granted
during any calendar year to any <FONT STYLE="white-space:nowrap">non-employee</FONT> director with a maximum of $1,200,000 for existing <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and $2,200,000 for new <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">45 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_25"></A>COMPENSATION DISCUSSION AND ANALYSIS </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Introduction </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Compensation Discussion and Analysis is designed to provide our stockholders with an understanding of our executive compensation philosophy and decision-making process. It discusses the principles underlying the structure of the compensation
arrangements for our Chief Executive Officer, our Chief Financial Officer, and our other three most highly compensated executive officers who were serving as executive officers on December&nbsp;31, 2019, collectively, our NEOs. Unless noted
otherwise, any reference within the Compensation Discussion and Analysis to decisions made by the board of directors refers to the decisions made by the independent members of the board of directors only. This Compensation Discussion and Analysis
primarily focuses on the compensation of our NEOs for 2019 that are identified in the table below. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="71%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Name</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Title</B></FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Chief Executive Officer</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Operating Officer and Chief Financial Officer</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Northcott</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President and Chief Commercial Officer</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jillian B. Thomsen</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President and Chief Accounting Officer</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jonathan Zalevsky, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Research and Development Officer</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our current compensation programs for the NEOs are determined and approved by the Organization and
Compensation Committee of our board of directors. As described in more detail above under the caption &#147;Information About the Board of Directors-Information Regarding the Committees of the Board of Directors&#151;Organization and Compensation
Committee,&#148; the Organization and Compensation Committee takes into account Mr.&nbsp;Robin&#146;s recommendations regarding the compensatory arrangements for our executive officers, although Mr.&nbsp;Robin does not participate in the
deliberations or determinations of his own compensation. The other NEOs did not have any role in determining or recommending the form or amount of compensation paid to any of our executive officers. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Company Performance Highlights </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In 2019, the Company achieved several important milestones that resulted in significant value creation. We believe these milestones were achieved as a result of a well-crafted long-term strategy and
investment priorities established by management over the past several years. The biotechnology industry is characterized by high stock price volatility and, as a result, our focus on pay for performance is based on an assessment of the level of the
Company&#146;s achievement against annual business and operating objectives rather than the stock price at any given point in time. Some of the significant accomplishments achieved in 2019 are summarized below. </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2019, we continued to evaluate our CD122-preferential <FONT STYLE="white-space:nowrap">IL-2</FONT> pathway agonist bempegaldesleukin <FONT
STYLE="white-space:nowrap">(NKTR-214)</FONT> plus Opdivo<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> (nivolumab) pursuant to a joint development plan under
our Strategic Collaboration Agreement (BMS Collaboration Agreement) with Bristol-Myers Squibb (BMS) that was executed in 2018. We believe this collaboration represented a landmark achievement in the biotechnology industry with a $1.85&nbsp;billion
upfront payment (comprised of a $1&nbsp;billion upfront payment and an $850&nbsp;million premium equity investment), $1.43&nbsp;billion in development and regulatory milestones paid by BMS, with the Company retaining a 65% profit interest and BMS
responsible for a majority of costs for the broad development plan. The joint development plan was updated pursuant to an Amendment No.&nbsp;1 to the BMS Collaboration Agreement that was entered into on January&nbsp;9, 2020, and includes the ongoing
registrational trials in first-line metastatic melanoma, first-line cisplatin ineligible metastatic urothelial cancer and first-line metastatic renal cell carcinoma (RCC), and muscle-invasive bladder cancer, and an additional registrational trial in
adjuvant melanoma, as well as a Phase 1/2 dose escalation and expansion study to evaluate bempegaldesleukin plus nivolumab in combination with axitinib in first-line RCC in order to support a future Phase 3 registrational trial. This amendment also
included up to $125 million in additional and accelerated milestone payments including a <FONT STYLE="white-space:nowrap">non-refundable,</FONT> non-creditable milestone payment in the amount of $25 million upon achievement of
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">46 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2">
the first patient, first visit in the registrational adjuvant melanoma trial, a non-refundable creditable milestone payment in the amount of $25.0 million following the achievement of the first
patient, first visit in the registrational muscle-invasive bladder cancer trial which occurred in the first quarter of 2020, and a non-refundable creditable milestone payment in the amount of $75.0 million following the achievement of the first
patient, first visit in a registrational first-line non-small-cell lung cancer trial evaluating the combination of bempeg and nivolumab. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In August 2019, we announced that the&nbsp;U.S. Food and Drug Administration&nbsp;(FDA) granted Breakthrough Therapy Designation for investigational
agent bempegaldesleukin in combination with&nbsp;Opdivo<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>&nbsp;for the treatment of patients with previously
untreated unresectable or metastatic melanoma. The Breakthrough Therapy Designation is based on clinical data reported at the 2019&nbsp;American Society of Clinical Oncology&nbsp;(ASCO) Annual Meeting from the cohort of patients with metastatic
melanoma that were treated with the doublet therapy in the ongoing <FONT STYLE="white-space:nowrap">PIVOT-02</FONT> Phase 1/2 clinical study. FDA Breakthrough Therapy Designation is intended to expedite the development and review of medicines aimed
at treating a serious or life-threatening disease where there is preliminary clinical evidence that the investigational therapy may offer substantial improvement over existing therapies on at least one clinically significant endpoint.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In June 2019, we announced the results of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> Phase 1a
study evaluating single-ascending doses of <FONT STYLE="white-space:nowrap">NKTR-358,</FONT> a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-class</FONT></FONT> T regulatory cell stimulator in clinical development for
the treatment of autoimmune and other chronic inflammatory conditions. The data show that <FONT STYLE="white-space:nowrap">NKTR-358</FONT> was safe and well-tolerated and led to a marked and selective dose-dependent expansion of T regulatory cells
with no measurable effect on conventional CD4+ and CD8+ T cells (Tcons). <FONT STYLE="white-space:nowrap">NKTR-358</FONT> is designed to correct the underlying immune system imbalance in people with autoimmune conditions, which are associated with
reduced numbers and impaired function of powerful inhibitory immune cells, known as T regulatory (Treg) cells. <FONT STYLE="white-space:nowrap">NKTR-358</FONT> works by targeting the interleukin <FONT STYLE="white-space:nowrap">(IL-2)</FONT>
alpha-beta-gamma receptor complex in the body to stimulate proliferation of Treg cells and their suppressive functional <FONT STYLE="white-space:nowrap">activity.&nbsp;NKTR-358</FONT> was discovered by Nektar and is being <FONT
STYLE="white-space:nowrap">co-developed</FONT> and commercialized in partnership with&nbsp;Eli Lilly and Company. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In October 2019, we announced the initiation of two Phase 1b studies of <FONT STYLE="white-space:nowrap">NKTR-358,</FONT> a novel T regulatory (Treg)
cell stimulator, one in patients with psoriasis and one in patients with atopic dermatitis. Nektar entered into a strategic collaboration with&nbsp;Eli Lilly and Company&nbsp;in 2017 to develop and commercialize
<FONT STYLE="white-space:nowrap">NKTR-358.</FONT> The two Phase 1b studies are Lilly-sponsored studies. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In October 2019, we also announced the initiation of a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human,</FONT></FONT>
Phase 1 clinical study evaluating <FONT STYLE="white-space:nowrap">NKTR-255,</FONT> an <FONT STYLE="white-space:nowrap">interleukin-15</FONT> <FONT STYLE="white-space:nowrap">(IL-15)</FONT> receptor agonist, as monotherapy for patients with relapsed
or refractory <FONT STYLE="white-space:nowrap">non-Hodgkin</FONT> lymphoma (NHL) or multiple myeloma (MM). The study will also combine <FONT STYLE="white-space:nowrap">NKTR-255</FONT> with multiple targeted antibodies, that function through an
antibody-dependent cell-mediated cytotoxicity (ADCC) mechanism, to evaluate the safety and efficacy in adults with relapsed or refractory MM. <FONT STYLE="white-space:nowrap">NKTR-255</FONT> is designed to activate the
<FONT STYLE="white-space:nowrap">IL-15</FONT> pathway and expand functionally superior natural killer (NK) cells and promote the survival and expansion of memory CD8+ T cells without inducing suppressive regulatory T cells.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In November 2019, we announced new data at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting for previously untreated metastatic
melanoma patients in the PIVOT-02 study of bempegaldesleukin with nivolumab. Key data highlights from this presentation included that at a median time of follow-up of 18.6 months, confirmed objective response rate (ORR) was 53% (20/38) in
efficacy-evaluable patients, with 34% (13/38) of patients achieving confirmed complete responses (CR). 42% (16/38) of patients achieved a maximum reduction of 100% in target lesions. DCR, also known as disease control rate (CR+ Partial Response +
Stable Disease), was 74% (28/38). At a median time of follow-up of 18.6 months, the Kaplan-Meier estimate of median progression-free survival (PFS) was not reached (95% CI: 5.3, NE). </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">47 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Throughout 2019 we continued advancing other molecules in our immuno-oncology portfolio. <FONT STYLE="white-space:nowrap">NKTR-262</FONT> is a small
molecule agonist that targets toll-like receptors found on innate immune cells in the body. <FONT STYLE="white-space:nowrap">NKTR-262</FONT> is designed to stimulate the innate immune system and promote maturation and activation of
antigen-presenting cells (APC), such as dendritic cells, which are critical to induce the body&#146;s adaptive immunity and create antigen-specific cytotoxic T cells. <FONT STYLE="white-space:nowrap">NKTR-262</FONT> is being developed as an
intra-tumoral injection in combination with systemic bempegaldesleukin in order to induce an abscopal response and achieve the goal of complete tumor regression in cancer patients with both therapies. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe that the above accomplishments, together with accomplishments achieved by the Company over the past ten years, directly
resulted in the Company: (1)&nbsp;building and advancing a significant drug candidate pipeline; (2)&nbsp;building an organization and infrastructure designed to execute on our mission of being a leading research-based development stage
biopharmaceutical company; and (3)&nbsp;establishing collaboration and proprietary product opportunities that have significant future economic potential based on milestone payments, royalties and sales. We believe that the compensation programs and
awards to our NEOs should be evaluated within the context of these significant accomplishments and performance over a sustained period. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Compensation Program Objectives and Philosophy </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In order to continue the execution and growth of our business as described above, we believe that it is vital that we continue to retain and attract highly experienced and skilled senior leadership by
offering competitive base compensation and benefits, significant performance-based incentives, and the potential for long-term equity compensation. Our goal is to structure a meaningful portion of executive compensation such that it will only have
value if the senior leadership is successful in building significant long-term value for Nektar&#146;s business and our stockholders.&nbsp;&nbsp;&nbsp;&nbsp; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our current executive compensation programs are intended to achieve the following four fundamental goals and objectives to: (1)&nbsp;incent and reward sustained long-term performance by aligning
significant elements of executive compensation with our stockholders&#146; interests; (2)&nbsp;attract and retain an experienced, highly qualified and motivated executive management team to lead our business; (3)&nbsp;provide economic rewards for
achieving high levels of our performance and individual contribution; and (4)&nbsp;pay compensation that is competitive, taking into account the experience, skills and performance of the executives required to build and maintain the organization
necessary to support our mission to be a leading research-based development stage biopharmaceutical company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">When structuring
our executive compensation programs to achieve our goals and objectives, we are guided by the following philosophies: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Alignment with Stockholders&#146; Interests</I>. Our compensation model should be designed to align the economic interests of our executives with
those of our stockholders. In 2012, we established a performance-based equity award program for our executive officers. Under this program, 50% of the annual equity awards to our executive officers are performance-based equity awards that only vest
if a performance condition is met within five years. The performance goal for 2019 is the Company&#146;s achievement of two (2)&nbsp;of the following five (5)&nbsp;events: (i) filing two (2)&nbsp;Investigational New Drug (&#147;IND&#148;)
applications with the FDA for drug candidates wholly-owned by the Company; (ii)&nbsp;two clinical collaborations with significant <FONT STYLE="white-space:nowrap">co-funding</FONT> support of at least 30% of clinical studies involving Company
proprietary drugs; (iii)&nbsp;a judgment by a federal court that a Company-owned patent validly covers a third party product or the settlement of a patent litigation resulting in a payment to Company; (iv)&nbsp;the filing of a New Drug Application
(&#147;NDA&#148;) by the FDA for a Company proprietary drug; and (v)&nbsp;the approval of an NDA by the FDA for a Company proprietary drug. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Pay for Performance</I>. The objective of our executive compensation program is to deliver compensation above industry median for exceptional
performance and deliver compensation below the median in </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">48 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2">
performance periods where the Company does not perform well. Since 2012 we have tied each NEOs&#146; annual merit equity award to an assessment of individual performance or the achievement of
what we believe to be rigorous and objective performance achievement milestones or criteria (such as the filing or approval of an NDA by the FDA for a company proprietary drug). </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Total Rewards Program.</I> The total compensation program must balance pay for performance elements with selected static <FONT
STYLE="white-space:nowrap">non-performance-based</FONT> elements in order to create a total rewards program that is competitive and will help us attract and retain highly qualified and motivated executives. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Flexible Approach</I>. The level of compensation provided to executives must take into account each executive&#146;s role, experience, tenure,
performance and expected contributions to our future success. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Focus on Achievement of Fundamental Business Goals.</I> The compensation program should be structured so that executives are appropriately
incentivized to achieve our short- and long-term goals that are viewed as fundamental to driving value in our business. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We believe that each element of our executive compensation program helps us to achieve one or more of these compensation objectives. For example, we believe that performance-based short-term cash
incentive opportunities in combination with performance-based equity incentive awards that are earned over time is the best way to align our executives&#146; interests with those of our stockholders and pay for performance with our objective to
measure performance based upon achieving business milestones that we believe will create long-term value. We also believe that the long-term vesting schedules applicable to equity awards also serve as a significant retention incentive as well as a
focus on building long-term stockholder value. Providing base salaries and certain severance protections helps us ensure that we are providing a competitive compensation package that attracts and retains qualified, experienced and highly skilled
executives. We designed our total compensation program to combine short- and long-term components, cash and equity, and fixed and contingent payments, in proportions that we believe are appropriate to achieve each of our fundamental compensation
philosophies as described above. It was our intent to design the structure of our compensation program to provide appropriate incentives to reward our executives for achieving our long-term goals and objectives, some of the most important of which
are building and advancing a robust drug candidate pipeline, entering into new collaboration partnerships and executing on our current collaborations, increasing the skill level and efficiency of our organization and improving our financial
performance. We believe that our compensation program has helped us both recruit and retain superior executive talent to continue to build an organization capable of executing on our mission to become a leading research-based development stage
biopharmaceutical company. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">49 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Relationship between Company Performance and Executive Pay </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">The biotechnology industry is generally thought to be characterized by a higher risk profile and by more binary
business outcomes than other, more traditional industries. This historically has led to high stock volatility for biotechnology companies. Mr.&nbsp;Robin&#146;s total compensation, as reported below in the Summary Compensation Table &#150; Fiscal
2017-2019, decreased by 25% in 2019 as compared with 2018. The graph below demonstrates that even with high levels of volatility in stock price, the total compensation for Mr.&nbsp;Robin is generally aligned with our stock price performance over the
past five years. In 2019, CEO (and other NEO) equity awards were targeted at the market 50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"> percentile factoring performance but also the company&#146;s then-current position relative to the peer group in terms of size. Individual executive awards were adjusted from 50</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile based on individual performance. We anticipate
reevaluating competitive positioning annually factoring Nektar&#146;s size relative to the peer group and performance. We adopted a value-based approach for sizing equity, consistent with market practices. Awards were delivered 50% stock options /
50% RSUs (ratio of two stock options: one RSU), with 50% of each vehicle tied to time-based vesting and the other 50% vesting upon achievement of performance milestones. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g910899g64s91.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2017, 2018 and 2019, equity awards made to Mr.&nbsp;Robin accounted for 85%, 80% and 88%,
respectively, of his total direct compensation. Our objective in providing a substantial portion of Mr.&nbsp;Robin&#146;s compensation in the form of equity awards is to ensure that substantial compensation value is made available to him that
fluctuates based on stock price performance. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, since 2012,
<FONT STYLE="white-space:nowrap">one-half</FONT> of Mr.&nbsp;Robin&#146;s annual equity compensation grants awarded to him included performance-based vesting conditions, and as a result these awards only have value if, for 2019 awards, the Company
achieves two (2)&nbsp;of the following five (5)&nbsp;events: (i) filing two (2)&nbsp;IND applications with the FDA for drug candidates wholly-owned by the Company; (ii)&nbsp;two clinical collaborations with significant
<FONT STYLE="white-space:nowrap">co-funding</FONT> support of at least 30% of clinical studies involving Company proprietary drugs; (iii)&nbsp;a judgment by a federal court that a Company-owned patent validly covers a third party product or the
settlement of a patent litigation resulting in a payment to Company; (iv)&nbsp;the filing of an NDA by the FDA for a Company proprietary drug; and (v)&nbsp;the approval of an NDA by the FDA for a Company proprietary drug. This performance hurdle is
in addition to a time-based vesting requirement that also applies to his equity awards. We believe these performance-based equity grants serve to further align Mr.&nbsp;Robin&#146;s interests with those of our stockholders and create appropriate
additional incentives to achieve performance objectives that we consider critical to the long-term growth and value of the Company.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"> </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">50 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Executive Compensation Practices </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Below we provide a summary of our executive compensation practices, including both the practices that we follow and those that we do not
follow, in each case based on whether we believe they serve the long-term interests of our stockholders. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Core Compensation Principles and
Practices </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9745;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Pay for Performance</I>. A substantial majority of the compensation awarded to our NEOs is either tied to specific company-wide and
individual performance objectives or has been made either in the form of stock option awards that will only have value if our stock price increases after the grant date or RSUs the value of which fluctuates with our stock price.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9745;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Performance-Based Equity Grants</I>. Since 2012, we have awarded 50% of each then-serving executive officer&#146;s annual equity grants in
the form of performance-based equity awards that only vest and become exercisable upon the achievement of the submission and acceptance of NDAs in the U.S. or MAAs in Europe for significant programs in our pipeline, or meeting significant program
goals, in addition to satisfying time-based vesting requirements. We believe this program is important in that it even more tightly aligns the economic interests of our senior leadership team with those of our stockholders.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9745;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Ownership Guidelines</I>. Effective 2019 we established ownership guidelines such that the CEO should own shares of our common stock equal
to at least three times his base salary, and that the NEOs should own shares of our common stock equal to at least one times his or her base salary. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9745;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Regular Peer Group Review</I>. The Organization and Compensation Committee regularly reviews the Company&#146;s compensation peer group.
This review occurred most recently in June 2019. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9745;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Double Trigger</I>. Our change of control severance benefit plan (&#147;CIC Plan&#148;) provides our executive officers with acceleration
of unvested equity awards held by them if they are terminated (without cause or constructively) in connection with a change of control transaction or within twelve months following a change of control transaction. Our award agreements and CIC Plan
do not mandate accelerated vesting of equity awards based on a change of control alone. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9745;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Reasonable Post-Employment and Change of Control Severance Arrangements</I>. We believe that our severance arrangements with our executive
officers are reasonable and in line with industry practice. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9745;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Compensation Claw-Back Policy</I>. We have implemented a claw-back policy which permits us to require reimbursement or cancellation of all
or a portion of any performance-based cash awards or equity incentive payments to the extent based on financial results that are subsequently revised. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9745;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Regular Review of Share Utilization for Equity Compensation</I>. We regularly evaluate and manage equity incentive plan share reserve pool
utilization by reviewing overhang levels (the dilutive impact of equity compensation on stockholders) and annual burn rates (the aggregate shares awarded as a percentage of total outstanding shares). </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9745;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Mitigate Undue Risk</I>. We have designed our executive compensation program to mitigate undue risk associated with compensation by
implementing the following: multiple performance targets and caps on potential payments of short-term incentive compensation (i.e., annual bonuses); awarding a substantial portion of executive compensation in the form of long-term compensation
(i.e., stock options and RSUs, with multi-year vesting requirements); and compensation claw-back provisions requiring reimbursement or cancellation of all or a portion of any performance-based cash awards or equity incentive payments (please refer
to the full policy on Nektar.com/governance). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9745;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Utilize Independent Compensation Consulting Firm</I>. The Organization and Compensation Committee regularly consults with an independent
compensation consulting firm which provides no other services to the Company. For more information on our independent compensation consultant, please see </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">51 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
&#147;Organization and Compensation Committee&#148; under &#147;Information About Our Board of Directors&#148; above. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9745;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stockholder Outreach</I>. We regularly meet with our stockholders to obtain feedback and discuss items of concern to them, including
executive compensation. We describe stockholder outreach efforts on executive compensation in more detail below in the section titled &#147;Role of Stockholder
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Say-on-Pay</FONT></FONT> Votes.&#148; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9746;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Stock Option Repricing</I>. Our equity incentive plans prohibit us from repricing, exchanging or otherwise providing value for
underwater stock options without stockholder approval. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9746;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Elimination of Excise Tax <FONT STYLE="white-space:nowrap">Gross-Ups</FONT> on Change of Control Payments</I>. On April&nbsp;5, 2011, we
amended our CIC Plan to eliminate any &#147;gross up&#148; payments for any excise taxes imposed on participants who became eligible to participate in the plan after January&nbsp;1, 2010 (for prior participants, the provision remains in effect).
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9746;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Accelerated Vesting of Equity Awards on Termination</I>. Whether one of our NEOs is terminated by the Company without cause or resigns
for good reason, our severance arrangements do not provide for accelerated vesting of outstanding equity awards (other than in connection with a qualifying termination after a change of control as provided in the CIC Plan).
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9746;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Inclusion of the Value of Equity Awards in Severance Calculations.</I> Our post-termination and change of control severance arrangements
do not include the value of equity awards in annual compensation for purposes of determining cash severance amounts. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9746;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Fixed Employment Terms</I>. We do not have employment contracts with our executive officers that provide for a guaranteed term of
employment. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9746;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Funded Pension or Retirement Plans</I>. We do not provide any guaranteed or funded retirement plan benefits other than a matching
contribution of up to $6,000 for 401(k) plan participants that we make available to all employees. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9746;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Hedging Transactions, Share Pledging, or Short Sales by Employees or Directors</I>. Our security trading policy prohibits any employee or
director from engaging in hedging transactions, short sales or trading in any derivative security of the Company. This policy also prohibits purchasing our shares on margin. This policy permits the holding of our stock in a margin account only if an
employee or director has, at all times, sufficient cash or securities other than our stock to meet a margin call.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">
</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Role of Stockholder <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Say-on-Pay</FONT></FONT> Votes </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Engaging with our
stockholders helps us to understand how they view us, assists in setting goals and expectations for our performance, and identifies any emerging issues that may affect our strategies, corporate governance, compensation practices or other aspects of
our operations. Throughout the year, members of Investor Relations and other subject-matter experts within the Company engage with our stockholders to remain well-informed regarding their perspective on current issues, as well as to address any
questions or concerns. These teams serve as liaisons between stockholders, members of senior management and the Board. Additionally, our stockholder and investor outreach includes investor road shows, analyst meetings, and investor conferences and
meetings. We seek stockholder feedback on executive compensation, governance and other matters throughout the year, concentrating our efforts on our largest stockholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We provide our stockholders with the opportunity to cast an annual advisory vote on our executive compensation program (referred to as a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-pay</FONT></FONT> vote&#148;).&nbsp;At our annual meeting of stockholders held in June 2019, approximately 97.7% of the votes cast on the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> proposal were voted in favor of the proposal.&nbsp;After considering the 2019
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> vote, the Organization and Compensation Committee reaffirmed the design and elements and did not make any changes to our executive compensation program in
response to the 2019 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> vote.&nbsp;The board of directors and Organization and Compensation Committee will continue to
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">52 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
consider the outcome of our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> proposals and direct stockholder feedback when making future compensation
decisions for the NEOs. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Design and Elements of Our Compensation Program </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The material elements of our current executive compensation programs for NEOs consist primarily of the following: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Base Salary.</I> Each NEO earned an annual base salary during 2019. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Short-Term Incentive Compensation.</I> Each NEO was eligible to earn an incentive cash compensation payment for the 2019 performance period
based on a combination of the Company&#146;s achievement of corporate performance objectives and individual performance. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Long-Term Incentive Compensation.</I> Each NEO was awarded annual equity grants with a mix of approximately 50% of equity award value in
the form of RSUs and 50% of equity award value in the form of stock options, in each case with the equity awards granted or vesting based on an assessment of individual performance or objective achievement milestones or criteria.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Direct Compensation Mix </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">While we review peer group company data regarding the mix of current and long-term incentive compensation and between cash and <FONT STYLE="white-space:nowrap">non-cash</FONT> compensation, we have not
adopted any formal policies or guidelines for allocations among these various compensation elements. Our executive compensation program is predominantly performance-based. As an executive&#146;s ability to impact operational performance increases,
so does the proportion of his or her <FONT STYLE="white-space:nowrap">at-risk</FONT> compensation. Target long-term incentive compensation grows proportionately as job responsibilities increase, which encourages our NEOs to focus on the
Company&#146;s long-term success and aligns with the long-term interests of our stockholders. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">53 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consistent with our pay for performance philosophy, we believe that a greater component
of overall direct compensation for the NEOs relative to other employees should be performance-based; therefore, in 2019 approximately 75% to 96% of total direct compensation of the NEOs was tied to Company and individual performance objectives or
linked to the value of our stock price. The graphics below illustrate the mix of fixed, annual and long-term target incentive compensation we provided to our CEO. These graphics also illustrate the amount of target direct compensation tied to
achievement of performance goals. In 2019, approximately 88% of total direct compensation to Mr.&nbsp;Robin was performance-based and not guaranteed. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g910899g76l04.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">50% of the annual merit-based equity awards granted to Mr.&nbsp;Robin in 2019 were contingent upon
achievement of a performance-based milestone in addition to time-based vesting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Use of Peer Company Data </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We regularly review the compensation practices of our peer group companies identified below in response to the fast-moving nature of the
biotechnology industry, including merger and acquisition activity, and changes in product pipeline and business stage.&nbsp;In determining the appropriate peer companies, we consider the following
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">54 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
factors: business model; commercial and business stage and complexity; therapeutic area; status of the drug candidate pipeline; manufacturing activity (if any); technology platform; product focus
and company size: revenue; market capitalization; and likelihood of competition for highly-skilled personnel. As a result of the Company having a combination of multiple drug candidates in diverse therapeutic areas, a mix of wholly-owned and
partnered drug candidates, a technology platform with the potential to enable multiple drug candidates in future years, and a significant legacy proprietary manufacturing operation, it is very challenging to identify truly comparable companies.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As part of its annual process, in June 2019 the Organization and Compensation Committee reviewed our compensation peer group
with the objective of aligning the Company&#146;s market capitalization and business model with that of the peer group to be used for the 2019 annual compensation decisions. After review, Regeneron Pharmaceuticals, Inc., and Vertex Pharmaceuticals,
Inc. were removed from our current peer group. Moderna and Sarepta Therapeutics were added to our current peer group. The peer group of companies considered when evaluating 2019 compensation decisions consisted of the following companies:
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">ACADIA Pharmaceuticals, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Alexion Pharmaceuticals, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Alkermes, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Alnylam Pharmaceuticals, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">BioMarin Pharmaceutical, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bluebird Bio, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exelixis, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Incyte Corporation</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Ionis Pharmaceuticals, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jazz Pharmaceuticals Plc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Moderna, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Neurocrine Biosciences, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Sarepta Therapeutics, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Seattle Genetics, Inc.</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">Given that certain of our peer group companies have larger or smaller market
capitalizations than the Company, the Organization and Compensation Committee also reviews equity and total direct compensation data for our executives against the compensation for similarly situated executives at peer companies contained in
surveys. In 2018, we adopted a value-based approach for sizing equity and Radford, part of the Rewards Solutions practice of Aon plc, our independent compensation consultant, provided recommendations which are benchmarked to the 50</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile, and adjusted based on the Company&#146;s performance and
size relative to the peer group. Although the Organization and Compensation Committee reviewed and discussed the compensation data for the peer group companies to help inform executive compensation decisions, it does not set compensation at any
specific level or percentile based solely on the peer group data. The peer group data and general industry compensation survey data is used only as one reference point taken into account in making compensation decisions. In determining total and
direct compensation, the Organization and Compensation Committee considers a number of factors including an assessment of individual and company performance, competitive market practices, the number of unvested stock options held by the executive
and average exercise price (i.e., the retention value) of these options, the number of unvested RSUs, the individual&#146;s overall contributions, and stockholder dilution. However, we do not use a formula or assign a particular weight to any one
factor in determining cash and equity award levels. The determination of equity grant levels is subjective, and the Organization and Compensation Committee awards equity grants at levels it believes in its judgment are reasonably competitive and
consistent with our philosophy that a substantial portion of our executives&#146; compensation should be performance-based and help to further link the interests of our executives with those of our stockholders. The Organization and Compensation
Committee does not use peer group or industry survey data as a standalone tool for setting compensation due to the unique aspects of our business and the need to attract and retain particular expert managers with unique experience and skills.
However, the Organization and Compensation Committee generally believes that reviewing and analyzing this information is an important component of its executive compensation decision-making process. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Base Salary </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Base
salary is the initial building block of compensation for the NEOs because it provides the executives with a specified basic level of cash compensation, which we believe is important to attract and retain highly
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">55 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
skilled and experienced executives. The Organization and Compensation Committee determines base salaries by considering competitive pay practices, cost of labor and compensation trends,
individual performance and promotions, level and scope of responsibility, experience and internal pay equity. However, the Organization and Compensation Committee does not use a formula or assign a particular weight to any one factor. Rather, the
determination of base salary levels is subjective, and base salaries are set at levels that the Organization and Compensation Committee believes to be reasonably competitive. In October 2019, Dr.&nbsp;Zalevsky was provided a base salary increase of
16.2% upon his promotion to his new position of Chief Research and Development Officer. In October 2019, Mr.&nbsp;Labrucherie was provided a base salary increase of 13.4% upon his promotion to his new position of Chief Operating Officer and Chief
Financial Officer. In December 2019, the Organization and Compensation Committee reviewed the base salaries of the NEOs and increased the CEO base salary by 3.5% and the other NEO base salaries by 4.8% to 5.1% for 2020. Due to his hire date of
December&nbsp;2, 2019, Mr.&nbsp;Northcott did not receive an increase to his base salary in 2019. The base salary earned by each NEO during 2019 is reported below in the Summary Compensation Table &#150; Fiscal 2017-2019. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Short-Term Incentive Compensation </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Incentive Compensation Plan.</I> We believe that our short-term incentive compensation program (&#147;Incentive Compensation Plan&#148;) for the NEOs rewards the achievement of important short-term
objectives that advance us toward our long-term strategic objectives. Our Incentive Compensation Plan applies to all employees and all executive officers other than Mr.&nbsp;Robin, who is subject to his own separate annual performance-based bonus
compensation arrangement with a combination of corporate and personal objectives established and evaluated by the Organization and Compensation Committee. However, Mr.&nbsp;Robin&#146;s bonus arrangement for 2019 was based on substantially the same
corporate objectives that we established under the Incentive Compensation Plan. Consistent with our compensation philosophy of paying for performance and maintaining a flexible approach, we use the Incentive Compensation Plan to incent the NEOs to
achieve important corporate goals while at the same time encouraging and rewarding excellent individual performance by recognizing and rewarding differences in performance between individual executives. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Plan Design.</I> The board of directors establishes a small number of important annual corporate goals each year
that include clinical development, research, manufacturing, organizational and financial goals which we believe are essential to building long-term stockholder value and are used to assess annual corporate performance. The relative weightings of
these corporate goals are based upon our assessment of the importance of each goal in creating long-term value for the Company and our stockholders. If we achieve the target level of performance for all of the stated goals, the overall corporate
performance rating should be approximately 100%. We endeavor to select corporate goals that, if met by management, represent significant levels of annual achievement, although we believe the long-term nature of our drug development business does not
lend itself to over-weighting the importance of annual goals. Following the conclusion of the annual performance period, the level of achievement for each corporate goal is assessed by the board of directors. The board determines whether each
corporate goal has been met, exceeded, or not satisfied. In addition, in assessing corporate performance, the determination of corporate performance may be adjusted upward or downward as deemed appropriate to factor in other significant corporate
events, either negative or positive, that occurred during the performance period.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"> </SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">After taking into account the level of attainment of each corporate goal and such other corporate performance factors as the board may determine appropriate in reviewing performance for a particular year,
the board of directors assigns an overall corporate performance rating for the year, which may range from 0% to 200%. The Organization and Compensation Committee then confirms the corporate performance rating for purposes of the Incentive
Compensation Plan. The total available bonus pool under the Incentive Compensation Plan is determined by multiplying the corporate performance rating by the aggregate target bonus of all eligible participants which includes nearly all of the
Company&#146;s full-time employees. The aggregate of all individual bonuses awarded under the plan cannot exceed the total available bonus pool so that the total cost of bonuses ultimately reflects our assessment of overall performance and is not
inflated by the sum of individual performance ratings. Mr.&nbsp;Robin does not participate in the final selection of the corporate goals or determination of the corporate performance rating. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">56 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">After the corporate performance rating is determined, the individual performance of
each NEO is reviewed by the Organization and Compensation Committee in consultation with Mr.&nbsp;Robin (other than with respect to his own performance) in order to determine the appropriate individual performance percentage rating to be assigned to
the executive for the performance period. Mr.&nbsp;Robin&#146;s individual performance is separately reviewed by the Organization and Compensation Committee. Each NEO&#146;s actual annual bonus is based on a combination of the corporate performance
rating and individual performance. The Incentive Compensation Plan does not provide for a specific allocation or weighting between corporate and individual performance.&nbsp;The actual annual bonus awarded for each NEO is solely determined by the
Organization and Compensation Committee based on criteria that includes an assessment of individual and company performance, and the maximum payout for each NEO, including Mr.&nbsp;Robin, could be up to 200% of his or her annual performance-based
compensation target (or, by the same token, an individual executive&#146;s award could be reduced to 0% based on individual performance regardless of the corporate performance rating). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Target Annual Short-Term Incentive Compensation for 2019.</I> The NEOs were each assigned a target annual incentive for 2019 ranging
from 50% to 85% of base salary. In 2019, Mr.&nbsp;Labrucherie&#146;s bonus percentage increased from 50% to 75% upon his promotion to the position of Chief Operating Officer and Chief Financial Officer; and Dr.&nbsp;Zalevesky&#146;s bonus percentage
increased from 50% to 60% upon his promotion to the position of Chief Research and Development Officer. The table below shows the target annual incentive assigned by us to each NEO as of December 2019 both as a dollar amount and as a percentage of
base salary. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Annual</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive&nbsp;for</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2019</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Annual</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive&nbsp;for</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2019</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(%&nbsp;of&nbsp;Base</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Salary)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">864,790</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">85</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">562,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Northcott</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jillian B. Thomsen</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">228,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jonathan Zalevsky, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">390,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">60</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Company Performance Objectives.</I> The 2019 corporate objectives and relative weightings assigned to
each objective were as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Objective</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target&nbsp;%</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Clinical</I></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Objectives related to <FONT STYLE="white-space:nowrap">NKTR-214</FONT> clinical study enrollment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Objective related to <FONT STYLE="white-space:nowrap">NKTR-181</FONT> approval</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Objective related to <FONT STYLE="white-space:nowrap">NKTR-262</FONT> and <FONT STYLE="white-space:nowrap">NKTR-214</FONT>
combination clinical study</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Objective related to <FONT STYLE="white-space:nowrap">NKTR-358</FONT> phase 1 clinical study</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Objective related to <FONT STYLE="white-space:nowrap">NKTR-255</FONT> clinical study enrollment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Research</I></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Objective related to advancing IND enabling work for <FONT STYLE="white-space:nowrap">NKTR-230</FONT> in 2020</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Objective related to advancing a development candidate status to support an IND filing in 2021</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Manufacturing/Supply</I></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Objective related to <FONT STYLE="white-space:nowrap">NKTR-214</FONT> <FONT STYLE="white-space:nowrap">scale-up</FONT> to meet
clinical and commercial requirements</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Objective related to manufacture of <FONT STYLE="white-space:nowrap">NKTR-181</FONT> for commercial supply</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Corporate and Financial</I></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Objective related to putting into place strategic resources and infrastructure to support immuno-oncology program</FONT></P></TD>

<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Objective related to <FONT STYLE="white-space:nowrap">year-end</FONT> cash position (not including payments from new
collaborations, financings, or stock option exercise proceeds)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">57 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">These performance objectives served as the corporate performance objectives under the
Company&#146;s Incentive Compensation Plan. This weighting of objectives is a reflection of our long-term focus as a research-based development stage biopharmaceutical company with the goal of building a broad, robust and diverse pipeline of
proprietary drug candidates.&nbsp;We believe this mix of corporate goals represents objectives important to building the long-term foundation of our business. A corporate performance rating in excess of 100% can only be achieved if the Organization
and Compensation Committee determines that the goal achievement for one or many of the goals substantially and qualitatively exceeded the target metrics, or the Organization and Compensation Committee uses its discretion to factor in other
significantly positive corporate events that occurred during the performance period. The maximum potential corporate performance rating is 200%. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Actual Annual Incentives Earned for 2019</I>. Management prepared a report on the status of achievement of the 2019 corporate objectives that was reviewed by the Organization and Compensation
Committee. The Organization and Compensation Committee determined that seven of the corporate goals identified above were met, one goal was significantly exceeded, three goals were partially met, and one goal was not met resulting in a 63% aggregate
corporate performance achievement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Organization and Compensation Committee, in consultation with Mr.&nbsp;Robin,
determined an individual performance rating for each of the NEOs excluding Mr.&nbsp;Robin, whose performance is determined independently by the Organization and Compensation Committee without his participation. Consistent with standards used to
determine annual incentive awards for all employees and our objective to tie pay to performance, the NEOs are eligible to earn annual bonus awards that exceed the corporate performance rating if their rating is &#147;exceptional&#148; or
&#147;exceeds expectations.&#148; Employees with ratings of &#147;solid performer,&#148; &#147;needs improvement&#148; or &#147;does not meet expectations&#148; received awards below the corporate performance rating level, and in some cases, they
received bonuses significantly below that level or no bonus award at all. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Organization and Compensation Committee
considered a number of performance factors in determining each executive&#146;s performance rating and associated annual incentive awards, including specific accomplishments of each NEO, the effectiveness of leadership within the NEO&#146;s
functional area, the level of their contributions to the achievement of the corporate objectives, the achievement of certain outcomes that were not corporate objectives but nonetheless important projects at the Company, and the ability to
effectively work with other members of the management team. Although the Organization and Compensation Committee determined that the NEO&#146;s individual performance merited annual bonus awards, Nektar&#146;s Executive Committee (which is comprised
of the NEOs and other executives) opted to forego their individual annual cash bonus awards completely to underscore their commitment to the long-term performance of the Company and to reinforce a culture of leadership accountability in a year
overall corporate performance did not meet their expectations. The table below includes the actual cash 2019 bonuses, as a percentage of the target bonus, that we awarded the NEOs for 2019. The long-term incentive compensation equity awards granted
to the NEOs, which included a 2019 annual equity award and an additional equity award, are discussed in the next section. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Actual&nbsp;Bonus</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>as a</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percentage&nbsp;of</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Target&nbsp;Bonus<BR>for&nbsp;Entire<BR>2019&nbsp;Year</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(%)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Northcott </FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jillian B. Thomsen</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jonathan Zalevsky, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Northcott was not eligible for an annual bonus due to his hire date of December&nbsp;2, 2019. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amount of each NEO&#146;s bonus for the 2019 fiscal year are reported in the Summary Compensation Table &#150; Fiscal 2017-2019.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">58 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Long-Term Incentive Compensation: Equity Awards </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Overview.</I> In accordance with our objective of aligning executive compensation with our stockholders&#146; interests, our current
long-term incentive program for the NEOs generally consists of annual awards of equity compensation that are subject to a multi-year vesting schedule. We believe that equity compensation is a very effective tool to align the interests of our NEOs
with the interests of our stockholders. Consistent with the 2018 program, the 2019 annual equity awards included a mix of approximately 50% in the form of stock options and 50% in the form of RSUs, with the number of RSUs are determined by treating
each RSU as the equivalent of two stock options. This ratio converts stock options to RSUs using a slight discount to the stock option fair value disclosed in the Summary Compensation Table &#150; Fiscal 2017-2019 to recognize that RSUs each
represent a full value share. Fifty percent (50%) of the 2019 annual stock option and RSU grants are subject to performance-based vesting conditions as well as a time-based vesting requirement. Annual stock options vest monthly over four years and
annual RSUs vest quarterly over three years. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Performance-Based Equity Compensation Program. In 2012, we established a
performance-based equity program for our executive officers. Under this program, 50% of the annual equity awards granted to our executive officers each year have been made in the form of performance-based equity awards that vest based on time-based
vesting schedules plus a separate independent performance condition that must also be achieved within five years of grant. The performance criteria for 2019 is the Company&#146;s achievement of two (2)&nbsp;of the following five (5)&nbsp;events: (i)
filing two (2)&nbsp;IND applications with the FDA for drug candidates wholly-owned by the Company; (ii)&nbsp;two clinical collaborations with significant <FONT STYLE="white-space:nowrap">co-funding</FONT> support of at least thirty percent (30%) of
clinical study costs involving Company proprietary drugs; (iii)&nbsp;a judgment by a federal court that a Company-owned patent validly covers a third party product or the settlement of a patent litigation resulting in a payment to Company;
(iv)&nbsp;the filing of an NDA by the FDA for a Company proprietary drug; and (v)&nbsp;the approval of an NDA by the FDA for a Company proprietary drug. In setting this performance hurdle, the Organization and Compensation Committee believed it
would be challenging to achieve and, if achieved, would help create long-term stockholder value. We believe that the advancement of the late stage drug candidate pipeline is a critical catalyst to stockholder value creation. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">Actual Long-Term Incentives Awarded. Consistent with our annual performance review process, the NEOs received an
annual equity award in December 2019. Our independent compensation consultant provided data created in December 2019 indicating that the CEO&#146;s and NEO&#146;s 2018 total compensation was around the median for comparable positions.&nbsp;Each of
the NEOs received a decrease in their annual equity grant values as compared to 2018 to reflect the market data and change in peer group. The 2019 award to our CEO, Mr.&nbsp;Robin, reflected the median CEO grant value of the 2019 peer group.</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"> </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2018, we adopted a value-based approach for sizing equity, consistent with market practices. In determining the grant levels for
equity awards, we consider a number of factors including an assessment of individual performance, competitive market practices, the number of unvested RSUs and stock options held by the executive and average exercise price (i.e., the retention
value) of these stock options, the individual&#146;s overall contributions, and stockholder dilution. However, we do not use a formula or assign a particular weight to any one factor in determining equity award levels. Rather, the determination of
equity grant levels is subjective, and the Organization and Compensation Committee awards equity grants at levels it believes in its judgment are reasonably competitive and consistent with our philosophy that a substantial portion of our
executives&#146; compensation should be performance-based and help to further link the interests of our executives with those of our stockholders, as well as to provide a retention incentive for the executive as well as an additional incentive to
help create value for our stockholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In connection to their promotions, we granted additional stock option and RSU awards
to Dr.&nbsp;Zalevsky and Mr.&nbsp;Labrucherie upon attaining the positions of Chief Research and Development Officer, and Chief Operating and Chief Finance Officer, respectively, in October&nbsp;1, 2019. We determined the size of promotion equity
(stock option and RSU) grants for Dr.&nbsp;Zalevsky and Mr.&nbsp;Labrucherie in relation to a combination of factors including </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">59 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
market data, their individual performance, expected contributions to the Company, internal pay equity, the number of unvested stock options and RSUs held (including the average exercise price)
and retention value. The promotion stock option awards vest monthly over a period of four years from the grant date and promotion RSUs vest quarterly over three years. We believe these promotional equity grants provide significant retention
incentives for Dr.&nbsp;Zalevsky and Mr.&nbsp;Labrucherie, as well as aligning their long-term compensation with value creation for our stockholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We also granted an equity award to Mr.&nbsp;Northcott in connection with his hiring as the Company&#146;s Senior Vice President and Chief Commercial Officer. We determined the size of
Mr.&nbsp;Northcott&#146;s equity grant awards during the process of negotiating his overall compensation package so as to create a sufficient long-term incentive package to secure his skills and experience in building and managing commercial
organizations. Consistent with market practice, the size of the new hire equity grant (which included a stock option grant and RSU grant) is several multiples of anticipated annual award levels. The stock option grant vests over four years with 25%
of the stock option vesting on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of Mr.&nbsp;Northcott&#146;s employment start date and the remainder vesting monthly over the following three years. The RSU grant vests over four years
with 25% of the RSU award vesting on the next quarterly RSU processing date one year after the vesting commencement date and the remainder vesting quarterly over the following three years in substantially equal installments on each RSU processing
date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition to the 2019 annual equity award, the Organization and Compensation Committee awarded an additional stock
option grant to all Executive Committee members as a recognition that they had voluntarily forgone their cash bonus that they otherwise would have earned based on the Organization and Compensation Committee&#146;s determination of corporate
performance for 2019. With the Executive Committee members having relinquished immediate compensation that would have been paid in cash, we believe these stock options provide an incentive for retaining the executives, as well as aligning their
long-term compensation with value creation for our stockholders. Our independent compensation consultant, Radford, assisted in determining the amount of the award that was commensurate with the approximate amount of the cash bonus that each
executive would have otherwise received. These grants vest monthly over four years. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Effective January&nbsp;1, 2019 the
Organization and Compensation Committee approved ownership guidelines for our executive officers, such that the CEO should own shares of our common stock equal to at least three times his or her base salary, and the NEOs should own shares of our
common stock equal to at least one time his or her base salary. The minimum stock ownership level is to be achieved by each executive officer within five years of the date of his or her appointment to executive officer. As of December&nbsp;31, 2019,
each NEO met the minimum stock ownership guidelines or was within the five-year grace period provided by the plan. The number of shares of common stock subject to stock option and RSU awards granted to each NEO during 2019 and the grant-date fair
value of these equity awards is presented in the Grants of Plan Based Awards in 2019 table below. A description of the material terms of the 2019 equity awards is presented in the narrative section following that table. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Severance and Change of Control Benefits </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If the employment of an NEO is terminated by us without cause or by the executive for a designated good reason outside of the context of a change of control transaction, the executive would be entitled to
severance benefits under the applicable agreement he or she entered into with the Company. Generally, these severance benefits include a cash severance payment based on the executive&#146;s then-current base salary and the amount of his or her
target annual incentive bonus, payment of COBRA premiums for up to a maximum of eighteen (18)&nbsp;months, and an additional twelve-month period to exercise vested stock options (an eighteen-month period for Mr.&nbsp;Robin, and a three-month period
for Dr.&nbsp;Zalevsky).&nbsp;In order to attract and retain these NEOs in a competitive environment for highly skilled senior executive talent in the biotechnology and pharmaceutical industry and to provide an incentive to obtain a broad release of
claims in favor of the Company, we determined it was often necessary to offer each of them severance benefits in the case of a termination without cause or </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">60 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
constructive termination outside the context of a change of control transaction. Many companies provide severance benefits for similar types of terminations of employment, and we believe that it
is important for us to offer these severance benefits in order to continue to provide a competitive total compensation program. These NEOs would also be entitled to certain termination benefits upon a termination of employment because of death or
disability. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We also maintain a Change of Control Severance Benefit Plan (the &#147;CIC Plan&#148;) that provides the NEOs
with certain severance benefits if their employment is terminated in connection with a change of control. The CIC Plan was originally established in 2006, and no amendments have been made to the plan since that time that would increase the severance
benefits available under the CIC Plan. Severance benefits under the CIC Plan are structured on a &#147;double-trigger&#148; basis, meaning that the executive must experience a termination without cause or resign for a specifically defined good
reason in connection with the change of control in order for severance benefits to become payable under the CIC Plan. Like the severance benefits under the letter agreements, we believe that these change of control severance benefits are an
important element of a competitive total compensation program. Additionally, we believe that providing change of control benefits should eliminate, or at least reduce, any reluctance of our NEOs and other key employees covered by the CIC Plan to
diligently consider and pursue potential change of control opportunities that may be in the best interests of our stockholders. At the same time, by providing change of control benefits only upon the occurrence of an additional triggering event
occurring in connection with the change of control transaction resulting in a job loss, we believe that this CIC Plan helps preserve the value of our key personnel for any potential acquiring company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the CIC Plan, the executive would be entitled to accelerated equity award vesting upon a termination described above. The other
severance benefits under the CIC Plan are generally similar to the severance benefits described above; however, Mr.&nbsp;Robin&#146;s cash severance would cover the <FONT STYLE="white-space:nowrap">two-year</FONT> period following termination and
Company-paid COBRA coverage would be eighteen months. Outplacement services received within twelve months following separation, up to a maximum of $5,000, are provided to all participants. In addition, each of the NEOs would be entitled to full
equity vesting and, except for Dr.&nbsp;Zalevsky and Mr.&nbsp;Northcott, a &#147;gross up&#148; payment for any excise taxes imposed under Section&nbsp;4999 of the Internal Revenue Code once a 10% cutback threshold is exceeded. The excise tax <FONT
STYLE="white-space:nowrap">gross-up</FONT> was included in the CIC Plan as originally adopted in 2006 to make the participants whole for any adverse tax consequences to which they may become subject under Section&nbsp;4999 of the Internal Revenue
Code and to avoid unintended differences in net severance based on individual factors like the date of hire and past option exercise decisions, which preserves the level of change of control severance protections that we have determined to be
appropriate.&nbsp;At the time the CIC Plan was established, we believed this excise tax <FONT STYLE="white-space:nowrap">gross-up</FONT> protection was a reasonable part of a competitive total compensation package and generally consistent with
industry practice at the time. On April&nbsp;5, 2011, the board of directors amended the CIC Plan to eliminate any &#147;gross up&#148; payments for any excise taxes imposed under Section&nbsp;4999 of the Internal Revenue Code for participants who
became eligible to participate in the CIC Plan on or after January&nbsp;1, 2010. The board of directors decided to eliminate this tax <FONT STYLE="white-space:nowrap">gross-up</FONT> provision under the plan for new participants based on its review
of current industry practices. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The &#147;Potential Payments Upon Termination or Change of Control&#148; section below
describes and quantifies the severance and other benefits potentially payable to the NEOs. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Other Benefits </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe that establishing competitive benefit packages for employees is an important factor in attracting and retaining
highly-qualified personnel, including the NEOs. The NEOs are eligible to participate in all of our employee benefit plans, such as medical, dental, vision, group life, disability insurance, commuting benefits, employee stock purchase plan and the
401(k) plan, in each case generally on the same basis as other employees. We do not offer a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> defined-benefit pension plan or any <FONT STYLE="white-space:nowrap">non-qualified</FONT> defined
benefit retirement plans, nor do we provide material perquisites to our executives. In 2019, we offered Mr. Robin the benefit of third party local ground transportation. These ground transportation benefits serve business purposes, such as allowing
Mr.&nbsp;Robin to safely increase his productivity by attending to business matters while in transit. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">61 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Other Compensation Policies and Practices </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Claw-Back Policy </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We
maintain a performance-based compensation recovery (&#147;clawback&#148;) policy which provides that, in the event that we are required revise our financial results, we may recover from any executive officer any incentive compensation erroneously
paid or awarded in excess of what would have been based on the revised financial results. This policy applies to any incentive compensation that is either granted or paid at any time during the period of three full fiscal years prior to the date on
which the financial results applicable to such award or payment are revised. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Tax and Accounting Considerations </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Deductibility of Executive Compensation </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Generally, Section&nbsp;162(m) of the Code (&#147;<B>Section 162(m)</B>&#148;) disallows a federal income tax deduction for public corporations of remuneration in excess of $1&nbsp;million paid in any
fiscal year to certain specified executive officers. For taxable years beginning before January&nbsp;1, 2018 (i) these executive officers consisted of a public corporation&#146;s chief executive officer and up to three other executive officers
(other than the chief financial officer) whose compensation is required to be disclosed to stockholders under the Exchange Act because they are our most highly-compensated executive officers and (ii)&nbsp;qualifying &#147;performance-based
compensation&#148; was not subject to this deduction limit if specified requirements are met. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant
to the Tax Cuts and Jobs Act of 2017, which was signed into law on December&nbsp;22, 2017 (the &#147;<B>Tax Act</B>&#148;), for taxable years beginning after December&nbsp;31, 2017, the remuneration of a public corporation&#146;s chief financial
officer is also subject to the deduction limit. In addition, subject to certain transition rules (which apply to remuneration provided pursuant to written binding contracts which were in effect on November&nbsp;2, 2017 and which are not subsequently
modified in any material respect), for taxable years beginning after December&nbsp;31, 2017, the exemption from the deduction limit for &#147;performance-based compensation&#148; is no longer available. In addition, under the Tax Act, once an
executive becomes a &#147;covered employee&#148; under Section&nbsp;162(m), the individual will continue to be a &#147;covered employee&#148; as long as he or she remains employed by the company. Consequently, for fiscal years beginning after
December&nbsp;31, 2017, all remuneration in excess of $1&nbsp;million paid to a covered executive will not be deductible unless it qualifies for transitional relief applicable to certain binding, written performance-based compensation arrangements
that were in place as November&nbsp;2, 2017 or transitional relief for applicable to certain newly public companies. These changes will cause more of our compensation to be <FONT STYLE="white-space:nowrap">non-deductible</FONT> under
Section&nbsp;162(m) in the future and will eliminate the Company&#146;s ability to structure performance-based awards to be exempt from Section&nbsp;162(m).</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"> </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In designing our executive compensation program and determining the compensation of our executive officers, including our named executive officers, the Organization and Compensation Committee considers a
variety of factors, including the potential impact of the Section&nbsp;162(m) deduction limit. While the Organization and Compensation Committee is mindful of the benefit of the full deductibility of compensation, it believes that we should not be
constrained by the requirements of Section&nbsp;162(m) where those requirements would impair our flexibility in compensating our executive officers in a manner that can best promote our corporate objectives. Therefore, the Organization and
Compensation Committee has not adopted a policy that would require that all compensation be deductible, though it does consider the deductibility of compensation when making compensation decisions. The Organization and Compensation Committee may
authorize compensation payments that are not fully tax deductible if it believes that such payments are appropriate to attract and retain executive talent or meet other business objectives. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">62 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Accounting for Stock-Based Compensation </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We follow FASB ASC Topic 718 for our stock-based compensation awards. FASB ASC Topic 718 requires us to measure the compensation expense
for all share-based payment awards made to our employees and <FONT STYLE="white-space:nowrap">non-employee</FONT> members of our board of directors, including options to purchase shares of our common stock and other stock awards, based on the grant
date &#147;fair value&#148; of these awards. This cost is recognized as an expense following the straight-line attribution method over the requisite service period. This calculation is performed for accounting purposes and reported in the executive
compensation tables required by the federal securities laws, even though the recipient of the awards may never realize any value from such awards. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">63 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_26"></A>C<SMALL>OMPENSATION</SMALL> C<SMALL>OMMITTEE</SMALL>
R<SMALL>EPORT</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>The material in this report is being furnished and shall not be deemed &#147;filed&#148; with the
SEC for purposes of Section&nbsp;18 of the Exchange Act or otherwise subject to the liability of that section, nor shall the material in this section be deemed to be &#147;soliciting material&#148; or incorporated by reference in any registration
statement or other document filed with the SEC under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), or the Exchange Act, except as otherwise expressly stated in such filing. </I></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Organization and Compensation Committee has reviewed the Compensation Discussion and Analysis and discussed it with management. Based
on its review and discussions with management, the committee recommended to our board of directors that the Compensation Discussion and Analysis be included in our annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal
year ended December&nbsp;31, 2019 and in our 2020 proxy statement. This report is provided by the following independent directors, who currently comprise the committee: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Lutz Lingnau&#151;Chairman </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jeff Ajer </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Karin Eastham </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">64 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_27"></A>SUMMARY COMPENSATION TABLE&#151;FISCAL 2017-2019
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table shows, for the fiscal year ended December&nbsp;31, 2019, compensation awarded to or earned by our
Chief Executive Officer, our Chief Financial Officer and our other three most highly compensated executive officers who were serving as executive officers on December&nbsp;31, 2019 (the &#147;NEOs&#148;). To the extent any NEOs were also named
executive officers for the fiscal years ended December&nbsp;31, 2018 or December&nbsp;31, 2017, compensation information for our 2018 and 2017 fiscal years is also presented for such executives.&nbsp;&nbsp;&nbsp;&nbsp; </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Principal Position</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000 ; display:table-cell;"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year<BR>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary<BR>($)<BR>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Bonus<BR>(S)<BR>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock<BR>Awards<BR>($)(1)(3)<BR>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Awards<BR>($)(2)(3)<BR>(f)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B><FONT STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive
Plan<BR>Compensation<BR>($)(4)<BR>(g)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All Other<BR>Compensation<BR>($)<BR>(i)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total ($)<BR>(j)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Howard W. Robin</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,017,400</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4,100,860</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4,652,065</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>0</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>168,925</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>9,939,250</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>President and Chief Executive Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2018</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>968,921</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4,998,206</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5,618,256</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,647,100</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>98,184</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>13,330,667</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2017</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>940,700</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6,884,888</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8,544,658</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,599,190</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>127,975</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>18,097,411</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Gil M. Labrucherie</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>683,325</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,131,971</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,661,047</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>0</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>12,498</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7,488,841</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Chief Operating Officer and Chief Financial Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2018</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>631,696</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,099,320</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,359,382</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>631,600</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>11,930</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5,733,928</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2017</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>607,400</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,958,794</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,672,084</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>531,475</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>10,338</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7,780,091</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>John Northcott</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>56,250</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP>&nbsp;</FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>200,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,895,980</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,189,480</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>0</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>13,313</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP>&nbsp;</FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6,355,023</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Senior Vice President and Chief Commercial Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Jillian B. Thomsen</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>457,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>649,340</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>795,957</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>0</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>13,787</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP>&nbsp;</FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,916,084</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Senior Vice President Finance and Chief Accounting Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2018</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>435,000</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4,461,658</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>899,489</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>424,100</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>13,347</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6,233,595</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Jonathan Zalevsky, Ph.D.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>582,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,131,971</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,552,0062</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>0</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8,120</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(11)</SUP>&nbsp;</FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7,274,153</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Chief Research and Development Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts reported represent the aggregate grant date fair value of RSU awards computed in accordance with Financial Accounting Standards Board
Accounting Standards Codification Topic 718, Compensation-Stock Compensation (&#147;FASB ASC Topic 718&#148;), based on the closing price of the Company&#146;s common stock on the grant date and excluding the effects of estimated forfeitures. For a
complete description of the assumptions made in determining the valuation, please refer to (i)&nbsp;Note 11 (Stock-Based Compensation) to our audited financial statements in our annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for
the fiscal year ended December&nbsp;31, 2019 and (ii)&nbsp;similar footnotes to our audited financial statements in our annual reports on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for prior years when the awards were granted.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts reported represent the aggregate grant date fair value of the stock options granted in the applicable year computed in accordance with
FASB ASC Topic 718, which excludes the effects of estimated forfeitures. For a complete description of the assumptions made in determining the valuation, please refer to (i)&nbsp;Note 11 (Stock-Based Compensation) to our audited financial statements
in our annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2019 and (ii)&nbsp;similar footnotes to our audited financial statements in our annual reports on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for prior years when the awards were granted. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">As noted in the Compensation Discussion and Analysis above, 50% of the annual equity awards granted to the NEOs in 2017, 2018 and 2019 were
performance-based and vest only to the extent a specified performance-based vesting condition is satisfied within 5 years of grant. If the performance-based vesting condition is satisfied, then the performance-based equity awards also remain subject
to a time-based vesting requirement. The amounts reported in the &#147;Stock Awards&#148; and &#147;Option Awards&#148; column of the table for 2017, 2018 and 2019 include the grant date fair value of performance-based RSUs and stock options, as
applicable for the year, based on the probable outcome (determined as of the grant date in accordance with generally accepted accounting principles) of the performance-based conditions applicable to the awards. The probable grant date fair value for
these awards was determined assuming that the underlying performance-</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">65 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
based vesting condition would be achieved (i.e., the maximum achievement of applicable performance conditions). </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts reported for 2017, 2018 and 2019 represent amounts earned under the Incentive Compensation Plan for that year or, for Mr.&nbsp;Robin,
under his amended and restated offer letter effective as of December&nbsp;1, 2008. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i) $59,034 for local ground transportation provided by a third party service provider, (ii)&nbsp;tax reimbursements of $50,187 for
such third party local ground transportation, (iii)&nbsp;life insurance premiums of $53,704 and (iv)&nbsp;a $6,000 contribution to the Company&#146;s 401(k) plan. The allowance for third party local ground transportation was valued based on the
amounts reimbursed directly to Mr.&nbsp;Robin or the service provider, as applicable. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;life insurance premiums of $2,385, (ii) a $6,000 contribution to the Company&#146;s 401(k) plan, (iii) $273 for parking,
(iv)&nbsp;a $238 public transit pass and (v) $202 for tax <FONT STYLE="white-space:nowrap">gross-ups</FONT> related to parking. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">$200,000 <FONT STYLE="white-space:nowrap">sign-on</FONT> bonus related to his commencement of employment in December 2019.</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"> </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents the <FONT STYLE="white-space:nowrap">pro-rated</FONT> salary for Mr.&nbsp;Northcott from the commencement of his employment in
December 2019. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;relocation allowance of $10,000 and (ii)&nbsp;a $3,313 contribution to the Company&#146;s 401(k) plan.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;life insurance premiums of $3,657, (ii) a $6,000 contribution to the Company&#146;s 401(k) plan, (iii)&nbsp;a $3,400
contribution to the Health Savings Account, (iv) $444 for parking and (v)&nbsp;tax gross ups of $286 related to parking. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(11)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;life insurance premiums of $2,120 and (ii)&nbsp;a $6,000 contribution to the Company&#146;s 401(k) plans.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_28"></A>Description of Employment Agreements </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each of the NEOs has entered into our standard form of employment agreement and an offer letter or letter agreement. The form of
employment agreement provides for protective covenants with respect to confidential information, intellectual property and assignment of inventions and also sets forth other standard terms and conditions of employment. The offer letter agreements do
not provide for any minimum or guaranteed term of employment. The letter agreements entered into by each of the NEOs establish the compensation arrangements following separation from us under certain circumstances. Please see &#147;Potential
Payments upon Termination or Change of Control&#148; below for more information on these separation arrangements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">66 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_29"></A>GRANTS OF PLAN BASED AWARDS IN 2019 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table shows, for the fiscal year ended December&nbsp;31, 2019, certain information regarding grants of plan-based awards to
the NEOs. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE="border-bottom:1px solid #000000 ; display:table-cell;"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name<BR>(a)</B></FONT></P></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant<BR>Date<BR>(b)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated Possible Payouts<BR>Under <FONT STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive Plan
Awards(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated Future Payouts<BR>Under Equity<BR>Incentive Plan Awards(2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All&nbsp;Other<BR>Stock<BR>Awards:<BR>Number<BR>of Shares<BR>of Stock <BR>or Units <BR>(#)(3)
<BR>(i)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All&nbsp;Other<BR>Option<BR>Awards:<BR>Number
of<BR>Securities<BR>Underlying<BR>Options<BR>(#)(4)<BR>(j)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise<BR>or&nbsp;Base<BR>Price&nbsp;
of<BR>Option<BR>Awards<BR>($/<BR>sh)(5)<BR>(k)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant&nbsp;Date<BR>Fair Value<BR>of Stock<BR>and<BR>Option<BR>Awards<BR>($)(6)
<BR>(l)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Threshold<BR>($)<BR>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target<BR>($)<BR>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Maximum<BR>($)<BR>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Threshold<BR>(#)<BR>(f)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target<BR>(#)<BR>(g)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Maximum<BR>(#)<BR>(h)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Howard W. Robin</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual&nbsp;Incentive&nbsp;Award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>864,790</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,729,580</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted Stock Units</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>94,100</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2,050,430</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted Stock Units</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>94,100</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2,050,430</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>167,650</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>21.79</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2,052,958</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>167,650</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>21.79</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2,052,958</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>44,600</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>21.79</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>546,149</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Gil M. Labrucherie</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual Incentive Award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>562,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,125,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted Stock Units</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>10/1/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>75,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,382,243</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>10/1/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>150,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>18.43</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,553,595</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted Stock Units</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>40,150</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>874,864</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted Stock Units</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>40,150</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>874,864</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>71,550</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>21.79</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>876,166</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>71,550</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>21.79</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>876,166</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>29,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>21.79</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>355,120</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>John Northcott</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual Incentive Award <SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted Stock Units</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/02/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>200,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>3,895,980</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/02/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>200,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>19.48</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2,189,480</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Jillian B. Thomsen</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual Incentive Award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>228,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>457,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted Stock Units</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>14,900</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>324,670</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted Stock Units</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>14,900</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>324,670</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>26,600</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>21.79</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>325,730</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>26,600</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>21.79</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>325,730</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>11,800</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>21.79</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>144,497</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Jonathan Zalevsky, Ph.D.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual Incentive Award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>390,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>780,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted Stock Units</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>10/1/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>75,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,382,243</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>10/1/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>150,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>18.43</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,553,595</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted Stock Units</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>40,150</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>874,864</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted Stock Units</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>40,150</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>874,864</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>71,550</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>21.79</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>876,166</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>71,550</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>21.79</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>876,166</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/12/2019</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>20,100</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>21.79</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>246,135</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Amounts reported represent the potential short-term incentive compensation amounts payable for our 2019 fiscal year under our Incentive
Compensation Plan (or for Mr.&nbsp;Robin, the potential amounts payable under his offer letter). The amounts reported represent each NEO&#146;s target and maximum possible payments for 2019. Because actual payments to the NEOs could range from 0% to
200% of their target bonus, no threshold payment amount has been established for the NEOs. The actual short-term incentive bonus amount earned by each NEO for 2019 is reported in Column (g) <FONT STYLE="white-space:nowrap">(Non-Equity</FONT>
Incentive Plan Compensation) of the Summary Compensation Table&#151;Fiscal 2017-2019 above. Although the Organization and Compensation Committee determined that the NEO&#146;s individual performance merited bonus awards, each of Nektar&#146;s
Executive Committee members opted to forego their individual annual cash bonus awards completely to underscore their commitment to the long-term performance of the Company and to reinforce a culture of leadership accountability.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">The RSU grants are subject to both a three year time-based vesting requirement (quarterly <FONT STYLE="white-space:nowrap">pro-rata</FONT>
vesting) and the achievement of specified performance criteria within five years of grant. The stock option grants are subject to both a four-year time-based vesting requirement (monthly <FONT STYLE="white-space:nowrap">pro-rata</FONT> vesting) and
the achievement of specified performance criteria within five years of grant. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">67 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Other than the vesting schedule noted in footnote (8), these grants are subject to a three-year quarterly
<FONT STYLE="white-space:nowrap">pro-rata</FONT> vesting requirement. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Other than the vesting schedule noted in footnote (9), these grants are subject to a four-year monthly
<FONT STYLE="white-space:nowrap">pro-rata</FONT> vesting requirement. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Exercise price is the closing price of our common stock on the date of grant. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Refer to Note 11 (Stock-Based Compensation) to our audited financial statements in our annual report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2019 for the relevant assumptions used to determine the grant date fair value of the stock options granted during 2019. The grant date fair value of the RSUs
was based on the closing price of our common stock on the grant date. The amounts reflected in this column for RSUs and stock options granted during 2019 that are subject to performance-based vesting conditions represent the grant date fair value of
these awards based on the probable outcome (determined as of the grant date in accordance with applicable accounting rules) of the performance-based conditions applicable to the awards. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Mr.&nbsp;Northcott joined Nektar December&nbsp;12, 2019 and therefore he was not eligible for any bonus in 2019. </FONT></P></TD></TR></TABLE>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">This grant vests over four years with 25% vesting on February&nbsp;15, 2021 and the remainder vesting over three years in equal quarterly
installments. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">This grant vests over a four-year period with 25% vesting on the first anniversary of the grant date and the remaining 75% of the shares
vesting in equal monthly installments over the three-year period thereafter. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Description of Plan-Based
Awards </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stock Options.</I> Each stock option granted to the NEOs during 2019 may be exercised to purchase the
designated number of shares of our common stock at an exercise price equal to the closing price of the underlying common stock on the grant date. Each NEO&#146;s stock option award granted in 2019 has a maximum term of eight (8) years and is subject
to a vesting schedule that requires the executive&#146;s continued service through the vesting date. Other than the new hire grant for Mr.&nbsp;Northcott, the 2019 stock option awards granted to the NEOs will vest on a monthly <FONT
STYLE="white-space:nowrap">pro-rata</FONT> basis over a four-year period following the grant date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Restricted Stock
Units.</I> Each NEO&#146;s RSU award granted in 2019 is subject to a vesting schedule that requires the executive&#146;s continued service through the vesting date. Other than the new hire grant for Mr.&nbsp;Northcott, the 2019 RSU annual awards
granted to the NEOs will vest on a quarterly <FONT STYLE="white-space:nowrap">pro-rata</FONT> basis over a three-year period following the grant date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In December 2019, each NEOs annual merit equity award was tied to either a qualitative assessment of individual performance or objective performance milestones or criteria that were designed to be
rigorous and challenging. As an example, the stock options were 50% of the equity granted to our executive officers and were made in the form of performance-based awards vesting based on the standard four-year monthly time-based vesting plus a
separate performance condition that must also be achieved within five years of the grant date and before the executive officer is permitted to exercise the performance-based stock option; and RSUs vesting based on the standard three-year quarterly
time-based vesting plus a separate performance condition that must also be achieved before the RSU is released. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
performance criteria for the 2019 awards is the Company&#146;s achievement of two (2)&nbsp;of the following five (5)&nbsp;events: (i) filing two (2)&nbsp;INDs with the FDA for drug candidates wholly-owned by the Company; (ii)&nbsp;two&nbsp;(2)
clinical collaborations with significant <FONT STYLE="white-space:nowrap">co-funding</FONT> support of at least thirty percent (30%) of costs from clinical studies involving Company proprietary drugs; (iii)&nbsp;a judgment by a federal court that a
Company-owned patent validly covers a third party product or the settlement of a patent litigation resulting in a payment to Company; (iv)&nbsp;the filing of an NDA by the FDA for a Company proprietary drug; and (v)&nbsp;the approval of an NDA by
the FDA for a Company proprietary drug. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Any stock options or RSUs that are unvested upon an NEO&#146;s termination of
continuous employment or services will be forfeited without any value, unless the termination of continuous service is a result of death, in which event, subject to any restrictions in the stock option or RSU agreement or equity incentive plan, the
stock option would become fully vested and exercisable as of the date of death and the RSU would become fully vested and released as of the date of death. For Messrs. Robin and Northcott, in accordance with their letter agreements, if any stock
options are unvested upon a termination of continuous employment as a result of a disability, 50% of the unvested stock options would become fully vested and exercisable as of the date of termination. In
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">68 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
accordance with the letter agreements for the NEOs described above, any stock options that are vested upon termination of continuous service by us without cause or by the executive for a good
reason resignation (as defined in the CIC Plan) will remain outstanding and exercisable for eighteen (18)&nbsp;months for Mr.&nbsp;Robin, twelve (12)&nbsp;months following termination for Messrs. Labrucherie and Northcott and Ms.&nbsp;Thomsen, and
three (3)&nbsp;months for Dr Zalevsky. This exercise period is also twelve (12)&nbsp;months if the termination of employment or continuous services is because of disability and is eighteen (18)&nbsp;months if the termination is a result of death. We
also have the discretion to extend the applicable exercise period in connection with other terminations of employment. Any vested stock options that are not exercised within the applicable post-termination of employment exercise period will
terminate. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the terms of the 2017 Plan, if there is a change of control of the Company, outstanding awards granted under
the plan will generally become fully vested and, in the case of stock options, exercisable, unless the Organization and Compensation Committee provides for the substitution, assumption, exchange or other continuation of the outstanding awards. Any
stock options that become vested in connection with a change of control generally must be exercised prior to the change of control, or they will be cancelled in exchange for the right to receive a cash payment in connection with the change of
control transaction. In addition, outstanding awards held by our NEOs may vest, upon certain terminations of the NEO&#146;s employment without cause or for a good reason resignation in connection with a change of control and in connection with
terminations of employment resulting from disability or death. Please see the &#147;Potential Payments Upon Termination or Change of Control&#148; section below for a description of the vesting that may occur in such circumstances. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2019 each NEO&#146;s stock option and RSU award was granted under, and is subject to the terms of, the 2017 Plan. The plan is
administered by the Organization and Compensation Committee, and this committee has the ability to interpret and make all required determinations under the plan. This authority includes making required proportionate adjustments to outstanding equity
awards to reflect certain corporate transactions and making provision to ensure that participants satisfy any required withholding taxes. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The NEOs are not entitled to any dividend equivalent rights on their stock option or RSU awards, and stock option and RSU awards are generally only transferable to a beneficiary of an NEO upon his death.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Short-Term Incentive Compensation.</I> All of the NEOs were eligible to earn a short-term incentive compensation payment
under the Incentive Compensation Plan or, for Mr.&nbsp;Robin, under an arrangement that mirrors the Incentive Compensation Plan. These opportunities are reflected in the &#147;Estimated Possible Payouts Under
<FONT STYLE="white-space:nowrap">Non-Equity</FONT> Incentive Plan Awards&#148; columns of the table above. Please see &#147;Compensation Discussion and Analysis&#151;Current Executive Compensation Program Elements&#151;Short-Term Incentive
Compensation&#148; for a description of the material terms of the Incentive Compensation Plan and Mr.&nbsp;Robin&#146;s related short-term incentive compensation arrangement. Although the Organization and Compensation Committee determined that the
NEO&#146;s individual 2019 performance merited bonus awards, each of Nektar&#146;s Executive Committee members opted to forego their individual annual cash bonus awards completely to underscore their commitment to the long-term performance of the
Company and to reinforce a culture of leadership accountability. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">69 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_30"></A>OUTSTANDING EQUITY AWARDS AT FISCAL <FONT
STYLE="white-space:nowrap">YEAR-END</FONT> FOR 2019 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table includes certain information with respect to the
value of all unexercised stock options and outstanding equity awards previously awarded to the NEOs as of December&nbsp;31, 2019. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant<BR>Date</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(b)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Exercisable<BR>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Unexercisable<BR>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number
of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Unearned<BR>Options<BR>(#)(1)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(e)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Exercise<BR>Price<BR>($)</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(f)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Expiration<BR>Date</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(2)</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(g)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number<BR>of<BR>Shares&nbsp;or<BR>Units of<BR>Stock<BR>That<BR>Have
Not<BR>Vested<BR>(#)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(h)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Market<BR>Value&nbsp;of<BR>Shares&nbsp;or<BR>Units of<BR>Stock<BR>That<BR>Have
Not<BR>Vested<BR>($)(3)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(i)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number&nbsp;of<BR>Unearned<BR>Shares,<BR>Units
or<BR>Other<BR>Rights<BR>That<BR>Have&nbsp;Not<BR>Vested</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(#)</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(j)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Market or<BR>Payout<BR>value
of<BR>Unearned<BR>Shares,<BR>Units or<BR>Other<BR>Rights<BR>That<BR>Have Not<BR>Vested<BR>($)(3)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(k)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Howard&nbsp;W.&nbsp;Robin</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">225,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">225,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">225,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/4/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">225,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/4/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/9/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">195,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16.305</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/8/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/9/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">225,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16.305</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/8/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">56,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15.55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">56,260</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15.55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">103,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">34,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">103,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">34,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">56.90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,624</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,626</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">56.90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">20,167</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">435,406</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">20,167</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">435,406</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">34,587</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">103,763</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">36.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2026</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">138,350</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">36.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2026</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">45,364</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,031,619</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">68,450</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,031,619</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">167,650</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">21.79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">167,650</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">21.79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">44,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">21.79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">94,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">935,238</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">94,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,477,836</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Gil M. Labrucherie</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">85,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/4/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">85,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/4/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/9/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">57,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16.305</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/8/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/9/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">87,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16.305</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/8/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">22,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15.55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">22,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15.55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/1/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">87,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15.53</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5/30/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">37,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">37,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">32,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">32,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">56.90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">32,499</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">32,501</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">56.90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">187,121</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">187,121</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14,525</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">43,575</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">36.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2026</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">58,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">36.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2026</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">19,167</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">413,816</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">28,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">620,713</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/01/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">143,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">18.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/1/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/01/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">68,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,484,313</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">71,550</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">21.79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">71,550</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">21.79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">29,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">21.79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">40,150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">866,839</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">40,150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">866,839</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">70 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant<BR>Date</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(b)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Exercisable<BR>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Unexercisable<BR>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number
of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Unearned<BR>Options<BR>(#)(1)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(e)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Exercise<BR>Price<BR>($)</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(f)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Expiration<BR>Date</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(2)</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(g)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number<BR>of<BR>Shares&nbsp;or<BR>Units of<BR>Stock<BR>That<BR>Have
Not<BR>Vested<BR>(#)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(h)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Market<BR>Value&nbsp;of<BR>Shares&nbsp;or<BR>Units of<BR>Stock<BR>That<BR>Have
Not<BR>Vested<BR>($)(3)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(i)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number&nbsp;of<BR>Unearned<BR>Shares,<BR>Units
or<BR>Other<BR>Rights<BR>That<BR>Have&nbsp;Not<BR>Vested</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(#)</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(j)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Market<BR>or Payout<BR>value
of<BR>Unearned<BR>Shares,<BR>Units or<BR>Other<BR>Rights<BR>That<BR>Have Not<BR>Vested<BR>($)(3)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(k)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>John&nbsp;Northcott</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/2/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">200,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">19.48</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/2/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/2/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">200,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4,318,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Jillian B. Thomsen</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">37,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">37,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">37,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">42,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/4/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">42,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/4/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/9/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16.305</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/8/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/9/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16.305</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/8/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">18,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15.55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">18,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15.55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">28,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">28,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">13,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">13,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">56.90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">13,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">13,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">56.90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,467</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">74,863</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,467</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"> (7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">74,863</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11/1/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">90,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(12)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,943,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5,537</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16,613</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">36.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2026</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">22,150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">36.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2026</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">157,607</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,950</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">236,411</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">26,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">21.79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">26,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">21.79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">21.79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14,900</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">321,691</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14,900</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">321,691</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Jonathan Zalevksy, Ph.D.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7/31/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">21,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.61</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7/31/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">29,688</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15.55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5/31/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">29,687</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7,813</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15.44</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5/31/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11/15/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">29,687</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">17,188</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">13.93</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11/15/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12.24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/16/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15.71</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/16/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4/18/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">19,792</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">18.585</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4/18/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/15/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">39,584</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">37,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">18.09</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/15/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11/15/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">39,583</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">47,917</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">43.07</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11/15/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">21,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">56.90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/15/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">120,904</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/26/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">181,820</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(11)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,925,494</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">36,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">36.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2026</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">48,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">36.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/13/2026</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15,967</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">344,728</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/14/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">23,950</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">517,801</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/01/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">143,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">18.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/1/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/01/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">68,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,484,313</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">71,550</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">21.79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">71,550</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">21.79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">20,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">21.79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">40,150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">866,839</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/12/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">40,150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">866,839</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">The stock options are subject to achievement of specified performance criteria as of December&nbsp;31, 2019. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">71 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">For all NEOs, the expiration date shown is the normal expiration date occurring on the eighth anniversary of the grant date, which is the
latest date that the stock options may be exercised. Stock options may terminate earlier in certain circumstances, such as in connection with an NEO&#146;s termination of employment or in connection with certain corporate transactions, including a
change of control. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted stock unit market value is calculated based on $21.59 per share, the closing price of our common stock on December&nbsp;31, 2019.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">The stock options vest <FONT STYLE="white-space:nowrap">pro-rata</FONT> on a monthly basis over a period of four years from the date of grant.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Specified performance criteria were met however stock options will continue to be subject to time-based vesting over a four-year period from
the date of grant. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">The stock options vest only after achievement of specified performance criteria and <FONT STYLE="white-space:nowrap">pro-rata</FONT> monthly
vesting over a four-year period from the date of grant. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">The RSUs vest <FONT STYLE="white-space:nowrap">pro-rata</FONT> on a quarterly basis over a three-year period from the date of grant.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">The RSUs vest only after achievement of specified performance criteria and <FONT STYLE="white-space:nowrap">pro-rata</FONT> quarterly vesting
over a three-year period from the date of grant. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">The stock options vest over a four year period, with the first 25% of the options vesting one year from the date of grant and the remaining
portion of the options vesting <FONT STYLE="white-space:nowrap">pro-rata</FONT> on a monthly basis over the following three years. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">The RSUs over a four year period, with the first 25% of the RSUs vesting on the next RSU processing date following the vesting commencement
date, and the remaining portion of the RSUs vesting <FONT STYLE="white-space:nowrap">pro-rata</FONT> on a quarterly basis over the following three years. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(11)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">The RSUs over a three year period, with the first 25% of the RSUs vesting on the next RSU processing date following the second anniversary of the
vesting commencement date, and the remaining portion of the RSUs vesting <FONT STYLE="white-space:nowrap">pro-rata</FONT> on a quarterly basis over the following year.<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"> </SUP>
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(12)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">This grant vests quarterly in substantially equal installments on November&nbsp;15, 2020, February&nbsp;15, 2021, May&nbsp;15, 2021 and August
2021 </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_31"></A>OPTION EXERCISES AND STOCK VESTED IN 2019 </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table includes certain information with respect to the exercise of stock options and vesting of stock awards held by the
NEOs during the fiscal year ended December&nbsp;31, 2019. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000 ; display:table-cell;"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of<BR>Shares<BR>Acquired<BR>on&nbsp;Exercise&nbsp;(#)<BR>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value&nbsp;Realized<BR>on Exercise<BR>($)<BR>(c)(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of<BR>Shares<BR>Acquired&nbsp;on<BR>Vesting (#)<BR>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value&nbsp;Realized<BR>on&nbsp;Vesting ($)<BR>(e)(2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Howard W. Robin</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">430,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,520,482</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">99,818</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,830,619</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Gil M. Labrucherie</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">180,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,503,397</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46,501</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,264,226</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>John Northcott</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Jillian B. Thomsen</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,119</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">507,212</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,584</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">583,728</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Jonathan Zalevsky, Ph.D.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23,033</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">598,723</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The value realized upon the exercise of stock options is calculated by (a)&nbsp;subtracting the stock option exercise price from the market
price on the date of exercise to get the realized value per share, and (b)&nbsp;multiplying the realized value per share by the number of shares underlying the stock options exercised. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The value realized upon vesting of RSUs is calculated by multiplying the number of RSUs vested by the market price on the vest date.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_32"></A>POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE OF CONTROL </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following section describes the benefits that may become payable to the NEOs in connection with their termination of employment with
us or in connection with a change of control. Please see &#147;Compensation Discussion and Analysis&#151;Severance and Change of Control Benefits&#148; for a discussion of how the payments and benefits presented below were determined. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Severance Benefits&#151;No Change of Control </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Messrs. Robin, Labrucherie and Northcott and Ms.&nbsp;Thomsen are a party to certain letter agreements or our standard form executive employment agreement, and these agreements include provisions for
severance benefits upon certain terminations of employment that are not related to a change of control. Upon a termination of </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">72 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
employment by us without cause or by the executive for a good reason resignation (as defined in the CIC Plan and described below), the executive would be entitled to the following severance
benefits: (i)&nbsp;a cash severance payment equal to his or her total annual cash compensation target (including base salary and the target value of his or her annual incentive bonus, as such bonus target may be adjusted downward to take into
account our performance through the fiscal quarter preceding termination), (ii)&nbsp;an extension of the exercise period for the vested and unexercised portion of all outstanding stock options held by him or her for up to eighteen (18)&nbsp;months
for Mr.&nbsp;Robin, twelve (12)&nbsp;months for Messrs. Labrucherie and Northcott and Ms.&nbsp;Thomsen, following termination and (iii)&nbsp;payment of all applicable COBRA premiums for the same period as the severance benefit following the
termination date. In order to receive the severance benefits described above, each executive must first execute an effective waiver and release of claims in favor of us. Each executive&#146;s cash severance payment would ordinarily be paid in a <FONT
STYLE="white-space:nowrap">lump-sum</FONT> within 60 days following the executive&#146;s separation from service, although payment will be delayed to the extent required to comply with Section&nbsp;409A of the Internal Revenue Code. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Zalevsky is not party to a letter agreement or our standard form executive employment agreement that provides for severance
benefits upon certain terminations of employment that are not related to a change of control. Upon a termination of employment by us without cause or by the executive for a good reason resignation (as defined in the CIC Plan and described below),
Dr.&nbsp;Zalevsky would be entitled to the following severance benefits: (i)&nbsp;a negotiated cash severance payment, (ii)&nbsp;an extension of the exercise period for the vested and unexercised portion of all outstanding stock options held by him
or her for up to three (3)&nbsp;months following termination and (iii)&nbsp;payment of all applicable COBRA premiums for the same period as the severance benefit following the termination date. In order to receive the severance benefit described
above, Dr.&nbsp;Zalevsky must first execute an effective waiver and release of claims in favor of us. Dr.&nbsp;Zalevsky&#146;s cash severance payment would ordinarily be paid in a <FONT STYLE="white-space:nowrap">lump-sum</FONT> within 60 days
following his separation from service, although payment will be delayed to the extent required to comply with Section&nbsp;409A of the Internal Revenue Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If an NEO&#146;s employment with us terminates due to death, the executive&#146;s outstanding unvested stock options will become fully vested and will be exercisable for up to eighteen months following
termination pursuant to the terms of the Company&#146;s equity incentive compensation plans and agreements. The NEO&#146;s RSUs will become fully vested and released. In addition, in the case of Messrs. Robin and Northcott, the executive&#146;s
estate would be entitled to a <FONT STYLE="white-space:nowrap">pro-rata</FONT> portion of the target annual incentive bonus for the year in which his death occurred. As Mr.&nbsp;Northcott was not eligible for bonus in 2019, this provision becomes
effective in 2020. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If an NEO terminates employment with us as a result of disability, vested stock options will be
exercisable for up to twelve months following termination pursuant to the terms of the Company&#146;s stock option agreement. For Messrs. Robin and Northcott, they are each also entitled to have 50% of outstanding unvested stock options become fully
vested upon disability for stock options granted under the equity plan in place at time of grant in accordance with the terms and conditions of their letter agreements. The NEO&#146;s unvested RSUs are forfeited. In addition, pursuant to their offer
letter agreements, Messrs. Robin and Northcott would each be entitled to receive a <FONT STYLE="white-space:nowrap">pro-rata</FONT> portion of the executive&#146;s target annual incentive bonus for the year of termination in the event of a
termination due to disability. As Mr.&nbsp;Northcott was not eligible for bonus in 2019, this provision becomes effective in 2020. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to our standard form employment agreement, following a termination of employment, each NEO will be subject to an indefinite restriction on the disclosure of our confidential information and a <FONT
STYLE="white-space:nowrap">one-year</FONT> <FONT STYLE="white-space:nowrap">non-solicitation</FONT> restriction covering our customers and employees. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">73 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table lists the estimated amounts that would become payable to each of
the NEOs under the circumstances described above, assuming that the applicable triggering event occurred on December&nbsp;31, 2019. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Executive &amp;</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000 ; display:table-cell;"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Triggering Event</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value&nbsp;of&nbsp;Cash<BR>Severance<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value&nbsp;of<BR>COBRA<BR>Benefits<BR>($)(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value of<BR>Vesting<BR>Acceleration<BR>($)(2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value of<BR><FONT STYLE="white-space:nowrap">Pro-Rata</FONT><BR>Bonus<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Total<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Without Cause or Good Reason</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,882,190</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49,494</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,931,684</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Disability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">321,406</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">864,790</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,186,196</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Death</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,039,935</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">864,790</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,904,725</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Without Cause or Good Reason</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,312,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35,589</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,348,089</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Disability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Death</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,390,509</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,390,509</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Northcott</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Without Cause or Good Reason</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,012,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49,494</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,061,994</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Disability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">211,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">211,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Death</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,740,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,740,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jillian B. Thomsen</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Without Cause or Good Reason</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">685,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35,589</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">721,089</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Disability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Death</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,305,517</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,305,517</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jonathan Zalevsky, Ph. D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Without Cause or Good Reason</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">3</SUP>&nbsp;</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">3</SUP>&nbsp;</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">3</SUP>&nbsp;</FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Disability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Death</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,052,715</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,052,715</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The value of COBRA benefits are based upon actual rates as of December 2019. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For purposes of this table, we have assumed that (i)&nbsp;the price per share of our common stock is equal to the closing price per share on
the last trading day of the fiscal year ended December&nbsp;31, 2019 ($21.59), (ii) the value of any stock options that may be accelerated is equal to the full &#147;spread&#148; value of such awards on that date, and (iii)&nbsp;the value of any
RSUs that may be accelerated is equal to the underlying shares multiplied by $21.59. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Zalevsky is not party to a letter agreement or our standard form executive employment agreement that provides for severance benefits
upon certain terminations of employment that are not related to a change of control. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Severance Benefits&#151;Change
of Control </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each of the NEOs is covered under the CIC Plan. The CIC Plan provides for certain severance benefits to
these executives and our other employees covered by the plan upon certain terminations of employment occurring in connection with a change of control of us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If a change of control of the Company occurs, each NEO will be entitled to severance benefits under the CIC Plan if the executive&#146;s employment is terminated by us or a successor company without cause
or by the executive for good reason, in each case within a period generally beginning on the date the agreement providing for a change of control is executed and ending twelve months following the change of control. Severance benefits under the CIC
Plan include: (i)&nbsp;a cash severance payment equal to twelve (12)&nbsp;months of base salary (twenty-four (24)&nbsp;months for Mr.&nbsp;Robin) and the target value of the executive&#146;s annual incentive bonus; (ii)&nbsp;payment by us of the
same portion of the executive&#146;s COBRA premiums as we pay for active employees&#146; group health coverage for up to twelve (12)&nbsp;months (eighteen (18)&nbsp;months for Mr.&nbsp;Robin) following termination; (iii)&nbsp;provision of up to
$5,000 for outplacement services received within twelve (12)&nbsp;months following termination; (iv)&nbsp;accelerated </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">74 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">
vesting of all outstanding stock options and other outstanding equity awards; and (v)&nbsp;other than in the case of Dr.&nbsp;Zalevsky and Mr.&nbsp;Northcott, a &#147;gross up&#148; payment to
compensate the executive for excise taxes (if any) on payments that are considered &#147;parachute payments&#148; under Section&nbsp;280G of the Internal Revenue Code and therefore subject to an excise tax imposed under Section&nbsp;4999 of the
Code, but only to the extent the excise tax cannot be avoided by reducing the severance benefits by an amount not exceeding 10% such that the executive receives a greater-after tax amount as a result of the
<FONT STYLE="white-space:nowrap">&#147;cut-back&#148;</FONT> in benefits. In April 2011, the board of directors amended the CIC Plan so that this &#147;gross up&#148; benefit is not available for new hires following January&nbsp;1, 2010 but is
grandfathered for employees who joined the CIC Plan before that date so long as they are not promoted to a position such that he or she would be entitled to additional benefits under the plan. Accordingly, Dr.&nbsp;Zalevsky and Mr.&nbsp;Northcott
are not entitled to this &#147;gross up&#148; benefit as they joined the CIC Plan after January&nbsp;1, 2010.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">
</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">In order to receive the severance benefits described above, the executive must first execute an effective waiver and release of claims in favor of us pursuant to a separation and
release agreement. Each executive&#146;s cash severance payment will ordinarily be paid in a <FONT STYLE="white-space:nowrap">lump-sum</FONT> within 60 days following the executive&#146;s separation from service, although payment will be delayed to
the extent required to comply with Section&nbsp;409A of the Internal Revenue Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the purposes of the CIC Plan, a good
reason resignation means a resignation upon the occurrence of one or more of the following events: (i)&nbsp;assignment of any authority, duties or responsibilities that results in a material diminution in the executive&#146;s authority, duties or
responsibilities as in effect immediately prior to the change of control; (ii)&nbsp;assignment to a work location more than 50 miles from the executive&#146;s immediately previous work location, unless such reassignment of work location decreases
the executive&#146;s commuting distance from his or her residence to the executive&#146;s assigned work location; (iii)&nbsp;a material diminution in the executive&#146;s monthly base salary as in effect on the date of the change of control or as
increased thereafter; (iv)&nbsp;notice to the executive by us or the successor company during the <FONT STYLE="white-space:nowrap">12-month</FONT> period following the change of control that the executive&#146;s employment will be terminated under
circumstances that would trigger severance benefits under the CIC Plan but for the designation of a date for termination that is greater than 12 months following the change of control and (v)&nbsp;for Mr.&nbsp;Robin, if he does not serve in his same
position in the successor company or is not appointed to the board of directors of the successor company. In order for a good reason resignation to occur, the executive must first give us timely written notice of the grounds for good reason
resignation, and we must have failed to cure such condition after a period of 30 days. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the CIC Plan, the
separation and release agreement that each of the NEOs will be required to execute to receive severance benefits under the plan will also require each executive to agree to continue to be subject to the restrictions on the disclosure of our
confidential information in his or her employment agreement, to <FONT STYLE="white-space:nowrap">non-solicitation</FONT> restrictions and to certain other restrictions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Had a change of control occurred (where outstanding equity awards were assumed, continued or substituted by a successor entity) during the 2019 fiscal year and had the employment of each of the NEOs
terminated on December&nbsp;31, 2019 under one of the qualifying circumstances described above, each executive would have been entitled to receive the estimated benefits set forth in the table below. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value of</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Cash</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Severance&nbsp;($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value of</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>COBRA and</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Outplacement</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Benefits ($)(1)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value of</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Vesting</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Acceleration<BR>($)(2)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated&nbsp;Value&nbsp;of</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Excise Tax</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B><FONT STYLE="white-space:nowrap">Gross-Up</FONT> ($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Total ($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,764,380</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49,494</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,039,935</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,853,809</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,312,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35,589</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,390,509</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,738,598</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Northcott</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,012,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,826</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,740,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,780,326</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jillian B. Thomsen</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">685,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35,589</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,305,517</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,026,606</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jonathan Zalevsky, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,040,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49,494</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,052,715</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,142,209</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">This amount includes estimated COBRA premiums based upon actual rates as of December 2019 and up to $5,000 for outplacement services.
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">75 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the terms of our equity compensation plans, these NEOs would also have been entitled to this same full equity acceleration
(i)&nbsp;if a corporate transaction (as defined in the applicable plan) occurred and the surviving or acquiring corporation refused to assume outstanding equity awards or substitute similar replacement awards for outstanding equity awards or
(ii)&nbsp;upon the acquisition by any person of beneficial ownership of 50% or more of the combined voting power of our shares in a transaction that is not a corporate transaction as defined in the applicable plan. See note (2)&nbsp;to the table
above for the calculation of these amounts. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>CEO Pay Ratio </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Dodd-Frank Wall Street Reform and Consumer Protection Act, we are required to disclose the median of the annual total
compensation of our employees, the annual total compensation of our President and CEO Mr.&nbsp;Howard Robin, and the ratio of these two amounts. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We have estimated the median of the 2019 annual total compensation of our employees, excluding Mr.&nbsp;Robin, to be $152,663. The annual total compensation of our President and CEO, as reported in the
Summary Compensation Table &#150; Fiscal 2017-2019 is $9,939,250. The ratio of the annual total compensation of our President and CEO to the estimated median of the annual total compensation of our employees was 65 to 1. We believe this pay ratio is
a reasonable estimate calculated in a manner consistent with SEC rules. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We selected December&nbsp;31, 2019 as the date to
identify our median employee. We determined our median employee based on the sum of taxable wages, FASB ASC Topic 718 value of option and stock awards, and other compensation including taxable benefits of each of our employees, excluding
Mr.&nbsp;Robin, as of December&nbsp;31, 2019.</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">76 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_33"></A>INFORMATION ABOUT OUR INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>I<SMALL>NDEPENDENT</SMALL> R<SMALL>EGISTERED</SMALL> P<SMALL>UBLIC</SMALL> A<SMALL>CCOUNTING</SMALL>
F<SMALL>IRM</SMALL> F<SMALL>EES</SMALL> <SMALL>AND</SMALL> S<SMALL>ERVICES</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table represents
aggregate fees billed to us for fiscal years ended December&nbsp;31, 2019 and December&nbsp;31, 2018 by Ernst&nbsp;&amp; Young LLP, our independent registered public accounting firm. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fiscal Year Ended</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2019</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2018</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,465,751</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,860,554</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit Related Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tax Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,474</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,906</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All Other Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,476,225</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,871,660</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Audit Fees</I>. This category consists of fees related to the audit of our annual consolidated
financial statements and our internal control over financial reporting, review of interim condensed consolidated financial statements included in our quarterly reports <FONT STYLE="white-space:nowrap">on&nbsp;Form&nbsp;10-Q,&nbsp;and</FONT> services
that are normally provided by the independent registered public accounting firm in connection with statutory audit, registration statements and other regulatory filings. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Tax Fees.</I> This category consists of fees related to services provided for international tax compliance and tax consultation services. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>All Other Fees</I>.&nbsp;This category consists of fees related to accessing Ernst&nbsp;&amp; Young LLP&#146;s online research
database in 2018. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee approved all fees described above. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_34"></A>P<SMALL>RE</SMALL> -<SMALL>APPROVAL</SMALL> P<SMALL>OLICIES</SMALL> <SMALL>AND</SMALL> P<SMALL>ROCEDURES</SMALL>
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has adopted policies and procedures for the <FONT STYLE="white-space:nowrap">pre-approval</FONT> of
audit and <FONT STYLE="white-space:nowrap">non-audit</FONT> services rendered by our independent registered public accounting firm, Ernst&nbsp;&amp; Young LLP. The policy generally requires <FONT STYLE="white-space:nowrap">pre-approval</FONT> for
specified services in the defined categories of audit services, audit-related services and tax services up to specified amounts. <FONT STYLE="white-space:nowrap">Pre-approval</FONT> may also be given as part of the Audit Committee&#146;s approval of
the scope of the engagement of the independent registered public accounting firm or on an individual explicit <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis before the independent registered public
accounting firm is engaged to provide each service. The <FONT STYLE="white-space:nowrap">pre-approval</FONT> of services may be delegated to one or more of the Audit Committee&#146;s members, but the decision must be reported to the full Audit
Committee at its next scheduled meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prior to Ernst&nbsp;&amp; Young LLP rendering services other than audit services,
the Audit Committee would review and approve such <FONT STYLE="white-space:nowrap">non-audit</FONT> services only if such services were compatible with maintaining Ernst&nbsp;&amp; Young LLP&#146;s status as our independent registered public
accounting firm. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_35"></A>R<SMALL>EPORT</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> A<SMALL>UDIT</SMALL>
C<SMALL>OMMITTEE</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>The material in this report is being furnished and shall not be deemed &#147;filed&#148; with the SEC for purposes of Section&nbsp;18 of the Exchange Act or otherwise subject to the liability of that
section, nor shall the material in this section be deemed to be &#147;soliciting material&#148; or incorporated by reference in any registration statement or other document filed with the SEC under the Securities Act or the Exchange Act, except as
otherwise expressly stated in such filing. </I></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">77 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee is currently comprised of four
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors, R. Scott Greer, the Chairman of the committee, Jeff Ajer, Karin Eastham and Roy A. Whitfield. Our board of directors determined that Messrs. Greer, Ajer and Whitfield and
Ms.&nbsp;Eastham meet the independence requirements set forth in Rule <FONT STYLE="white-space:nowrap">10A-3(b)(1)</FONT> under the Exchange Act and in the applicable NASDAQ rules. In addition, the board of directors determined that Mr.&nbsp;Greer
and Ms.&nbsp;Eastham qualify as Audit Committee financial experts as defined by SEC rules. The Audit Committee has the responsibility and authority described in the Nektar Therapeutics Audit Committee Charter, which has been approved by the board of
directors. A copy of the Audit Committee Charter is available on our website at <I>www.nektar.com</I>. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee is
responsible for assessing the information provided by management and our independent registered public accounting firm in accordance with its business judgment. Management is responsible for the preparation, presentation and integrity of our
financial statements and for the appropriateness of the accounting principles and reporting policies that are used. Management is also responsible for testing the system of internal controls and reports to the Audit Committee on any deficiencies
found. Our independent registered public accounting firm, Ernst&nbsp;&amp; Young LLP, is responsible for auditing the annual financial statements and for reviewing the unaudited interim financial statements. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In fulfilling its oversight responsibilities, the Audit Committee has reviewed and discussed the audited financial statements in the
annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2019 with both management and our independent registered public accounting firm. The Audit Committee&#146;s review included a discussion of the
quality and integrity of the accounting principles, the reasonableness of significant estimates and judgments and the clarity of disclosures in the financial statements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee reviewed with our independent registered public accounting firm the overall scope and plan of the audit. In addition, it met with our independent registered public accounting firm,
with and without management present, to discuss the results of our independent registered public accounting firm&#146;s examination, the evaluation of our system of internal controls, the overall quality of our financial reporting and such other
matters as are required to be discussed under generally accepted accounting standards in the United States. The Audit Committee has also received from, and discussed with, our independent registered public accounting firm the matters required to be
discussed by Auditing Standard No.&nbsp;16, &#147;<I>Communications with Audit Committees&#148;</I> issued by the Public Company Accounting Oversight Board (&#147;PCAOB&#148;). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has discussed with Ernst&nbsp;&amp; Young LLP that firm&#146;s independence from management and our Company,
including the matters in the written disclosures and the letter regarding independence from Ernst&nbsp;&amp; Young LLP required by applicable requirements of the PCAOB. The Audit Committee has also considered the compatibility of audit related and
tax services with the auditors&#146; independence. Based on its evaluation, the Audit Committee has selected Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2020.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In reliance on the reviews and discussions referred to above, the Audit Committee recommended to the board of directors, and
the board of directors approved, the inclusion of the audited financial statements and management&#146;s assessment of the effectiveness of our internal controls over financial reporting in the annual report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2019 filed with the SEC. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Audit Committee
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jeff Ajer
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Karin Eastham </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roy A. Whitfield
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">78 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_36"></A>OTHER MATTERS </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The board of directors knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are
properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc910899_37"></A>ADDITIONAL INFORMATION </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our website address is
<I>http://www.nektar.com</I>. The information in, or that can be accessed through, our website is not deemed to be incorporated by reference into this proxy statement. Our annual reports on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K,</FONT>
quarterly reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and current reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> and amendments to those reports are available, free of charge, on or through our website as soon as
reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The public may read and copy any materials we file with the SEC at the SEC&#146;s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549.
Information on the operation of the Public Reference Room can be obtained by calling <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-SEC-0330.</FONT></FONT></FONT> The SEC maintains an
internet site that contains reports, proxy and information statements and other information regarding our filings at <I>www.sec.gov</I>. In addition, a copy of our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal
year ended December&nbsp;31, 2018 filed with the SEC is available without charge upon written request to: Secretary, Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, California 94158. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:55%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:55%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Mark A. Wilson </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:55%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mark A. Wilson </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:55%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Senior Vice President, General Counsel and
</I></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:55%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Secretary </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">April&nbsp;29, 2020 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">79 </FONT></P>


</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit A </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NEKTAR THERAPEUTICS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>AMENDED AND RESTATED 2017 PERFORMANCE INCENTIVE PLAN </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PURPOSE OF PLAN </B></FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The purpose of this Nektar Therapeutics Amended and Restated 2017 Performance Incentive Plan (this &#147;<B>Plan</B>&#148;) of Nektar Therapeutics, a Delaware corporation (the
&#147;<B>Corporation</B>&#148;), is to promote the success of the Corporation and to increase stockholder value by providing an additional means through the grant of awards to attract, motivate, retain and reward selected employees and other
eligible persons. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ELIGIBILITY </B></FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Administrator (as such term is defined in Section&nbsp;3.1) may grant awards under this Plan only to those persons that the Administrator determines to be Eligible Persons. An &#147;<B>Eligible
Person</B>&#148; is any person who is either: (a)&nbsp;an officer (whether or not a director) or employee of the Corporation or one of its Subsidiaries; (b)&nbsp;a director of the Corporation or one of its Subsidiaries; or (c)&nbsp;an individual
consultant or advisor who renders or has rendered bona fide services (other than services in connection with the offering or sale of securities of the Corporation or one of its Subsidiaries in a capital-raising transaction or as a market maker or
promoter of securities of the Corporation or one of its Subsidiaries) to the Corporation or one of its Subsidiaries and who is selected to participate in this Plan by the Administrator; provided, however, that a person who is otherwise an Eligible
Person under clause (c)&nbsp;above may participate in this Plan only if such participation would not adversely affect either the Corporation&#146;s eligibility to use Form <FONT STYLE="white-space:nowrap">S-8</FONT> to register under the Securities
Act of 1933, as amended (the &#147;<B>Securities Act</B>&#148;), the offering and sale of shares issuable under this Plan by the Corporation or the Corporation&#146;s compliance with any other applicable laws. An Eligible Person who has been granted
an award (a &#147;participant&#148;) may, if otherwise eligible, be granted additional awards if the Administrator shall so determine. As used herein, &#147;<B>Subsidiary</B>&#148; means any corporation or other entity a majority of whose
outstanding voting stock or voting power is beneficially owned directly or indirectly by the Corporation; and &#147;<B>Board</B>&#148; means the Board of Directors of the Corporation. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PLAN ADMINISTRATION </B></FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.1</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>The Administrator</I></B><B>.</B> This Plan shall be administered by and all awards under this Plan shall be authorized by the
Administrator. The &#147;Administrator&#148; means the Board or one or more committees appointed by the Board or another committee (within its delegated authority) to administer all or certain aspects of this Plan. Any such committee shall be
comprised solely of one or more directors or such number of directors as may be required under applicable law. A committee may delegate some or all of its authority to another committee so constituted. The Board or a committee comprised solely of
directors may also delegate, to the extent permitted by Section&nbsp;157(c) of the Delaware General Corporation Law and any other applicable law, to one or more officers of the Corporation, its powers under this Plan (a)&nbsp;to designate the
officers and employees of the Corporation and its Subsidiaries who will receive grants of awards under this Plan, and (b)&nbsp;to determine the number of shares subject to, and the other terms and conditions of, such awards. The Board may delegate
different levels of authority to different committees with administrative and grant authority under this Plan. Unless otherwise provided in the Bylaws of the Corporation or the applicable charter of any Administrator: (a)&nbsp;a majority of the
members of the acting Administrator shall constitute a quorum, and (b)&nbsp;the vote of a majority of the members present assuming the presence of a quorum or the unanimous written consent of the members of the Administrator shall constitute action
by the acting Administrator. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2">With respect to awards previously intended to satisfy the requirements for
performance-based compensation under Section&nbsp;162(m) of the Internal Revenue Code of 1986, as amended (the &#147;<B>Code</B>&#148;), </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-1
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2">
this Plan shall be administered by a committee consisting solely of two or more outside directors (as this requirement is applied under Section&nbsp;162(m) of the Code); provided, however, that
the failure to satisfy such requirement shall not affect the validity of the action of any committee otherwise duly authorized and acting in the matter. Award grants, and transactions in or involving awards, intended to be exempt under Rule <FONT
STYLE="white-space:nowrap">16b-3</FONT> under the Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;), must be duly and timely authorized by the Board or a committee consisting solely of two or more <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors (as this requirement is applied under Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act). To the extent required by any applicable listing agency, this Plan
shall be administered by a committee composed entirely of independent directors (within the meaning of the applicable listing agency). </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.2</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Powers of the Administrator</I></B><B>.</B> Subject to the express provisions of this Plan, the Administrator is authorized and
empowered to do all things necessary or desirable in connection with the authorization of awards and the administration of this Plan (in the case of a committee or delegation to one or more officers, within the authority delegated to that committee
or person(s)), including, without limitation, the authority to: </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">determine eligibility and, from among those persons determined to be eligible, the particular Eligible Persons who will receive an award under
this Plan; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">grant awards to Eligible Persons, determine the price at which securities will be offered or awarded and the number of securities to be
offered or awarded to any of such persons, determine the other specific terms and conditions of such awards consistent with the express limits of this Plan, establish the installments (if any) in which such awards shall become exercisable or shall
vest (which may include, without limitation, performance and/or time-based schedules), or determine that no delayed exercisability or vesting is required, establish any applicable performance targets, and establish the events of termination or
reversion of such awards; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(c)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">approve the forms of award agreements (which need not be identical either as to type of award or among participants);
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(d)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">construe and interpret this Plan and any agreements defining the rights and obligations of the Corporation, its Subsidiaries, and participants
under this Plan, further define the terms used in this Plan, and prescribe, amend and rescind rules and regulations relating to the administration of this Plan or the awards granted under this Plan; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(e)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">cancel, modify, or waive the Corporation&#146;s rights with respect to, or modify, discontinue, suspend, or terminate any or all outstanding
awards, subject to any required consent under Section&nbsp;8.6.5; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(f)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">accelerate or extend the vesting or exercisability or extend the term of any or all such outstanding awards (in the case of options or stock
appreciation rights, within the maximum <FONT STYLE="white-space:nowrap">ten-year</FONT> term of such awards) in such circumstances as the Administrator may deem appropriate (including, without limitation, in connection with a termination of
employment or services or other events of a personal nature) subject to any required consent under Section&nbsp;8.6.5; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(g)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">adjust the number of shares of Common Stock subject to any award, adjust the price of any or all outstanding awards or otherwise change
previously imposed terms and conditions, in such circumstances as the Administrator may deem appropriate, in each case subject to Sections 4 and 8.6 (and subject to the no repricing provision below); </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(h)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">determine the date of grant of an award, which may be a designated date after but not before the date of the Administrator&#146;s action
(unless otherwise designated by the Administrator, the date of grant of an award shall be the date upon which the Administrator took the action granting an award); </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-2
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(i)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">determine whether, and the extent to which, adjustments are required pursuant to Section&nbsp;7 hereof and authorize the termination,
conversion, substitution or succession of awards upon the occurrence of an event of the type described in Section&nbsp;7; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(j)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">acquire or settle (subject to Sections 7 and 8.6) rights under awards in cash, stock of equivalent value, or other consideration (subject to
the no repricing provision below); and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(k)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">determine the fair market value of the Common Stock or awards under this Plan from time to time and/or the manner in which such value will be
determined. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Notwithstanding the foregoing and except for an adjustment pursuant to Section&nbsp;7.1 or a
repricing approved by stockholders, in no case may the Administrator (1)&nbsp;amend an outstanding stock option or stock appreciation right to reduce the exercise price or base price of the award, (2)&nbsp;cancel, exchange, or surrender an
outstanding stock option or stock appreciation right in exchange for cash or other awards for the purpose of repricing the award, or (3)&nbsp;cancel, exchange, or surrender an outstanding stock option or stock appreciation right in exchange for an
option or stock appreciation right with an exercise or base price that is less than the exercise or base price of the original award. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.3</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Binding Determinations</I></B><B>.</B> Any action taken by, or inaction of, the Corporation, any Subsidiary, or the Administrator
relating or pursuant to this Plan and within its authority hereunder or under applicable law shall be within the absolute discretion of that entity or body and shall be conclusive and binding upon all persons. Neither the Board nor any Board
committee, nor any member thereof or person acting at the direction thereof, shall be liable for any act, omission, interpretation, construction or determination made in good faith in connection with this Plan (or any award made under this Plan),
and all such persons shall be entitled to indemnification and reimbursement by the Corporation in respect of any claim, loss, damage or expense (including, without limitation, attorneys&#146; fees) arising or resulting therefrom to the fullest
extent permitted by law and/or under any directors and officers liability insurance coverage that may be in effect from time to time. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.4</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Reliance on Experts</I></B><B>.</B> In making any determination or in taking or not taking any action under this Plan, the Administrator
may obtain and may rely upon the advice of experts, including employees and professional advisors to the Corporation. No director, officer or agent of the Corporation or any of its Subsidiaries shall be liable for any such action or determination
taken or made or omitted in good faith. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.5</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Delegation</I></B><B>.</B> The Administrator may delegate ministerial, <FONT STYLE="white-space:nowrap">non-discretionary</FONT>
functions to individuals who are officers or employees of the Corporation or any of its Subsidiaries or to third parties. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SHARES OF COMMON STOCK SUBJECT TO THE PLAN; SHARE LIMITS </B></FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.1</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Shares Available</I></B><B>.</B> Subject to the provisions of Section&nbsp;7.1, the capital stock that may be delivered under this Plan
shall be shares of the Corporation&#146;s authorized but unissued Common Stock and any shares of its Common Stock held as treasury shares. For purposes of this Plan, &#147;<B>Common Stock</B>&#148; shall mean the common stock of the Corporation and
such other securities or property as may become the subject of awards under this Plan, or may become subject to such awards, pursuant to an adjustment made under Section&nbsp;7.1. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.2</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Share Limits</I></B><B>.</B> Subject to Section&nbsp;7.1, the maximum number of shares of Common Stock that may be delivered pursuant to
awards granted to Eligible Persons under this Plan (the &#147;<B>Share Limit</B>&#148;) is equal to: </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">29,200,000 shares of Common Stock, less </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-3
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The number of any shares subject to awards granted under the Corporation&#146;s 2012 Performance Incentive Plan (the &#147;2012 Plan&#148;) on
or after March&nbsp;31, 2017. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shares issued in respect of any &#147;Full-Value Award&#148; granted under
this Plan shall be counted against the foregoing Share Limit as 1.5 shares for every one share issued in connection with such award (the &#147;Full-Value Award Ratio&#148;). (For example, if a stock bonus of 100 shares of Common Stock is granted
under this Plan, 150 shares shall be charged against the Share Limit in connection with that award.) For this purpose, a &#147;Full-Value Award&#148; means any award under this Plan that is not a stock option grant or a stock appreciation right
grant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following limits also apply with respect to awards granted under this Plan: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The maximum number of shares of Common Stock that may be delivered pursuant to options qualified as incentive stock options granted under this
Plan is 29,200,000 shares. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The maximum number of shares of Common Stock subject to options and stock appreciation rights that are granted during any calendar year to any
individual under this Plan is 3,000,000 shares. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(c)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Additional limits with respect to performance-based awards are set forth in Section&nbsp;5.2.2. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(d)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The aggregate value of cash compensation and the grant date fair value (computed in accordance with generally accepted accounting principles)
of shares of Common Stock that may be paid or granted during any calendar year to any <FONT STYLE="white-space:nowrap">non-employee</FONT> director shall not exceed $1,200,000 for existing <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors and $2,200,000 for new <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each of
the foregoing numerical limits is subject to adjustment as contemplated by Section&nbsp;4.3, Section&nbsp;7.1, and Section&nbsp;8.10. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.3</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Awards Settled in Cash, Reissue of Awards and Shares</I></B><B>.</B> Except as provided in the next sentence, shares that are subject to
or underlie awards granted under this Plan or the 2012 Plan, the Corporation&#146;s 2008 Equity Incentive Plan, the Corporation&#146;s 2000 <FONT STYLE="white-space:nowrap">Non-Officer</FONT> Equity Incentive Plan, or the Corporation&#146;s 2000
Equity Incentive Plan (collectively, the <B>&#147;Prior Plans</B>&#148;), which expire or for any reason are cancelled or terminated, are forfeited, fail to vest, or for any other reason are not paid or delivered under this Plan or a Prior Plan
shall again be available for subsequent awards under this Plan (with any such shares increasing the Share Limit based on the Full-Value Award Ratio specified in Section&nbsp;4.2 or, with respect to awards granted under a Prior Plan, the Full-Value
Award Ratio as specified in such Prior Plan). Shares that are exchanged by a participant or withheld by the Corporation as full or partial payment in connection with any award under this Plan, as well as any shares exchanged by a participant or
withheld by the Corporation or one of its Subsidiaries to satisfy the tax withholding obligations related to any award, shall not be available for subsequent awards under this Plan. To the extent that an award granted under this Plan or a Prior Plan
is settled in cash or a form other than shares of Common Stock, the shares that would have been delivered had there been no such cash or other settlement shall again be available for subsequent awards under this Plan (with any such shares increasing
the Share Limit based on the Full-Value Award Ratio specified in Section&nbsp;4.2 or, with respect to awards granted under a Prior Plan, the Full-Value Award Ratio as specified in such Prior Plan). In the event that shares of Common Stock are
delivered in respect of a dividend equivalent right granted under this Plan, the number of shares delivered with respect to the award shall be counted against the share limits of this Plan (including, for purposes of clarity, the limits of
Section&nbsp;4.2 of this Plan). (For purposes of clarity, if 1,000 dividend equivalent rights are granted and outstanding when the Corporation pays a dividend, and 50 shares are delivered in payment of those rights with respect to that dividend, 75
shares (after giving effect to the Full-Value Award premium counting rules) shall be </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-4
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
counted against the share limits of this Plan). To the extent that shares of Common Stock are delivered pursuant to the exercise of a stock appreciation right or stock option granted under this
Plan, the number of underlying shares as to which the exercise related shall be counted against the applicable share limits under Section&nbsp;4.2, as opposed to only counting the shares issued. (For purposes of clarity, if a stock appreciation
right relates to 100,000 shares and is exercised at a time when the payment due to the participant is 15,000 shares, 100,000 shares shall be charged against the applicable share limits under Section&nbsp;4.2 with respect to such exercise.) Refer to
Section&nbsp;8.10 for application of the foregoing share limits with respect to assumed awards. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.4</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Reservation of Shares; No Fractional Shares; Minimum Issue</I></B><B>.</B> The Corporation shall at all times reserve a number of shares
of Common Stock sufficient to cover the Corporation&#146;s obligations and contingent obligations to deliver shares with respect to awards then outstanding under this Plan (exclusive of any dividend equivalent obligations to the extent the
Corporation has the right to settle such rights in cash). No fractional shares shall be delivered under this Plan. The Administrator may pay cash in lieu of any fractional shares in settlements of awards under this Plan. The Administrator may from
time to time impose a limit (of not greater than 100 shares) on the minimum number of shares that may be purchased or exercised as to awards granted under this Plan unless (as to any particular award) the total number purchased or exercised is the
total number at the time available for purchase or exercise under the award. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>AWARDS </B></FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.1</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Type and Form of Awards</I></B><B>.</B> The Administrator shall determine the type or types of award(s) to be made to each selected
Eligible Person. Awards may be granted singly, in combination or in tandem. Awards also may be made in combination or in tandem with, in replacement of, as alternatives to, or as the payment form for grants or rights under any other employee or
compensation plan of the Corporation or one of its Subsidiaries. The types of awards that may be granted under this Plan are (subject, in each case, to the no repricing provisions of Section&nbsp;3.2): </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.1.1</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Stock Options</I></B><B>.</B> A stock option is the grant of a right to purchase a specified number of shares of Common Stock during a
specified period as determined by the Administrator. An option may be intended as an incentive stock option within the meaning of Section&nbsp;422 of the Code (an &#147;<B>ISO</B>&#148;) or a nonqualified stock option (an option not intended to be
an ISO). The award agreement for an option will indicate if the option is intended as an ISO. Each option, or portion thereof, that is not an ISO, shall be a nonqualified stock option.&nbsp;&nbsp;&nbsp;&nbsp;The maximum term of each option (ISO or
nonqualified) shall be eight (8)&nbsp;years. The per share exercise price for each option shall be not less than 100% of the fair market value of a share of Common Stock on the date of grant of the option. When an option is exercised, the exercise
price for the shares to be purchased shall be paid in full in cash or such other method permitted by the Administrator consistent with Section&nbsp;5.5. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.1.2</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Additional Rules Applicable to ISOs</I></B><B>.</B> To the extent that the aggregate fair market value (determined at the time of grant
of the applicable option) of stock with respect to which ISOs first become exercisable by a participant in any calendar year exceeds $100,000, taking into account both Common Stock subject to ISOs under this Plan and stock subject to ISOs under all
other plans of the Corporation or one of its Subsidiaries (or any parent or predecessor corporation to the extent required by and within the meaning of Section&nbsp;422 of the Code and the regulations promulgated thereunder), such options shall be
treated as nonqualified stock options. In reducing the number of options treated as ISOs to meet the $100,000 limit, the most recently granted options shall be reduced first. To the extent a reduction of simultaneously granted options is necessary
to meet the $100,000 limit, the Administrator may, in the manner and to the extent permitted by law, designate which shares of Common Stock are to be treated as shares acquired
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-5
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
pursuant to the exercise of an ISO. ISOs may only be granted to employees of the Corporation or one of its subsidiaries (for this purpose, the term &#147;subsidiary&#148; is used as defined in
Section&nbsp;424(f) of the Code, which generally requires an unbroken chain of ownership of at least 50% of the total combined voting power of all classes of stock of each subsidiary in the chain beginning with the Corporation and ending with the
subsidiary in question). There shall be imposed in any award agreement relating to ISOs such other terms and conditions as from time to time are required in order that the option be an &#147;incentive stock option&#148; as that term is defined in
Section&nbsp;422 of the Code. No ISO may be granted to any person who, at the time the option is granted, owns (or is deemed to own under Section&nbsp;424(d) of the Code) shares of outstanding Common Stock possessing more than 10% of the total
combined voting power of all classes of stock of the Corporation, unless the exercise price of such option is at least 110% of the fair market value of the stock subject to the option and such option by its terms is not exercisable after the
expiration of five years from the date such option is granted. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.1.3</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Stock Appreciation Rights</I></B><B>.</B> A stock appreciation right or &#147;<B>SAR</B>&#148; is a right to receive a payment, in cash
and/or Common Stock (as specified in the applicable award agreement), equal to the excess of the fair market value of a specified number of shares of Common Stock on the date the SAR is exercised over the &#147;<B>base price</B>&#148; of the award,
which base price shall be set forth in the applicable award agreement and shall be not less than 100% of the fair market value of a share of Common Stock on the date of grant of the SAR. The maximum term of a SAR shall be eight (8)&nbsp;years.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.1.4</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Other Awards; Dividend Equivalent Rights</I></B><B>.</B> The other types of awards that may be granted under this Plan include:
(a)&nbsp;stock bonuses, restricted stock, performance stock, stock units, phantom stock or similar rights to purchase or acquire shares, whether at a fixed or variable price or ratio related to the Common Stock, upon the passage of time, the
occurrence of one or more events, or the satisfaction of performance criteria or other conditions, or any combination thereof; (b)&nbsp;any similar securities with a value derived from the value of or related to the Common Stock and/or returns
thereon; or (c)&nbsp;cash awards. Dividend equivalent rights may be granted as a separate award or in connection with another award under this Plan; provided, however, that dividend equivalent rights may not be granted in connection with a stock
option or SAR granted under this Plan. Notwithstanding anything in the Plan or an award agreement to the contrary, any dividends and/or dividend equivalents as to the unvested portion of an award (including, without limitation, a restricted stock
award) will be subject to termination and forfeiture to the same extent as the corresponding portion of the award to which they relate. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.2</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Performance-Based Awards</I></B><B>.</B> The grant, vesting, exercisability or payment of performance-based awards shall depend on the
degree of achievement of one or more performance goals relative to a <FONT STYLE="white-space:nowrap">pre-established</FONT> targeted level or levels using one or more of the Business Criteria set forth below (on an absolute or relative (including,
without limitation, relative to the performance of other companies or upon comparisons of any of the indicators of performance relative to other companies) basis) for the Corporation on a consolidated basis or for one or more of the
Corporation&#146;s subsidiaries, segments, divisions or business units, or any combination of the foregoing. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.2.1</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Performance Goals</I></B><B>. </B>The specific performance goals for performance-based awards may be, on an absolute or relative basis,
established based on one or more of the following business criteria (&#147;<B>Business Criteria</B>&#148;) as selected by the Administrator in its sole discretion: earnings per share; cash flow (which means cash and cash equivalents derived from
either net cash flow from operations or net cash flow from operations, financing and investing activities); working capital; stock price; total stockholder return; revenue; gross profit; operating income; net earnings (before or after interest,
taxes, depreciation and/or amortization); gross margin; operating margin; net margin; return on equity or on assets or on net investment; cost containment or </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-6
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
reduction; regulatory submissions or approvals; manufacturing production; completion of strategic partnerships; research milestones; any other measure selected by the Administrator or any
combination thereof. As applicable, these terms are used as applied under generally accepted accounting principles or in the financial reporting of the Corporation or of its Subsidiaries. The applicable performance goals may be applied on a <FONT
STYLE="white-space:nowrap">pre-</FONT> or <FONT STYLE="white-space:nowrap">post-tax</FONT> basis and may be adjusted to include or exclude determinable components of any performance goal, including, without limitation, foreign exchange gains and
losses, asset write-downs, acquisitions and divestitures, change in fiscal year, unbudgeted capital expenditures, special charges such as restructuring or impairment charges, debt refinancing costs, extraordinary or noncash items, unusual,
infrequently occurring, nonrecurring or <FONT STYLE="white-space:nowrap">one-time</FONT> events affecting the Corporation or its financial statements or changes in law or accounting principles (<I>&#147;Adjustment Events&#148;</I>). The applicable
performance measurement period may not be less than three months nor more than 10 years. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.2.2</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Form of Payment; Maximum Performance-Based Award</I></B><B>.</B> Grants or awards under this Section&nbsp;5.2 may be paid in cash or
shares of Common Stock or any combination thereof. The maximum number of shares of Common Stock which may be subject to performance-based awards (including performance-based awards payable in shares of Common Stock and performance-based awards
payable in cash where the amount of cash payable upon or following vesting of the award is determined with reference to the fair market value of a share of Common Stock at such time) that are granted to any one participant in any one calendar year
shall not exceed 3,000,000 shares, either individually or in the aggregate, subject to adjustment as provided in Section&nbsp;7.1; provided that this limit shall not apply to Options and SARs (which are covered by the limit of Section&nbsp;4.2(b)).
The aggregate amount of compensation to be paid to any one participant in respect of all performance-based awards payable only in cash (excluding cash awards covered by the preceding sentence where the cash payment is determined with reference to
the fair market value of a share of Common Stock upon or following the vesting of the award) and granted to that participant in any one calendar year shall not exceed $5,000,000. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.2.3</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Certification of Payment</I></B><B>. </B>Before any performance-based award is paid under this Section&nbsp;5.2, the Administrator must
certify in writing that the performance target(s) and any other material terms of the Performance-Based Award were in fact timely satisfied. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.2.4</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Reservation of Discretion</I></B><B>. </B>The Administrator will have the discretion to determine the restrictions or other limitations
of the individual awards granted under this Section&nbsp;5.2 including the authority to reduce awards, payouts or vesting or to pay no awards, in its sole discretion, if the Administrator preserves such authority at the time of grant by language to
this effect in its authorizing resolutions or otherwise. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.3</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Award Agreements</I></B><B>.</B> Each award shall be evidenced by either (1)&nbsp;a written award agreement in a form approved by the
Administrator and executed by the Corporation by an officer duly authorized to act on its behalf, or (2)&nbsp;an electronic notice of award grant in a form approved by the Administrator and recorded by the Corporation (or its designee) in an
electronic recordkeeping system used for the purpose of tracking award grants under this Plan generally (in each case, an &#147;award agreement&#148;), as the Administrator may provide and, in each case and if required by the Administrator, executed
or otherwise electronically accepted by the recipient of the award in such form and manner as the Administrator may require. The Administrator may authorize any officer of the Corporation (other than the particular award recipient) to execute any or
all award agreements on behalf of the Corporation. The award agreement shall set forth the material terms and conditions of the award as established by the Administrator consistent with the express limitations of this Plan. Notwithstanding anything
contained herein to the contrary, the Administrator may approve an award agreement that, upon the termination of a participant&#146;s employment or service, provides that, or may, in its sole discretion based on a review of all relevant facts and
circumstances, otherwise take action regarding an award </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-7
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
agreement such that (i)&nbsp;any or all outstanding stock options and SARs shall become exercisable in part or in full, (ii)&nbsp;all or a portion of the restriction or vesting period applicable
to any outstanding award shall lapse, (iii)&nbsp;all or a portion of the performance measurement period applicable to any outstanding award shall lapse and (iv)&nbsp;the performance goals applicable to any outstanding award (if any) shall be deemed
to be satisfied at the target, maximum or any other interim level. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.4</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Deferrals and Settlements</I></B><B>.</B> Payment of awards may be in the form of cash, Common Stock, other awards or combinations
thereof as the Administrator shall determine, and with such restrictions as it may impose. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Administrator may also require or permit participants to elect to defer the issuance of shares or the settlement of awards in cash under such rules and procedures as it may establish under this Plan. The Administrator may also provide that deferred
settlements include the payment or crediting of interest or other earnings on the deferral amounts, or the payment or crediting of dividend equivalents where the deferred amounts are denominated in shares. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.5</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Consideration for Common Stock or Awards</I></B><B>.</B> The purchase price for any award granted under this Plan or the Common Stock to
be delivered pursuant to an award, as applicable, may be paid by means of any lawful consideration as determined by the Administrator, including, without limitation, one or a combination of the following methods: </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">services rendered by the recipient of such award; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">cash, check payable to the order of the Corporation, or electronic funds transfer; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">notice and third party payment in such manner as may be authorized by the Administrator; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the delivery of previously owned shares of Common Stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">by a reduction in the number of shares otherwise deliverable pursuant to the award; or </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">subject to such procedures as the Administrator may adopt, pursuant to a &#147;cashless exercise&#148; with a third party who provides financing for
the purposes of (or who otherwise facilitates) the purchase or exercise of awards. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In no event shall any
shares newly-issued by the Corporation be issued for less than the minimum lawful consideration for such shares or for consideration other than consideration permitted by applicable state law. Shares of Common Stock used to satisfy the exercise
price of an option shall be valued at their fair market value on the date of exercise. The Corporation will not be obligated to deliver any shares unless and until it receives full payment of the exercise or purchase price therefor and any related
withholding obligations under Section&nbsp;8.5 and any other conditions to exercise or purchase have been satisfied. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.6</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Definition of Fair Market Value.</I></B> For purposes of this Plan, &#147;fair market value&#148; shall mean the closing price (in
regular trading) for a share of Common Stock on the NASDAQ Stock Market (the &#147;<B>Market</B>&#148;) for the date in question or, if no sales of Common Stock were reported on the Market on that date, the closing price (in regular trading) for a
share of Common Stock on the Market for the next preceding day on which sales of Common Stock were reported on the Market. The Administrator may, however, provide with respect to one or more awards that the fair market value shall equal the closing
price (in regular trading) for a share of Common Stock on the Market on the last trading day preceding the date in question or the average of the high and low trading prices of a share of Common Stock on the Market for the date in question or the
most recent trading day. If the Common Stock is no longer listed </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-8
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
or is no longer actively traded on the Market as of the applicable date, the fair market value of the Common Stock shall be the value as reasonably determined by the Administrator for purposes of
the award in the circumstances. The Administrator also may adopt a different methodology for determining fair market value with respect to one or more awards if a different methodology is necessary or advisable to secure any intended favorable tax,
legal or other treatment for the particular award(s) (for example, and without limitation, the Administrator may provide that fair market value for purposes of one or more awards will be based on an average of closing prices (or the average of high
and low daily trading prices) for a specified period preceding the relevant date). </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.7</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Transfer Restrictions. </B></FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.7.1</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Limitations on Exercise and Transfer.</I></B> Unless otherwise expressly provided in (or pursuant to) this Section&nbsp;5.7 or required
by applicable law: (a)&nbsp;all awards are <FONT STYLE="white-space:nowrap">non-transferable</FONT> and shall not be subject in any manner to sale, transfer, anticipation, alienation, assignment, pledge, encumbrance or charge; (b)&nbsp;awards shall
be exercised only by the participant; and (c)&nbsp;amounts payable or shares issuable pursuant to any award shall be delivered only to (or for the account of) the participant. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.7.2</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Exceptions.</I></B> The Administrator may permit awards to be exercised by and paid to, or otherwise transferred to, other persons or
entities pursuant to such conditions and procedures, including limitations on subsequent transfers, as the Administrator may, in its sole discretion, establish in writing. Any permitted transfer shall be subject to compliance with applicable federal
and state securities laws and shall not be for value (other than nominal consideration, settlement of marital property rights, or for interests in an entity in which more than 50% of the voting interests are held by the Eligible Person or by the
Eligible Person&#146;s family members). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.7.3</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Further Exceptions to Limits on Transfer.</I></B> The exercise and transfer restrictions in Section&nbsp;5.7.1 shall not apply to:
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">transfers to the Corporation (for example, in connection with the expiration or termination of the award); </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the designation of a beneficiary to receive benefits in the event of the participant&#146;s death or, if the participant has died, transfers
to or exercise by the participant&#146;s beneficiary, or, in the absence of a validly designated beneficiary, transfers by will or the laws of descent and distribution; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(c)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">subject to any applicable limitations on ISOs, transfers to a family member (or former family member) pursuant to a domestic relations order
if approved or ratified by the Administrator; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(d)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">if the participant has suffered a disability, permitted transfers or exercises on behalf of the participant by his or her legal
representative; or </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(e)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the authorization by the Administrator of &#147;cashless exercise&#148; procedures with third parties who provide financing for the purpose of
(or who otherwise facilitate) the exercise of awards consistent with applicable laws and the express authorization of the Administrator. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.8</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>International Awards.</I></B> One or more awards may be granted to Eligible Persons who provide services to the Corporation or one of
its Subsidiaries outside of the United States. Any awards granted to such persons may be granted pursuant to the terms and conditions of any applicable <FONT STYLE="white-space:nowrap">sub-plans,</FONT> if any, appended to this Plan and approved by
the Administrator. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>EFFECT OF TERMINATION OF EMPLOYMENT OR SERVICE ON AWARDS </B></FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-9
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6.1</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>General.</I></B> The Administrator shall establish the effect of a termination of employment or service on the rights and benefits under
each award under this Plan and in so doing may make distinctions based upon, inter alia, the cause of termination and type of award. If the participant is not an employee of the Corporation or one of its Subsidiaries and provides other services to
the Corporation or one of its Subsidiaries, the Administrator shall be the sole judge for purposes of this Plan (unless a contract or the award otherwise provides) of whether the participant continues to render services to the Corporation or one of
its Subsidiaries and the date, if any, upon which such services shall be deemed to have terminated. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6.2</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Events Not Deemed Terminations of Service.</I></B> Unless the express policy of the Corporation or one of its Subsidiaries, or the
Administrator, otherwise provides, the employment relationship shall not be considered terminated in the case of (a)&nbsp;sick leave, (b)&nbsp;military leave, or (c)&nbsp;any other leave of absence authorized by the Corporation or one of its
Subsidiaries, or the Administrator; provided that, unless reemployment upon the expiration of such leave is guaranteed by contract or law or the Administrator otherwise provides, such leave is for a period of not more than three months (or such
other period of time as required by applicable law). In the case of any employee of the Corporation or one of its Subsidiaries on an approved leave of absence, continued vesting of the award while on leave from the employ of the Corporation or one
of its Subsidiaries may be suspended until the employee returns to service, unless the Administrator otherwise provides or applicable law (including Section&nbsp;409A of the Code) otherwise requires. In no event shall an award be exercised after the
expiration of the term set forth in the applicable award agreement. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6.3</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Effect of Change of Subsidiary Status.</I></B> For purposes of this Plan and any award, if an entity ceases to be a Subsidiary of the
Corporation a termination of employment or service shall be deemed to have occurred with respect to each Eligible Person in respect of such Subsidiary who does not continue as an Eligible Person in respect of the Corporation or another Subsidiary
that continues as such after giving effect to the transaction or other event giving rise to the change in status unless the Subsidiary that is sold, <FONT STYLE="white-space:nowrap">spun-off</FONT> or otherwise divested (or its successor or a direct
or indirect parent of such Subsidiary or successor) assumes the Eligible Person&#146;s award(s) in connection with such transaction. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ADJUSTMENTS; ACCELERATION </B></FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.1</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Adjustments.</I></B> Subject to Section&nbsp;7.2, upon (or, as may be necessary to effect the adjustment, immediately prior to): any
reclassification, recapitalization, stock split (including a stock split in the form of a stock dividend) or reverse stock split; any merger, combination, consolidation, or other reorganization; any <FONT STYLE="white-space:nowrap">spin-off,</FONT> <FONT
STYLE="white-space:nowrap">split-up,</FONT> or similar extraordinary dividend distribution in respect of the Common Stock; or any exchange of Common Stock or other securities of the Corporation, or any similar, unusual or extraordinary corporate
transaction in respect of the Common Stock; then the Administrator shall equitably and proportionately adjust (1)&nbsp;the number and type of shares of Common Stock (or other securities) that thereafter may be made the subject of awards (including
the specific share limits, maximums and numbers of shares set forth elsewhere in this Plan), (2)&nbsp;the number, amount and type of shares of Common Stock (or other securities or property) subject to any outstanding awards, (3)&nbsp;the grant,
purchase, or exercise price (which term includes the base price of any SAR or similar right) of any outstanding awards, and/or (4)&nbsp;the securities, cash or other property deliverable upon exercise or payment of any outstanding awards, in each
case to the extent necessary to preserve (but not increase) the level of incentives intended by this Plan and the then-outstanding awards. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:9%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Unless otherwise expressly provided in the applicable award agreement, upon (or, as may be necessary to effect the adjustment, immediately prior to) any event or transaction described in the preceding
paragraph or a sale of all or substantially all of the business or assets of the Corporation as an entirety, the Administrator shall equitably and proportionately adjust the performance standards applicable to
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-10
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2">
any then-outstanding performance-based awards to the extent necessary to preserve (but not increase) the level of incentives intended by this Plan and the then-outstanding performance-based
awards. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2">It is intended that, if possible, any adjustments contemplated by the preceding two paragraphs be made in a manner
that satisfies applicable U.S. legal, tax (including, without limitation and as applicable in the circumstances, Section&nbsp;424 of the Code and Section&nbsp;409A of the Code) and accounting (so as to not trigger any charge to earnings with respect
to such adjustment) requirements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Without limiting the generality of Section&nbsp;3.3, any good faith determination by the
Administrator as to whether an adjustment is required in the circumstances pursuant to this Section&nbsp;7.1, and the extent and nature of any such adjustment, shall be conclusive and binding on all persons. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.2</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Change in Control&#151;Assumption and Termination of Awards.</I></B> Upon the occurrence of a Change in Control, then the Administrator
may make provision for a cash payment in settlement of, or for the termination, assumption, substitution or exchange of any or all outstanding share-based awards or the cash, securities or property deliverable to the holder of any or all outstanding
share-based awards, based upon, to the extent relevant under the circumstances, the distribution or consideration payable to holders of the Common Stock upon or in respect of such Change in Control. Upon the occurrence of a Change in Control, then,
unless the Administrator has made a provision for the substitution, assumption, exchange or other continuation or settlement of the award or (unless the Administrator has provided for the termination of the award) the award would otherwise continue
in accordance with its terms in the circumstances: (1)&nbsp;unless otherwise provided in the applicable award agreement, each then-outstanding option and SAR shall become fully vested, all shares of restricted stock then outstanding shall fully vest
free of restrictions, and each other award granted under this Plan that is then outstanding shall become payable to the holder of such award; and (2)&nbsp;each award shall terminate upon the Change in Control; provided that the holder of an option
or SAR shall be given reasonable advance notice of the impending termination and a reasonable opportunity to exercise his or her outstanding vested options and SARs (after giving effect to any accelerated vesting required in the circumstances) in
accordance with their terms before the termination of such awards (except that in no case shall more than ten days&#146; notice of the impending termination be required and any acceleration of vesting and any exercise of any portion of an award that
is so accelerated may be made contingent upon the actual occurrence of the Change in Control). </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Administrator may adopt such valuation methodologies for outstanding awards as it deems reasonable in the event of a cash or property settlement and, in the case of options, SARs or similar rights, but without limitation on other methodologies, may
base such settlement solely upon the excess (if any) of the per share amount payable upon or in respect of such Change in Control over the exercise or base price of the award. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:9%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Subject to applicable law, in the event of a Change in Control, the Administrator may take such action contemplated by this Section&nbsp;7.2 prior to such Change in Control (as opposed to on the
occurrence of such Change in Control) to the extent that the Administrator deems the action necessary to permit the participant to realize the benefits intended to be conveyed with respect to the underlying shares. Without limiting the generality of
the foregoing, the Administrator may deem an acceleration to occur immediately prior to the Change in Control and, in such circumstances, will reinstate the original terms of the award if an event giving rise to an acceleration does not occur.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Without limiting the generality of Section&nbsp;3.3, any good faith determination by the Administrator pursuant to its
authority under this Section&nbsp;7.2 shall be conclusive and binding on all persons. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.3</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Other Acceleration Rules.</I></B> The Administrator may override the provisions of Section&nbsp;7.2 by express provision in the award
agreement and may accord any Eligible Person a right, subject to Section&nbsp;409A </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-11
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
of the Code, to refuse any acceleration, whether pursuant to the award agreement or otherwise, in such circumstances as the Administrator may approve. The portion of any ISO accelerated in
connection with an event referred to in Section&nbsp;7.2 (or such other circumstances as may trigger accelerated vesting of the award) shall remain exercisable as an ISO only to the extent the applicable $100,000 limitation on ISOs is not exceeded.
To the extent exceeded, the accelerated portion of the option shall be exercisable as a nonqualified stock option under the Code. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.4</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Definition of Change in Control.</I></B> With respect to a particular award granted under this Plan, a &#147;Change in Control&#148;
shall be deemed to have occurred as of the first day, after the date of grant of the particular award, that any one or more of the following conditions shall have been satisfied: </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The acquisition by any individual, entity or group (within the meaning of Section&nbsp;13(d)(3) or 14(d)(2) of the Exchange Act (a
&#147;<B>Person</B>&#148;)) of beneficial ownership (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act) of more than 30% of either (1)&nbsp;the then-outstanding shares of common stock of the
Corporation (the &#147;<B>Outstanding Company Common Stock</B>&#148;) or (2)&nbsp;the combined voting power of the then-outstanding voting securities of the Corporation entitled to vote generally in the election of directors (the
&#147;<B>Outstanding Company Voting Securities</B>&#148;); provided, however, that, for purposes of this clause (a), the following acquisitions shall not constitute a Change in Control Event; (A)&nbsp;any acquisition directly from the Corporation,
(B)&nbsp;any acquisition by the Corporation, (C)&nbsp;any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Corporation or any affiliate of the Corporation or a successor, or (D)&nbsp;any acquisition by any
entity pursuant to a transaction that complies with Sections (c)(1), (2)&nbsp;and (3)&nbsp;below; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Individuals who, as of the Effective Date, constitute the Board (the &#147;<B>Incumbent Board</B>&#148;) cease for any reason to constitute at
least a majority of the Board; provided, however, that any individual becoming a director subsequent to the Effective Date whose election, or nomination for election by the Corporation&#146;s stockholders, was approved by a vote of at least <FONT
STYLE="white-space:nowrap">two-thirds</FONT> of the directors then comprising the Incumbent Board (including for these purposes, the new members whose election or nomination was so approved, without counting the member and his predecessor twice)
shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect
to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(c)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consummation of a reorganization, merger, statutory share exchange or consolidation or similar corporate transaction involving the Corporation
or any of its Subsidiaries, a sale or other disposition of all or substantially all of the assets of the Corporation, or the acquisition of assets or stock of another entity by the Corporation or any of its Subsidiaries (each, a &#147;<B>Business
Combination</B>&#148;), in each case unless, following such Business Combination, (1)&nbsp;all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Company Common Stock and the Outstanding Company
Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock and the combined voting power of the then-outstanding voting securities entitled
to vote generally in the election of directors, as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity that, as a result of such transaction, owns the Corporation or all or substantially
all of the Corporation&#146;s assets directly or through one or more subsidiaries (a &#147;<B>Parent</B>&#148;)) in substantially the same proportions as their ownership immediately prior to such Business Combination of the Outstanding Company
Common Stock and the Outstanding Company Voting Securities, as the case may be, (2)&nbsp;no Person (excluding any entity resulting from such Business Combination or a </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-12
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Parent or any employee benefit plan (or related trust) of the Corporation or such entity resulting from such Business Combination or Parent) beneficially owns, directly or indirectly, more than
30% of, respectively, the then-outstanding shares of common stock of the entity resulting from such Business Combination or the combined voting power of the then-outstanding voting securities of such entity, except to the extent that the ownership
in excess of 30% existed prior to the Business Combination, and (3)&nbsp;at least a majority of the members of the board of directors or trustees of the entity resulting from such Business Combination or a Parent were members of the Incumbent Board
at the time of the execution of the initial agreement or of the action of the Board providing for such Business Combination; or </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(d)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Approval by the stockholders of the Corporation of a complete liquidation or dissolution of the Corporation other than in the context of a
transaction that does not constitute a Change in Control under clause (c)&nbsp;above. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>OTHER PROVISIONS </B></FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.1</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Compliance with Laws.</I></B> This Plan, the granting and vesting of awards under this Plan, the offer, issuance and delivery of shares
of Common Stock, and/or the payment of money under this Plan or under awards are subject to compliance with all applicable federal and state laws, rules and regulations (including but not limited to state and federal securities law and federal
margin requirements) and to such approvals by any listing, regulatory or governmental authority as may, in the opinion of counsel for the Corporation, be necessary or advisable in connection therewith. The person acquiring any securities under this
Plan will, if requested by the Corporation or one of its Subsidiaries, provide such assurances and representations to the Corporation or one of its Subsidiaries as the Administrator may deem necessary or desirable to assure compliance with all
applicable legal and accounting requirements. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.2</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>No Rights to Award.</I></B> No person shall have any claim or rights to be granted an award (or additional awards, as the case may be)
under this Plan, subject to any express contractual rights (set forth in a document other than this Plan) to the contrary. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.3</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>No Employment/Service Contract.</I></B> Nothing contained in this Plan (or in any other documents under this Plan or in any award) shall
confer upon any Eligible Person or other participant any right to continue in the employ or other service of the Corporation or one of its Subsidiaries, constitute any contract or agreement of employment or other service or affect an employee&#146;s
status as an employee at will, nor shall interfere in any way with the right of the Corporation or one of its Subsidiaries to change a person&#146;s compensation or other benefits, or to terminate his or her employment or other service, with or
without cause. Nothing in this Section&nbsp;8.3, however, is intended to adversely affect any express independent right of such person under a separate employment or service contract other than an award agreement. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.4</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Plan Not Funded.</I></B> Awards payable under this Plan shall be payable in shares or from the general assets of the Corporation, and no
special or separate reserve, fund or deposit shall be made to assure payment of such awards. No participant, beneficiary or other person shall have any right, title or interest in any fund or in any specific asset (including shares of Common Stock,
except as expressly otherwise provided) of the Corporation or one of its Subsidiaries by reason of any award hereunder. Neither the provisions of this Plan (or of any related documents), nor the creation or adoption of this Plan, nor any action
taken pursuant to the provisions of this Plan shall create, or be construed to create, a trust of any kind or a fiduciary relationship between the Corporation or one of its Subsidiaries and any participant, beneficiary or other person. To the extent
that a participant, beneficiary or other person acquires a right to receive payment pursuant to any award hereunder, such right shall be no greater than the right of any unsecured general creditor of the Corporation. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-13
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.5</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Tax Withholding. </I></B>Upon any exercise, vesting, or payment of any award, or upon the disposition of shares of Common Stock acquired
pursuant to the exercise of an ISO prior to satisfaction of the holding period requirements of Section&nbsp;422 of the Code, or upon any other tax withholding event with respect to any award, the Corporation or one of its Subsidiaries shall have the
right at its option to: </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">require the participant (or the participant&#146;s personal representative or beneficiary, as the case may be) to pay or provide for payment
of at least the minimum amount of any taxes which the Corporation or one of its Subsidiaries may be required to withhold with respect to such award event or payment; or </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">deduct from any amount otherwise payable in cash (whether related to the award or otherwise) to the participant (or the participant&#146;s
personal representative or beneficiary, as the case may be) the minimum amount of any taxes which the Corporation or one of its Subsidiaries may be required to withhold with respect to such award event or payment. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In any case where a tax is required to be withheld in connection with the delivery of shares of Common Stock under this Plan, the
Administrator may in its sole discretion (subject to Section&nbsp;8.1) require or grant (either at the time of the award or thereafter) to the participant the right to elect, pursuant to such rules and subject to such conditions as the Administrator
may establish, that the Corporation reduce the number of shares to be delivered by (or otherwise reacquire) the appropriate number of shares, valued in a consistent manner at their fair market value or at the sales price in accordance with
authorized procedures for cashless exercises, necessary to satisfy the applicable withholding obligation on exercise, vesting or payment. Shares of Common Stock to be delivered or withheld may not have an aggregate Fair Market Value in excess of the
amount determined by applying the minimum statutory withholding rate (or, if permitted by the Corporation, such other rate as will not cause adverse accounting consequences under generally accepted accounting principles then in effect). Any fraction
of a share of Common Stock which would be required to satisfy such an obligation shall be disregarded and the remaining amount due shall be paid in cash by the holder. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.6</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Effective Date, Termination and Suspension, Amendments. </I></B><B> </B></FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.6.1</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Effective Date. </I></B>This Plan is effective as of March&nbsp;28, 2017, the date of its approval by the Board<B><I> </I></B>(the<B><I>
&#147;</I></B><B>Effective Date</B>&#148;). This Plan shall be submitted for and subject to stockholder approval no later than twelve months after the Effective Date. Upon such stockholder approval, no further awards shall be granted under any Prior
Plan. Unless earlier terminated by the Board, this Plan shall terminate at the close of business on the day before the tenth anniversary of the Effective Date. After the termination of this Plan either upon such stated expiration date or its earlier
termination by the Board, no additional awards may be granted under this Plan, but previously granted awards (and the authority of the Administrator with respect thereto, including the authority to amend such awards) shall remain outstanding in
accordance with their applicable terms and conditions and the terms and conditions of this Plan. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.6.2</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Board Authorization.</I></B> The Board may, at any time, terminate or, from time to time, amend, modify or suspend this Plan, in whole
or in part. No awards may be granted during any period that the Board suspends this Plan. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.6.3</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Stockholder Approval.</I></B> To the extent then required by applicable law or any applicable listing agency or required under Sections
422 or 424 of the Code to preserve the intended tax consequences of this Plan, or deemed necessary or advisable by the Board, any amendment to this Plan shall be subject to stockholder approval. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.6.4</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Amendments to Awards.</I></B> Without limiting any other express authority of the Administrator under (but subject to) the express
limits of this Plan, the Administrator by agreement or resolution may </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-14
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
waive conditions of or limitations on awards to participants that the Administrator in the prior exercise of its discretion has imposed, without the consent of a participant, and (subject to the
requirements of Sections 3.2 and 8.6.5) may make other changes to the terms and conditions of awards. Any amendment or other action that would constitute a repricing of an award is subject to the limitations set forth in Section&nbsp;3.2.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.6.5</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Limitations on Amendments to Plan and Awards.</I></B> No amendment, suspension or termination of this Plan or amendment of any
outstanding award agreement shall, without written consent of the participant, affect in any manner materially adverse to the participant any rights or benefits of the participant or obligations of the Corporation under any award granted under this
Plan prior to the effective date of such change. Changes, settlements and other actions contemplated by Section&nbsp;7 shall not be deemed to constitute changes or amendments for purposes of this Section&nbsp;8.6. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.7</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Privileges of Stock Ownership.</I></B> Except as otherwise expressly authorized by the Administrator, a participant shall not be
entitled to any privilege of stock ownership as to any shares of Common Stock not actually delivered to and held of record by the participant (subject to the last sentence of Section&nbsp;5.1.4). Except as expressly required by Section&nbsp;7.1 or
otherwise expressly provided by the Administrator, no adjustment will be made for dividends or other rights as a stockholder for which a record date is prior to such date of delivery. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B><B>8.8</B><B><I></I></B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Governing Law; Construction; Severability. </I></B></FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.8.1</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Choice of Law.</I></B> This Plan, the awards, all documents evidencing awards and all other related documents shall be governed by, and
construed in accordance with the laws of the State of Delaware. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.8.2</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Severability.</I></B> If a court of competent jurisdiction holds any provision invalid and unenforceable, the remaining provisions of
this Plan shall continue in effect. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.8.3</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Plan Construction.</I></B> </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT></U>. It is the intent of the Corporation that the awards and transactions permitted by
awards be interpreted in a manner that, in the case of participants who are or may be subject to Section&nbsp;16 of the Exchange Act, qualify, to the maximum extent compatible with the express terms of the award, for exemption from matching
liability under Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act. Notwithstanding the foregoing, the Corporation shall have no liability to any participant for Section&nbsp;16 consequences of awards or events
under awards if an award or event does not so qualify. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Section</U><U></U><U>&nbsp;409A</U>. It is intended that the provisions of the Plan comply with, or be exempt from, Section&nbsp;409A of
the Code, and all provisions of the Plan shall be construed and interpreted in a manner consistent with the requirements for avoiding taxes or penalties under Section&nbsp;409A of the Code. If, at the time of a participant&#146;s &#147;separation
from service&#148; (within the meaning of Section&nbsp;409A of the Code), (i) such participant shall be a specified employee (within the meaning of Section&nbsp;409A of the Code and using the identification methodology selected by the Corporation
from time to time) and (ii)&nbsp;the Corporation shall make a good faith determination that an amount payable pursuant to an award constitutes deferred compensation (within the meaning of Section&nbsp;409A of the Code) the payment of which is
required to be delayed pursuant to the <FONT STYLE="white-space:nowrap">six-month</FONT> delay rule set forth in Section&nbsp;409A of the Code in order to avoid taxes or penalties under Section&nbsp;409A of the Code, then the Corporation shall not
pay such amount on the otherwise scheduled payment date but shall instead pay it on the first business day after such <FONT STYLE="white-space:nowrap">six-month</FONT> period. Such amount shall be paid without interest, unless otherwise determined
by the </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-15
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Administrator, in its sole discretion, or as otherwise provided in any applicable award agreement between the Corporation and the relevant participant. Notwithstanding any provision of the Plan
to the contrary, in light of the uncertainty with respect to the proper application of Section&nbsp;409A of the Code, the Corporation reserves the right to make amendments to any award as the Corporation deems necessary or desirable to avoid the
imposition of taxes or penalties under Section&nbsp;409A of the Code. In any case, a participant shall be solely responsible and liable for the satisfaction of all taxes and penalties that may be imposed on such participant or for such
participant&#146;s account in connection with an award (including any taxes and penalties under Section&nbsp;409A of the Code), and neither the Corporation nor any of its affiliates shall have any obligation to indemnify or otherwise hold such
participant harmless from any or all of such taxes or penalties. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.9</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Captions.</I></B> Captions and headings are given to the sections and subsections of this Plan solely as a convenience to facilitate
reference. Such headings shall not be deemed in any way material or relevant to the construction or interpretation of this Plan or any provision thereof. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.10</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Stock-Based Awards in Substitution for Stock Options or Awards Granted by Other Corporation.</I></B> Awards may be granted to Eligible
Persons in substitution for or in connection with an assumption of employee stock options, SARs, restricted stock or other stock-based awards granted by other entities to persons who are or who will become Eligible Persons in respect of the
Corporation or one of its Subsidiaries, in connection with a distribution, merger or other reorganization by or with the granting entity or an affiliated entity, or the acquisition by the Corporation or one of its Subsidiaries, directly or
indirectly, of all or a substantial part of the stock or assets of the employing entity. The awards so granted need not comply with other specific terms of this Plan, provided the awards reflect only adjustments giving effect to the assumption or
substitution consistent with the conversion applicable to the Common Stock in the transaction and any change in the issuer of the security. Any shares that are delivered and any awards that are granted by, or become obligations of, the Corporation,
as a result of the assumption by the Corporation of, or in substitution for, outstanding awards previously granted by an acquired company (or previously granted by a predecessor employer (or direct or indirect parent thereof) in the case of persons
that become employed by the Corporation or one of its Subsidiaries in connection with a business or asset acquisition or similar transaction) shall not be counted against the Share Limit or other limits on the number of shares available for issuance
under this Plan. <B> </B></FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.11</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I><FONT STYLE="white-space:nowrap">Non-Exclusivity</FONT> of Plan.</I></B> Nothing in this Plan shall limit or be deemed to limit the
authority of the Board or the Administrator to grant awards or authorize any other compensation, with or without reference to the Common Stock, under any other plan or authority. <B> </B></FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.12</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>No Corporate Action Restriction.</I></B> The existence of this Plan, the award agreements and the awards granted hereunder shall not
limit, affect or restrict in any way the right or power of the Board or the stockholders of the Corporation to make or authorize: (a)&nbsp;any adjustment, recapitalization, reorganization or other change in the capital structure or business of the
Corporation or any Subsidiary, (b)&nbsp;any merger, amalgamation, consolidation or change in the ownership of the Corporation or any Subsidiary, (c)&nbsp;any issue of bonds, debentures, capital, preferred or prior preference stock ahead of or
affecting the capital stock (or the rights thereof) of the Corporation or any Subsidiary, (d)&nbsp;any dissolution or liquidation of the Corporation or any Subsidiary, (e)&nbsp;any sale or transfer of all or any part of the assets or business of the
Corporation or any Subsidiary, or (f)&nbsp;any other corporate act or proceeding by the Corporation or any Subsidiary. No participant, beneficiary or any other person shall have any claim under any award or award agreement against any member of the
Board or the Administrator, or the Corporation or any employees, officers or agents of the Corporation or any Subsidiary, as a result of any such action. <B> </B></FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-16
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.13</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Other Company Benefit and Compensation Programs</I></B><B>.</B> Payments and other benefits received by a participant under an award
made pursuant to this Plan shall not be deemed a part of a participant&#146;s compensation for purposes of the determination of benefits under any other employee welfare or benefit plans or arrangements, if any, provided by the Corporation or any
Subsidiary, except where the Administrator expressly otherwise provides or authorizes in writing. Awards under this Plan may be made in addition to, in combination with, as alternatives to or in payment of grants, awards or commitments under any
other plans or arrangements of the Corporation or its Subsidiaries. <B> </B></FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.14</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Clawback Policy</I></B><B>.</B> The awards granted under this Plan are subject to the terms of the Corporation&#146;s recoupment,
clawback or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require repayment or forfeiture of awards or any shares of Common Stock or other
cash or property received with respect to the awards (including any value received from a disposition of the shares acquired upon payment of the awards). </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-17
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit B </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>N<SMALL>EKTAR</SMALL> T<SMALL>HERAPEUTICS</SMALL> </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="4"><B>A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL> E<SMALL>MPLOYEE</SMALL> S<SMALL>TOCK</SMALL> P<SMALL>URCHASE</SMALL> P<SMALL>LAN</SMALL> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>DOPTED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL>
F<SMALL>EBRUARY</SMALL>&nbsp;10, 1994 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>PPROVED</SMALL> <SMALL>BY</SMALL> S<SMALL>TOCKHOLDERS</SMALL>
F<SMALL>EBRUARY</SMALL>&nbsp;18, 1994 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
M<SMALL>AY</SMALL>&nbsp;10, 2002 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>PPROVED</SMALL> <SMALL>BY</SMALL> S<SMALL>TOCKHOLDERS</SMALL>
J<SMALL>UNE</SMALL>&nbsp;25, 2002 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
S<SMALL>EPTEMBER</SMALL>&nbsp;15, 2009 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
M<SMALL>ARCH</SMALL>&nbsp;23, 2010 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>PPROVED</SMALL> <SMALL>BY</SMALL> S<SMALL>TOCKHOLDERS</SMALL>
J<SMALL>UNE</SMALL>&nbsp;29, 2010 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
A<SMALL>PRIL</SMALL>&nbsp;11, 2014 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>PPROVED</SMALL> <SMALL>BY</SMALL> S<SMALL>TOCKHOLDERS</SMALL>
J<SMALL>UNE</SMALL>&nbsp;25, 2014 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
M<SMALL>ARCH</SMALL>&nbsp;31, 2020 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>P<SMALL>URPOSE</SMALL>. </B></FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;The purpose of the Plan is to provide a means by which Employees of the Company and certain designated Related Corporations may be given an opportunity to purchase shares
of the Common Stock of the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Company, by means of the Plan, seeks to retain the
services of such Employees, to secure and retain the services of new Employees and to provide incentives for such persons to exert maximum efforts for the success of the Company and its Related Corporations. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Company intends that the Purchase Rights be considered options issued under an Employee Stock
Purchase Plan. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>D<SMALL>EFINITIONS</SMALL>. </B></FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Board&#148;</I></B><I> </I>means the Board of Directors of the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Code&#148;</I></B><I> </I>means the Internal Revenue Code of 1986, as amended<I>.</I> </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Committee&#148;</I></B><I> </I>means a committee appointed by the Board in accordance with
Section&nbsp;3(c) of the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Common Stock&#148;</I></B> means the common
stock of the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(e)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Company&#148;</I></B> means Nektar Therapeutics, a
Delaware corporation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(f)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Contributions&#148;</I></B> means the payroll deductions,
and other additional payments specifically provided for in the Offering, that a Participant contributes to fund the exercise of a Purchase Right. A Participant may make additional payments into his or her account, if specifically provided for in the
Offering, and then only if the Participant has not already had the maximum permitted amount through payroll deductions withheld during the Offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(g)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Corporate Transaction&#148;</I></B> means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following
events: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;a sale, lease, license or other disposition of all or substantially all of the
consolidated assets of the Company; </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-1
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a sale or other disposition of at least ninety
percent (90%) of the outstanding securities of the Company; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;a merger, consolidation or
similar transaction following which the Company is not the surviving corporation; or </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp; a
merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by
virtue of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(h)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Director&#148;</I></B><I> </I>means a member of the Board. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Eligible Employee&#148;</I></B><I> </I>means an Employee who meets the requirements set forth in the Offering for eligibility to participate in the Offering,
provided that such Employee also meets the requirements for eligibility to participate set forth in the Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(j)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Employee&#148;</I></B><I> </I>means any person, including Officers and Directors, who is
employed for purposes of Section&nbsp;423(b)(4) of the Code by the Company or a Related Corporation. Neither service as a Director nor payment of a director&#146;s fee shall be sufficient to make an individual an Employee of the Company or a Related
Corporation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(k)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Employee Stock Purchase Plan&#148;</I></B><I> </I>means a plan
that grants Purchase Rights intended to be options issued under an &#147;employee stock purchase plan,&#148; as that term is defined in Section&nbsp;423(b) of the Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(l)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Exchange Act&#148;</I></B><I> </I>means the Securities Exchange Act of 1934, as amended. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(m)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Fair Market Value&#148;</I></B><I> </I>means the value of a security, as determined in good
faith by the Board. If the security is listed on any established stock exchange or traded on the Nasdaq National Market or the Nasdaq SmallCap Market, the Fair Market Value of the security, unless otherwise determined by the Board,<I> </I>shall be
the closing sales price (rounded up where necessary to the nearest whole cent) for such security (or the closing bid, if no sales were reported) as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in
the relevant security of the Company) on the Trading Day of the relevant determination date, as reported in <I>The Wall Street Journal</I> or such other source as the Board deems reliable. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(n)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Offering&#148;</I></B><I> </I>means the grant of Purchase Rights to purchase shares of
Common Stock under the Plan to Eligible Employees. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(o)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Offering Date&#148;</I></B>
means a date selected by the Board for an Offering to commence. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(p)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;</B><B><I>Officer</I></B><B>&#148; </B>means<B> </B>a person who is an officer of the Company
within the meaning of Section&nbsp;16 of the Exchange Act and the rules and regulations promulgated thereunder. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(q)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Participant&#148;</I></B><I> </I>means an Eligible Employee who holds an outstanding
Purchase Right granted pursuant to the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(r)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Plan&#148;</I></B><I> </I>means
this Nektar Therapeutics Amended and Restated Employee Stock Purchase Plan, as amended and restated March&nbsp;31 , 2020. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(s)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Purchase Date&#148;</I></B><I> </I>means one or more dates during an Offering established
by the Board on which Purchase Rights shall be exercised and as of which purchases of shares of Common Stock shall be carried out in accordance with such Offering. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-2
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(t)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Purchase Period&#148;</I></B> means a
period of time specified within an Offering beginning on the Offering Date or on the next day following a Purchase Date within an Offering and ending on a Purchase Date. An Offering may consist of one or more Purchase Periods. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(u)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Purchase Right&#148;</I></B><I> </I>means an option to purchase shares of Common Stock
granted pursuant to the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(v)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Related Corporation&#148;</I></B><I> </I>means
any parent corporation or subsidiary corporation, whether now or hereafter existing, as those terms are defined in Sections&nbsp;424(e) and (f), respectively, of the Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(w)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Securities Act&#148;</I></B><I> </I>means the Securities Act of 1933, as amended. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(x)</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;</B><B><I>Trading Day</I></B><B>&#148; </B>means any day the exchange(s) or market(s) on which shares of Common Stock are listed, whether it be any established
stock exchange, the Nasdaq National Market, the Nasdaq SmallCap Market or otherwise, is open for trading. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>DMINISTRATION</SMALL>. </B></FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board shall administer the Plan unless and until the Board delegates administration to a Committee, as provided in Section&nbsp;3(c). Whether or not the Board has
delegated administration, the Board shall have the final power to determine all questions of policy and expediency that may arise in the administration of the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board (or the Committee) shall have the power, subject to, and within the limitations of, the express provisions of the Plan: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To determine when and how Purchase Rights to purchase shares of Common Stock shall be granted and
the provisions of each Offering of such Purchase Rights (which need not be identical). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;To
designate from time to time which Related Corporations of the Company shall be eligible to participate in the Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iii)</B>&nbsp;&nbsp;&nbsp;To construe and interpret the Plan and Purchase Rights, and to establish, amend and revoke rules and
regulations for the administration of the Plan. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan, in a manner and to the extent it shall deem necessary or expedient to make the Plan fully
effective. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iv)</B>&nbsp;&nbsp;&nbsp;&nbsp;To amend the Plan as provided in Section&nbsp;15. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(v)</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Generally, to exercise such powers and to perform such acts as it deems necessary or expedient to
promote the best interests of the Company and its Related Corporations and to carry out the intent that the Plan be treated as an Employee Stock Purchase Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board may delegate administration of the Plan to a Committee of the Board composed of two (2)&nbsp;or more members of the Board. If administration is delegated to a
Committee, the Committee shall have, in connection with the administration of the Plan, the powers theretofore possessed by the Board, subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from
time to time by the Board. The Board may abolish the Committee at any time and revest in the Board the administration of the Plan. If administration is delegated to a Committee, references to the Board in this Plan and in the Offering document shall
thereafter be deemed to be to the Board or the Committee, as the case may be. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>S<SMALL>HARES</SMALL> <SMALL>OF</SMALL> C<SMALL>OMMON</SMALL> S<SMALL>TOCK</SMALL> S<SMALL>UBJECT</SMALL> <SMALL>TO</SMALL>
<SMALL>THE</SMALL> P<SMALL>LAN</SMALL>. </B></FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-3
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Subject to the provisions of Section&nbsp;14 relating to adjustments upon changes in
securities, the shares of Common Stock that may be sold pursuant to Purchase Rights shall not exceed in the aggregate three million five hundred thousand (3,500,000) shares of Common Stock. If any Purchase Right granted under the Plan shall for any
reason terminate without having been exercised, the shares of Common Stock not purchased under such Purchase Right shall again become available for issuance under the Plan. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>G<SMALL>RANT</SMALL> <SMALL>OF</SMALL> P<SMALL>URCHASE</SMALL> R<SMALL>IGHTS</SMALL>; O<SMALL>FFERING</SMALL>.
</B></FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board may from time to time grant or provide for the grant of
Purchase Rights to purchase shares of Common Stock under the Plan to Eligible Employees in an Offering (consisting of one or more Purchase Periods) on an Offering Date or Offering Dates selected by the Board. Each Offering shall be in such form and
shall contain such terms and conditions as the Board shall deem appropriate, which shall comply with the requirement of Section&nbsp;423(b)(5) of the Code that all Employees granted Purchase Rights shall have the same rights and privileges. The
terms and conditions of an Offering shall be incorporated by reference into the Plan and treated as part of the Plan. The provisions of separate Offerings need not be identical, but each Offering shall include (through incorporation of the
provisions of this Plan by reference in the document comprising the Offering or otherwise) the period during which the Offering shall be effective, which period shall not exceed twenty-seven (27)&nbsp;months beginning with the Offering Date, and the
substance of the provisions contained in Sections&nbsp;6 through 9, inclusive. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;If a
Participant has more than one Purchase Right outstanding under the Plan, unless he or she otherwise indicates in agreements or notices delivered hereunder: (i)&nbsp;each agreement or notice delivered by that Participant shall be deemed to apply to
all of his or her Purchase Rights under the Plan, and (ii)&nbsp;a Purchase Right with a lower exercise price (or an earlier-granted Purchase Right, if different Purchase Rights have identical exercise prices) shall be exercised to the fullest
possible extent before a Purchase Right with a higher exercise price (or a later-granted Purchase Right if different Purchase Rights have identical exercise prices) shall be exercised. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>E<SMALL>LIGIBILITY</SMALL>. </B></FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;Purchase Rights may be granted only to Employees of the Company or, as the Board may designate as provided in Section&nbsp;3(b), to Employees of a Related Corporation.
Except as provided in Section&nbsp;6(b), an Employee shall not be eligible to be granted Purchase Rights under the Plan unless, on the Offering Date, such Employee has been in the employ of the Company or the Related Corporation, as the case may be,
for such continuous period preceding such Offering Date as the Board may require, but in no event shall the required period of continuous employment be greater than two (2)&nbsp;years. In addition, the Board may provide that no Employee shall be
eligible to be granted Purchase Rights under the Plan unless, on the Offering Date, such Employee&#146;s customary employment with the Company or the Related Corporation is more than twenty (20)&nbsp;hours per week and more than five (5)&nbsp;months
per calendar year. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board may provide that each person who, during the course of an
Offering, first becomes an Eligible Employee shall, on a date or dates specified in the Offering which coincides with the day on which such person becomes an Eligible Employee or which occurs thereafter, receive a Purchase Right under that Offering,
which Purchase Right shall thereafter be deemed to be a part of that Offering. Such Purchase Right shall have the same characteristics as any Purchase Rights originally granted under that Offering, as described herein, except that: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the date on which such Purchase Right is granted shall be the &#147;Offering Date&#148; of such
Purchase Right for all purposes, including determination of the exercise price of such Purchase Right; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;the period of the Offering with respect to such Purchase Right shall begin on its Offering Date and
end coincident with the end of such Offering; and </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-4
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iii)</B>&nbsp;&nbsp;&nbsp;&nbsp;the Board may provide that if such person first
becomes an Eligible Employee within a specified period of time before the end of the Offering, he or she shall not receive any Purchase Right under that Offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;No Employee shall be eligible for the grant of any Purchase Rights under the Plan if, immediately after any such Purchase Rights are granted, such Employee owns stock
possessing five percent (5%) or more of the total combined voting power or value of all classes of stock of the Company or of any Related Corporation. For purposes of this Section&nbsp;6(c), the rules of Section&nbsp;424(d) of the Code shall apply
in determining the stock ownership of any Employee, and stock which such Employee may purchase under all outstanding Purchase Rights and options shall be treated as stock owned by such Employee. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;As specified by Section&nbsp;423(b)(8) of the Code, an Eligible Employee may be granted Purchase Rights
under the Plan only if such Purchase Rights, together with any other rights granted under all Employee Stock Purchase Plans of the Company and any Related Corporations, do not permit such Eligible Employee&#146;s rights to purchase stock of the
Company or any Related Corporation to accrue at a rate which exceeds twenty five thousand dollars ($25,000) of Fair Market Value of such stock (determined at the time such rights are granted, and which, with respect to the Plan, shall be determined
as of their respective Offering Dates) for each calendar year in which such rights are outstanding at any time. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(e)</B>&nbsp;&nbsp;&nbsp;&nbsp;Officers of the Company and any designated Related Corporation, if they are otherwise Eligible
Employees, shall be eligible to participate in Offerings under the Plan. Notwithstanding the foregoing, the Board may provide in an Offering that Employees who are highly compensated Employees within the meaning of Section&nbsp;423(b)(4)(D) of the
Code shall not be eligible to participate. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>P<SMALL>URCHASE</SMALL> R<SMALL>IGHTS</SMALL>; P<SMALL>URCHASE</SMALL> P<SMALL>RICE</SMALL>. </B></FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;On each Offering Date, each Eligible Employee, pursuant to an Offering made under the Plan, shall be
granted a Purchase Right to purchase up to that number of shares of Common Stock purchasable either with a percentage or with a maximum dollar amount, as designated by the Board, but in either case not exceeding fifteen percent (15%), of such
Employee&#146;s Earnings (as defined by the Board in each Offering) during the period that begins on the Offering Date (or such later date as the Board determines for a particular Offering) and ends on the date stated in the Offering, which date
shall be no later than the end of the Offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board shall establish one (1)&nbsp;or
more Purchase Dates during an Offering as of which Purchase Rights granted pursuant to that Offering shall be exercised and purchases of shares of Common Stock shall be carried out in accordance with such Offering. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;In connection with each Offering made under the Plan, the Board may specify a maximum number of shares
of Common Stock that may be purchased by any Participant on any Purchase Date during such Offering. In connection with each Offering made under the Plan, the Board may specify a maximum aggregate number of shares of Common Stock that may be
purchased by all Participants pursuant to such Offering. In addition, in connection with each Offering that contains more than one Purchase Date, the Board may specify a maximum aggregate number of shares of Common Stock that may be purchased by all
Participants on any given Purchase Date under the Offering. If the aggregate purchase of shares of Common Stock issuable upon exercise of Purchase Rights granted under the Offering would exceed any such maximum aggregate number, then, in the absence
of any Board action otherwise, a pro rata allocation of the shares of Common Stock available shall be made in as nearly a uniform manner as shall be practicable and equitable. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp; The purchase price of shares of Common Stock acquired pursuant to Purchase Rights shall be not less than the lesser of: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i)</B>&nbsp;&nbsp;&nbsp;&nbsp;an amount equal to eighty-five percent (85%) of the Fair Market Value of the shares of Common Stock on
the Offering Date; or </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-5
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:9%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ii)</B>&nbsp;&nbsp;&nbsp;&nbsp;an amount equal to eighty-five percent (85%) of the
Fair Market Value of the shares of Common Stock on the applicable Purchase Date. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>P<SMALL>ARTICIPATION</SMALL>; W<SMALL>ITHDRAWAL</SMALL>; T<SMALL>ERMINATION</SMALL>. </B></FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;A Participant may elect to authorize payroll deductions pursuant to an Offering under the Plan by
completing and delivering to the Company, within the time specified in the Offering, an enrollment form (in such form as the Company may provide). Each such enrollment form shall authorize an amount of Contributions expressed as a percentage of the
submitting Participant&#146;s Earnings (as defined in each Offering) during the Offering (not to exceed the maximum percentage specified by the Board). Each Participant&#146;s Contributions shall be credited to a bookkeeping account for such
Participant under the Plan and shall be deposited with the general funds of the Company except where applicable law requires that Contributions be deposited with a third party. To the extent provided in the Offering, a Participant may begin such
Contributions after the beginning of the Offering. To the extent provided in the Offering, a Participant may thereafter reduce (including to zero) or increase his or her Contributions. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;During an Offering, a Participant may cease making Contributions and withdraw from the Offering by
delivering to the Company a notice of withdrawal in such form as the Company may provide. Such withdrawal may be elected at any time prior to the end of the Offering, except as provided otherwise in the Offering. Upon such withdrawal from the
Offering by a Participant, the Company shall distribute to such Participant all of his or her accumulated Contributions (reduced to the extent, if any, such deductions have been used to acquire shares of Common Stock for the Participant) under the
Offering, and such Participant&#146;s Purchase Right in that Offering shall thereupon terminate. A Participant&#146;s withdrawal from an Offering shall have no effect upon such Participant&#146;s eligibility to participate in any other Offerings
under the Plan, but such Participant shall be required to deliver a new enrollment form in order to participate in subsequent Offerings. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;Purchase Rights granted pursuant to any Offering under the Plan shall terminate immediately upon a Participant ceasing to be an Employee for any reason or for no reason
(subject to any post-employment participation period required by law) or other lack of eligibility. The Company shall distribute to such terminated or otherwise ineligible Employee all of his or her accumulated Contributions (reduced to the extent,
if any, such deductions have been used to acquire shares of Common Stock for the terminated or otherwise ineligible Employee) under the Offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(d)</B>&nbsp;&nbsp;&nbsp;&nbsp;Purchase Rights shall not be transferable by a Participant otherwise than by will or the laws of descent and distribution, or by a beneficiary designation as provided in
Section&nbsp;13 and, during a Participant&#146;s lifetime, shall be exercisable only by such Participant. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(e)</B>&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise specified in an Offering, the Company shall have no obligation to pay interest on
Contributions. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>9.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>E<SMALL>XERCISE</SMALL>. </B></FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;On each Purchase Date during an Offering, each Participant&#146;s accumulated Contributions shall be applied to the purchase of shares of Common Stock up to the maximum
number of shares of Common Stock permitted pursuant to the terms of the Plan and the applicable Offering, at the purchase price specified in the Offering. No fractional shares shall be issued upon the exercise of Purchase Rights unless specifically
provided for in the Offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;If any amount of accumulated Contributions remains in a
Participant&#146;s account after the purchase of shares of Common Stock and such remaining amount is less than the amount required to purchase one share of Common Stock on the final Purchase Date of an Offering, then such remaining amount shall be
held in such Participant&#146;s account for the purchase of shares of Common Stock under the next Offering under the Plan, unless </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-6
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
such Participant withdraws from such next Offering, as provided in Section&nbsp;8(b), or is not eligible to participate in such Offering, as provided in Section&nbsp;6, in which case such amount
shall be distributed to such Participant after the final Purchase Date, without interest. If the amount of Contributions remaining in a Participant&#146;s account after the purchase of shares of Common Stock is at least equal to the amount required
to purchase one (1)&nbsp;whole share of Common Stock on the final Purchase Date of the Offering, then such remaining amount shall be distributed in full to such Participant at the end of the Offering. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;No Purchase Rights may be exercised to any extent unless the shares of Common Stock to be issued upon
such exercise under the Plan are covered by an effective registration statement pursuant to the Securities Act and the Plan is in material compliance with all applicable federal, state, foreign and other securities and other laws applicable to the
Plan. If on a Purchase Date during any Offering hereunder the shares of Common Stock are not so registered or the Plan is not in such compliance, no Purchase Rights or any Offering shall be exercised on such Purchase Date, and the Purchase Date
shall be delayed until the shares of Common Stock are subject to such an effective registration statement and the Plan is in such compliance, except that the Purchase Date shall not be delayed more than twelve (12)&nbsp;months and the Purchase Date
shall in no event be more than twenty-seven (27)&nbsp;months from the Offering Date. If, on the Purchase Date under any Offering hereunder, as delayed to the maximum extent permissible, the shares of Common Stock are not registered and the Plan is
not in such compliance, no Purchase Rights or any Offering shall be exercised and all Contributions accumulated during the Offering (reduced to the extent, if any, such deductions have been used to acquire shares of Common Stock) shall be
distributed to the Participants. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>10.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL>. </B></FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company shall seek to obtain from each federal, state, foreign or other regulatory commission or agency having jurisdiction over the
Plan such authority as may be required to issue and sell shares of Common Stock upon exercise of the Purchase Rights. If, after commercially reasonable efforts, the Company is unable to obtain from any such regulatory commission or agency the
authority that counsel for the Company deems necessary for the lawful issuance and sale of shares of Common Stock under the Plan, the Company shall be relieved from any liability for failure to issue and sell shares of Common Stock upon exercise of
such Purchase Rights unless and until such authority is obtained. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>11.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>U<SMALL>SE</SMALL> <SMALL>OF</SMALL> P<SMALL>ROCEEDS</SMALL> <SMALL>FROM</SMALL> S<SMALL>HARES</SMALL> <SMALL>OF</SMALL>
C<SMALL>OMMON</SMALL> S<SMALL>TOCK</SMALL>. </B></FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proceeds from the sale of shares of Common Stock pursuant
to Purchase Rights shall constitute general funds of the Company. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>12.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>R<SMALL>IGHTS</SMALL> <SMALL>AS</SMALL> <SMALL>A</SMALL> <SMALL>STOCKHOLDER</SMALL>. </B></FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A Participant shall not be deemed to be the holder of, or to have any of the rights of a holder with respect to, shares of Common Stock
subject to Purchase Rights unless and until the Participant&#146;s shares of Common Stock acquired upon exercise of Purchase Rights are recorded in the books of the Company (or its transfer agent). </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>13.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>D<SMALL>ESIGNATION</SMALL> <SMALL>OF</SMALL> B<SMALL>ENEFICIARY</SMALL>. </B></FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;A Participant may file a written designation of a beneficiary who is to receive any shares of Common
Stock and/or cash, if any, from the Participant&#146;s account under the Plan in the event of such Participant&#146;s death subsequent to the end of an Offering but prior to delivery to the Participant of such shares of Common Stock or cash. In
addition, a Participant may file a written designation of a beneficiary who is to receive any cash from the Participant&#146;s account under the Plan in the event of such Participant&#146;s death during an Offering. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Participant may change such designation of beneficiary at any time by written notice to the
Company. In the event of the death of a Participant and in the absence of a beneficiary validly designated under </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-7
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
the Plan who is living at the time of such Participant&#146;s death, the Company shall deliver such shares of Common Stock and/or cash to the executor or administrator of the estate of the
Participant, or if no such executor or administrator has been appointed (to the knowledge of the Company), the Company, in its sole discretion, may deliver such shares of Common Stock and/or cash to the spouse or to any one or more dependents or
relatives of the Participant, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>14.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>DJUSTMENTS</SMALL> <SMALL>UPON</SMALL> C<SMALL>HANGES</SMALL> <SMALL>IN</SMALL> S<SMALL>ECURITIES</SMALL>; C<SMALL>ORPORATE</SMALL>
T<SMALL>RANSACTIONS</SMALL>. </B></FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;If any change is made in the shares of
Common Stock, subject to the Plan, or subject to any Purchase Right, without the receipt of consideration by the Company (through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other
than cash, stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or other transaction not involving the receipt of consideration by the Company), the Plan shall be appropriately adjusted in the
type(s), class(es) and maximum number of shares of Common Stock subject to the Plan pursuant to Section&nbsp;4(a), and the outstanding Purchase Rights shall be appropriately adjusted in the type(s), class(es), number of shares and purchase limits of
such outstanding Purchase Rights. The Board shall make such adjustments, and its determination shall be final, binding and conclusive. (The conversion of any convertible securities of the Company shall not be treated as a &#147;transaction not
involving the receipt of consideration by the Company.&#148;) </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;In the event of a Corporate
Transaction, then: (i)&nbsp;any surviving or acquiring corporation may continue or assume Purchase Rights outstanding under the Plan or may substitute similar rights (including a right to acquire the same consideration paid to stockholders in the
Corporate Transaction) for those outstanding under the Plan, or (ii)&nbsp;if any surviving or acquiring corporation does not continue or assume such Purchase Rights or does not substitute similar rights for Purchase Rights outstanding under the
Plan, then, the Participants&#146; accumulated Contributions shall be used to purchase shares of Common Stock within ten (10)&nbsp;business days prior to the Corporate Transaction under the ongoing Offering, and the Participants&#146; Purchase
Rights under the ongoing Offering shall terminate immediately after such purchase. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>15.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>MENDMENT</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>. </B></FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board at any time, and from time to time, may amend the Plan. However, except as provided in
Section&nbsp;14 relating to adjustments upon changes in securities and except as to amendments solely to benefit the administration of the Plan, to take account of a change in legislation or to obtain or maintain favorable tax, exchange control or
regulatory treatment for Participants or the Company or any Related Corporation, no amendment shall be effective unless approved by the stockholders of the Company to the extent stockholder approval is necessary for the Plan to satisfy the
requirements of Section&nbsp;423 of the Code or other applicable laws or regulations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;It is
expressly contemplated that the Board may amend the Plan in any respect the Board deems necessary or advisable to provide Employees with the maximum benefits provided or to be provided under the provisions of the Code and the regulations promulgated
thereunder relating to Employee Stock Purchase Plans and/or to bring the Plan and/or Purchase Rights into compliance therewith. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c)</B>&nbsp;&nbsp;&nbsp;&nbsp;The rights and obligations under any Purchase Rights granted before amendment of the Plan shall not be
impaired by any amendment of the Plan except: (i)&nbsp;with the consent of the person to whom such Purchase Rights were granted, or (ii)&nbsp;as necessary to comply with any laws or governmental regulations (including, without limitation, the
provisions of the Code and the regulations promulgated thereunder relating to Employee Stock Purchase Plans). </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>16.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>T<SMALL>ERMINATION</SMALL> <SMALL>OR</SMALL> S<SMALL>USPENSION</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>.
</B></FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Board in its discretion may suspend or terminate the Plan at any
time. Unless sooner terminated, the Plan shall terminate at the time that all of the shares of Common Stock reserved for issuance under the Plan, </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-8
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
as increased and/or adjusted from time to time, have been issued under the terms of the Plan. No Purchase Rights may be granted under the Plan while the Plan is suspended or after it is
terminated. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;Any benefits, privileges, entitlements and obligations under any Purchase
Rights while the Plan is in effect shall not be impaired by suspension or termination of the Plan except (i)&nbsp;as expressly provided in the Plan or with the consent of the person to whom such Purchase Rights were granted, (ii)&nbsp;as necessary
to comply with any laws, regulations, or listing requirements, or (iii)&nbsp;as necessary to ensure that the Plan and/or Purchase Rights comply with the requirements of Section&nbsp;423 of the Code. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>17.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>E<SMALL>FFECTIVE</SMALL> D<SMALL>ATE</SMALL> <SMALL>OF</SMALL> P<SMALL>LAN</SMALL>. </B></FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Plan shall become effective as determined by the Board, but no Purchase Rights shall be exercised unless and until the Plan has been
approved by the stockholders of the Company within twelve (12)&nbsp;months before or after the date the Plan is adopted by the Board. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>18.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>M<SMALL>ISCELLANEOUS</SMALL> P<SMALL>ROVISIONS</SMALL>. </B></FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a)</B>&nbsp;&nbsp;&nbsp;&nbsp;The Plan and Offering do not constitute an employment contract. Nothing in the Plan or in the Offering
shall in any way alter the at will nature of a Participant&#146;s employment or be deemed to create in any way whatsoever any obligation on the part of any Participant to continue in the employ of the Company or a Related Corporation, or on the part
of the Company or a Related Corporation to continue the employment of a Participant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b)</B>&nbsp;&nbsp;&nbsp;&nbsp;The
provisions of the Plan shall be governed by the laws of the State of California without resort to that state&#146;s conflicts of laws rules. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-9
</FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g910899g35s26.jpg" ALT="LOGO">
 </P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date TO VOTE, MARK
BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY D16672-P38611-Z76739 For Against Abstain For Against Abstain NEKTAR
THERAPEUTICS ATTN: SECRETARY 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO, CA 94158 Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint
owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. NEKTAR THERAPEUTICS 4. To ratify the selection of Ernst &amp; Young LLP as our
independent registered public accounting firm for the fiscal year ending December 31, 2020. 5. To approve a non-binding advisory resolution regarding our executive compensation (a &#147;say-on-pay&#148; vote). 2. To approve an amendment of our
Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">stock authorized for issuance under the plan by 10,000,000 shares. 3. To approve an amendment and restatement of our
Amended and Restated Employee Stock Purchase Plan to increase the aggregate number of shares of common stock authorized under the plan by 1,000,000 shares. 1a. Karin Eastham 1b. Myriam J. Curet 1c. Howard W. Robin The Board of Directors recommends
you vote FOR proposals 2, 3, 4 and 5. The Board of Directors recommends you vote FOR the following: 1. Election of Directors Please indicate if you plan to attend this meeting by live webcast. For address changes and/or comments, please check this
box and write them on the back where indicated. Nominees: Yes No VOTE BY INTERNET Before The Meeting - Go to www.proxyvote.com Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M.
Eastern Time on June 16, 2020. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. During The Meeting - Go to
www.virtualshareholdermeeting.com/NKTR2020 You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions. VOTE BY PHONE -
1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time on June 16, 2020. Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your
proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. 910899-006 28Apr20 17:33 Page 1 </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g910899g42a53.jpg" ALT="LOGO">
 </P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">D16673-P38611-Z76739 Important Notice Regarding Internet Availability of Proxy
Materials for the Annual Meeting: The Notice and Proxy Statement and Form 10-K Wrap are available at www.proxyvote.com. Address Changes/Comments: (If you noted any Address Changes and/or Comments above, please mark corresponding box on the reverse
side.)NEKTAR THERAPEUTICS PROXY SOLICITED BY THE BOARD OF DIRECTORS FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 17, 2020 The undersigned hereby appoints Howard W. Robin and Mark A. Wilson, and each of them, as attorneys-in-fact and
proxies of the undersigned, with full power of substitution, to vote all of the shares of stock of Nektar Therapeutics which the undersigned may be entitled to vote at the Annual Meeting of Stockholders of Nektar Therapeutics to be held on
Wednesday, June 17, 2020 at 2:00 p.m. Pacific Time by live webcast at www.virtualshareholdermeeting.com/NKTR2020 only (and at any and all postponements, continuations and adjournments thereof), with all powers that the undersigned would possess if
personally present, upon and in respect of the matters listed on the reverse side and in accordance with the instructions specified on the reverse side, with discretionary authority as to any and all matters that may properly come before the
meeting. You hereby revoke all proxies previously given. Unless a contrary direction is indicated, this Proxy will be voted FOR all nominees listed in Proposal 1, and FOR Proposals 2, 3, 4 and 5, as more specifically indicated in the Proxy
Statement, and at the discretion of the proxies with regard to any other matter that may properly come before the meeting or any continuation, adjournment or postponeent thereof. If you vote by telephone or Internet, you do not need to mail back
this Proxy. 910899-006 2Co8nAtipnure2d0 a 1nd7 t:o3 3be s ig n e d o n r ePveargsee s i2d e </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g910899g35s26.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g910899g35s26.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X1":17AI9@  34T *@    @ ! $[  (
M   -   (2H=I  0    !   (6)R=  $    :   0>.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $5U;FEC92!6
M:7)A>0    'J'  '   (#   "&H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     $4 =0!N &D 8P!E "  5@!I '( 80!Y    _^$*
M96AT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN
M/2?ON[\G(&ED/2=7-4TP37!#96AI2'IR95-Z3E1C>FMC.60G/SX-"CQX.GAM
M<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR9&8Z4D1&('AM;&YS
M.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X
M+6YS(R(^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z9F%F-6)D
M9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SID8STB:'1T
M<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B+SX\<F1F.D1E<V-R:7!T
M:6]N(')D9CIA8F]U=#TB=75I9#IF868U8F1D-2UB83-D+3$Q9&$M860S,2UD
M,S-D-S4Q.#)F,6(B('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE
M;65N=',O,2XQ+R(^/&1C.F-R96%T;W(^/')D9CI397$@>&UL;G,Z<F1F/2)H
M='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX\
M<F1F.FQI/D5U;FEC92!6:7)A>3PO<F1F.FQI/CPO<F1F.E-E<3X-"@D)"3PO
M9&,Z8W)E871O<CX\+W)D9CI$97-C<FEP=&EO;CX\+W)D9CI21$8^/"]X.GAM
M<&UE=&$^#0H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(#P_>'!A8VME="!E;F0]
M)W<G/S[_VP!#  <%!08%! <&!08(!P<("A$+"@D)"A4/$ P1&!4:&1@5&!<;
M'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_VP!# 0<(" H)"A0+"Q0J
M'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BK_P  1" -W K4# 2(  A$! Q$!_\0 'P   04! 0$! 0$
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MA'QZU?4=.\4:8EA?7%LC6>66*0J"=[<\5K_\*<\2&/<OCVYW$9 ,+XS]?,H
M]@HKPKX=>*?$&G?$.;P3XDNGO8I&EM]S/N,;JI.Y6ZX('Z@U[=:VD=H)!&7/
MF/O.]B<' &!Z#@<4 3T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS$DG ZDDFI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR!/=+NVHQ4':I/J>P[_0&O3?@1XO@2WF\)7R);W2.\ULVW:9?[ZGU88S]/\
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M\C%<. \B*2I(&X9Q3-7\=:+I"W2N;NZGMCM-O:VLCM*V]$VH<!6(:1%.#P6
M.,BL#^S_  M9ZKHLD&N:7'9Z/)->.7OHE;_2/F1=J@*(RQ#CIS&F >HO3Z/X
M6EU.:>;7TRK27*V_VN();[9TEF<#&<&2W^8L3C#@;<F@#M**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HJAKMS?6?A^_N-(A6>_BMW>WB=697D
M^4$+R1GTYKCI?%OC&2W6>R\.;6:V$ZVEQ;2B1F>X:-$+CY%*QA7?)R,Y QT
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MV,VW 1&R<[@XQM S0!W=%16CR26<+SC;*T:EP4VX;'/RY./ID_4U+0 4444
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M20W$:2Q2*4>-U#*RD8((/4$51'A[15LQ:#2+ 6RA@(1;)L 9@S#;C'+ $^I
M- &!K7Q*TO0].M+V?3]4GAN;-+TM;P*WD1MC;YF6 4G+''/".>@J*Z^*WAVT
MFN8Y/M)-K(L4Q5%(5S'(P7.[KNA>/']_ Z'-=5+I6G7 Q/86LHV+'\\*GY0&
M 7D= '< ?[3>IIDFAZ3*D:2Z79NL80(K6Z$*$)*XXXP6;'ID^M &/-XXLX5B
M?^S[YXI]Q@E41;945U0ORXVJ"Z\OMZBG2>-;2-4D_L^^:WD5I([@"/:\:NJ-
M(!OW8RZ\$;CG@'!QIMX>T5Y1*^CV#2+(90YM4)#D@ELXZD@<]>*9<>&=#NHY
M%FTBS/F,S,RP*K;F^\P8#(8\?,#G@<T ,U/Q'::5<3I=1S>3:VXN;NY&P1V\
M9+ %LL"?N-PH8\>XSF3?$31;;1M+U6Y\Z"SU(96:5HU6#YU0[V+XR"_12W"L
M>@S6_<Z5IUY=1W-Y86MQ/$5,<LL*LR%6W+@D9&& (]#S1_96G>?%/]@M?-A=
MGCD\E=R,Q)8@XX))))[DF@#G(?B/IEUIDVH66GZG=6T,?F%XH5.5^T/ 3C=D
M &)W); "#/4$#6T#Q-9^(VO5LHIXS9S&%_-"_,<D;EVDY4X.#WJU)HFE31&*
M;3+.2,A5*-;J00I8J,8[%F(]-Q]34UII]G8>;]AM(+;SG+R>3&$WM_>.!R?>
M@"Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 <+9^-]0_M/2DO([.:WUIYVM5B5HG@B290C.Q9@^8B7X
M"\H>W(S_ /A:5_<QQSV.A0M"S)Y:-=DR7&^WCD11\@"9:XMQD[OO,,9YKM$\
M*>'H[*2SCT'3$M92ID@6SC".5^Z2N,'&>/2ITT'2(V4QZ58H4*E2ML@VE?+V
MXX[>3%CT\M/[HP <O9_$"[O;J.&'1X#LU3^R[H_;C^[E$CJQ0>7\X"QEN=O7
M'8FJFK^-/$&D:EJDJ+IM[8:?<3 PF&2&0P16HG=_-WN"071/N<G/W:Z,>#M,
M'BJ+7MO^D0%FAC6"%%C9E8,=RH)&SOD.&8C+L<9QC4?2=.D,A?3[5C(LB.3"
MIWK)@R \<AMJY]=HSTH Y&Y^(%W+;ZQ_9>CR;[4O;V4]PD@BFN1/]G",=@7F
M0C 1V) .=IJ@OQ4EN+ZT;3].%U97%C$RE4D+O<R,N% 16.Q5\S<0K'<A&/E-
M=VNC:6DD\B:;:*]Q*DTS"!0971MR.QQRRMR">0>13'\/Z-);/;R:38O ZJC1
M-;(5958LH(Q@@,S$#L6)[T <5_PLK5;ZW']E^&9X97,,0>^69(XIGE@C:-SY
M>,J9FZ,3^Z?(' +;+XGW]Q'#(=$@FAN[N.UM98[LKO:41O&678<(JSQJS@D[
M@<)V';'P]HI:5CH]@6FV>:3:IE]A!3/'.TJN,],#'2JVH>%-+O=*%A!;06,0
MX7[/:0-M'&5"R1LN#M7M_"/2@!F@^)?[5TZQEO+*6UN;QYT6.!9+B)?+=ER9
M@@50P4$;MN<X&36*GC>Y2*&XF-M(^H!38Z>+>6,C=<) -]R2R9!D4LH7<,\
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MEN(Q,NYI(_OJ%ZDCKQV(/0TLGB/1HM7_ ++DU2U6^"[F@\T;D&47YO[N3(@
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MGU&[U?;&MS).QG,D:1V[?.T3,DJ$@.TK DX'F$;2* /0Z*** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5P&V8P:T?A5XUU3Q)K$MOKNK33SK9Q2I;_Z*D9#00,6V*!-NW.YSC9@XZC%
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M#D%,*2)HP2V#^\4'E@*UKCQ1X>T:Y;3WG$,XG:,6T%L[,\A5)&VHBDMQ,A)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ***1T62-DD4,K A@1P10 M%>36G@3Q&FDW]O<PJRV#06&G0BX
M ^UV$=QYK*6S\I=-J$''^KYX-._X5RVH75C/=>&[6&S&N+,NGS>4YL[/[,RL
MAP2NUI0&V*2 2#ZX /5Z*\JT+PCK=IX-\:Z;<:)#!>:E!=K;3)'"K71D,Q0-
M*)6+??7&Y4VYQSUJCIGP^U\^%HH7LVTR\_M/9BVDCC*6,R1QW"A0[JHPI< .
M26 88)Q0!['17FGCOPEX@N/$6E:AX/MT3^S--FMK<>:J*C.R1[<$C@1L[?\
M  .N*YWP]X%\;:'J.BSP:?%]B\/&:&WMWOE62=9;IF>1<94YB(&&*\\]1B@#
MVVBO-/"6A:_H/Q%U6]N]&F>QU%YE2YCGA*Q WEQ*K,I?=@K(IX!//UKTN@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1?ZQK'E:DNG)IT<,TDM]'*D2,B,_[]0\I;R\* ?E(')+<8H ])HHHI %%%%
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MQ<\-27$$+M/&\UU%:Y+1.B/(9 ,NCE2!Y?)!.-Z>IQ=C^(5A(BG^S=21I !
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M1'<LS*"^U Z% %W8DQAC_JS5AM#TY].O;%[?=;W[2/<J78F0O][)SGVX/
MP *D&E6BW-S<(DB373QR32+,X+%,;1D'A>/NC@Y;(.XY +E%%% !1110 444
M4 %%%% &=9:!IMA<-<0VYDN&??Y]Q*\\@.TKP[DL!@D8!QR?4UHT44 %%%%
M!1110!#=6T=Y:O;S-*J.,$PS-$P^C(0P_ U#!I-A;Z2NF):QM9!"AAD&\,#U
MW;L[LGDDYR>M7** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK'\6V\]U
MX/U6.R:Z6Z%I*UN;25XY?,"$IM*$-G..._2@#8HK@1;7UGJAMXCKS74=[:BR
M+37$L!M<1&;>S$H3_K\^8=_3;_!3_%,7B?\ M:_LM#-Z8;F W\5Q&Y_=R1Q,
MGD*2=J[I!;L%/# RY'4T =W17G5QIUQ?R-_9;^)$L$N; )YUU>0R%FG(N/O,
M'*^7LSGY1R5P=U:7@_49+:>[M=96]BN[K4KB*W-U)<OYP#S.NT2($11&G&PE
M<;<D$@$ [.BO+IY/&4=[<6,2:D]O<:X+T76U\Q6RW>QH >RE1&X[%&D["HY+
MGQE?+>;M.U>-=6GM[JV26=H%@1;E5,1:(L\*M T98$*<K,<'G !ZK17F_@\^
M(UUF!O$)UA[%8[>.'>KJPN1:QB4S*.J%MV""4W[RV24-4%NO$EKXCU"1X=9^
MRIJ6YR@NYMT8OH\%4*;0ODEAB(L"H);T !ZO17FVM3>(9K?4)="76/\ A('G
MD:S#I*MK]G*$ID-B('&.&P^_K5O5_MYTW2_^$2&NM']O;[<+AKA9C%Y#[@IG
MZ'[NW^'?C!!YH [ZBN/\.R7/]M:FD0U2>TDMUE@N+U;J)HL\"'9-@$@<[EYZ
MA^>6XWPU+XF5M$;5[77'@,["1)KB_&UO(M?F<A"[#?YYVR )DN V "0#V*BO
M-+6^U"[TBQ754\2*8-*$?[BWNHY#>C[V\A06_AP6S&?FR:SKD?$&+[4BC4#+
M8HT*R1L66YDO0QW@="MO(T8!'"J& X% 'KE%<'XD@\21>*;$:#)?/!:I;OM+
M,8I]D=V71STR^(E)/0E#V%9GB.3Q*WPQ\./91:N=4:#_ $A8FG2=9#:R;3)L
M!.1)LX?"EL!B!S0!Z?17"V^JZA!=6PNH]886FLW9N\65PP:!A/Y6,*1(F3%@
M+N XZ8X9\/FUD7UY'KL&HBX%O!MDO)KDJ?\ 1X-P"LOE9W[\E6+9W9'4T =[
M17EDL6OW%AI\5@FO-=O' -66YN+B!#/]H@W!9!G:NWS\F'Y OMMIWB)O$R_#
MG1ULX]7;4UEGCG6![@2(XBG"9906=1($VL_ROA"Q ;- 'J-%>:ZI?>)[S39M
M&T>VUG^T1J-W,]R(6B5(DD=H%$LA5&5F,(*JQS&'&*V-)O+C4-8N+O5;;6+6
M><))IT&VX6&.(VR%ED"_NPXD\T?/\V0N/X: .RHKSS1V\0?\*RU)-075AXC&
MFJ26,ARQB/E^4?[W'S#[^[.[@J3@I_PL"+3].LXO[2ENEM(IDN9BX#-)<VY,
M<O\ M(!,#D?<(SGYJ /8:*X[6);^;P/:V6AV^MBYOI!;R2,2MW;J"3,Y=V 5
ML*P5MP7+*5R,9I>$KS6)]>@DUFVU,W,L'EW:S)<116DL:A&V@GR)%=E+!ERP
MW=6'( .^HKS72;;5+;1=&/B6/7$@EMI7N?L=[>7$QG(B\LR;0)(\CS?D&8P>
MISMI=,U;7;(62:Y'K37$6I0R7>RRGE4Q&P56YC4JP\X\A<@-DXXS0!Z317G-
MW!K6H--#ITVMVVKRW%YODD,R6R0[93;E<XC'/V?A</U#?QUF0?\ "6:G-J#:
MI)K.F6,[QZO;,L4[O&)!Y8LV6$A\  LRK@J2&X/- 'K-%8WA>>6XT5'N(KRW
MDX#6]WO8Q?*.%=U#.#][+9(+$'!&T;- !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !115
M/4]4@TFV6>ZCNI$9P@%K9RW+9P3RL2L0..N,=/44 7**Y_\ X332_P#GUUS_
M ,$%]_\ &:N2>(;.+28=1:'43!,^Q473+EI@>?O1"/>H^4\E0.GJ,@&I17/_
M /"::7_SZZY_X(+[_P",UH?VU:_V+_:GE7WV?^Y_9\_G?>V_ZG9YG7_9Z<].
M: -"BN?_ .$TTO\ Y]=<_P#!!??_ !FM#^VK7^Q?[4\J^^S_ -S^SY_.^]M_
MU.SS.O\ L].>G- &A17/_P#"::7_ ,^NN?\ @@OO_C-:']M6O]B_VIY5]]G_
M +G]GS^=][;_ *G9YG7_ &>G/3F@#0HKG_\ A--+_P"?77/_  07W_QFKD?B
M&SETF;45AU$00OL9&TRY68GC[L1CWL/F'(4CKZ' !J45S_\ PFFE_P#/KKG_
M ((+[_XS5R/Q#9RZ3-J*PZB((7V,C:9<K,3Q]V(Q[V'S#D*1U]#@ U**Y_\
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M\RYM[_S(W5689B;8-^-ISNV<\+O-=)J&JZ-8:K?+/::O]JGA2&>:TTR]D#(
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M\NX6!RI\S"@.Z??*\-GL<9MWX6T'4;'_ (2+4Y-:O;A581W,M@WVJ%MRJCI
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M8T;4QINI6\$EMYDEOY\<D3E6*E-R\@H""#]<T 8K?%_PT%NV07C_ &73QJ!
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MK:WBAMHFBPZ%0=[,^?FW9!Q@8P?7@ V**** "BBB@ KG/&0D,.E9_M+[+_:
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MG_8?QA_Z&W0__ /_ .PH_L/XP_\ 0VZ'_P" ?_V%>F44 >9_V'\8?^AMT/\
M\ __ +"C^P_C#_T-NA_^ ?\ ]A7IE% 'F?\ 8?QA_P"AMT/_ , __L*/[#^,
M/_0VZ'_X!_\ V%>F44 >9_V'\8?^AMT/_P  _P#["C^P_C#_ -#;H?\ X!__
M &%>F44 >9_V'\8?^AMT/_P#_P#L*/[#^,/_ $-NA_\ @'_]A7IE% 'F?]A_
M&'_H;=#_ / /_P"PH_L/XP_]#;H?_@'_ /85Z910!YG_ &'\8?\ H;=#_P#
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M;\@)D&UN<@=!Q5=_BQ<PM=QS^'T6>!WC5%O\AW2\CM7!/EC W2A@<'(!! H
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M1DX'09-6Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M63XK_P"1,UK_ +!\_P#Z+:M:LGQ7_P B9K7_ &#Y_P#T6U '/_!S_DD.@?\
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MQ/P<_P"20Z!_UP;_ -&-7;4 %%%% !7F'[0?_))KC_K[A_\ 0J]/KS#]H/\
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MMP5,LUS=2W$C[1A07D9FP,G S@9/K6C10 4444 %%%% !1110 4444 %%%%
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M &#Y_P#T6U:U9/BO_D3-:_[!\_\ Z+:@#G_@Y_R2'0/^N#?^C&KMJXGX.?\
M)(= _P"N#?\ HQJ[:@ HHHH *\P_:#_Y)-<?]?</_H5>GUYA^T'_ ,DFN/\
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M$ABB?:<95I45A^()'XUE7^@Z/X?\:^%)-!TJQTQ[F\GAG-G;)#YJ?996VMM
MR-RJ>>XH [BBBB@ HKF/&\,=W!HME=1K-:W6K0QSPN,I*FUVVL.A&5!P>#BJ
M5GI.FZ#\4K2VT33[73H+G1KF2:*TA6)9&2: *Q"@ D!V /N: .THHHH **Y3
MQ18VNK>+?#NGZI;0WEE(+J5[:X0/&[*BA25/!QN.,],U%X9L+32/'WB/3M*M
M8+*R6SL9EMK:,1QJ[&<,P48 )"+GUP* .PHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "LGQ7_R)FM?]@^?_ -%M6M63XK_Y$S6O^P?/_P"B
MVH Y_P"#G_)(= _ZX-_Z,:NVKB?@Y_R2'0/^N#?^C&KMJ "BBB@ KS#]H/\
MY)-<?]?</_H5>GUYA^T'_P DFN/^ON'_ -"H ]/HHHH **** "BBB@ HHHH
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MO)G(CE"!U!+D@8C0#GC'&.: ,.[^+6F6FI21MIMZUBD4KK>911,T=PEN0H+
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M,<Y6"(<_W?4G,_BO_D3-:_[!\_\ Z+:@#G_@Y_R2'0/^N#?^C&KMJXGX.?\
M)(= _P"N#?\ HQJ[:@ HHHH *\P_:#_Y)-<?]?</_H5>GUYA^T'_ ,DFN/\
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MTY=1S0!Z717EVH>./% \/7=Y&VFVK[&C01P&8PR+8K=,^\2%'7.]1@8^Z<D
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MFQ6TL(S'"K,^&=G9F9BS,68DL2Q)))))-6J** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ //6N<A\!:! (DC@O/L\+K)':-J5RUNI5MR@0F3R\ @$+
MMP,#BNCHH **** (;NT@O[*:TO(EFM[B-HY8W&0ZL,$'V(-9%GX-T>RN[:Y1
M;Z=[5MT"W>I7-PD3;2NY4DD900"0#C(SQ6[10 4444 4]4TJSUFP:SU&(RPL
MRO\ *[(RLIRK*RD,I! ((((JIIOA?2]*U WUNMW+=>68A->7T]RR(2"54RNV
MT$@9QC.!GI6O10 5D^*_^1,UK_L'S_\ HMJUJR?%?_(F:U_V#Y__ $6U '/_
M  <_Y)#H'_7!O_1C5VU<3\'/^20Z!_UP;_T8U=M0 4444 %>8?M!_P#))KC_
M *^X?_0J]/KS#]H/_DDUQ_U]P_\ H5 'I]%%% '):W-=1>.])EM(]0^S0B1[
MYHC=-&T8ADVKY84Q-\Q4Y!\S(4 &NM'-%% $=Q MS;R0R&14D4J3'(T; >S*
M00?<'->>Z8WB32[#P];Q-JQ>:&U>=9TDN?-E:51<":20,T06/+*-RC.<9QM/
M;Z[?S:7X>U&_M;<W,UK:R31PC/[QE4D+QSR1VYKE/#_B+5]9\;+;'5;"ZTN"
M&?\ >V%MB.\91;D.&+O@*9F7"D\HV3SA0"GXK\0Z_8^*98+275+/3%:"*29+
M$2C<\]LN83Y)!)2248+.V0<*,#.5'XC\:7#ZG%;W&IO=VV]$A&EKL6/[(SQR
M%O+XF,GE$QD\;R-F.E_4?'=X;%9)9M$,BQ3W7V.>!F>*>%D,=F?WG^O8L2#C
M.4)5&ZB"_P#'.O:3;ZQJ45OI+1P,9&1;.19)<W$MM'N?S.2!"I)QR. !UI@7
M;W5?&&F7=RUN-2U); .\UNUBF)XTEB">6ZQ@/))$97(7.&4#Y!P;OA:]\8)>
M:G%XHW3K:VV$\F JTLB@?/'^Z5/GY./,?!(&% (JC+XW\06%Q/!J#Z4=DGDF
MX6VD2.'YK7,K9D.45;IB1D?ZO)8 \6?#WC/6M4U.$W:6(L9+\6 $4#AY/]&:
M83*Q<@(V 0,$X;K0!0TW5_&MT]K)*NIQPQ7!RLEFH:XC,UL!YF8$(PDD_P!U
M4^X3DA<F_K^J>*&\675AHHU*"T\N-#-]C5T1C+; O$QBVD!'FR&9CE6.U0N3
M3UGQWK%G//):W%A(+&^N8)+>*'>)@MO-)%'Y@D/SDQ@,NU6#<;<8W1ZG\0-4
M32=1,&HZ7$;:VG>UOXX<IJ;*.!;@R$97H<E\GH,4 ,O-2\?6EN8K66\G=I2O
MVFXL1B,!KM5.(H6)!\NV)PI.'X*!@1=EOO%MO=0&:XU0V=U/<_:9(K!'DLHT
MN"L7EJL1+;D*_>#G:"PZ&K>N^.+G2/AW%KOGV'VZ0N%B,3&+>%=_(8M(FQ@$
MVEB<[E.$R0M9^I>/M2;4H;"UN;&REAO2+T21%VBA^VQ0Q[@6&W?')NR>O;&<
M@ I:;<^.DTB*9KK5]\-AYH@FLD)DDCMK9@C%H]^7DDF!YSE2!C!IYU7X@7%K
M<N[75M,KR,(;>SWLC+#<L$#/;A2C,L"C:7.<_/\ ,*?:>.O$-II-A_:UWI2O
M=6MO<?;YK9TCA61+AL2*' +$P(H(*C,G"] 7IX^UH:?+J>HR66G1FWNWAMY+
M<G8\=Q#$B2$R#+$LRY!106!/2@#9M+O5[+PCJ\EP^L3WRZE*(\0 R1QM,-GE
M_NF#1A&#$A7P-P'*[1B6VI^._P"QK>^F?4'GF>*&>W_L]0((S:1R23(OE[RX
MD\P ,2"WRXS@4ZS^(>MRW,UO=_V1;Q1RQQ/J6Y3!%D<RE!/O,;_P$A!\R\MG
M-6G\?7>F>"](U&_GLVFO-">[668;1/= 1;44 C[WF,=HYX]C0!);3^)_^$>L
M6L)M3EN&U.]=FN[8))-"OGM"L@=/W:,5B7("G! &W(K!GU'QU=Z-/')=:F))
MK:?RUL[&1)8F6 ,-SO:H&RX=0$VD90 N<D:/_">ZY'I=K)?W.CV3WEM!<B[D
MMI!#;+(EPP5P9?F.8$4'*\OT/ -;PW\0O$VLW.F6+6]E$UQ)#%)/<*K.!Y+.
MS&-)0WS[25)5%&?XJ +.J:GXGNO$$L-C_;D6F036TAD-H%9L3Q*P4" 91D9F
M(RY^4Y"@%32MM3^(EUI[R33W=O-'937!CBL,L;A5CQ"?,MU&TL7V["Y(!^=L
M9K<US7?$-O\ $--(T[4K*&&5(I(H9[3?\ODW3.3APS?/$G((QP/7<_P7XYU+
MQ1=WGVG3X;6WCMEFC7S$\Q20"-RB0N0V<@E$&!_%G- &+/JOQ!CO-2MT-P([
M=;I;24V9=[E%$PC?"V^P2;A'C+J"H^X2P-=!X>;7X_'VL6^K76I7%C#;I'9/
M/ JPSX.YG+)&%#C>%&,9 /#%21SEE\2]2GCM+BYOM.\A].%P]Q:VQ:%9G: "
M)@TO#(9""2Z@!P6Q@UM>%/&>LZU-ILU\EBMK?2)!Y4$3;XW-DER6\PN0RY++
MC;Z<GN 4](D\4ZIKVB-J%WK*6T3127T;6@MT$YAG,L1(0%HE98@IRRDN?F<X
MVW+O5_%$'B"XVB^:UBN,SQ+I^^..$7,(0Q,$W2%H6F9@"Q!'\.!G)F^(NN:=
M;W<@^Q:J+>YN4DCBB*RP$3RPV\3D-C<[^2 =H^4-D'AJ[:6YU"'QCI-K)= V
M]QI]PT\*1@*94:'# G+#[[#&: ,3PMJ_B&6PU_6-<BU*6.&:7[!ISV0B=XE&
MY-J[ Y8YV\D].F<USMO<?$&UM[BPD.K03VUK/?K.UO%.+F1EC*P[OW@ $GGX
M4$,$V#CBM#4O&%X;CS+#7D"3WJQ2PQ1Q.ME9F1 MV&P3@HP;>Y9/WF<86I-(
M\7:A)JUI_:>J+'")65HI(D19[00RO]M+8RH+(O.0@Z8RP- %/5-6\?6T\\-C
M]I=8(K@022V9)N2LLZ@D) R[MBP%>8U);^,'B:\O/%T=X;&XN=7DB@O;5;>X
M@L1F\4RPM+YK)'A$568 C:" P).""2^++[^V4A;Q$(()KBZ2_P 11?\ $KC2
M<)"V2OR[UP,R;@V[<N *L>'?%&I7VO6L-SJ_G2/>F 6/D(GG6@MBZW>-N\;G
M ^<'R^=@&: ,>XU7QU<^#\W\NIV]Y-#,0-/T]VE$VR#;"^81M7<T_P Z\ !1
MYA(RV_XNUCQ/;^()[;P];ZB8A8RY<6P>(2>4S1M&?*.6WA5(9^IQL.<UGCQU
MKLLMQ<07&G/'I\%Y+<PQP>9'*(F@*JDBRGDK(WS<=<&,$5"?B9K,^K:K!I45
MG=P:=:7-Z'^RL&G$8^6( 2L5;=U+ ''\ XR 6I[SQ4=6LK2>XUGRXM0A16BL
M1MNHQ>2K(TTB1@(!"L1X*!@QX8$XAUF7Q?8>*M9O--CU!K623RK<J\LJ!<VF
MYA%L=4VIYY5E5]S%\@D!6U]#\;W-WJVGV^KSZ;!'>0.R"&2-V=A,Z*24F8(K
M )C[X+%EW @ ]Q2 \QCOO%US"%OKK5-T-Q93,]C9.BB/S461"'MT9R5)=BO'
M4%5 PU(ZSXXF9[^W360$^T);6]Q9[<YBMV'F@0#E<SD,%(W*%!?.&];HH \V
MTB_\676O:2FL3:AL%^WR063K!+;>5-AYG:&,APVQ2I"@D*P7Y@0EM)XCDU*]
MM;9M5LI9=9F5[L^=-_HP$S)M2:,PHO$8!C+9R,X)Q7I5% 'E<>O>,(KJSMKF
MYU+[9+:M/%!_9Z$32^79G9(1%\D8>692WRXQRV12VVH^-H](BCBFU"._CM@1
M'=V68/+%EO\ ,>5DSYAN!L(W9VD_)_'7J!@B-PLYB0S*A19"HW!202 >N"0.
M/84EQ;07EM);W<,<\$JE9(I5#*ZGJ"#P10!Y)'XD^(=U'+>6\4JV]PZ3P1FU
M<M':2F-P5V6[J945W4Y9C\G^K8_>Z:^GUL^'=!N[LW=S?I+F>TM([F,7(+ ?
M,Z(AC8#!_>*J$Y! &"O<*H50J@  8  Z4M 'EJW_ (TL(9X+235;R\AG86D=
MU9 Q79-W*)!++Y8V(L(C92"H^;C?]P:.E7^OOXQLM\^M3:3+:1?:+BZT_P L
MBX#R?NMFQ0JG()D . J@M@@UZ#10!YS"OB;2=1N=9E?4&LFU.XCEM4,UT\D&
MZ7RW6(@^6 ?+ $8Y4[B>U)I]_P"+7MXIM9NM6MX9C&DGV?3D=XF%M$V HB+!
M6D>7<Q!VE% V\UZ/10!Y5)JGC71] LX(AK6H7GV.TG61[56_>E&\V&0B%CC*
MCKALM\T@XJYI>L>-)?%%K;3"=M/6Y99;BXM)(UG7(X51; H I&-S*-V[YW K
MTFB@#SG4[/Q+%K^K:K;RZG]DBU&".*U@FD=IXR;5F*1GY%50LPR.&WMNZ55T
M/5?&]Y=7,]V=3BM;6:U6"&:R0&Z22<"0N3 ARJ$YVJN,9YZGU"B@#S_4[KQ#
M9>)M75+S64L'F#Q/;6 N/+_<+L6,>61M9Q)NZX*IG;OW&;4I/%D^L6,<$EWI
MXN+6U^U26L*RI"^RY:0+O5E'S+$"<9P5]17=44 >>:;J7BO4AIHO)M4T^]GN
MD-W;IIZB&&#R688D>(C+,%#98E2Q&!Q5.PU[QO\ V9I!OX;TWUQ?1><L=DWE
MQQ9MQ+'+FW&/OS%64A0 <R.5Y]/HH \Z\-ZMXPNO%%A;W_VHZ<L?[Z:ZLWB%
MRV)MQ4>0I3D0D!RF,L/WF0P@D_X2RWN+Z:TOM9DELAJ4R126X,<[">)H(AF/
M#*8\X*_,,L 1@J/3** ."\/ZOXI?PAJ=WK\=VUXD:&.*VMF$\<A7YPJO JE5
M;I@2\9^9^,X)\3>-DM+3[2;ZWU*=IHK6U-@#%<A;:X=69FB4B0O&OR?)D ':
M 3CUNJ<VCZ;<WIO+C3K26Y,1A,[P*SF,]4W$9VG)XZ4 >96NN>,;N;7Y--U#
M5;RTT^X@@MOM&G)"\@:51,Q @W;D3<0 AZ@[6X!FN_$?BFQU"RAOKC4WGG3:
M;>PTT>7(HLE=I4=X2V\3E_D(R ,;..?3+.QM-.M5MM/M8;6!,[8H(PBKDY.
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M!O\ T8U=M0 4444 %>8?M!_\DFN/^ON'_P!"KT^O,/V@_P#DDUQ_U]P_^A4
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M^\>&*HA(P<L?3@G_  FWB&S\066C7<&GW,KW:PS7$:^0CJ5M6(422\/BXD(
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ME3C'/S # V=?\3>(?^$1T?5+*Y@L)9X[J2X2*..?S/+MI9$VL'=0"8P< MU
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M#_Z%0!Z?1110!R>HZW-IOQ @AN]6@73I;?\ X\UGB#0E4E=YI59-PCPJC<'
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M259U3?N*-)'P<_=.,YYKT/3=,M=)MF@LD=59S([22M([L>K,[$LQ]R>P%6Z
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M7M^Q:;C&,;]\/Z[OUKTBL>+PAX:@U 7\'A[2H[Q9/-%PEE&) ^<[MP7.<]Z
M-BBBB@#F?B3N_P"%8>)-F<_V;-T]-AS^E-\6>1YOA?RO+V_VQ#Y6W&,>5)]W
M\/3M73NBR1LDBAT8896&01Z&LK3_  GX=TF\6[TO0-+LKE00LUM91QN >#AE
M - &M1110!S/C?9]CTCS=OE_VS9[MW3_ %@QG\<4S5-O_"U/#NW&_P#LR_WX
MZ[=]MC/MG-='=V=MJ%I):W]O%=6\HVR0S('1QZ%3P:IZ7X=T31)))-%T?3]/
M>0!7:TM4B+@=B5 S0!I5D^*_^1,UK_L'S_\ HMJUJR?%?_(F:U_V#Y__ $6U
M '/_  <_Y)#H'_7!O_1C5VU<3\'/^20Z!_UP;_T8U=M0 4444 %>8?M!_P#)
M)KC_ *^X?_0J]/KS#]H/_DDUQ_U]P_\ H5 'I]%%% !17#>(O$.K:7XHO?L\
MLJV5M;V66D2(VL!FF>-Y9LXE(50&PK ?(=Q49-7/"7B34]>U.Z6Y>R:SMK<%
M7MX'!N&,\T:RJQ<@(R0A@N&^^,,0.0#K:*\CO?BAJD^AWTUC?Z7;"/SOL]Y)
M;G]_MCMV2-4\U@LI\]^&+']WR@Y N1>/=>GUAEMIK"<>7'))81VQ:2WPEW(\
M+$29\X_9T7)X&<[#W /4**\L3XE:VUA:2RC1H)+B.4H&GA;S&4;AG%SB,8#
M$L067#&/<*Z?4/%,T6DZ'<Q7EG9Q:E!YK7UY"5B!V*RH%\P;6?<< L<;3][B
M@#K**\JD^(^LZ/H%FVJ36=S?26=I=J%M"GVA948M'S* '!0G(SG/$9Q5D>/M
M<ATVTEU"?1[0WEM!=?:I;>18;9)([AMK@R?,<P(N<KR_0\ @'IE%>3V?Q3UR
MYTJ>]N+73K..*.%V:5X]RA@"Q6(W =\@EE!V<# WG&>@\:>.+GPYK4-E8?9I
MI&LY9W@FB(8;89W5@V\%ANA *A#@9)89&0#N**\OU3X@ZOILDMMJ=]I=@UE=
M6Z37!@91=J\D)=8@SG:4CD^;.[J",=0MQX\\1:9:,+I;/[88)+@6=Q"?.16@
MDN%<[& ,:$) >,DC)?)&0#T^BN=U+6;S3=8T33KB\L(#=QL9[F:(JL\BM$OD
MQ*9!M=][%<LQ&WHW)'&#XC^(KBU,EF-)?R].DU"9OL\C*C*J%K4_O 1(A?#$
M^H^4'(H ]5HKSG_A+_$\VJBQ@?2E99S;,[V4I#.'NQO $W VVH^7GE^O:JFG
M_$G7M9E"VEG8V7G&!$%SMD>(R2P(&,:S!W4K*[ E4 VKRVZ@#U&BO,=(\?ZO
M/J5K]OO--6*\N;-1:^4!-$DT,9RBF4%E,C,NX!BI!X8 [>D\5^*CI5CI-UIF
MHZ9#;W\[+]LNP9(2H@DD7:5=<[B@ .3UZ$XH ZJBO*(/B;K43I]MMH((]LT\
MOVA4\R-!-.I55,J%_*6)"517+;L$KP2]OBAJB:?%.?[-=I0RHL01L[;MH3,W
M[_"1A 'R24)#*9%X) /5**X^;Q7?Q^%-%U"XDT[39-0F\JXN[EEEMK<!)&#D
MI+MPQ15'[S +@9)P#S'_  L'Q1INA6#72:??75W;6\Z3,@@51(EPVV0O(J D
MP1KNRHS(<*2 I /5Z*\VN?'NIQ^++6T%YIT4$EQ=6\]NT1S8+',J)+<-NSAU
M!V<(N9%Y8?-6CXGUW6[+Q4UAIVHVEO'+'8F"*6VWL3)=^7*WW@64*5! QC>O
M*]2 =Q17G&A^.]4NM>6TU&6R1&U26P*K'\[-&D8S&A<,$+%R6_>%=RYXR0_4
M?&^JZ9X@UBT2>RN4@N_+2W:(^99Q>1"WVB0AAF(,[9X!]&[  ]$HK@] \;:C
MJGB:RTZ8Z>]I.LV;J&-P)61YE0)\Q'[Q(_-7DX5'^\&5JK2^.]6NO$MYI&C2
M:>_E7B0)/-;,?*XN=ZNBRY)!MP QV9W$[<8) /1:*X#PKXVO_$?B:PBFFM+>
M&XLIYWTU$_?1;3!L=V+'AA(Q7 7@]^V7J7Q+\06>OZII*:9;"2T@NGBF>&0H
MTD#B1@V&X!MGB.?[[@=#B@#U.BO*K_QQXET?5KD7=W8S1Q@Q"(6HC3?_ *'N
MD!:4?*HN';!8< Y8#!7H;CQ'JS^'_#6H&>SL&O;T17F0DT;*4DVA660JNYE0
M##-RRC)Z$ [2BO*;3XB^(X;/3(+F&QNKF94+SL$@6;,%M($_>2HJN?/?D%O]
M7PG)VZOA_P 8^(+W4]+CU,:<8+Y('*V]M(C()HIW W&0C*F#!XYW=L<@'H-%
M%% %34M6T[1K47.KW]K80%@HENIEB4GTRQ S2:9K.F:U TVCZC::A$C;6DM9
MUE53Z$J3S6-K6/\ A/O#&_&-EYMS_>\M>GOC=^&:9I/_ "4_Q+CI]AT_./[V
M;C]<8_2@#J**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)\
M5_\ (F:U_P!@^?\ ]%M6M63XK_Y$S6O^P?/_ .BVH Y_X.?\DAT#_K@W_HQJ
M[:N)^#G_ "2'0/\ K@W_ *,:NVH **** "O,/V@_^237'_7W#_Z%7I]>8?M!
M_P#))KC_ *^X?_0J /3Z*** .$\6^-]1T&\U!+1;)FM(P8;*9&,]T#&6,RD,
M!Y:$<C!^XW(XJ2Y\1:VF@O+-=V-M=66LVMI=7"VY\IXI&A)PK.=O$P!))Z'&
M,C';T4 >4?\ "P?%&FZ%8-=)I]]=7=M;SI,R"!5$B7#;9"\BH"3!&N[*C,AP
MI("G<\4>+[_0?%Z6Z7=HEH;6V?['/ 7FF+W#)(T15@243#$8;A?X<EJ[NB@#
MRJ+XE:GJ&C:DZ7>G6+VUO<-;7,D(_P!.=4W*(5\YE# $$@L_4<#D#;N/&NIP
M>!K;7DM[>69[@Q3V@1]\!=66*)QGB3S6A5N ,,V!T-=U10!YE:^._$5Q>V4\
MD-K! '\BYMC _P [+/:02E6)RI266<#J"$&1GD8]WX]U[7=%_?V%L(/L[W4T
M=O<%9  (U,1\JY!78926,A3(4Y1<<>RT4 >>7GB[5-/\"Z7J-G#9Q2%KM!'%
MLDA=(H9S%_JW8 'RT)57)!RN:K7OCK6H[^UL7O=-MIEOHK>1?L[![T?;)87\
MH,YV@+$I;[Q^?JO!/IE% 'E)^)NH6O@C^U+J^TR/45A79I\\'[UV$)?<[>:@
M59-I*G;C!  8\4LWQ&\0V%Y-:K;VFI3I=S@1?NX&95GVK -TP/F"/#C"L6#Q
MC SN/JM% ')>"?$DNMS:G'>:MI]^\=PHMS9*$0IY$+.%!9B=K28))."1TZ5U
MM%% !1110 54_LJQ L0EM'&NGG-HD8V+#\ACP%'&-K$8Z"K=% !1110 4444
M %%%% !1110 4444 %%,FFBMH'FN)$BBC4L\CL%50.I)/05G:;XHT#6;DV^D
M:YIM_.%W&*UNXY6 ]<*2<4 :E%%% !14%[?6FFV;W>HW4-I;1C+S3R!$7MRQ
MX%5M+\0:-K;2#1=7L=1,0!D%I<I+LSTSM)Q0!H4444 5-2TG3M9M1;:O86M_
M &#"*ZA650?7# C-)IFCZ9HL#0Z/IUII\3MN:.U@6)6/J0H'-7** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R?%?_(F:U_V#Y__ $6U
M:U9/BO\ Y$S6O^P?/_Z+:@#G_@Y_R2'0/^N#?^C&KMJXGX.?\DAT#_K@W_HQ
MJ[:@ HHHH *\P_:#_P"237'_ %]P_P#H5>GUYA^T'_R2:X_Z^X?_ $*@#T^B
MBB@#S[QAI_B6YUS5KO1KB^AAM=+5H5AGE GE*7"^6D8^4MN:)BWWAL4 <UEV
M'B#QT4TX7T-\9YKJ#S52R?9&"\0GC?-LN%PS%"K8 #$R-@9]5HH \UT;6/&<
M_B#3H+C[4;,;!--=6;QK<G?()#@6P* *(RH<QX)/,@YJO%?^.K<W\P;4GB.J
MSV\<+6:OY5MAG\],H68CHH)*GA<=*]2HH \PT:]\2QZM_IMQKRZ7*[_Z6U@S
MS,?M-SY:^68SL5DV9(08 C^Z"*IG6?'$S/?VZ:R GVA+:WN+/;G,5NP\T" <
MKF<A@I&Y0H+YPWK=% 'FVICQ7J6B:5$;O48I;@31W,]A&\;JAO(%4G=$A5Q"
M7^;8O1B,"I]3UCQ.OBW4+".XN8],LY8WDN+.S6:989E4IM78Q9D>*53\I^60
M$Y(KT*HH;6WMY)I(((XGG??*R( 9&P!EB.IP ,GL!0!P^D:[XG>YT^UU>WNX
M[B1Q+=,+$B&./["K$&3;M!^T$C&XGC'2N:M_$'C"ZT_3[Z"77+N&73 _VE+$
M1G[2XA)!00,#&.=K"-CAGP<#(]B(!!!&0>H-,AACMX(X;>-(HHU")&BA550,
M  #H * .(T&[\67^HO\ VJU[;175HX$?V9$6UD$%L058IG.^2<?,6&4QCY35
M7PEJ'B=KC2(-0?59.(TGBN[':AA^QAFE:4H#YOVC*8+9(_A(^>O1** /(+F]
M\9ZK:7<RW'B*S007BVJ)9A96;R('17Q O.[S@&4#D;58D_-HPZAXYO\ 6#;_
M &F[L[22]D0R+8YDCB7S3&PWVX0!E6/=\SG<W1,[1Z=10!YUH%[XHU;6K8ZN
M^JV4LNG7/G0"T\NWMW/D^4RN4PSX+G#%L'<,#!SDZ9)XTAT?3YC<:Y.T^HV<
M$\%S;G,<0A@:23[@<#>LBGG:=S<9.:];HH \[GU'Q;+X/M9+.74Q?I-<>;-]
MA4-.$MY'3$;P@HC2*@P5#<X#'ACF:AJ_Q'LM5U"TL!+=I:Q V<UQ:$"\8QEF
MW>7 5RK%0OS1CCDMSCU>B@#Q^\OO'2V.I745SJT]Q]G@-A'%:2;25N/G+@V\
M7SA2N1M 92>&P<:=]J_BK2-4:WOK_4C:1WEE%;77V&,K=F5X%E20K%M11O8*
M1M))(R2M>FU5N-,L+N[@NKNRMY[BV.8)I8E9XCZJ2,K^% 'G7B+6_%&@ZQJU
M]8-J,]K:WZSRVDUKF!K,0P[O*E*??+;P%#=<G P<V-?D\8:=>Z=/;-?W;VEM
M9RWOV:'<ER42Y:X0(/EW/M1>.A9,<[:]"N+6WO(Q'=P1SH'5PLJ!@&4Y4X/<
M$ @]B*EH \^TBX\=W=YJ=IJ$PMG_ +.;[,[6_P JSM#$5=3Y6PA9&E4AG)(5
M?D&"S9$WB#XC7$330V-Q:0S-]H4/:X:"&5E$4>!%(Q=/+DWC8QQ*N<8!KUBB
M@#R[3]1\90K=K/-JKL9I6N1_9Q9;9#=0@-;%H\R?N6G8*=^-JC:,!6DBU[Q0
M]Y<F ZX]C%/;K%]HTW9<3@M.K@?Z,%4$+$_(P!P70M\OIM% &!X*FNSX4T^#
M59+Z74(K=?M,E[ R.7RP(R54-@J1D9R-IR=P8[]%% '-?$+'_"#7V_&S?#OS
MTV^<F<^V,Y]J9XE_Y'/P;CK]ON,X_N_9)OTSC]*Z6:&*Y@>&XC26*12KQNH9
M6!Z@@]16=IOA?0-&N3<:1H>FV$Y7:9;6TCB8CTRH!Q0!J4444 <UXRQYGA[?
MC9_;4&<],[7Q_P"/8Q[XIEQ_R5S3\?\ 0#NMV/\ KO;XS_X]C\:Z&]L;34K-
M[34;6&[MI!AX9XPZ-WY4\&JVE^']&T1I#HND6.G&4 2&TMDBWXZ9V@9H T**
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LGQ7
M_P B9K7_ &#Y_P#T6U:U9/BO_D3-:_[!\_\ Z+:@#G_@Y_R2'0/^N#?^C&KM
MJXGX.?\ )(= _P"N#?\ HQJ[:@ HHHH *\P_:#_Y)-<?]?</_H5>GUYA^T'_
M ,DFN/\ K[A_]"H ]/HHHH **YK7?'6G^']4DLKZUO&\N 3--$J%.4FD"\L&
MR5@D[8Z<\U9_X3'1/(DF6ZE:**7RI)%M965#S\Q(7A.#\Y^7@\T ;E%8<7C+
M0YG@5+N3_2)!%$S6LJJQ+!%.XK@*68*&/RL> 2:74/%^CZ9=207<TB>1(8YY
M?)81PD0M,<N1M.$7) )(R.* -NBN>A\=:!/<Q6Z7-P)I9C $DL9T*.#&I#Y0
M;.98QEL#YA5K4?%.CZ5>/;7UTT<J(78+!(X ",Y&54C=L1FVYSA2<8H UZ*P
M?^$UT'RHY?MCB"6-I(IS;2B*8*2#L?;M<G!("DEA@@$$&JH^(.B_;UM9$OX6
M:^BL \]C+$/-D3>@PP!P>!TXR"<*0U '445E2>)M*CTBVU3SY'L+G'EW$=O(
MZ8/1F*J=J_[387WIT'B+3+C31J$4TGV4W"6ZRM;R*'=W5%VY7YE+.!N'R]>>
M#@ TZ*YZ'QWX<N'18=1WB1D5'$$FQF?;M4/MVDD2(<9SM8-TYJ_9>(=-U#59
MM.LYI);F!&>4""0(@61HB"Y7;G>C@#.3M) QS0!I45S\'CG0+FR-W!=3M;AE
M5I/L4X"AL[7;*<(<'YS\O!YI%\=^'FO6M3>RI(DC1LTEI,D8*LR'YR@7&Y&4
M'."00"30!T-%<X?'>A9MO+FN)1<;MHCM9&=2" %,>W>"<Y V\@$].:OIXALF
MT,ZJRW(@5VCD1+=Y9(W1RCJ4C#'*LK XR!@\XH U**YV;Q[X<AD9'OI&*O'&
M#':3.)'<(51"J$.Q$J':N3AL]C4\7C#1)Y!';W4DTAA\X)':RLQ')VX"YWX!
M^3[W!XH VZ*YH>/_  _(Q6"YFE99%C?%M(H0E&D()90 51'9ESN 4\9XJRGB
M[39-/U&\1;KR]/M1>2+) T;O"0Y#JKX."8W SC)4]B"0#<HKGX/'/A^X$.V\
MD1YI!&L<MK*CJQ$>-RLH*@^=%R< ^8O/(IL'CSP[<0+,E[(J/!YZ^9:3(60]
M,!D!+$<A?O,"" 00: .BHK"M_&FA75Y%:PW4QEE*J,VDRJC%W0*[%,(V^-UV
ML0<KC&:/$WB_3O"=NT^J).8UM9KG=$H.1&4!09(^8^8,#IA6R1B@#=HKFH_'
MVBOJ%I:DW*+>(C0W!A)B8N(=H+#.W/VB, G R<9S2_\ "P/#68L7\A\[)0BT
MFP4PI\S.SB/#*1(?E(.0: .DHK)U7Q+IVCWD-K=M,UQ,8PJ10L^T/((U9F V
MJ-Q[D9[9/%9W_"Q?#/DF47TY0;3D6,YRK(\BN/DY0I&[;Q\N!G- %GQI?:AI
M/A6ZU;2I0LFFC[9+$R@B>&/YI(R2#C*@X(Y! ]ZX6+X@>*M/O9]-O+>RN+F.
MQ:Z\VYEB@7<T)F!!WJQC5B(L[.V2X.:[A?&^A_:WMIKB6&2.1D=GMW\M,221
M@M( 47+1/C+ G'3FK=CXDTW4K&ZN[)KF2.T.V9?L<RR E XQ&4#-E64C .<T
M 2>'M2.L^&].U)P0UW;)*08C'RR@GY23M^F3]36C67I?B32]:N&ATV:29T0.
M_P#H\BJG.-K,R@*W^P3NZ\<&LS5?B#HFD,Z7"Z@\D9E#HEA*"GEQ/(2=RC@J
MC;2.#@X. 2 !GQ#U/5]+\.6\GAV9(;^?4;6VC:1 RGS)57!R.ASC/7TKC-&^
M*.N74\0>VC=+B^<10W$1$TT;7AB$4>T@!HH_F8D'('..37=R^._#]O"TD]U/
M&J@'YK.;)8[?D'R?,X+J"@RPYR!@TO\ PG?A_;*QNYU\MBN&LIU+E7*-L!3+
MX8$';G'>@#H:*S-,\1:5K$QATR\6X=49R%5AA1(T>>1T+HX'KM)&1S5.Y\<>
M'K-YUNM0,0@=HW=H)-FY2P8!MN&PR%."?FPOWB 0#?HK!B\::%//Y$%U-+,6
M 6*.TF9V!+ ,JA,E,HPWCY?E/-,?QSH2WEA;I<32&_C$L<B6[[$C*.X=V(PH
M(C?KSQTP"0 =#16+8>+M&U.^@L[*>>2XGW[8S9S*4V*K$OE!L&V1""V,[UQG
M(K:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LGQ7_ ,B9K7_8
M/G_]%M6M63XK_P"1,UK_ +!\_P#Z+:@#G_@Y_P DAT#_ *X-_P"C&KMJXGX.
M?\DAT#_K@W_HQJ[:@ HHHH *\P_:#_Y)-<?]?</_ *%7I]>8?M!_\DFN/^ON
M'_T*@#T^BBB@#D/$=OX874]2.MO/!=:CIPM6G^S,<1+O)6*3807.\_("2<#Y
M:X[^R_A_/IYTX3ZI:12W+DV\>E ,Q$KPJ'VP$YWHP0O^\!Z$$XKJ_$'AKPQJ
MGB^.XU;6_)U1(Q)!;&YA5XL*<2(&4N -I;&=N4R0<&H+2Q\'6B^<_BN&X>=T
MO#--?P?O/+NWFW_* -OFR,IP,8P.#3 R+'3_  .WB:"_%W=37T]VLD<DNFQ.
MDI;R'4\08B&Z:/YOD8LYR2<&I-5?PMXBOH]1>;59Y]2V6J0QVVR*-I+20JKR
M)$<_NY"22SE-V1A<UH1:'X)TY/F\1PH+4PQN9+^$;&7[.R!N."?LB<=_FQVP
MU=!\)V%[9R1^(Y#/:):I D4L#.$P(X]P6/<RN)<;FS@2':5S0!BV4FB6NC2Z
M[XBO]6N[BZ+ZC&T=G+^]C$D+A59H(PQ_T5#]U?D).,?-6MJ:>#+_ ,33W[7M
MW#J-XWV,^1IVZ1Y-KQ'RW,+."H#*Q1@%*D-@YJ6U\&>%/$<-E<V.L3W<0TPV
MML$FB)6'RC 6&4W*>3D<+O'*Y%(;;PGI=W<ZQ/KMU(V@7KA_-4,EK--N+KM2
M,%@S2Y."<$  J%( !%JG@WPGINJ60U+4M162W3%FFT2+9)G;&0XC)C12RA=S
M!<HI.X@FJVNV&BZGX1N-5M];U"XDU%V%K/<VS)ON/L[Q><J1P!SB,%_E&W]T
M"-HW$[MY::)?:C;:7J_B)O[6>PABNXPT<)U*++$90KT)60XC((#,.A%,E'A5
M_#^E:?;^)5MH=.C+VM_!=1':J+Y#9D*F/.)@I!&<L",$ @ Q=8O/!NNVMKX;
MN9=5MK'35:%&BM"T+)&D(#$E& 4"6,B3"XY(8 @FU(VAW&A:MX;T+4Y9]2UR
M6<QM+;/&(Y2JAIAY404*I </C#-GYLDD21:7X'-K=W$7B".WM+[3,>4]W%&L
M-M)'#&) & 901#'@MD9/O5K0M$\&>&9I=7T[5K&*&U,D,LGFVR1Q>8R?*[HJ
MDG*@#>2>3R<T@,)8?"$\[VBR:W90PSM':Q"V&T7%NL,'G0IL9V8?*H&"OR.2
MO4G9\,:MX7TK3VU>/5;QSJ 7S&O8QO+L)+L#;&@&XK.QP/\ 9 YZRC2/"NHW
M$=]8>(T$]E)=7,=Q;7D+F R2"65N01@9QR,!7YZ@UGQ^%O![ZEI^CP^))I+F
M$8@M([J)BT\$2Q^:<)GS57:<9 ^7.W@T 5+W0?!]_:I:WEWK5O;V_P!FTPB6
MU(5BJ@Q;PT1V,3< !F"'/W<=[UK8>"_$,'V2*^O)5U0QXAFB>)I 9;B[4[6C
M!"MB;#'@JH .>2M[H_A2[ODN[[Q8\LL-S]JFF>XM_+:2(VZ_.?+V(P*1#C:W
MSL!P33[#2M*N/%NF/H'B'3]^FZ7;VT2Q7*3SSPJR/ED&  8R5#C/$[$ <&F!
MD7FB>%--DET2"]N(H\QV-Y'#IT49DD:2,Q;7\D1%D\[<2OS@,&!RO.MN\.:Q
MX-BL+G5+DV]Y?DRW%M:OY;33R"0(V^-E\MC.FW>,,&4@GK3)M+T*\\<75CJ^
MMR->W&JK=66G1<!)([>!RQ^3.=J<G<5P^!AC3['P1X273H%T_6%-GHMSYLOD
MO;;$>,QMB8B/[R^2HWG$F"P+<T@,&'0M'O)+6VL-=NT#7]G>:6KV[JL,:)#&
MLI+0\2.L$JIN.QLG /.)=0L_ &D3:C<27]]'<1Q,EW=)9*9"?-$4LJRM#\Q#
ML0ZHQ4_,-AY%:MEH'@?3M5CU<^(K&:>W07#R7$ED5"[V*N/W8\H;I&YCV9+<
MY-5X]'T*]\0ZA<:CXCT\Z7:%F6TCU**00E[I9V+_ "*8PSJ!M+-UP","F!+I
M>D^%]%N(-(T'59ENH]2,V7M]R([(\#+E8Q&F1YFP'@NF " 13-"3PY#IGB&S
MEN;VWLA;7%B3-:^2WV>%F,TB!4"X$ERR@!0!L "\&K-AX>\"Z7J>ER1Z[927
M=G'#'']IGM99)BS/)&Y+J6#L9'8,A4MGO@4VYM_!FM:;<-#XI:UM?])%Q<1S
MQ(K)<7!+H7=",&2(@8P<#J002 5IO^$4U(?\)9+'J9-M=6_R_98YSNFCM=NU
M-KD<+#\RX8$-M/(!H+%X%35)%8:A;RV<,=H][+:1?NO(24+,)F0L"HM&/RG:
M2!E3\P'5Z=H/AO[!>>'-+UKS)S]GF=8KF)YX#$D0C?;@@?ZN,_,I!SZ'%9\O
MAGP9J4K6Y\0K*+V2:W,$=]#^]D/GEU&!NW 7<G / VY'J 3II_AO3] EUF6_
MU*2T:=)KBY:!F=9(+F6=F=%CRF)&DW94 8Q\M6]:3P]KFCP2:O<WMQ!I-ZJ-
M,+=PUQ,"82F%0>8&=L$1C&X#IBJ6I:3X/OO!\FAR^([6VL;"9A<O;S6D01GW
MH5D0)Y8.6;^$'<H/WAFB=?""C5],D\46ZR:LTDEP#);$1"( NN"A080C)<%]
MO))VY" J6NE>#-)TC2M/BU"_*6:206ZE'>:4QW43."HCW,PEC1< #Y<X&!D5
M_#/AWP;>R7>DZ7)?03"WNK%DDL4MV:(-'&Y#B)?,*X3EBS#=\W)-78_#OA..
MZM+ZW\6O&PCEFT]Q?0,(OFW32QEE._)5MQ;<.6Z=K,5YX/TRXL;E?%L"R++,
MR3_:X65S<.+A]Y"[5#"(X/'!.#G!I@'BU?#M]XFM5UN[OH;C2A%=11VULLF_
M+.V<K&TFT>5EAD+PI/.*Y72+70I?MD>M:E?,GE?9+2*V5[E8H$CN;51YJP!2
M6S+L!RQ(7EB<5UL]GX;U+Q UVGBA[?5[LO;Q%+B%)?+4LC0QHR?,FX,<X)R,
MAJ>/"_A70/*TZ745L_M4L+6]M-=(A<Q7#3*J C)&^7:>IQM'7D@&7/9^#W\,
MK=7T]^EIKD*7IBFB8L(DF:X+.%0[(PT^&8_* 5Y[FGHVIZ*OAS6XM<\22,VH
MF&Y9[<M)+%"UH'CY\E-Q,=N[8,?3Y2">NP=.\+7WAVQMQXF>*VM-+^SM*;B*
M.22RE"#;*&7Y0P5 & 5AV().:K^%/ 5NMR[:W#"'BF$A.H1@(ESC8>> %0[8
MR>BL1SP: $T)O!GA.XCNH-4NX_(MIK<Q3V7E>2F_S6#A859?FSM5L#YB$'-0
MVGASPA<6VJWJ:EJQ15-S?3SVQC(0P2 JQ:$%CY5P2<YDQMYJ[X@\'>#KOQ!/
M<ZK?(FHZD IC(@DD(D"PJ4#(S(,XPRXY)R<=+JS^%&UF]N(_%=E]KOH18>6M
MU:G9C@ +M^=L]!)OQD@  D4 80'A)KYK/4M5UB-=.N%NU%[;>3$)Q&+EI=WE
M##LJ.S(Q'63:H!!J:^TCP3KMO$ES>7+-8RN1'/:C=')<W)(#12Q$9+@J R\
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MF@N-3;4S&^V\CXEWV\BQ ^6@=O\ 1XQ\JCJPQD9KTND 4444 %%%% !1110
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MBB01M&\<J;U\JW1@3',A.3;(1G(Y((; (]!HHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "LGQ7_R)FM?]@^?_ -%M6M63XK_Y$S6O^P?/_P"B
MVH Y_P"#G_)(= _ZX-_Z,:NVKB?@Y_R2'0/^N#?^C&KMJ "BBB@ KS#]H/\
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M/_Q-'_" ^#_^A3T/_P %L/\ \30!T%%<_P#\(#X/_P"A3T/_ ,%L/_Q-'_"
M^#_^A3T/_P %L/\ \30!T%%<_P#\(#X/_P"A3T/_ ,%L/_Q-'_" ^#_^A3T/
M_P %L/\ \30!T%%<_P#\(#X/_P"A3T/_ ,%L/_Q-'_" ^#_^A3T/_P %L/\
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M_A ?!_\ T*>A_P#@MA_^)H Z"BN?_P"$!\'_ /0IZ'_X+8?_ (FC_A ?!_\
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M'_X,H?\ XJC_ (3[P?\ ]#9H?_@RA_\ BJ .@HKG_P#A/O!__0V:'_X,H?\
MXJC_ (3[P?\ ]#9H?_@RA_\ BJ .@HKG_P#A/O!__0V:'_X,H?\ XJC_ (3[
MP?\ ]#9H?_@RA_\ BJ .@HKG_P#A/O!__0V:'_X,H?\ XJC_ (3[P?\ ]#9H
M?_@RA_\ BJ .@HKG_P#A/O!__0V:'_X,H?\ XJC_ (3[P?\ ]#9H?_@RA_\
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M *&S0_\ P90__%4?\)]X/_Z&S0__  90_P#Q5 '045S_ /PGW@__ *&S0_\
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MJ1Y9&PG!7! X;)P*%[#H<6E_:K3PKX6>[O$633]/DT+:-IN8X?GN/N%AO&5
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MP?\ ]"GH?_@MA_\ B:/^$!\'_P#0IZ'_ ."V'_XFN0_X6[J__1,_%7_@&_\
M\31_PMW5_P#HF?BK_P  W_\ B: ._P!+T#1]#\W^Q=)L=.\['F_9+9(O,QG&
M=H&<9.,^IK0KS#_A;NK_ /1,_%7_ (!O_P#$T?\ "W=7_P"B9^*O_ -__B:
M/3Z*\P_X6[J__1,_%7_@&_\ \31_PMW5_P#HF?BK_P  W_\ B: /3Z*\P_X6
M[J__ $3/Q5_X!O\ _$T?\+=U?_HF?BK_ , W_P#B: /3Z*\P_P"%NZO_ -$S
M\5?^ ;__ !-'_"W=7_Z)GXJ_\ W_ /B: /3Z*\P_X6[J_P#T3/Q5_P" ;_\
MQ-'_  MW5_\ HF?BK_P#?_XF@#T^BO,/^%NZO_T3/Q5_X!O_ /$T?\+=U?\
MZ)GXJ_\  -__ (F@#T^BO,/^%NZO_P!$S\5?^ ;_ /Q-'_"W=7_Z)GXJ_P#
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M:49DC965"0F=@*+\O3"@=.*U/^%NZO\ ]$S\5?\ @&__ ,30!U__  @/@_\
MZ%/0_P#P6P__ !-'_" ^#_\ H4]#_P#!;#_\37(?\+=U?_HF?BK_ , W_P#B
M:/\ A;NK_P#1,_%7_@&__P 30!U__" ^#_\ H4]#_P#!;#_\31_P@/@__H4]
M#_\ !;#_ /$UR'_"W=7_ .B9^*O_  #?_P")H_X6[J__ $3/Q5_X!O\ _$T
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G HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g910899g36i66.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g910899g36i66.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[0@<4&AO=&]S:&]P(#,N,  X0DE- ^T
M     !  8     $  0!@     0 !.$))300-       $    'CA"24T$&0
M    !    !XX0DE- _,       D           $ .$))300*       !   X
M0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      !M    !@              )P   ,     & &< ,P V
M &D -@ V     0                         !              #
M)P                                             X0DE-!!$
M  $! #A"24T$%       !     (X0DE-! P     !8     !    <    !<
M  %0   >,   !60 &  !_]C_X  02D9)1@ ! @$ 2 !(  #_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1"  7 ' # 2(  A$! Q$!_]T !  '_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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M &@ ;P!P    $P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ #8
M+@ P     0 X0DE-! 8       < "  !  $! /_N  Y!9&]B90!D0     '_
MVP"$  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$" @(" @(" @(" @,# P,# P,# P,! 0$! 0$! 0$! 0(" 0(" P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# __
M !$( "< P ,!$0 "$0$#$0'_W0 $ !C_Q "6   " P # 0$            )
M"@8'" (#!0 ! 0 # 0$                  P0! A   00! P("!0@%" L
M     @$#! 4& !$'$@@A$S$B%':VM!5UM18V-SA!83+4"2.4-5:6%U<847%2
M8C/3)"55E281  (" 04! 0$! 0         !$0(Q(5$2,@-Q84$B0O_:  P#
M 0 "$0,1 #\ *[JLF#+]B/.RYIB;O%61S2=R;"88.T#\AU3=M,/;)J.U'0C4
MB-_'7G 9VW3_ *5QE!39LUTCTK#E8&TM*AY"":6,/M "T?*_XI<D^_V8_$5C
MJI81/;+^GA1<1RR=':EPL8R&9$?!'&)46ELI$=X%540VGFHQMN JIZ454T2M
MS(>QW_8;-OZGY3_9^V_=-$K<(>QIWLWQ3**WN1XYFV.-W]?#9^U_G2YM/8Q8
MK7F8'E#3?FOOQFVF_,=<$1W5-R)$3Q77-VN+U.J)\EH9BSG[[9A[TY!];2]=
M+".7EA].UK\O?%/NLQ\JE:GOV8^O5&:.\#NT'"FK#BWC.R7[9NHL7*,BAEX8
MM'<;$CK:R2V>WVC>$]G'!W]B'=$V?7=GJE)U>#F]HT601];17MWYY5%/;6_D
M*'M)5M?,G^23W6K?GK%9=\M7?++IZMNKI7;T+IPH]%S"<R: W7<2R=MML"<<
M<<H;4 ; $4C,S*(@B BFZJO@B:)6X0]B,:T"4#A&:$*$.(900DB$)#06RB0J
MFZ*BI$V5%362MPA[!&>Q"1)XSQ?N$RS,*JUI:RDIL.NG5LH,FN.5'J(N>RI+
M,/VUI@7Y!;@ B.ZJXX ^DDW7Z:NJ0RFBLV#=RK([+,,FO\KN7$=M<CN+&ZGF
M/5T)*LI;LMT&1)54&&B=Z6Q]  B"G@FF)0DA;<N0E'\.;DA >S/B>:YLCZ?;
M>AZC5$\UM(-1?110O!3-KV-T!%?0#I;+XJBO188SS>4%4TH:+1\K_BER3[_9
MC\16.JEA$]LOZ<J?B7E7(:V+<T'&7(-Y43@-R%:T^&9'9ULP&W39,XLZ%6OQ
M9  \T0*H$J(0JGI1=$K=!#V.NZXJY0QJ [:Y%QOGM!5L;>?976'Y#50&=UV3
MS9DZN8CM[KZ-R31*>&9#646QP=W0<C<.7M>JW-KDF$^> 7&'V<]V7#.$:JCS
ME*4PGEIK%I#ZP)E0;<,41T3#PUS:BM].JV:^!*N4^)LMY=R?&N0,,L1D4=M2
M0K7'K=+UZM6OC6L'&W*89<9$,F:ZAD1Y%W&=B-R94F7*<87V=/+D@I-)0QC3
M>J/_T"NZK)BQJ.WS+A#DV-9,M.5&88#D+S,F'(0D!9$)UR'95LI 45>K[**3
MC+BBNSC#JJ)>*+K-++\-UJ_T8<XVY H>4<)H,XQUU#KKR$#Y1U<!R16S@_DY
M]5,\OP&972A)H_!$51ZD]5459FFG#'IRI)SK#1:/E?\ %+DGW^S'XBL=5+")
M[9?T-YVR9?B4#@3BZ'.RC'8<N/C##;\67=UD>0R?M,E>AUAZ2#K9[+Z%1%TB
MR?)Z#JM<5J7M]N\(_KEBO]H:C]\US#V-E;GJ5E_171/#3753;%'0"?&LLH<\
MF!<4D;)Y(KSJMH:@NREMOLNWHUAHM'G/WVS#WIR#ZVEZJ6$3/+" V_=:WQ?V
MW\7\>\?6#3O(MAA\5;.TCJQ(;PN"[+D$GF"XV\P=_/9W1IDDZHS1><:(I,H:
M^$V;>!G**I+)C#B'B/,><\V;QG'?6=<5;'(;Z>9.1:>M)\1EVLXR-'I;YNN[
M-M"JN/O$B;HG48]MJJEG"3LP^W$_%6*\.8;7X;B<90C1MY%A8OBVMC=VCHBD
MJULG0$4<D/**"(IZC+0BV"( HFI[-V<L>DDH1(,[^Y&9>ZN0_5$S0LH'ABQV
MJB<:&HOZ$IOHJO\ DC.I7EE)A;^(+R2N-\95. 07^BRS^S0YX@:HX&.8^Y'F
MRA7H)"#VRV<B F_JN-@Z.R^.W?FI<[''HX4 WN"^$;+F4.23@B__ /%X'97L
M$6 )PYV2JO504J"*HO5:C$DHB[+XM[;>.Z-M;C JJF2*<+<@/<7<I85G#9F,
M>ENF/G4 ]+U'.$ZZ\81.DT4W*J6\@>"])]*IXHFBRE- G#3&167FI++4B.X#
MS#[3;S+S1(;;K3HH;;C9BJB8&!(J*G@J+J8H%J.5_P 4N2??[,?B*QU4L(GM
ME_0Y7:%^7#B[Z*M?B2ZU/?LQU.J-$S&8DF)*CSVHS\!^,^S-8F-M.Q'HCK1!
M):E-/(3+D9QDB0Q-%%1547PUR="Q64)3CDN1#CRFM -[;)1JXNYK3I/D)6*:
M_I-871O^O52P3/+C PMVYU\^KX)XGAV2.#+'!Z)\@=14=:9F0PF1&'!55)LV
M(D@ 45V4>G9414V2>W9E%>J/_]$KNJR8+%W^<$K/AL\W8U#4IE>U%K,\88$B
M<D5P^7$I\@\M$7J*O]6+)+Q7R%9+9 :,M)\[?\L;Z5_Z*-[&.=$X_P X/CG(
M9GE8EG\QAN X^9(Q3Y@HA&@/IZ1;9O@$(;R[?\48Y*H@!JO7I65*R<TM#C^!
MJ]('"T?*_P"*7)/O]F/Q%8ZJ6$3VR_I)J#MZYKRFFK\@Q_CG(K6EM8Z2JZQB
M,,%'EQR(A1UHBD"2@I"J>*)Z-9RJM&PXM_P]C_*WW!_X495_-XW[SHYUW#C;
M8W]V'<4<C<;6W)+^=8C;8PU;5V,M5KEFVTV,QR))N3D@SY;KFZLC(!5WV_:3
M2_1II0QE$U,H%;G/WVS#WIR#ZVEZ:L(4\L_,9PK*\S*W'%J"RO%H*>;?W/L#
M"NC75%>VKLJ9(+<1$1$=A!%5QTO5 2+PT-I98)-X)3PYRM?\-9[49O0F3BQ2
M*)<5BN$W'NZ.23?SA5RMO!1=1L7&B5%\J0VVXB*H)K++DH-3AR,185F-!R!B
MM'F6,3$G4>006YT)[U$=;0E4'XDML#<%B= D@;+[74JM/-D*KNFIVFG#'IRI
M1QSO[D9E[JY#]43-"R@>&+':J)QH:B_H2F^BJ_Y(SJ5Y92 :[P>2/[Q^<LH=
MBOJ]2XB0X73;*JMJW1NOA:R VV!P95\]*,'$_;9\OQ5$1=/HHJA%W-F$:[&<
M5I\&X5BW-A,K8EYGME)R&8C\R.U+;JF"*MH8KHFX*HTL6.<MM-M]IB[K^A%^
MCFWX,HH0+#N*PF-@',^>8_7$P=.5R[<T912;.*E1?"-O#C1S:(@(*X9BQ5_W
MF%TVKFJ%64-H,%V9<C?W@\%XXS*D>=<X2IX7:(1)YBM5+;14;RIX$H'0OQ@4
MUWZW6C\55%TFZBPZCFJ H<K_ (I<D^_V8_$5CIZPA-LOZ2+'.X#F?$*2!CF-
M<B9#34=6VXU7UD-]@8T1MU]V2X#0DP9(AOO&2[JOB2ZQUJ]6@Y-89RR'N#YK
MRJHF4-_R7E5A46#:LSH!6"L,S&"\#CRO908-^,XB[&V2J!IX$BZ%6JU2!V;R
MR0]M&+\4Y=RA14_*MU,KJZ3,CM5-6,/_ +5D5LZZ+<.GM;EN8#]2Q*?(139@
MA?5>A76MT4BTI.#:I-J1A1IIMEMMEEL&F6@!IIIH!;;:;;%!!ML!1!  %$1$
M1$1$34P\_](KNJR8:-LZV!<UT^HM8C%A66D.376,&4VCL:9!F,G'E17VR]5Q
ME]APA)%]*+J0I%Y^X7ANRX.Y+M,87VEVBDE\\8?;.>F=12736.!O"J(MA5/"
M4:1X JN->8@H#@;TU?)23V7%A=NT3G0>9>.&HMS*1W.L,"+49*CA)Y]G'5LA
MJ<CV01%?G-E@P?V]$IEQ=A$PW3>O%_@ZEI7Z!3Y7_%+DGW^S'XBL=/6$)ME_
M0YW:_;U+';_Q6R_:5S+K>+L"XT[-C-N 7M4I=C W4(5_UIJ>R_TQU>J+Y^?:
M3_S-5_[")_SM9#V.CL:N*E]P&6+2N>=<7I;::FQG'#+_ &0 '5(E_4B:R& L
M]G/WVS#WIR#ZVEZJ6$3/+#H=GN(8YC? V$SZ:JC0Y^5U@W>13A%3EVU@X_):
M%R6^XI&;49@4;::14;;'?I%%(E)%VW9CZ+_*!E]XO;^7#^<ED6/0U;X^S25(
ME5 LM[1Z"X+=^QQPNA$!EA%4GX2;#O&56TZE8,E;2W):Y%WK#E8)-V5=Q*\9
MY0/'>5S4#!,QL&QBRY+JBSC&2R$"/'FJ9;@U5VZBVQ*ZND&C1MY2 0=Z\O65
M*R%+0X> PV=_<C,O=7(?JB9I*RAKPQ8[51.,4\M\B#Q7P5>YH+HMV%=B<.+1
M[[*IW]K&C5E+LVHGYHLV$H'3'9?Y)LE79$54F2FT%%G";%[Z.CO,MNX-%0U\
MR[OKB5Y$&!$ I$R;*<0G"045=R+I$B(B79$12541%75&/A/DN3_*WW!_X495
M_-XW[SK.==S>-MB*9CPEROQ_4)?9G@E]CU.LMF#\XSV&QC)+D Z;#)&TZXH$
MZ+);*J(FZ;;[JFA63PP=6LHU%_#^Y'^S'*UA@LMQ!K>1*M6HZ$I(@9!CK4RR
MKUW\0 9%:Y-:7?93<)M-]T1%Y]%*G8Z\W#@R5RO^*7)/O]F/Q%8Z[6$<VR_H
M<KM"_+AQ=]%6OQ)=:GOV8ZG5%OY[@&*\E8U98KEU3%M*RQBR(Z$\PPY+KWGV
MU +"KD.MN'!L8I[&TZ&Q"8IZ4\-8FTY1K2:ABT]E!D4]I/K7RZ9=7/E07B;)
M/5D09#C#A 0$J>#C2[*BK^I=4DXRGQC>R\HXVX]R:>O5/R+!\3O9I?Z9=O0P
M+"2OALGB](+4ST;10M4F?__3*[JLF&F]2%)COO0PG \WXT2-D&4XCBN:5"3[
MK )&39!3T#MJ_#:8^>J*(Y:2(YR6+.,;0$+:](2DC&:H*>/=&T\:'%TFLZ@I
M^VK+N0<&Y0J\DP'&LHS#V(.C*\<Q:HL+F59XI(?89LFWHM?'D$VK9F#D=UQ$
M!N4+>Z[;HKK)-0V*JVG*16W)<D)O(_($QMN0TW+S;*I+;4R+(A2VP?O9[H-R
MH4MMF5$D )[&TZ N-DBB2(J*FM6$#RR$ZTP^T 7[VM_F#XH]ZH_R:3KF_5FU
M[(JS.DVS?,47;=,JR%/!45/"WF>A4545/UIK5A&/+#Y]K7Y>^*?=9CY5*U/?
MLQ]>J)#SGCG'V7<:WV.<E7E)C6/6H-QX]_>65?4L5%YZSE//BS;*1%C#.CR@
MZA;ZT\X$-M=P(D4JVG*1MH:U%UKVI.ANK2E.=5V95<^5!6RI+"-;4\](SQ-#
M,K+*(;D>;!DB*&VX*^(JFZ(NZ)03AHNWO/N1<DX)RW%^3L1S*CO<4PNT9JLB
MR3&[NKB97CCM+,&N?;LK"#'C2[2N;$6G=C4WV5:>W,E>(4V25DTQU6^+30$C
M3Q(4KO\ LAR0L0XNQ2'378XHU$AY!>9 E9/^S[MT]!=KL?I_GA&$KOG)B*S/
M?.,KBN*#C9]*(B*JO.);_HSTG1?PJ?\ A]4./3>7K"_N;:FC6='0R(V*T\VR
M@1K:UN;AN0$N33US[PS;$*O'X4SVA6 +R1?$C44].^D\3//(:G2!Q1G<I08[
MD_"6?4F2VU/1QI=.3E79WEG7T\%C)(3K<_'&BL;-^-%CE,N(K3*[F*F#A"G[
M6VNJRK*#FT-.1?\ PB?D55F6*VF)19D[**W(*B?C\*!$>GS)EO#GL2($6/!C
MMO/37)$EL0\H0)7-^G9=]M4.(<X$+*@[<^GN6N=YK:.P9=8[99;D<]RMGM&Q
M.KW)EQ,D'!FL.@VZS+B$YY;@$(D)BJ*B+X:%A \L.YVA?EPXN^BK7XDNM3W[
M,?3JC26N3H6VYOKXM7S#R?"@S8EA"#.LF=B2X,B-*CN1I=M*EL@+T-QV.KK#
M;Z-N"*HH."0J@DBBE-<(GMEAS.URTE6W '%KLR#8U\B)BL"K\FRA383CL6L!
@8==.B^VM-K+KK&L:9D1WFE-EQIQ.@O#9$7[,=7JC_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g910899g42a53.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g910899g42a53.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X1#R17AI9@  34T *@    @ ! $[  (
M   -   (2H=I  0    !   (6)R=  $    :   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $5U;FEC92!6
M:7)A>0    60 P "    %   $*:0!  "    %   $+J2D0 "     S P  "2
MD@ "     S P  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*BHJ*BK_P  1" -\ K<# 2(  A$! Q$!_\0 'P   04! 0$! 0$
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M?UMI_7?7J5LV_P"M-_Z[''^#H]3OOBI>ZEJUQ+#<OHMG--9M%'B-GWYCSMW
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M1-]DBPN^XP$QGD#GY1UQUJ[:>*_$VJ:AINFV.O$V=SJ\UI#JZVD1-W L&_<
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M#/((!/T%-AU?3;B 36^H6LL32&(2).K*7'5<@]?;K4V]WE_K9+\]?F.ZO?\
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M0E?E(&0,YX'K7844=;ATL</8>%]<TT6TD,&F7$BQ7L<B3W4K;?/G$BX<H6?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH W**R]3U:\L+E8K7P_J.I(4#&:UDME53D_*?-E0YXSTQR.>N*?_  D>J?\
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M0!T%%9>F:M>7]RT5UX?U'34"%A-=26S*QR/E'E2N<\YZ8X//3-/_ (2/5/\
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MU:'_ . )_P */[%^+/\ T-6A_P#@"?\ "O1J* /.?[%^+/\ T-6A_P#@"?\
M"C^Q?BS_ -#5H?\ X G_  KT:B@#SG^Q?BS_ -#5H?\ X G_  H_L7XL_P#0
MU:'_ . )_P *]&HH \Y_L7XL_P#0U:'_ . )_P */[%^+/\ T-6A_P#@"?\
M"O1J* /.?[%^+/\ T-6A_P#@"?\ "C^Q?BS_ -#5H?\ X G_  KT:B@#SG^Q
M?BS_ -#5H?\ X G_  H_L7XL_P#0U:'_ . )_P *]&HH \Y_L7XL_P#0U:'_
M . )_P */[%^+/\ T-6A_P#@"?\ "O1J* /.?[%^+/\ T-6A_P#@"?\ "C^Q
M?BS_ -#5H?\ X G_  KT:B@#SG^Q?BS_ -#5H?\ X G_  H_L7XL_P#0U:'_
M . )_P *]&HH \Y_L7XL_P#0U:'_ . )_P */[%^+/\ T-6A_P#@"?\ "O1J
M* /.?[%^+/\ T-6A_P#@"?\ "C^Q?BS_ -#5H?\ X G_  KT:B@#SG^Q?BS_
M -#5H?\ X G_  H_L7XL_P#0U:'_ . )_P *]&HH \Y_L7XL_P#0U:'_ . )
M_P */[%^+/\ T-6A_P#@"?\ "O1J* /.?[%^+/\ T-6A_P#@"?\ "C^Q?BS_
M -#5H?\ X G_  KT:B@#SG^Q?BS_ -#5H?\ X G_  H_L7XL_P#0U:'_ . )
M_P *]&HH \Y_L7XL_P#0U:'_ . )_P */[%^+/\ T-6A_P#@"?\ "O1J* /.
M?[%^+/\ T-6A_P#@"?\ "C^Q?BS_ -#5H?\ X G_  KT:B@#SG^Q?BS_ -#5
MH?\ X G_  H_L7XL_P#0U:'_ . )_P *]&HH \Y_L7XL_P#0U:'_ . )_P *
M/[%^+/\ T-6A_P#@"?\ "O1J* /.?[%^+/\ T-6A_P#@"?\ "C^Q?BS_ -#5
MH?\ X G_  KT:B@#SG^Q?BS_ -#5H?\ X G_  H_L7XL_P#0U:'_ . )_P *
M]&HH \Y_L7XL_P#0U:'_ . )_P */[%^+/\ T-6A_P#@"?\ "O1J* /.?[%^
M+/\ T-6A_P#@"?\ "C^Q?BS_ -#5H?\ X G_  KT:B@#SG^Q?BS_ -#5H?\
MX G_  H_L7XL_P#0U:'_ . )_P *]&HH \Y_L7XL_P#0U:'_ . )_P */[%^
M+/\ T-6A_P#@"?\ "O1J* /.?[%^+/\ T-6A_P#@"?\ "C^Q?BS_ -#5H?\
MX G_  KT:B@#SG^Q?BS_ -#5H?\ X G_  H_L7XL_P#0U:'_ . )_P *]&HH
M \Y_L7XL_P#0U:'_ . )_P */[%^+/\ T-6A_P#@"?\ "O1J* /.?[%^+/\
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M,:E8ZOX9L;[2IY[BTEC_ '<EP29#@X(8GG<""#]*U:;5G8E:H****0PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** /.=%_Y.&\2?]@FW_F*]&KSG1?\ DX;Q)_V";?\ F*]&H **** "
MBBB@#S3X(_\ (%\4?]C+=_\ H,=>EUYI\$?^0+XH_P"QEN__ $&.O2Z "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLMH/)ABL_+DC^8_>DWG?_P!\BN0OKO19;7XAZ1=QI=ZO<ZG(;&TBC\R<R&-
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MO\_.W=TSCG'6CJOZZ7_X!*^%OT_-?YFO_P )EH/]@C6OMW_$O-Q]F\[R9/\
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M[9:S8:C?W]E9S^9<:?(L5RFQAY;,H8#)&#P0>,U6O_%6C:7X@L=$O[T0ZAJ
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MYY]*UQJ4]G\0/$.H_P#"/ZS>0:IIMJMJBZ=(!*P5\HQ8!4/S#(8C%#VT\_\
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MJ%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M><Z+_P G#>)/^P3;_P Q7HU><Z+_ ,G#>)/^P3;_ ,Q7HU !1110 4444 >:
M?!'_ ) OBC_L9;O_ -!CKTNO-/@C_P @7Q1_V,MW_P"@QUZ70 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% 'G.B_\ )PWB3_L$V_\ ,5Z-7G.B_P#)PWB3_L$V_P#,5Z-0
M 4444 %%%% 'FGP1_P"0+XH_[&6[_P#08Z]+KS3X(_\ (%\4?]C+=_\ H,=>
MET 4-<,Z:'=RVMS);2PPO(LD:J3D*3T8$8_"N=77=5TW4)!,?[0LXM/M;F9Y
MI$C=&DDD5BH6/YN .#@?+UYKKIX8[FWD@F7='*I1USC((P15"ZTK31'(T]L[
M":**U<)O8E%8[!A>0 7))].2<"A;L;VM_73_ ()2T7Q2FL7[P)#$J&-Y(GCN
M!(VU7VGS% &PG((&3QGIBJLGC&8V&FS6NF++-J%O!,D;W.Q5,KJF"VT\#=G.
M.W2M'2TTBWO6CTR63?<+)((O.D:,!9,.54DJOSG' %5GT+P]I5Y:EH)EFFD2
M*W3S9I0I0^8JJN2$4$9Z!1CTH72_];_U\B7L[;]"AJ/BW46T>_\ [-TZ-;VU
MMKB28M<_+$8V9 4)0[R2I(!"CCG&:0^/"J2^19PW)1GB0+= .TB,$;>NWY 2
M6P><XZ#(K2U?0O#YMMFIPND=R\D9\N:5/,,A+NI*')4D$X/%36NB:/=6XNK5
M)FM[M1*$%Q*(VSM8-Y>[:"2H.< ]?4Y%L5*W3^D9TOBB[CE>&_M([*6&YBC:
M..Y+.RLZKN :( H<GD'/;Y3TB/C+4@MO_P 22'-Y%!+:C[<>1+($ ?\ =_*0
M&!.-WH,UN2>'M-FO?M<\4LT^X,K2W$CA"'#_ "@MA1N .!@' '05F:5X,@LK
MTW-Y*D[*L:PQQ"5(X@C[Q@-(^ &QA00H QBG'I?O^!,KZV^1!/XY%N LEG"L
MT?FFXC:[ ($<GED1_+F1C@D#"].<9J>PU_4-1\0:>OV9+?3KJWN)(R)=[2;'
M0*6&T;>"3@$]>>E:;>'M-:99EBFBD5W??#<R1DEVWL"589!;G!X]J+;P]IEG
MJ8O[>!UN%5U0F=RJ!V#.%0MM7) )P!TI+I<?5V.=@\9WEA8&35[6)A))<+;3
M?: N_9<")0XV@(/G7G+< D\U8_X3:0+<RFPA:"SMY)[F6.[W+A20!&=F'S@<
MDJ!D^E:*:7H6HM-9) S_ &-GC?!D4(TA$C8?C+9VMD'*\8Q5M="T\1RQO%),
M)H6@D-Q/)*60DDJ2[$XR3].@XH_K_(-+>9SB>+=5NM;2"QLK6816UP\\:7H,
M3E?)9627R\D_O"N, 9SGH*TM'\6IK.H1VD-J4D8/))F3/EQ;49&/'5A(O';Y
MN3BG1>'M#U)1*ANYS;M-;B1[ZXW#)"R)DODKE!QTXSWJ6UL++3-=U&^=D:ZF
MMXU\J"W.Y((]P48&2QRS=/88XIZ"?]?U_6IG/XSE^U26EK:V%Y<B:.-!;ZCO
M3YY&3YVV?(1MR1@]QVILGC.\0WO_ !)XR-.@>:\_TS[H5V4A/D^?A"PSM]#B
MIF\'Z)>(!8-+&(9HT?%S*VP1-N$:9?\ =X)_AQBC_A&=$.L.3YLBK$EL]LCR
MGDNTA,I#?.&W9._(]3S2CTO_ %V*=KNWE_P2&_\ &$T6G277V(Q6LS3Q6T\=
MP/,9X@V25*$*#L?!^;H,CGB/4?&.I1:3J$\&G01&,7J6LC7);<UN6&679P#M
M8XR>@'?-;;^%M'EDF:2U9A-OW(9I-@+_ 'RJ[MJD]RH!.3ZFIGT#3);<P26H
M:(M,Q4NV"9L^9W[[C],\8IZ6".CU[HKV.M7,^MOIUW:PVS+$'5C.Q:;Y5)*#
M8 R@M@G=D8Y R*PSXODMM.TZYN7N"!-<F[/V4J)(XXYFP&*A<_(O0\X^M=#8
MZ7IGVS[7;///+;EH09;N641G 5@ [$ \8R!GKZFI3HFG-;P0-;*T5NSM&C,2
M 7#*V<GG(=A@^M(4=-S&F\83Z?>K;:OIJ6Y:,2EX;GS%52DC 'Y!SF)E].5P
M3G BL_&[WVCQ7JVEG:$H@F6^OQ$D4Q9U:'?L.Y@4QTYR*TW\*Z(+.2*:U:2(
MM%(S37$DC?NCN0;F8D*IYVYQR>.320>&]"GL=]G 4AN9WOA);SR1LTDBG<X9
M6!&0QX!QS0]G;^OZU^[U#^OZ_KJ9ECXVN=3,36.E1&.XEBA@:6[*EG>!9SD!
M#@!">><D#CGA;?7-17P_8:G?2K$%U.2"\0!6'EF62)1NP/NL8^>"0.>M:L?A
MK1K+3#;0VS0V\920%)I R&-%12&#;@0J <'GG.<G,%CI_AW5_#-QHUI']HTM
MAMFB=I,GS )>68[LD2!LY[^U4[._+Y#TT,?PGXBU?5[ZXT^_G7[5:ZB[RXC4
M?Z*T8DC7&/\ IHBYZG::N>--9NM): VUW<6RFUN)3Y$*R;G39MW;E(5?F.3P
M/4BM.XL-%TJ[N=2>%H;G45CM998?,,D@ (10$Y! )Y&#WSQ3]3_L>/>^ID-]
MFM'W[RS$0O@-D#KG:/4\5+UV_K3^F"=G=F;<^)[R*&5S9(L"RM:?:5FRPF"9
MR(]N-F[C.[/MBJUKXIOQ;Z?'J=F(;B:*&;=#<*XD5U;.[*#!RO('J,-UK93P
MMI"2B06SD@<*UQ(5SLV;MI;!?;QNQN]Z2U\*Z/9QHD-L^(]@0R7$DA4("%4%
MF)"@,V%Z<]*3O9_+_@B7^9#H?B*YU.(_;;"*SD:RBO4"W/F+LDW8#-M7!&WG
M@CGK5&V\97%[)#;V%G87=Q)<>26@U'? !Y)EW"01Y/3&-M:]GIVD7FG![6$2
M6L]HMI\Q;#0KD!<'ZGGK2V?AS3+&X%Q!%*TPD\WS)KF25MVS9G+L?X>,=*IV
MN["ULOZ_K4P6\7WVHVEO<:99K#;_ &NSAN)7F!=3*8V90FT@C;(!G(/)P.*<
M?$]WIOB/Q NHR>;8P ?8HU0 JZPQLT>>Y8RC&?0UKCPGHP: K:NHMVC9$6XD
M"[H_N$J&PQ'')!Z#TJ>X\/Z7=S>;<VBR/]K2\RS-Q,BA5?KV"@8Z<4:?U\O^
M"5I<YS3?%=]I^AV)UV>QN;N2:6*<M<B&5BMP8\QQ!3N !'<=!U)IP\7Z@^J:
M.'LXXQJ<5P+>U6?=YK*T>UF<H-F%,AP,\>IP*TH-"\/:NKS6\,S(D[*Y66:)
M9'65G.>0' D+$=1DG%67T71+B1+!H5:2TM\)&)'#11R,#D'.02T0(/4%>"*.
MMP,CQMXGET.:UCM+R&V:%&OKI9-O[V",@-&,_P 3;C@CGY#6_J\URWAVZN-'
MD'VG[.TENV 0Q R.N>#T_&ITT^U2ZGN1%F:XC6*5V8MN1<X'/;YF_.H-%M]/
MATN'^R3(;0QJL0>1V 51M  <\<#\>M+I;^OZV#K?^OZW.2?Q;?W.M7,5G=*+
M74K-1I3"-3LE#HCMG'S<S*<'(PA]ZFB\6WT%W.QC-Q;I&@)N) BP?OKE6D=T
MC)"_ND'W<#C)ZD[+^'_#NB6-C.UDD$&CL\EJ5WL86DR&P!DL3N/'/7CM4-UI
M_ANWN;6UN#-:S:KNBA1+B>(S8\R0J=K#'^LD.#CK[##NK60EUO\ UL5[[QK+
M96$VH?V:DMDCW$,<B77S/)$CD@KLP%)C<!LD]#CGC9TG4[B^FN;>^M([6XM]
MA98IC*I#KD<E5YZCIVJG!X>\/:E!))!;&2!C+"8Q+(L:MS%)M3("MPR[@ >3
MSSS,(]-EFM=8@NY84ED495V5;@X,:*P/4#<<#UP>PHTV!_YE'6?&(T>\NX&B
ML[@PP2R)'%>YFRD1DP\>WY 0",Y/;CGAP\3:@U\--&E0?VB<-L^V'R@FS=G?
MY><YXQM]\U=N?"FCWEQ+-<6\CM*) Z?:90G[Q=CD(&V@E<C(&>3WJ#6[?0K:
M5)M3BNEEG=$66V6?=NY10&BY7.XC&1G-3TMU I0>*I[;POHES=+!)?:A!O;[
M3<+ @(3<V6"D9S@  <Y]*2?QW#;RQ;H+>19X@\445V#<*QC#JLD14;,Y(SN/
M;UXTK32]%O\ 2+:ULHYDMM/)A@\N66&2$J-I7=D/T..M.E\):-/.99[:24G?
ME7N963+KM8["VW)'?&>IZG-4]V#\C-O_ !!K6F:C,]U86K6]O8?:9XH[LG8
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M:=I4#:<J6YGL]B,DKA)59BA=0Q!:,DD\X!Y(K9T_6=7O$@66:PMWO+-;Z)S
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M;T-*UBWD;RK2!V(^3S"NX'J2.2/3&-/IFL+9SSQSZV;C[)J$X47,Y'G++^X
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M$=L9C&3;@.K_ "C9@\HOW@W"@=,YR+:*_N-:T>748]6>^6_\R3*R_9TB^SL
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M_E?]16TM\CT^BBBD!YSHO_)PWB3_ +!-O_,5Z-7G.B_\G#>)/^P3;_S%>C4
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MK%N8.KL'SYFT#$;@Y.01TY%/&N6<TEA?-I4^V;$45XZ1?N6<E?+/S;P=P .
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M@CL9]C1KY6^-/)60LV9,,.>-I)Z<=:L1^$[%8[D237,LEU&4FE=UW,Q<OOX
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M(\K*[* FT^FX CD'GBNAM/&5G=*TC1M%#;Q#[8Q)9K><MM$&U02SYR,#G[N
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MRJRQX*F5]X_B_A('U]JZ6BCI8=WL<DW@EWG,[7L)DF5DNP8YREPI(QD>?DG
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M2W4IPYP3YASU)K<MO VJIX!&C2R6,=V=7%^WE._E*GVH3%0=H.=O'3K3TO\
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M;BZ,.V7!QP$D9AT/4"N9\&>!]9\/ZY8W&H?V7]GT_27TV-[:1S)/^]#J[@H
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M9 HQ('9(N#P7)W$< 5B0^(?$,/B74#IUW+=36[ZP\-K<RN\3F*2'8I4,.@+
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M_@?<>5VWCOQ#IXT8W%Y!>S7^CV1#R1%88Y9Y]GFN V3A2 <$ GIMSQHMX_\
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MHTO_ %WO^6@=_P"NEOSU,/2?%\M[X!O-;OGL[.:T>>%IB&:W9HW*!P!\Q4D
MX!)[9-<Q9_$3Q%J6I1Z58_V:+@7EQ ]U<:?<1*RI LH/DNX=3DX()]Q7I?\
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MO5%"=K>7_!_S_(#Q6]\!^))?->RT2*WTB2^FEBT.013>0&B1%D"">.,'<'8
M2?*6S@FKD_P[UB:QUJ>ZM&O=4ECTZ*VN9)D5I1&L7G$C>0#E.<GG'&>*]>HH
M3M^'X!O_ %\SS#PAI1G^)VKFWGBN-%T>XFFM#$VY4N;@+YJ$CC*%7X[>946N
M>#]:NK[Q"5T?[9=7MW'-!J/GQKOM%\LM:9+;TSM88 VG/)KU2BEM;R5OZ_K;
M0?5OO_7]>9X^?A[J5]> S:$EOI#7-W+!I<DL16T5K8(@*JQ4;I 6PI(!YXJ)
M? 'B6VT6>WLK"-/.L]-:ZMY)$=;N6,M]H5@)%#$_+G+*&'&ZO9:*/^!^ O\
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MP)!%>MZ<TBF>V.G?8;:U816V&0K*@48*JOW0.F#CIZ5=HHN*P4444AA1110
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M'RCGYN1UK,3P'XPV:,L]N/\ 1[.&&.7$<TFGNDS,64F= N5V@E0Y(&,>HM;
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MLQ\Q((.0-N0=^ :]%\%6FH:3HUA;7E@YEODDOK^Z\Q0([B1MY0J3N/WB 0,
M+S1_7]?C^'<'I_7]>7](ZJBBBD 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YSHO_ "<-XD_[
M!-O_ #%>C5YSHO\ R<-XD_[!-O\ S%>C4 %%%% !1110!YI\$?\ D"^*/^QE
MN_\ T&.O2Z\T^"/_ "!?%'_8RW?_ *#'7I= !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/7/^_-C_ /(U=!10!S__  CFJ?\ 0YZY_P!^;'_Y&H_X1S5/^ASUS_OS8_\
MR-7044 <_P#\(YJG_0YZY_WYL?\ Y&H_X1S5/^ASUS_OS8__ "-7044 <_\
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M^;'_ .1J/^$<U3_H<]<_[\V/_P C5T%% '/_ /".:I_T.>N?]^;'_P"1J/\
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M #ZZY_X(+[_XS0!T%%<__P )II?_ #ZZY_X(+[_XS1_PFFE_\^NN?^""^_\
MC- '045S_P#PFFE_\^NN?^""^_\ C-'_  FFE_\ /KKG_@@OO_C- '045S__
M  FFE_\ /KKG_@@OO_C-'_"::7_SZZY_X(+[_P",T =!17/_ /"::7_SZZY_
MX(+[_P",T?\ "::7_P ^NN?^""^_^,T =!17/_\ "::7_P ^NN?^""^_^,T?
M\)II?_/KKG_@@OO_ (S0!T%%<_\ \)II?_/KKG_@@OO_ (S1_P )II?_ #ZZ
MY_X(+[_XS0!T%%<__P )II?_ #ZZY_X(+[_XS1_PFFE_\^NN?^""^_\ C- '
M045S_P#PFFE_\^NN?^""^_\ C-'_  FFE_\ /KKG_@@OO_C- '045S__  FF
ME_\ /KKG_@@OO_C-'_"::7_SZZY_X(+[_P",T =!17/_ /"::7_SZZY_X(+[
M_P",T?\ "::7_P ^NN?^""^_^,T =!17/_\ "::7_P ^NN?^""^_^,T?\)II
M?_/KKG_@@OO_ (S0!T%%<_\ \)II?_/KKG_@@OO_ (S1_P )II?_ #ZZY_X(
M+[_XS0!T%%<__P )II?_ #ZZY_X(+[_XS1_PFFE_\^NN?^""^_\ C- '045S
M_P#PFFE_\^NN?^""^_\ C-'_  FFE_\ /KKG_@@OO_C- '045S__  FFE_\
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M_@@OO_C-'_"::7_SZZY_X(+[_P",T =!17/_ /"::7_SZZY_X(+[_P",T?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#4[.W9+R[T^T>/8S7!A95DR(6*(&<X;$K<DGH..M(#<^Q^,?^@[H?_@EF_\
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M*N["A@3P /7K5BX\#>'+N%HKG35D1K*.P(:5_P#4H=R*/FX(/(;[WO272_\
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M>:?\+<U'_HF_B[_P ;_"C_A;FH_]$W\7?^ #?X4 >ET5YI_PMS4?^B;^+O\
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MH_\ 1-_%W_@ W^% 'I=%>:?\+<U'_HF_B[_P ;_"C_A;FH_]$W\7?^ #?X4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
EBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g910899g64s91.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g910899g64s91.jpg
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M=9BR(S1!<[2U,E%A)#9"8H&Q&3-2<9,E4U15A/_$ !@! 0 # 0
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M[3J])^OT]'C?)C^K_P#MBR4IM*]R*-R3=QF>02, 8 P!@# & , 8 P!@# &
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M(C1(O(V=W<R='BE)Q>MK5#8A5IVLCK' Z5;F:C2!#UQB/T HT0+?1^78K/\
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M6"Z$T94D8!'$^MNOJP7P9LF[\-G7V1+FJ"PU,4S/SR-TDKTK3-[<F4B8FMS
MR-YSBN;VXQ_?A-D?2.+FU(%CH0L=&\E2'8^,'M^"6.\2QFAJQ_=A0IW=H^]O
M9D'G#5##GN/O3A&Y$U1V?/,<;X1,5T<D+2Z,,B3Q"0/@V)Y;5[6ZZ2+D:D@H
M2U(@PCGEQ?6-/VP@F\J<RSM1]2TM;53-W.DIE+'*XY,I=&)I!X8WUTIEL]KJ
M0QBNYV^LME0QD?8$YMT1D!Z*1G:;5.@!)_)<[L&9[ ^5%#V?-4T!@<ZW)'MQ
M:5[RR.**+S(N$2A(TMT9=W@B'66KCR>NIB[,C;,8\L>F*+REW>V@I8HTXMZ8
M;2\ ;PE\T\*F+[YK\;MGOR0J:2!6N8W)$U)VY!5=N.#G-5;A+7B#$#J9M104
M]=<Z N4L#PVKG:IB)HU-9:$;HYK4C.:G<#0S7=TLQNWG91'F%QWGDFA<2B,\
M5O3I8!34&,*R(-89$:.>'J%.5CML,>)FLB:>(1:R#X*SN,I,K&5/C+821H3A
M4+8RG\H2A/"7SYHVT,QY%>8VT/RBY_T!R8:K%=2L5'@^A-&02, 8 P!@# &
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MROU4/GQ=!\SR_L7W+HR\%7AW1>/G*:C & , 8 P!@# & , 8 P!@# & , 8
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MG,W#Y%>8VT/RBY_T!R8:K%=2L5'@^A-&02, 8 P!@# & , 8 P!@# & , 8
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M@# & , 8 P!@# & , 8!\5*DA&G/5JC0$)DI)JA0>8+02R220",--&+?X!
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MI.WLW9'C1]?H&,6@AUKGRL*ACDE)25[ZFD+;5M_@VUS,L, 8 P!@# & , 8
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M9?FYBEDF(9I-,RI*YSD2YX:%;HL0E$JY\Y:G#J4RDM WM_0I@O1S@S'NK2Y
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MCU86IVS_ &<-PAB0IOJ I)!XVK'L6XB@>Z,>'ZM90A3O&G5T2NL:=#VE(2Z
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M$@!/"E:@5"6-:Q,9'R # HT43;2E).'.4W;HLEHK_P (<,LZV<HLVE?=;_\
MS2VM3#95R'=XG)K&87.#H42>)FMI445/#Y*F91-TJS=?%.LL(&JK<4;)@4..
MFZPV;OT>E,O=(RW1I>O6QWJF[*3'')Q4LI6>BUZ)*;;V*\E0)I.=9SL5E9)_
MY3FY6)I)SJ2O4MBD6E#"Y42G;4X@/\NCBG3*\ZD3&H5Q"4N\7/<&-^TA;-.S
M,Z":?M-M6;;TA@DBLHLX@!Y9@=6A><IJ]K98VIIZ5M*Q*3EL3M4G:DZ3=]YZ
MZ:N\V==_D6(_#[?G#%5XOJ;0T6"Z&=9!)$+B^(FFY$*540\&FN\$1HD@FR//
M[TG).'*3@:&Z+&9L7I&1)H1P-B<'H]O0 !HTP:D)9!PB[RG Z617I:-$Z[BO
MU_CW,ZF;C(VB'RMVAT>*ETN:XT^N,6BA[JG8B)/(T36J4L<>.>U8#4K,4].9
M25M,=5)9B=N I$K. ,LD0=T+%9;MR\N>&\9Y);!C_&IC/*MLA^;+DC#[QFN*
M"*8.F/1,%C:K^<-@9TK+IEE@-=2U,X./(N3NLYKI; 4<<L(AMDQ4B$:H%I)M
M:)J^=M]-+5*SLF3)3O*.P9Q;I,?DS-$ 5_-F3F2^P5+'&Q])FL6(X<<BX10#
MJEESFND#BU2Y=97Z;$2Y$0SQR%;@2AM41%9N9&J"Y"2(:LX<U/ESV&O<%YN<
MC;"D]55@V-U&,TYO:E*6Y)PV5N$=F[A"(- K@KOD/-0UU)6@BPT#E.)?'W.C
M&]D#/VN1P9F>6:7.DK+K] .&;CDE$M)7U:Q:EIE96>G&TW2);8ISFX9LB>:-
M\@B</Y5<>XP[2!J8W4M))HRT6S!6Q[4M[:\J&XXDIW9BGKR8A<>U&%;4IM&F
MH! $(C!%'@^AIEX/1/Q69[+L@ZA^57*NZ7^R%MB/[[&;^62?<:D[M#$/'PV8
M6[%"'ZIX 0\^/C%I45ICG#:XK6*80V<M3U%MO;0L&\$B8IV325BH]%LD[7;8
M[*K20'X43T@XMZHH]\7SS-8*/'LC".JP[LN'XW^CS1/J=K3X,9<I'[XONBZL
MTAHL%T-6^6,:Y.D6BPS&LZ+A'+VE7NJG6O)IQSGMKLM9-#-. S)JE3%:.F^9
M0^7P6;D*V]%N..0'8A-(X@6WHUL3*<RWZ1(MU+*6ERVRGNV:<=-$;#<3H%9U
M7\<*>@%S/;9(+.B\,0-TN6LKBX/+,C7Z,//(CS0^.Z1 [/[7$V\Y'%F^0.J%
M$Y/R1G)=UZ1,K6G$@!VMRL1L-@@IKXY+K1JKD?<CY8S192)NMR6V!#H64]12
MPB1L\\D_(J<.D 99.].X#XMR!*.KEU-EL0L*IDK;&>/W'Z K*\F@'D3:DF;N
M+.B5FC?9RP=6YR1 <&K2TDIE:K;&JOE YT235-&,G(^"EMMM.,TE/+YGJ#D\
MCM:>[86]8.4S=N7S"04RWN5I1$#M7#Y8::"SY _&H:_<)C'WSY\_U+DYREIE
M16.4K;-$]M4R1N-!%ZTD^53,>3+=<([CB267L/*&PE2>8R*$62U3E'5D)H"(
MPMP*/50R>R97-'&,H&)DA(5[W&) TV@I>"659.U1\Q!R<Y4G8EHK.=B=*V2H
MJ(Q9NKFY2YC6[G,*^Y KJY:WU41X0)I^Q;2>]7!+3)=;!\*?8''&O:YUM.(L
M4F611_?C*F;GMCW4:V'0I<2K:8BIB$=$<+;%2RU5NT[YWLS3C96O(QGL2EM6
M9&[M!9K+9M;N[3,)&MF#Q&(UP]2\1!Q]XK6P)EMS7PETF26\3) FE4/=7)WG
MK[8;C$;*-)>F=@2RQB!RT2VJ]S=J\W6632=J_(KS&VA^47/^@.3#58KJ4BH\
M'T)HR"1@# & , 8 P!@# & , 8 P!@# & , U\L9>KG,I;:P9#A!2E&EKY2L
M*_6"043U#=$"W_P[TD+$ W98M[ :X'HB=[ 82/+PV)Q/!?/EDRC;;S4\?G+1
M<3NW-Z1J0I&U 2%.C0IRDR8D/[ %$@T &M[W^(A;UKI&,6]B&/8ABWL0M[W2
MI>AS, 8!J[S2]&*V/X6R?%C!FF2_DAW_ -65C]KW=4><G.PQ& , 8!8CX,_S
MZROU4/GQ=!\QR_L7W+HR\%7AW1>/G*:C & , J-\*1_>*0_R;&_K@V=&0^O\
M?_1GE-&_L5,YT&8P!@# +R?!_1QBD7'(Y.]M2)R+U/I-H&U)(1'%=*)DZ=D*
M ]50G%OIW^N0:6+\=_C^.<N5;64<G*Q&D"3A<UI\&RRRF%#0H&XU]*'*.*][
MZWD2@\TY";O7_"4,XK^V\3K_ .A80Y=;?[?\.BF?.R))_*XX2)S)4;3^7'&U
M8%CPO?BYW%=NS<7T:$_,N@:UH&OVG'[(T-#TB_'J%'%M(M_CO>NC7XLV%^UR
M=S^3ZC.:]RGM7R70D>.65#91XLMN>"25AG1K3<X]"%=U]_L+++.%HI2/_GI&
M<H#_ .;\-]$.%JO$LHDZ<#.\J2>;WF)Z2]M_F!+_ +&U9V9+^.'?_9F,?N>[
MHBO9UX\5W(E$E428R:2$<D<$BO6W*QI]LUB0(W)I?P1V.*2)(2K9XX=)FA-(
M5C.D/+1K%9:)$I*-9F5A;6N7DX7.<[;FU9;9=*;8SXDDE)2N2ML:F[+7)RG=
MMFWD2BGX:K?&:2J#YL8^,$4>X4UN'WF6, XB/R,*#3T28$N4A+5N"\UI:%AK
MXK >^!<6AI<2G$M<VHU!,YJLMBL4JO9.M\D1G-*5DFYT3M5*KE2UK2SZJJDB
M"QX.?U)TP.>!-JMK0KC+"GAAC$F</LW[0,C@#)&(J/K5^FE"!8O:2TBU00!0
ME,/VE<'$A6S5-.V:VOC6N%XSG2S@MM;+:Z>R,NC,998>RIF"/I3$C8E.7J0@
M4+5SFL4+75P5.SJXN#FZ*5CFYN;JZKEKFYN3BK5+G!>K4JU:@X\XPP4I)*2_
MWM;VMVL-MN;\4LHK#U>5=YLZ[_(L1^'V_.&*KQ?4VAHL%T,ZR"2.0^=P[U<I
M?B97EOH_+L5^O\>YFKPT-<@:'1@?&]&[,CVW+FAX:G @M4@<VMR3&HG!O7)3
M@B*4HUJ0XY,I(-"(LXDT98P["+>MU+&NC3PWXVM<&8*\-JQA>XZQF#5*M2#R
MIU<IBY*VE@8WEUL=R//TIL5;)6N+1M')M3,3TC?4K"RHW!(<B:&U,E$S=?E9
MV76W&8HN.%%-LC?I<@JZ)(Y))I WRIY=T[=HM4?(6V;-]E%NB;JCT4V*%UAM
M3=.GW366C*DDN1DR&0EN;L':K83?!2W&)=C;BWJ.J(F"C8 5'SWA$^:;B&CR
M?2-8VLCW&&Y,U*2#2UC,R-T6DTGBB"--*A%'445D\EC29J*8Y \(%H3;T_/E
M;W:;'(4*)L1(VUM1I6]N;TJ="@0(4Y21$A1)"@$)4:-*0 LA,E3$%EDITY)8
M"B2@ ++ $ 0AT(//=X()\J 7(&Z(]'83QD,M(,4E:^56Y1UC<LI.?+D2.70!
M.!-'X-<W&^L:,KF(+8PXUBK=D-!V(YL#J!KKQ8TQ=5#@QYP84OG#PB\5%:Y7
M-)2>FD3;MG53OM,L\*)Z0<6]44>^+YYFL%'CV1SQU6'=EP_&_P!'FB?4[6GP
M8RY2/WQ?=%U9I#18+H5S>%=H^1R^.U]/*?@*N<WBZN;W 4:=PMSE"P, 8?"*
M@O:\"6IEJ>@.2/'LF:3R6R>'I80S.(G?;HDU*25[P)QC\;)(;J_.OS_A>%RG
M65;);%644N!N+P)6/Z[A]0ZB4,^V!^W#ADKVG9D[&-,)*]NR4@1I5H6%:MCM
MYZI*20K4,\ZL"22QC./,9WY2E<D*AN1B(JNM=->BY*5QMY@@=&OP_#]GXZ_Z
M;Z-ZZ=?^F]Z_^V]X P!O6M_MUT_LW^/_ #UOIUO_ --_CK_K@# & 0OR*\QM
MH?E%S_H#DPU6*ZD14>#Z$T9!(P!@# & , 8 P!@# & , 8 P!@# ,(L&8$0J
M-JW3>P#7F_\ 9&E.+HWX]>:$7BQ"#TZWLA,'0E)_XZULLOQ6A:,-+UN85-RX
MX$1.2=MLK,3'JFAY\?9CGEWT,R224?VBY&G].U!)1PA'$)3!"UUM&BV8)4LU
MO01;4G;*'H7DY>\F)S=E%8B(5)3=7:R6,J6& , U=YI>C%;'\+9/BQ@S3)?R
M0[_ZLK'[7NZH\Y.=AB, 8 P"Q'P9_GUE?JH?/BZ#YCE_8ON71EX*O#NB\?.4
MU& , 8!4;X4C^\4A_DV-_7!LZ,A]?X_^C/*:-_8J9SH,Q@# & 7Q^#D]'D[\
M_P E_P!$QYR9;WO!&L%'CV1OKF1<;UK>MZWKIUO\-ZW^S>O^6\ C>1U1"I+X
MPT]K"W+1].]KVC84)VQ[_'8S"0 $C/'O?1L0STQAF_V:'KIWEE$UIW,JX4Z\
M=)@GZ(VO"/UHE(BI2U%?B%F>>C1P2P_B$HH*D[J! '73K?D;DB$,7_"GWL71
MJ9PNJD[UUQW,B4:HYX_[\HJ5Y%4S-)U9\XG#4)J.=7-S*->8H(_R%S:%Q+<B
M3"1ZVJ,$G,V,! %(-*ST1OBSR]  :'JFCZ((E#"E)RMD[YMO89Q3FYV,TL>H
M^^1Q7M"_-+@T*M=/02O2FI]F!#OHV,D1@= /*Z?V&DB,+%K>MA'O6];S2:=&
MGO(.GR0, 8!ZGJN\V==_D6(_#[?G!%5XOJ;PT6"Z&=9!)'(?.X=ZN4OQ,KRW
MT?EV*_7^/<D;*EA@# & 818\[0UG")#.W*/S>4HHXD*5J(_7$,D-AS=S":K3
MH]$Q^&11"Y2!^5@&I"<:E;$*@XI(4H5C"$A.:,()3LZM+F["CWP4;*]/5\SB
MQIO4SG3,U)I@V);K!3Q!Y=T<V5C']2:"MK!'&^T+QOV<5=,EKA"X' 6Y49&*
M:K:;S&-0:$#7&-\:K1NBC:+QI*CGMSX8I[DIJV=6]-YRO"B>D'%O5%'OB^>9
MK!1X]D<\=5AW9</QO]'FB?4[6GP8RY2/WQ?=%U9I#18+H5L^&!JJ(SR)<<Y8
MZQ$MW>:[N=?Y;81D&Y+72EHV"3&I[-:7BP'>A>*M@U[9]A('Z3((C6J9:F=D
MZ&).,R(D3DKTR('E X5+PNM+5IE;:J-II<&;L\$$RI)Q H!,LJA#2*DJ (0C
MK1M8)7%$3#KRM;LI:3%9XI6SR,;E!6P2TV.3M<OF[&<^F-<O<%TB2.2LX0ZN
MV=M9SYZ<=)MK@@T5X]<LU]O3NQVJ1DEQMO0++M/K2%[K*9MK[((=0=P.-.3"
M8I[,=),?&)H,YZ)CRMQC#5"(JJB2B9,S26[3%,29(% EJ7+FITXVZ37&#\W.
M1E@2>KJO;6VC6>>7E25,<E8=*G"/S=?!H1 ;>KOD),PUS(VDBP4#G-YA'W:C
MD#)JP&R10=E>626N4L+K]O,AVXU)!+24W;5K%J7*VFB^TSSBASDL#D>MHR=+
M8C$HW4_(M-937$8D0G?#+-@<BJZ-L+TX.,OD2AX$P/S'(E@)BB2-R"&QI8P$
M ABHYW?S']:G; :2G;25NA[,?#,1:><5Z2*;49 V]HJ9L6<O=O#O2;XLC<Q=
M$E01Z++;!=7M%;[21/FLRQ)"Z0B'MXF/<:>*K2E39Q=8^I3JT#(!U<@DK9SL
M2GCT2XV<NVHKG3:UNO->/2Z)U\RP=PNN&\99Y'41$C72\RRY#QI37\YV+"90
M<^)V@==(G!Y88HVQ5SARI[<&4+_,SYBBVV)HZX"&I=5QH[%;\E=O9R*\QMH?
ME%S_ * Y,-5BNI6*CP?0FC()& , K0>.65X1MCYG.KG%X*@G])16P[!K.D9T
MBL*#*5%9UH\RAL+L;=C!B[Q';<CL_C+.S3M-NN ;3PI^D;;4DT=H\\B.DA L
ME:KG)3VOI=;64T2*AY=F./)9#3:HE'%8NA-@D5<'AS@%EOH9A9UB5<ZVHVQ-
MCL%H2I:T@(6N.E,YZ0,M<'IUF*Y0ZL2=OC"PJ+JI@(E9/NK+;J_$YD.3CG%<
MZ"\;TI^OJM898N@+!/=P!(%JEZP<JD$)8*8>@!:94VJ_T;LE_5[LJ6%2>F8.
M2DL>M$4 +=I:I"CF$=\H$R4DWUQT54[)-V.=E&;U4'9A5N5>RS/[:;7QQ&YR
MR.2$]KATSKTIOE,,EKW$9*PJH18>]S2-.D>>618RNK<__P#:=N"%0K3;$WJ4
M8Q"K^;Z$QX P!@# & <<M6E-4*$A2E.8J2!(&J3%G%C4)@*=&;3#4$A%LPD*
MC11NR!&!#HW19FR]BT 70!R, 8!_!"" (AC$$  AV(0A;T$(0AUTB$(6^C6@
MZUK>][WO6M:UT[_# -<FH(K9L(Q[."(R&0TWQ+84/6_$N*_0]& ,V 7ZH]*#
M"PK%&MZZ=(R4"8\O6SA;WH_\5+ZG79\\F:_RB;=$[-ORIL=F9H, 8 P#5WFE
MZ,5L?PMD^+&#-,E_)#O_ *LK'[7NZH\Y.=AB, 8 P"Q'P9_GUE?JH?/BZ#YC
ME_8ON71EX*O#NB\?.4U& , 8!4;X4C^\4A_DV-_7!LZ,A]?X_P#HSRFC?V*F
M<Z#,8 P!@%\?@Y/1Y._/\E_T3'G)EO>\$:P4>/9&^N9%Q@# & >=#E:]/##R
MBMA>R.:]J6 D"36E+>J.2F[#ID:=]08B1@V,O?\ XBQ]8L>NG0@[UO>L[,DI
MY.&>W^S,8_<]W1'2,O(MY-2::+ 8&><LX^@)OE:5,F7]'_#UQ:T0:W'B+#^(
M.E$0<(7XB5!WOK:EP:4Y/1,J<"8(Z*?(ZXR"'N3K%Y G+ 85%5Q*@XA6<8:
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MZ,O!5X=T7CYRFHP!@# *C?"D?WBD/\FQOZX-G1D/K_'_ -&>4T;^Q4SG09C
M& , OC\')Z/)WY_DO^B8\Y,M[W@C6"CQ[(WUS(N, 8 P#S>\Q/27MO\ ,"7_
M &-JSLR7\<._^S,8_<]W1&M.:%1@# & >IZKO-G7?Y%B/P^WYP15>+ZF\-%@
MNAG6021$X,36[W(B5+R#33V>"(US>(M:N2A)4@E)Q@1F%)%)!2L&A$E[V2K
M>1O6MAV7L(QZ%:?^&,4N167^>$,^9(<D;E;Q'7YI0&M!*YT971N1'2!E%)&$
ME6N0GIDYKW'0.3,-^:"SC0#<F4#PTB=$>CD(7)#L_2HJI8K<C?"&[$%21ZO"
M[EJ.',SG9Z*V;&IEHI:=R7C^C)00R#-3+1=7QL[D!%)-#Z09)Q$E=BOL:3R
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M&$/_  )5,?8MD[_Y:&(BQ D[UK]GXHA:_'IUK7[-V].+3!#Q7@K-*CBT:/\
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MH5:9:06I6HAG)#RE)0%C:L/;G%(,PD8P!4H'!*J0K2-[T:E6)CTIX"SR3 !
MY. , 8 P"A#PHGI!Q;U11[XOGF:P4>/9&4=5AW9</QO]'FB?4[6GP8RY2/WQ
M?=%U9I#18+H31E21@# & , 8 P!@$+\BO,;:'Y1<_P"@.3#58KJ1%1X/H31D
M$C *$O")^D8I_)47_P#9PSKR/L6+,HZK#NS13-2@P!@# /23Q$]&RHORQO\
MW-PSBRGOBQ-H/:M_5FQ^4+# & , \H4F_P"\<@_C;K_KU&=\-%@NASG29(&
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MG)K<VY86<D7MS@C/.2+42HDU,J3'&D'EC*,$'8&"5)3M;T9"V^ 5;$VJ)QQ
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MM/@QERD?OB^Z+JS2&BP70FC*DC & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M+&!O4KB$#K+ES:<_NI8W%T4^7+SO*71Q.T-6<*MS;=[;XD]X(& , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P"A#PHGI!Q;U11[XOGF:P
M4>/9&4=5AW9</QO]'FB?4[6GP8RY2/WQ?=%U9I#18+H31E21@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# '[?V8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8!0AX43T@XMZHH]
M\7SS-8*/'LC*.JP[LN'XW^CS1/J=K3X,9<I'[XONBZLTAHL%T)HRI(P!@# &
M , 8 P!@# & , 8 P!@'FPDMG^%;*D;^6TMG(C;66]NH&W::HAG)]MX%YX4>
MR#?T*'XTG:;1?BC.N/K@ZHNL+IZ=[?X?_/(Q_P __KF=)]Z7A:__ .LY'>YX
M?T1C_#_YY#_/_P"N9O4VCYL27AO#YF?);0B/)9CNMOCA1+[$W<L:Z$VO(D%*
M.;S+Z]0(6LE]9:N9+#47<QJ5C;HA"_UBUJE[@ECIDAV=G%*=DJ:+S6"<FHMM
M:V6JM)NS?1V',4W=RYK^47)%=1U]/KFK40H%"$08)<=D6RI9DLJI^#UW< YP
M[UJXPR?$.K!(IG/+:?S[#L&0M[:E/=$%>NTAK*Q([(ZEY)Z;=LDM.WA3FB<>
M)5F\IK6E25;<J <*B3!1\)<EC,HJB31-5-;-?+>Y'PM\<A/DR3L+HU ;8-5U
M6RL4/*B+(XHQ6"6Z.J1M;7MA:THAI*G5/0KMK=NPL#P0:'\U9!R-8S*VU01$
MW/"J!+MRO]#HT*0Z"(D49^Q/M'>FIS\DWO1KOY)K^Q\?K2G_ .9XG]37)J!S
MSY:)3;5\Z;BD3B3LG*5T[31;]/O"*_\ \"[?=J/Z5S260V<8O)6<>WA_HG'C
M;,.:;G=<(0VJDM,J GFOFI .10<30S! 7&'HUN\M<=Q]%I-K;N!!HC?E)7C%
M.R2>D?C.H*L:R6:\V6=9*UWJ=7<3"XIJ<Y8;,";Y"J/%S%>4UL*.1:5A);*4
M%QR(K/?(4FG5ZLYUDOW@FV#NG _=\Y/89,%I)F22\Q*(ZTUR1'G% 0A95DQ7
M*,#71HTSM4]%)V\-IH9Q[6V$&EN)H+^>.80X:LA#BIY(+8^I\(*3:26]]535
M0H$V3A>O<5EQ-<>.7#O R5:JP]II]19!$#;U:<#@J:DBP6<IQ2ELH[+;E*=*
MVR-H9) KAFO"[CT;+'/D4AM%NNGC:W*AQBRKFKBTSZ8EG+VK8](16V364IB[
MVYOY?&A4I,M-9,"U3A$E.YF_+CV1U3NKD4(5C=*.YVI.U3O9%MGV]S'^S[0A
MT%%9D8##1VLG/+;J+L.2O5=PBG[\KJ-T_)HQ9TE3O^KU?;VH@4GG<H;$"N:2
M5:H7*@MVF1SATB;WP)+9HJ[+9SFJV8[;4U+L9G=?)NP+7/KIJB5IJ*P06CQY
M=-2!93\[@STB,KGG'Q#:G9:0XI8TD8SH38]42:S)P[I3Y9)G$^#1AT>WYBK=
M@3N\?/!2ZRMV.N^4KYZ22K3ED_BEO<H)*O8.1$NMB',Z=^X3P&(!Y%!H2=L;
M3030[I&.8)ZM-2TT[2!^Y!!LV/3'=NJ-/37'1UT8G.:D*F)K3P4K*)::3KQI
M*GDC&1\@><A\=LE55@7>5M$%@5_S^"3N5\4K C+W;+W6=0TA-H96Q]=.ZN*O
M#0*36C++#@:->A;DKS*&)C<(S&TQDTB[C.# 4IJ=--JO:G.5DM]]'(^-Q\G>
M8E8RM=5J%2;(9NV,?*M]KL]HXU3>1FW_ ""JVSB"]T_%-H8RX.:"OH3*)+?L
MUK226.>K"P)=1U (^3L<A3+5AX))VTM2JK)SG.:K)?)I$F<M7!:NG_)QI?[+
MDM8Q>)\7N+4E9)$TQ^T90@2,SQR&O)ROQO<&JGE;=8**+SB)UG6\'M*9Q1Q;
M'2NX4YD2@3RUI@&#/$)4O;:Z2ZX&6<.Y#)%UFFM"J$2NLFTKB-0JIYK.5R6=
M2=3#7%JMCD;#X6ZE.%E(VJ?G'V!$(XH7B,GK(RV 5'(Y#VN:L[,^-2AK3 \9
MN;NV;?\ 59-ECV"#!ILIGJ<IOW!F]I7#$8HTY:<C @&4#02O)?)PF*T90@CW
ML_QV]F#,UL).@ ZNS!:E9NEM72_XRL6=]/RA'_VE?_[OQC_\R7YWEI07OYN*
M_P#Z?,T?:5__ +OQC_\ ,E^=XE!>_FX?_I\EV-;>8CC8+#(N.,Q816;*'1@<
MW$E]H:M@<BF)BLY>_2&KR=.ZFSJ1UJ.QU_K?2)W4QJ*WF-55$[B\CG9,K+9V
MYF53B(T>SG<:K;);;'+!.NZVZYZPL=J<QJ?AJV.*T5AOZ.9/,_<H@_):,E[X
MX56O/Y#W0G0-LK<4[=8#RY1M]A22&G(G ,%E#N6I<&LI@8$$<E+<NB(F2:JD
M]KK9RZ;ZY*'D%SS<JV%8BZ*$Q$Q\GG'^&N$:/IR?(U57Q:7\/ZQN:S;$Z4<9
MM&8R'R;D+*7>C0A#7+VRP,(%X965Y9%9"]-(-*^_K+"BFJ3>XS'D9R3Y-US$
M./K:P":R[DGG%2Y[4?XY!*)M:TF^9WW6;106XK7;%'ST#'.J^@$RFMCO; O?
M+!96%W;&U4U,3JJB$P7(G!""2<[IJK2L<_&C:=18EK<S6-H3V,FC;T\N6[CY
M/1EIBS-55@K"JSJN"6#*X#%9P[1B,/Y:JY%[C!6XBS8TC7M189SY,T-5>-A;
MD]E.KF(LFL%ITROE9;9U9G<+NOE*^<D8'"DHD3E20VN/GG2V:TO=%?O]GQ]P
M8;"42.4)0 JE;%H;*H[)6B)M*=JE,OK]M5-J9Q>!1M0CM.M#VH)*5;=WF>VG
M1G66+82>'WCS5+E*+F)/:]!0'&E[98I6S)R23 6V.W61?#7,HK0\D@:".LT?
M>'%J>:(3S-; I,U 5,JC[?G;X:RL,L=&D-"I.;K+96>^4S#(.-]F$7@48F<P
MLN4(N-/'9YF\S?0%\CBYD==]VK)3 Z[9P.32UL?)EVW45=,]G,KU(7!N061(
MX=8D'LUQ$F6N&W00FF]K2J:=DFY7I2:T'45%);38DW (4S=>3IST9R4Y'QJ9
MI#6GD9(H:[TV\,_*YLK>06$=(8T=)!0K<H44.BK5QY%K54M8(\EBCZN=EQPW
M^=/0.5M*+C9.7.<J;"XS!48 P!@# & , 8 P!@# & , 8 P!@# *$/"B>D'%
MO5%'OB^>9K!1X]D91U6'=EP_&_T>:)]3M:?!C+E(_?%]T75FD-%@NA-&5)&
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- N5DX%1<WY(;;J?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g910899g76l04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g910899g76l04.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_X6]I:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C8M8S$T." W.2XQ
M-C0P-3 L(#(P,3DO,3 O,#$M,3@Z,#,Z,38@(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+R(*(" @(" @(" @(" @>&UL;G,Z>&UP1TEM9STB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O:6UG+R(*(" @(" @(" @(" @
M>&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(@H@(" @
M(" @(" @("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S
M+S$N,2\B"B @(" @(" @(" @('AM;&YS.GAM<%109STB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+W0O<&<O(@H@(" @(" @(" @("!X;6QN<SIS=$1I
M;3TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+T1I;65N<VEO
M;G,C(@H@(" @(" @(" @("!X;6QN<SIS=$9N=#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+W-4>7!E+T9O;G0C(@H@(" @(" @(" @("!X;6QN<SIX
M;7!'/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R\B"B @(" @(" @
M(" @('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O
M;6TO(@H@(" @(" @(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(*(" @(" @(" @(" @
M>&UL;G,Z<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP
M92]297-O=7)C945V96YT(R(*(" @(" @(" @(" @>&UL;G,Z:6QL=7-T<F%T
M;W(](FAT=' Z+R]N<RYA9&]B92YC;VTO:6QL=7-T<F%T;W(O,2XP+R(^"B @
M(" @(" @(#QX;7 Z0W)E871E1&%T93XR,#(P+3 T+3(U5# Y.C4R.C$S+3 T
M.C P/"]X;7 Z0W)E871E1&%T93X*(" @(" @(" @/'AM<#I#<F5A=&]R5&]O
M;#Y!9&]B92!);&QU<W1R871O<B R-"XP("A7:6YD;W=S*3PO>&UP.D-R96%T
M;W)4;V]L/@H@(" @(" @(" \>&UP.DUO9&EF>41A=&4^,C R,"TP-"TR-50P
M.3HU,CHQ,RTP-#HP,#PO>&UP.DUO9&EF>41A=&4^"B @(" @(" @(#QX;7 Z
M365T861A=&%$871E/C(P,C M,#0M,C54,#DZ-3(Z,3,M,#0Z,# \+WAM<#I-
M971A9&%T841A=&4^"B @(" @(" @(#QX;7 Z5&AU;6)N86EL<SX*(" @(" @
M(" @(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM
M9SIW:61T:#XR,38\+WAM<$=);6<Z=VED=&@^"B @(" @(" @(" @(" @(" @
M(#QX;7!'26UG.FAE:6=H=#XR-38\+WAM<$=);6<Z:&5I9VAT/@H@(" @(" @
M(" @(" @(" @(" \>&UP1TEM9SIF;W)M870^2E!%1SPO>&UP1TEM9SIF;W)M
M870^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG.FEM86=E/B\Y:B\T04%1
M4VM:2E)G04)!9T5!4T%"24%!1"\W44%S54=H=F1'.7IA1SEW241-=4U!0311
M:VQ.02LP04%!04%!0D%!4T%!04%!14$F(WA!.T%10DE!04%!05%!0B\K-$%$
M:T9K8C)*;$%'5$%!04%!068O8D%)44%"9U%%0D%514)G549"9VM'0E%92D-W
M9T="9V=,1$%O2T-W;TLF(WA!.T1"04U$07=-1$%W441!-%!%03A/1$)-5$9"
M451%>'=B1WAS8TAX.&9(>#AF2'@X9DAW14A"=V-.1$$P645"05E':%521E)O
M9DAX.&8F(WA!.TAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X
M9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9B\X04%%46="04%$64%W15(F(WA!
M.T%!25)!44U2068O14%A24%!04%(05%%0D%114%!04%!04%!04%!449!=TE'
M05%!2$-!:TM#=T5!06=)1$%114)!445!04%!04%!04$F(WA!.T%104-!=U%&
M0F=C24-1;TQ%04%#05%-1$%G44-"9V-$0D%)1T%N34)!9TU20D%!1DE227A1
M5D5'13)%:6-9155-<$=H0GA7>%%I4$(F(WA!.U5T2&A->%II.$-2>6=V16Q1
M>E)4:W%+>5DS4$-.55%N:S9/>DYH9%5:2%1$,'5)24IO34I#:&=::$I21E)Q
M4S!6=$Y62T)R>30O4$4F(WA!.S%/5#!:6%=&;&%7,7AD6&PY5UHR:'!A;71S
M8E<U=EDS4C%D;F0T95AP-V9(,2MF,T]%:%EA2&E);4MI-'E.:F\K0VLU4U9L
M<&59;5HF(WA!.W%B;DHR96XU2VIP2U=M<#9I<'%Q=7-R839V;U)!04E#05%)
M1$)1545"45E%0T%-1&)114%!:$5$0D-%4TU514954DYH26=:>&=:17DF(WA!
M.V]B2'=&34A2-%-.0T962FEC=D5Z2D121&=H85-5>5=I63=,0T(S4%-.94I%
M9WAD56MW9TI#:&=:2FI:1D=I9&MD1E4S.'%/>G=Y9W F(WA!.S K4'IH2E-K
M=$U453504FQD65=6<&)81C%E6#%2;%IM9&]A5W!R8D<Q=6(R4C%D;F0T95AP
M-V9(,2MF,T]%:%EA2&E);4MI-'E.:F\F(WA!.RM$;$I75VPU:5IM<'5C;EHV
M9FMQ3VMP86%N<4MM<7$V>71R<2MV+V%!07=$05%!0T5135)!1#A!.54T<3=&
M6%EQ-T9867%W+S@Q=&4F(WA!.S!842]*='IQ1W(S,3-9,C9-;VDO4CAX=#=M
M85EG*VY!:VDW<GI053EG2VYB1EAK2&Q4>EHU,FXX>&58;W)J6#=N57(Y-3E)
M:'1)64@F(WA!.UIR3S<P,E-+6#E+5'5O2$-6;TI&2TY+9'=62#@R-59.-S=5
M9DTR;F54=DUQ;EA,-C9I,'9Z9#E6=DQM5S@Y0SEK<T)B=T9R93)N*T(F(WA!
M.UEN85-11E94:C-!,T]+;RLK,3=Z5D0U3SAG+S1T,4,K,%A4<C5*=CA5-G)!
M6&AU161)83)I5%-X<GIH17 K,G=O86IE;2M"5U!196(F(WA!.TPV3#AY=&%S
M9$<Q93@Q6#!B3S-F>7A&8V%V8T):6D1O-GEX+S9%5F1,<C%P84UX67)1;FQV
M:%9K;C5B83EF,V9M:E%9=$XQ<E5D86HF(WA!.W5T3&QL.#1X6'I34$AA6'ER
M15EW;V-!45-'4FY8,&LR-#<P4%A&54AO4&YM-7-.0C%J6'(S56(W569Z0W,T
M<FQT43AQ,T5S>5=T<V<F(WA!.W4Q:D1R84M&5# T67ER.#$K2FQR,S9+;U,W
M+U!R>GI&1&5Z43)7;50R*VU78SDK,35W=55H=F])3#)+,3E7,'))4W%30V9B
M;'DS53<F(WA!.VM91E8Y9CA!>C$X-#915W1:64Y+4RMT<C-78D-E4FMU5$9.
M2G!K3G108G!!<7EC;&5F-GHV5D=**TMH.6EQ:7(S.#AV3FM8;4A7=$TF(WA!
M.R]18U9M3D\P<39V-#1B<F%62'0Y4$XR:VHO=F\S:VEE565M5E-)538X*V]#
M<4AM+U!0>FQA>$Y(9#)E;2]727)V5#%M94):;DIT=%(F(WA!.W,P=6Q71S-E
M84XU6E5-9U)U3"LT43164S-Z1"ME6&Y+.51Z3%EA4#9&;V1-:D8S8F%G3&1L
M;%-'1%5O<E,T4U-*-7!I1'=L-49N4D,F(WA!.T9R.% R5WA62"\X04LS=DY'
M;6%D<59X1S%P8V@Y8C%#,U15-VM856QM<3(Q;&)Z=W=224I'9$=U;FM:65)Y
M-&IW2C9Q<#$U32].>GHF(WA!.V1R4&TR=S W571.=&)05#E1=C<W5%)B9U-R
M95<X,6Q9>#,S-S!S-U)T=$HV8D%+3GA8,G=+.#8X-BMB4'I&5%503U9N<#)Q
M6'E71C,F(WA!.V58<S%R9'AZ>7 Y4FDP4#%$8U)1=7(Q45-S66QO=$(W659:
M3DHK8UAM8E)T2#%+*W1V<3DO2V1C=G)68E,V*W13>4IA=S)%32]W0EHF(WA!
M.UAG-SA98F1N-5-Q1F]64'<X5#%6938R12]R,DYT4#8P9'@V<U-0.$%725%2
M1DIY54AN1T-Z,%9U;RM)-V0X0W$K2W5X5C)+=7A6,DLF(WA!.W5X5C)+=7A6
M,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5D%896<V5&5A=G K<UA%2%!59$M7
M9$Q#9FTT.4YB<%9766-146IC9VDO84(F(WA!.W R>%9(-'$W1EA9<3=&6%EQ
M-T9867$W1EA9<3=&6%EQ-T9867$W1E5(639Z<$8O8UA6=EDS,79D,T9I+W!8
M<TU%<5-00DIU3T5Q<5,F(WA!.U5B-%1S,DMQ<U8O67DS:SEL1F-X4UAL<W%0
M8S)Y=7!L:E=7=G!S-D$X;$0X5'AQ3C99<7(T<3=&5FQX8U%7,$5L>&-32D1B
M=V\P:S F(WA!.S!J0E521D976FU.04%!2VMN1E9,5#E3,#=5<D]/*S V-FAV
M8DM917<S5G9)<W-49T5Q94QO5U4P24DR3TMR-VDV=&):1F4U;5-&2&0F(WA!
M.TEK85)G9TUK<D)),$)*2'A/-T)62&,W67%Q-'$W1EA9<3=&6%EQ-T9867$W
M1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1E@F(WA!.VQU=69K6D1F
M=4HW5%=8<S=Q6%4W;E5B,E8T0F1,2DA08WDS36--85131F)D;T1/-%-72VAQ
M>DY3<DA&54U0.$%N2#9W:3 K3S%T.5(F(WA!.VAI:R\P8U,S2#%&95@W:7AT
M-U0Q675-<65N8T(W9#5O<&%N9S!J+T,Q4U-Q9TIV>5$X<39:9#9B8E-A-UE7
M97)Z0S)85&QM=%E&;&XF(WA!.VUS53 Y5V%/37I+,&QF<45H9%8O,RLQ9CAP
M5D=19FM!,&1R8G)*<G-4,VM-6FAE6F10:FEI:VEA5SEM93--2U-G3&)34&5X
M:#1625@F(WA!.VI&454U9D-Q:6)F.&MB.41R-%!M6#9T1')T:SEI8E=W,#8R
M=#1O,&MI35AP<TA->G9"2%@Y,&Y*5VI58U9E;&%Q;V(O04I53F9.1F,F(WA!
M.U)3*UE)2E9N=$I,66@Y3C5(,4ID45154%9L:V4U86$T.4XT-E)R8T\T+VTU
M075'5F$P+SAG<G$R,6TP,4LT.'AI."MQ86EM;W)(2EDF(WA!.U)O5#9D>D)C
M5C52>7 O<$1F5B]4831:4WA6:4M9<3E1;3!7>FQL85)P3&]--4I)4S=U:U=P
M.$9744M0:T)I<4AS,FLP,U4O,&1.2DHF(WA!.TQA6%E-;6Y3>74P:DLV:7-T
M=7IU5UIT=C-I5DI.3U$V24U65$LT=3=3,EAN8WI2=W(O3DEW469E4TU64VDT
M.#AE57)C:U-A<$$Q4#DF(WA!.SEK>2\X;7<R3DMG6"]-+WE9<&],,6Y(:7--
M=%!X55EA5S V,%!89% Q=7IA.'-'6F]&8W@Q9%-P-4M!5'-F;F=634U69&ER
M<U9D:7(F(WA!.W-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<D-V4&XU
M8DAZ6G)';%@O04]L2# Y3D]I=4E8:FEJ6FYC5'9&27)+-&M25EI(9T(F(WA!
M.TA*2$AC55E+=U9E9F%F.$%L6C5.:W5,>4<S.#4V5CEF=C1*3$993$-+,VE7
M2DI98FUY84M#15A-:G%J6$8S2$EY8W0U53=&=FA66C<F(WA!.S5$+TQE-SAS
M87IF-G!C-FQ"9E1A9TIF6$U6;6)D>3@Q,4ID1FDW>C-*-' V>%955&ET3GI6
M=#A66GII<4<Q1%4Y4# V03-&.6-2,C@F(WA!.TDO86M90W X04]P4'--5EE,
M<E@U=V%F0U=J,&TQ83998D-E87-C9&9%3#ET:#@K3T=K5W=46"]/+VUF5UEJ
M2$QE;3-65T5K271W22LF(WA!.T5I;7%S0U!J,E!I,D=L62]&97I864UL=WAA
M-$)+>FAM3$5/3W4U,W S2'1I<2]&6%EQ.6TO2U O04I25B]W1&U+:R\T:6U!
M<4=A-$4F(WA!.W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+
M=7A6>$%)25!1-V)B2#=X:7)Y368X-"]O:U9V2D1R,'-'<#)J5S=16',F(WA!
M.U5C>7%0<4YR1%DR6DU!=694-5)W4E-C;D9'6C-Q0W%J9U98<DQY4G=X1U-6
M=W-C67$X:FM+04(Q2D]W1TMV4%!.2#5S45%L-UA1;$4F(WA!.S!G<4=V6D(K
M-T(O>48O82M:,BME1VM7.# Q1%4Y43%'-$YX9EA$,T5X+V)C,6]0041O0C=$
M0W%L8E=T>F-Z3$1B4E!.32MY>'AQ5UDF(WA!.R])0W!X5FPR:R]L6#5L=E%R
M,U%J<TEJ=BLY4$M3;BMO=&8X06AI349R4V-4+VQ4;W5J=D9Q5C5C5%AL<4-)
M.5-556E667IS<S%">4XF(WA!.TDR4'@O1CEG:S$K2$<Q6F1(-4XX:S9E;UIR
M0S)11#EQ-%!-9CAL4S)+5GI89FM+>F]P:S!Y1W4Q1CE!9$\R,DMQ12\U:&9L
M>'!43&(F(WA!.WHV.7!T:UA(<4Q%,#A55E%35C5!5D9D,4ER9U9',F9N8GED
M96]J,FUU,D4V>4-Q8TQM16MG-V1!,6-65&E+84M:0DI%-GE2=#!D0T<F(WA!
M.T(K:UEQ=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%9!
M-C%R96YA3EET95@X=G!X3'-Q:F1N86Q1<41U5&ER>&(F(WA!.WI:-30Q5'I"
M2UEY5&(V97 O9#)I;EDP-DY)9C)J*T%Y4T=047=Z5'EP1$-J4WEY2&EK84%S
M>D4Y9T(Q>%8V2#5A+TM7-&Y#,T]U4T<F(WA!.S-J3S1T26E055 X07)T=48K
M43,K5T,Q<&TW>F559DM6;E0Y>EE)4EAI3C5:2V9E-R]49U-X1%=F>FQ51F\Y
M27-U6%5#935.0CAW:6XF(WA!.SEB66%28D1D53@K96%T4U8P;G9N4T=18U=H
M:$%J56<Y4CA/-2MK-%99>$103TI$851Y3DE9>%<S9'E72FDV57%E-F9:4#!(
M=FEQ=FDF(WA!.W)Y-S@S4#A!:G972"]-078O55).9TQ+3$)S0U5X,'IZ1'(K
M;'-R86)Q5C%:1D169G$X,&MD1%=V4E--5F5H*U<O=T1N2E0X,'1(9%(F(WA!
M.V-8>6%V8F=G=$9F4FAM24A94TIW9C=Y8U55.6XX;"\X-59E5$Y784\R.'=7
M.&UH,V)50FY0-S8Q3$@O3%5C,4@K<W8P-')4,F)4.5,F(WA!.S O57)33S@P
M*S5J=3=356-O<#181&]W3RMZ2U--54EJ1EA9<3=&6%EQ-T9867$W1EA9<3=&
M6%EQ-T95=#AW95E.4#!05#-V8C$V06(F(WA!.U)21#=C:CEL55EQ.$PX>&59
M.5$Q-U5'=3=X<4%B47=!+T)';CAQ+WA09DI)8CAU*U=D53$V."MR,E5F=W)1
M>E1T=$A'4$9J-"M!1RLF(WA!.TMV661$.',K6'9+9&<Q>3=)2E98+U-.46UO
M1W S0S$K>5!99FIG4W<S>E0K8E4X<&4Q,$9F4VHV1SEC9D=F.$%552]:*UIX
M<$9V3S<F(WA!.VTV=6)Q6G W;58U<&Y.5VMC;&U0,&Y#<6QI<G-654QU1C5%
M5C1Q0V5).#1I9&=4,$MN,EEB2#<X5E9)2FMM:5=62V=.,E!516)%2#,F(WA!
M.T(R3TMV369Z8R\T-S%H+WI!3"\Q15190WEI=V)!;#)+=7A6,DMS:SAM9FU(
M-74X;EAO=71"=C-T=U175S%9.#=E465$>$@T5#@K=G8F(WA!.VET4'%J.')0
M*V-I9DQ8;3DT=$PQ54QO*W9U2TQ%-V8V4$\S+T%"5DEE:D@K4G0O0W5,1VYR
M=4MQ9'IC,CER8GE81GA)26]);$QY4TXF(WA!.W-!;S9N1EAN5G(K8FM4*UE8
M4V5(:&]J,&IJ:W K.%%G+W="-C%/>#=R,B]785)B,&5+5T]73DI9;D1X=4%Y
M3W!Q0T1U0T--0U8R2W4F(WA!.WA6,DMU>%8R2V]85DY4<SE-<TIR-CAF,#=E
M0F542'5F0E%/-4HR1TMV0F9-+VU3.3$O53)V3&<X63%Q='9!1%99,'(P.7HT
M;G9K:TLF(WA!.S-L4'EN9CA!;4LO.4='<V1R1U%B;35),E%E03A74%E9<3EF
M=6)N>3DU33!*44%)644R:6E&1$I.2E0O:&U08S5&3'AZ>E0U=C%4>D0F(WA!
M.V1C-VQV5'152CE#,%4O06\X5"]-,W9K:TI&:7)S5F1I<G-69&EQ1F(O4G)R
M;"]U:3590G8X;5AO1#AN-F9/;FII<GIJ.#-0*T\Y668F(WA!.SAW0R\Y4D4R
M07-O<U(P>E-D5C%7-D9P<&1L4&8S4E5U3&4R:65A5&EO<7IC141.441R9U-P
M0S!U;718=3%H8S)K8G)&2F-"5#9A>4\F(WA!.T=:14PP-&AM5D=)2&5H.$U6
M56-69&ER<U9E-68X-#@O;&8X05@W=&9.*W)W,7,W5G8Y>%5,:F%36E1V3E1U
M<4@W4#A!;&9,1D),-F@F(WA!.W-D5$M5:FY.53=/96\K94M%1#4R.'94*UET
M1$56:F-L6%%I84I!=SE+8F)9368X06E*-EE1<G=Y-'0U-V%E4S-U23)I;6E9
M<DI'=V\F(WA!.WES3V])=V]:>BM7+VYC-F1/;6HV:$HO;T5Z570U5U Y>3=(
M;U0O27@K-"]49TMV6'-#6%EQ-T9867$W1EAI+S5K96)4<D=P9E5B5C8F(WA!
M.S9D6G-10T1T2DM.;68S039,.2]F0T5-9#!$47(S5SE4:7-,469%*SAK:"MY
M:40W5'0X<TMV8D=B42]*;FQZ66-,83-(5&(Q2G!34'@F(WA!.UIQ9C5G6D9,
M>%!Z2#5I,418=%)E.'9',C-%14DK>D=N6E8O:64K4U%L5TMU>%8R2W5X5C)+
M=7A68DY%:S!44E-#<4]#1TAZ>%8U5BLF(WA!.V%2;B]!13%9<$]0,VE74W)Z
M,F\T13@Q2#(V5C=J>'=&:T5R.&QE6G)B>3=R0G9R<7IF54Q6-&UH;G-&:VIJ
M:FY2;55M3V8Q66)K4$4F(WA!.S-(9%%Q=#!+<W!!3T),,2]4=GI&.'AX,U5.
M=6XU9#9Z9$IP<V1N83-&<6)U*V59>7=W,V)+='A)8F1P5U=74%5+:48Y=4-G
M0W$P;V\F(WA!.W!G,VUR.'@Y4G5V3$YX-65V3$\T=$PR55=-2W=824HK<E=6
M=%HR>7-S5%!X9B]42G)71V1L-$)6-$-H8FQ52S X-GA3>DPX<F9Y.74F(WA!
M.R]/=FU33WI&63E-=#93-FQC0W9W>#$K=W O;F9O4'9X45,Y<'9F2T@U;5=U
M:W=79FPW.4EA96)70V$S=EDT<GE$,#=M67=Y>'=3,E,F(WA!.U-Z4TQB44LW
M3'E4.3(S16=Q3V%!-%5*9C5M,2\X,5=M9S!A,W9797E6-4E,+U5&*W!E;SA1
M=EI12%E"2T9J82ML.6EG*S!'56LW2W8F(WA!.U)F269N9#E-;%149%%K3&%C
M-7!&23(U:%DO.$%':#<K1TI#1U$O;4PU3%16-U$V<G V039J0W185E X060X
M64AT,5I2.6YX-F5'258F(WA!.S0U:%8W2"M76&TP-FY99F]U.&5T.5IQ4%1:
M:G9*0TYG9FUV42]29TMS-'=*9&ER<U99:"M:6&U5-E)O:'1R9"M..68Q:FI)
M3S92+W0F(WA!.W8Y,G<K9G1H0W9&04-304)5;EE!65508V9);FQI3'DY;W!M
M=6=%=G)H9E9V2D<O655#;U-V64M/=G9G2UAL+VYV>F),-6<Q52MK>$<F(WA!
M.VY7>$M7<V9J-'E%94QF<7=O67II<G-66D(U8SAX,C)L5V1X87HR+S%I2S=U
M3&1R;4TO6F$S:D5N<7(Y<&%S95DT.&=2,S))0GA63VTF(WA!.S@U95=)<G1X
M6C)":7,S<R]Q-W0Y5W16;&%6<&Q:<$I!;D986&=V,DYL2C)O0F=61$1Z5#59
M5SAH8V%7:'1O-&=K9TYR8F-N:V$V5C4F(WA!.UI+1V](2T)31D9F9TIO=3(K
M1E528BMA=DI55G5J4'!:;'9#651-1W1B5#!62$M-,TE10VI(;GAB:GDK>E=G
M-&I!<4)G,7IY:71L4$8F(WA!.U!9>4\W,G%244EK1G5V0U99;5)Y6FIZ:V)N
M25)*>G!Y56IJ=7114W)&-51%6EA-2W-K4EDK;6IS2%E,6%E&9T5"4'9167$X
M<B].>B\F(WA!.T%)-S%H+WI!3"\Q15190WEI=V)!;#9J82]N:E!B>'-"<$EA
M6F]O<E8U1VQI:U9R57=A9$)D;SAC,79+:G9/=6M,>&1G94A.=&UO<$,F(WA!
M.VEM3&9M2#4Q6'IL<G%A,#)N4C9F95-1<6PX66TU0V5C1FDP=C)5<%5%2T9.
M4T%0=$A&25-04TY*=CE8,4\R,'I4-&I.95AC9VEH:D@F(WA!.V1J-"MW-FLK
M1TMV<R]W1$QR>4Q995103&-';%<O1U,U86ML+V1!54US>$AX2"]62%)2-%E7
M3$A0>E4Q=3AN1G!P96ET8W)C3$]0<FPF(WA!.SEA6$)I14M!:FUR4BMR17,S
M269#47=93'9T>3)X47=F>3=B-CEB4$Q$<4I-<UA%1TMD;DI.06%+;$,X:E9P
M=3%39CA!5V)S5E1Z1E@F(WA!.W!V-6$K8E1/9S!3.65S<UER6GE.,5I2,6I0
M=4\S=&=+:&HS-6]E57AP="M.5G1%-#)6-'@Y5E(P4UDW;C5"*V\Y-C1H5TDV
M4G%L>G F(WA!.U=P5RMO5WAP3F)U1T$W161'52MZ1%DT5F91=6PV:F(V;' Y
M=F97-7)$8TE(6'A&96]0=41S8VEL1EEQ-T989UAN8EA4<EAM1S5U;&(F(WA!
M.VQB4FXP8EAW.4Y$445F-GAQ,S U2D-B9FQF-6-'<#8P8C8T5&QA8692-DAO
M,'@K=U!O<'DK-T%66E X06UZ-6U.;EE*;S%S.4HW=V,F(WA!.W)G9S=R0T0P
M+W=";69W>$-L-4)H5C)+=7A6:U!L=E=V3#EL05ET57-0<DQ'4G5--E)X4T]S
M8VE#<$%L0E5S:GAO541#;$,Y971#<6XF(WA!.T(X,2M4.316,#EL=%AM4U8T
M,'1B5F9H4G!#<6IK,&A*2'%!.&U*0C0X94E6:F=61#-N;7)Y-7AG5WAS5$A$
M2'%%1C1B47=W;W9P42LF(WA!.W!Y57EQ>E!)6#E1541#:3E"=&A62%)E879,
M:U=N-F1D6$EF57)Y,FYD6EIB:4=%,U4T4F\U63-K:V%34U--2GI+<%)M-6-A
M1V=W2V@F(WA!.TI03E!L95=94U0R3%1K4&(X;6$R=#%,2D-T=7)';DEH0E-'
M44-.9FA04&8W3TMS6#%A-G1B<2MA93)I14UB<$AY:D-Q9SE14G%*4W$F(WA!
M.W X255Y0FE!3S)&6&M8-75F.&0V=R\U9T8O-FE*<T):4EE.9U,W1EA9<2MO
M4"MC9B]W07-$;U=M1'I,<7-82%8Y46HO04Y&:6-584,F(WA!.S-B9F-(;SAN
M52M!=W-35V,K8F9.4#%25W-,1B\Y3$\P,'$O-W)(9T0O3BMR-3E&1$%S2W5X
M5C)+<6QV8U17,#AD>$%X4V%*9SAB:G$F(WA!.T-$55EQ.6]T2F)(>F@U54M4
M04%82V5N34)U635L-VHU3E)H9U,X3G8W2S1S8C)E>G5&-'HR-W1(25!D5%1B
M,G=O96IF;$)R,RLY3VDF(WA!.U1.,')C5W1F;T5I+W%0,S1#;V5M-$5S9#@O
M-G=D3#AR6&-Q3GAN=4(Y5VA0*U9,<U-08TIY3T5+.$=W;V4X*U1.2FDP2'ET
M07,Q234F(WA!.T=1,U8T>#=-=S5'=BMQ;T$K:DEP94ME63E:;#%J5W)R54I#
M851/9E-5+W-X:EI&*VAC:VA,8U9D:7)S5F1I<65E5W19,'94579L=EDF(WA!
M.TI::F929E9362M0=U%Y02MO,4<V<T=#1E)T+W)$=7%N6"M*+TI-;'I%-S95
M,$U(1B]R2U%W5WI&>3%'05@Q2SA">6515E=H-&A+97<F(WA!.U9F0C5W.')Q
M.357=T5-5G<U06A3>71N57AR3VMI1G9J:C92;T8T9EHU9D5A;75+<TQU6&EE
M-6QE145233='34U&0D-K-U9#9TPP.$XF(WA!.W-+<5=+=DQV>F,O-#<Q:"]Z
M04PO04Y213)!<V]S1W=*9&ER,7(X:&9Y=U!M5%=0,#=Q:TI/:6%A-$UA='-T
M>&-$8THW<6Y6=G4X8U4F(WA!.T5V;UAZ5C5N5%1O>EHR:D$S>FIC:G!%<$A5
M+S522%%F5#163$8U-GI--T9M2EIM3E=9-VMK.7IH5G)&6%EQ-T9867%Z6#AR
M.6).<'$F(WA!.S<V8DDS-VDK2'=$<TI61E(O=T%%3G-"54YF;2]O9V<Q1S,Q
M94IA2F1R-E4U2"LO67@X2E K<VTS*WAX0VQH,VPO5E@P;E=R4%5%<E,F(WA!
M.T-11G=/<%$W3W8P<5--2W9O;$A6,%8P25I'04MS3VA",T)Y2UAL=C5Y86M7
M=3=$5%9/,&%.8U-$,V,X1BLW:69V=VA"66@U4#!S87 F(WA!.S5L<TQ2;#52
M3DE(;4(V1DEX>EE(-6AA659E<69M:'$O,41Y=$Y%:E5M=FU&=797=D4O12\O
M0VEN,#1!:W9$<TM(67$W1EA9<3=&6%DF(WA!.W%Y>51Z9D1#0TQA835U:71R
M8E)2=&1+051.8C-3,T%A46E6>59!-7%T0T-!45!F1E5(-7,Q>E1.6&MT6G)3
M1U-+94I':6U,.4=65#@F(WA!.T1#<GE(:S%76G%M=%0Q8G)I<D@X5F1I<GDW
M.#-0*T\Y668X04U!=B]!1D5464-Y:7=B06QK6&M0>5AQ6&Y$>DAB-E):07%J
M2&YD,TXF(WA!.TMR1$-0=$]F,4%D>FEP9E=D>F-A5#5.,$<Q,$Q2;VA',$U1
M4S-J1R]!9#58<C%::E4W.51H64U):VMK;&MA4U)I.&IK<S=S86MK.5,F(WA!
M.U1H5F)I<G-69&ER<U9D:7%R83--=')C>%A-4C1Y=W5S:4@S53%'2W994$XY
M=D9R,VME865%0FE95G9)4%EO3UI!.2M02F-#6&AM1D0F(WA!.S-N.'9T4RMV
M*U4W1C).6DE&3G9*+W=!.&IX6"]!25-M07!E5F9M2&5M-S@S-F<Q9FAI6EE6
M2&@V86A4+T%-3EA#14HY*U1L:C9M<E@F(WA!.S$V4E57.$MX2V8X04ML878V
M;WIG2VA.4'I04S)V8C(P=$II+T="1$I21T,P6GI4=4=(4F-1<%E"3#5C0B]U
M3&ME-&Q5<4%0;79/=C,F(WA!.T1#<4-L,%15-"MK0FM"-F5K4DEF;E)A:V93
M35915$M62E9H4FAS465O3TMT67$W1EA9<3=&6%EQ-T9867$X=2].>B]J=E=(
M+T%$04PF(WA!.R]W0E)%,D%S;W-,=&)A-'5R;4LR=&\R;'5*,U=/2TI"5FUD
M:E)603A38T-8,5HU2#AS,D@U6BM5,&ED634O33)O<4I,>'AV43<X5G(F(WA!
M.S$Y3T]T4#A!2TYF;TQ%;$QB:31M=4IN;FYC>5-Y2&LW=#%*=V]63%!4-RLY
M6FMS-V%7-5I"5FQH4G!#0C1K2T1I<6Q,1DQ&23A5<4XF(WA!.TA,1U-R;W=+
M<W)!,$E)3S1)>%9B:7$U235*0U%I;'E!5TE516UI:7)(8G-!2VY&6%)X4WE%
M<D=J3W=6;4E516M+;S5-9'5W07%C5E(F(WA!.T@V2C%8:'HK<%0X4%0Y9FPV
M5# Y3"]F;&%F6B]Y=6U+<4TY=&,R-T):-&YI63%O2%5Q9FA9;S-8=UI31#<T
M<3ED+TQA.$8U-5930U$F(WA!.V@O<3=V07EN*U4O14%F;V)!579'9%-S,G-T
M4G5R3G9T5S!R>$@O64U6+VAH43E-+TIM.4Q75W!74D\P56E42U K36EL5"]Y
M8D=!<4@F(WA!.VTR<UA(,6Y6<C(T<E@Q<FE74W8K<S50.&-+=E5F>6-T9VUH
M,W1X5&57-31F4D=I:V9I-7=&46QF;D=C>F59<G)W:DMX:B]9<5 T-%$F(WA!
M.W%3-'$W1E<S26M!5U96;%9F<W));V-$-4)G8U918W5J-EI,,6A-6C9K>$U1
M5#E$8W@Y=WA60E,K6$%F-VDU2'5*5DMG1#5R>G(Y=W@F(WA!.U9"4S9*<6-F
M4T%Y03E04TEK4'IO=%-0<$=+;TIL2VMQ=V]W,DE054A&5W-69&ER<U9E6&9M
M-2]X,W)$+T%*9T8O=T-O:6)!5U579"\F(WA!.VMP-4YT.41S1C@W-GI%2'9,
M9T9D07,S1D11,4181%8W2&]V=#@X46=L;#$U9#-&-6-Y6$YW-65743%::BMO
M97<W655+3TMO;E1R,S8F(WA!.VY.2DQW-2MP0DY"4W1+971%,%A,;V5N3W5+
M<VI0;C91;#%A>C4R-W9)-U=Z4VMX;C%(;F-G<GAO4GEN5"]G0CE!<%9&+TY%
M;S%'-#$F(WA!.VE,5$%K5G=21TI785)Y2&IJ47AG>4@T1TM34G!,.6YK935W
M<6DW:CAW6356:T-71'=I4TXT*TM82F]#-E-,>4@W=FPX4'$O0T,Q1D$F(WA!
M.T%!1T-L83%$>G=:;TI!3DYK=%DW<3-L:51J3S-">$E*27EZ8VLO94EJ365#
M9V=,4V<Y;6Q133-M-4HW4#9V3%IK.&)C5S9!4TPV6DLF(WA!.WA*1W-J;UEY
M4S9S;DI71$$O<S%O3GEQ03$W5VAQ=#!K=V@Y0E9$+T%7-2]&3$TX-VUV1F1U
M57!O2V102$9782]L1&,O0G%6<65X:FPF(WA!.T@P.&Q0-FAG2VAH;C5H5W=T
M+T]/<$E"44\V>40O;G!'<FXX5&A#<'HK5# O1'I$9%%K-U,R<D5F3DI%+V=4
M9TMH9VA*2DI*<51U4V,F(WA!.TMV869Y;E92-5-59V)T4$M4.#EH+T1!56AI
M=FU*=5=U,S5R6#DX-'%063!W;U,W1EA9<3=&6%EQ-T9867$R-45G0WEQ<W%R
M.6Q:1D0F(WA!.V=F24U$:7%$;#!J5$IE<TIJ3F%L;VU+:VXU3GI51#5$1E5&
M3#5C52\S1GE+:R]:;%5G068V>3AQ;B]9:D952$QO;7!X.4E42T-A1# F(WA!
M.VE*0U(T.%9Q=TAZ1TMS5#%,>5I(<F9N5WEU=%5J66%0<#EK:'59.3%-,&]U
M2FET=40R<BLR97DK-4="3G,Q=DQY83=M37-T0E%"56HF(WA!.U554D55559%
M2%I62%1#:%)X5C)+=7A6,DMS;#!(>DY*8E<Q='!K3VU#-TMU,&Y"5V-V3$DO
M3D@K14)H4F](2U5#,3<Q-UEQ;7-F;78F(WA!.U8K1C5)=6I84#%I6EI1:W%0
M345H:U9/13!I>&A/25E33WI-96\U57=+;%=O96$R;5,U=#5B4U=*,W0O<6I2
M;6%G4FQK9#DQ.4U.>%4F(WA!.W1262M60E1E=4973EEQ-T9792]L1U0K:S<X
M9&I!<' O<SA"54I(*V%I<5!..'A!,V%'26XU.&%F=W=H4W4O2VQI4$XP64)O
M1$)+1#<F(WA!.VEG3T%Q1TA95F4Q9FQ1469+4U504V57=C-J055H:65V4G)(
M<E8X:3E"4$HQ.3)*=V]11TMU>%8R2W5X5C)+=7A6,DMU>%8R2W1->6\F(WA!
M.W!D>49645-Z2&]!3GE4:7)Z>3DX,V%J3'%5<SAB0C=5;FI&8GEJ:V]24E)E
M+TIA.51X3TMP:EIE64Y.=7%+-T<Q;$]W5U4Q42]+44$F(WA!.T0O9V=-5E1-
M<5)3;S9I;U!I1#-'2W19<3=&6%EQ<E=5='1&9%)36$U*=4E%64Y*04@Y4&U"
M,C5586YV=&ER26PX.51X=$<X5G16;&LF(WA!.V52>DMY4V,O,W-K,&1F,V%H
M94UK,5=+9U9O2V-E=4Y+:U=R6#!6.7%%,3-&04QD2E-$-E%02VAO07AQ0795
M-SE-5E%M2W5X5FYV-5(F(WA!.V<O<$\O4%E1<4-F;2M!<45K+TY59RMB<&%(
M<$1&6"]G8U%P9"M66"]!0VPP9B]'1U@Y5TI535HQ4T$R*W S8T(V>%1326$O
M-4QK658F(WA!.V5Q+VLY8T(O3#DQ0BLQ1F1&=F]E3DMF:7!W1E%K,VTR2F]V
M34XV0U!T3TA(>5I18TE62TU69&ER<U9D:7)S5F1I<G-69&ER<U99>C4F(WA!
M.S,Q8C9T6DQ9>&UK,3!+>54V:4E(+VI9-V9F:7)!.$-U>%9&,D]R6#EK85%3
M;C!Q,6%&=FEJ3F%6*T4Y0V%D4G8W-'%Y0WDX>3)-.48F(WA!.W518E=5+W1B
M=$5F<#-:9G!R.#A+<'-+1D9D4T=J8C=%:6M-<' Q;W=Q1&ER<U9D:7)S5F1I
M<G-69&ER,&HX;V)B-$Y3=6HS36-1*VHF(WA!.VMX+U=-0E5-3R]-831%,VY,
M55-0<V]9-'@O<TDQ0B]'=45+;3,U4'=&+TUL>$PK>D9A='8W<S9!9FA8059#
M4V5F<DTR;FTW56MP45,F(WA!.U,K<W X9E9!8R]I,D5+>6(X;7(S:F8V:EI%
M+S-S4U1,+W=!.#)+;B]!2D]90V]43#AW<E5X-G1$8V9S>GA!9E-H;V9W27A#
M;&DR1E8F(WA!.W(X=41C9G153E!N:7)Z>4A49GI2<V]T3'-O3&U35T=63&1T
M4G4R:V=K:VA:;2\P:% Y2DTW=7ER47%W8FHY<C1D,4-H2TEL<V9Z26DF(WA!
M.VU32S!U6FA&4&1L-34R83%K-%%.9%-H>4)+1V]W="]236%Q3TDK3V\U8U)I
M<7!E<BM:8U5L>$I!6G)I3C5(14U#4%E2;%5A4V9G5F0F(WA!.S0R*WEK8T@R
M=5@R,C=J66]885HO>7-R:$<K<&,V4WE2=E!&06),,4EL-3-!84])<T]"5V=T
M*U)A<#0X=5!X67%M,VQ'6'II,79)4$TF(WA!.U9V2$<O3G5$:59'96=62T%*
M16=49U<U;%-7-4%50C5F87A5<VAX5EI.3$A$13@P<F-9-#%,=3-G<6EP3TMV
M2SE7,4-454Y1;74S,CDF(WA!.U$O078X<6I:4CDR0E5*:7)S5F1I<G-64D9N
M<48U6D]8='!41U<K,'5X5G%D3U-M<713=F-9<6XQ;#5P='!+2F52*VDO5#%9
M-G-N,'$F(WA!.V9I2'91;C595E1M3C0U66A,0S9Y>$AB,45)659)<E$P-D=N
M63<T<75X5C)+=7A6,DMV679Y,'-F<79L94]6,31T9%-0350O:R]:6#@F(WA!
M.T9W1DEE3V%Z92]8=%AV8G=D3&EE4U9F:S=K:CA-2TAO;C5-,EI%3W S<$=Z
M3DA#:"]W0E5&;2\T:W5!<45$*V-E;6U053=,549(=S,F(WA!.T52:&-J*V%)
M,49F;4@O1$5+5T]E4DY51VYE87)#6FI32U(O46PX3TUO-&(O04-99S13<C%B
M>CE9;30P9&)H4E9R5G=X+W="5G9H4#@F(WA!.TU!4UAN1T9$<U99,S5M6'IM
M3&MT;U)6-V8P0WAJ2FA6=E91<W9"5VQ6=#5"2T="231G>&EU>D5&5DEG;C5O
M;FIC34IJ36M%:6U!4%DF(WA!.WAX=$MY4F1"4UA:4W-N0FU*4$QJ5E%N25E%
M<3<R=C5H6$18<&Y-:4TR:U-25W=H;&AJ:D8W2D1B,$LX1T1I451#8C1J.$E&
M3THS3E8F(WA!.U=R9E1F3U5%9TI&,T]90D%86G)K56M%1C5'>E)W0G)H9U).
M04@S;4%B.6QN87!O54UR,$=,54DY35%8-6(V,#AK.')*27=D:U=76C4F(WA!
M.TDT>7=,1#DR:DMM>'!T='1I<5E9<7A0>C%Q,W!W2G!S6BM/5VMK.5 U069H
M6#971F9O>%9H3T)867$W1EA9<3=&6%EQ-T965S)U<FTF(WA!.S%K.5<S;&%*
M-E5,2V%62%=H.%(W2$95.7,O3EE.1G9O=FY00T%$.4U:;W8S169,0W%E5S@Y
M=F-X;5,R;%=E3F9T36QA<C(K2E-!>2LF(WA!.S%2=FEQ+T964S)T-6)M-&ET
M-&A74UHQ4D(W<V%$1EAS,VU394Q14$I6=W-20VU',D9T0E0K9'=)=U(Y+TQ!
M;#10:%$Y,"],8E1462LF(WA!.U5R5&M+4UA2835F+T%*-D@T1"]W05A!571F
M;51P0C%(>71C36DQ;7-Y3&U0>&]L430O-$%K-&A8:&]*0D)";U(P3T9$,R]Y
M-W%-4&TF(WA!.TQY=D1.2U%X=4EJ1&1$=VM!-'8X<6YC6D9,>E<K<S5B3SAM
M=%I24C172VXS<#!0,&I*255-5F1I<GHX4F9M<$)'-W=+<DY,4$ID1T8F(WA!
M.S5O6F5+4VA:4F)H<$%/4$)O;6EO=G=G4U9$2&I50E99<BM::#%+-5%.2VUN
M=U)U64I3,6<X;'<O2D8K1E)'=D0T3V)X:'8R<6,R<'0F(WA!.VA635!*,%AM
M-DMA95!7=G)$5SE*1VAE-6$Q66=T8T]Y:7-"9&U0<'-T9G-Q=C)66'9I<%I6
M:7%L9#-55G)A>3-->'!(17!D=F\W1#,F(WA!.U!167$X<'8W>5<Y=DIR<5@W
M8W)&:5!!9&=0:TYS0W%'2W5X5C)+=7A6,DMU>%8R2W5X5C)+<F]P<%E:1FQI
M9&\U1C-6,$I6:#AI358F(WA!.U1Y>3@Q5$M1;#='2E4O,S='07-G*VHW3%4K
M9RLK1EAP+W=#53%L839V<7@Q3TIV571R158S0E5I6G@X2W-0141F66M90W%9
M+VY$<EDF(WA!.V%3,#!A2G$K;B]P3G="+TUA<D=$.494.4EX0VPU+W!/;E,V
M;'%D<EE29F)U6D9J0CA!5'4S,$1F0W(V3F=H:F=G:F=I2$=/2E%I3#0F(WA!
M.TMO;T)K57)M5EA5<7=$2W=O=U!19S1Q*V903E=I4&]U=3-69U%F4U9U9'5X
M-WA.=6@K-UDK*U-1>6HX<'9-471.4VLP:60V45AV>%$F(WA!.U9/=VU59% Y
M;78T9UE#;UI2*UE':D9G;7%1<CEM:V1X5'<O6F(K1TE5<TAW<3=&56TX>%)A
M:$I*<'=S;V)H>70Q1S@X,79-26A(16HF(WA!.T)N.5-.<%EH2TA!-#!)86=*
M3DMG07%S8G5D1C@X,G=S-VEX=4HU,V=L;DUT<DQ/5S5W<&1Y4$%R3S!W5G5C
M8VE6<71E2V-E42MY5E<F(WA!.V5I=$XK=F9&6%EQ=S-Z,W$Q4VUM4DAP4U<T
M<#0O<TPO04UB9F1I<D0X0W5X5DYV2VUT=&]N;4MW,5!N2VM6=$UJ,T-W1VIV
M14="9$\F(WA!.W%G.&PR;U11-'%Y-U90>D$X<C9H6G%L>'!H=4QX-T-/,G5B
M>64S=#5*,W56=%HT;6Q--T9P9C<P=T97-59O<"ML5D(S6&UN>45.8FPF(WA!
M.W9,5%%P1&%T0T9J:&Q&=G=74TTK<D=0459#4#=X15)N-3%A4&QY1$UX2E94
M1TAZ>"M8.7),85175VM3>'E14&%/>&4Q<S)C0T=93DLF(WA!.VEY06<P.5!L
M4FEV<4\Q3U1Q1C-6548X-2M326102U=M;E-W86<Q:SEV3&1#,71F:FME,FQH
M8TQX6E1'<GE3<DE81E<R2V99;T%Q.#DF(WA!.WA6,DMU>%8R2W(T65I:-6\T
M659,>7ES16I29'EZ36%!1#5N1E@Q0C50,$MZ.&QE5$9J=5-&:VEJ3GIQ16]P
M=DM25F=01VUY<F=3.&(F(WA!.S%J5DQJ5F14=611=40K.75(3&MD94DV2V\Y
M;%=G>5-'9&9L1&]*;'9,:E=P5B]D=T%W5WA095)H.%I(*W%U,S T0V]E<31%
M=7A69S,F(WA!.S5Q*U=Z9C93=7%7-C%U9%!"36](5F]$=3,O04@T=FQ80T5&
M-4)$3$Q$2VLP5$9*63)$>'5U>$1+86=J-4A#<C-N>7)R,7(U;3!!4U,F(WA!
M.W%R5&-F4G9O97=E;35P-$XQ1U)3=U18.49M,&Y51V=A<&AB-&]*4#5K+W%/
M*U-1;'5+=7A6,DMU>%9$86IF4E=.;$YD>2]::5=O6' F(WA!.WE04E8K:S=9
M<3AQ=6)I5S5U2DQI53AP2E=,=69C;75"5E!&6%EQ>G)Y<C5L,%5W859P3CAZ
M3&(X-&)E-71:,5$R1F9R-'57=DI#-S F(WA!.S4K:BLU24UF,F8R<69$:7%-
M5'HW-5)Q67I93VQV.5%N<VQ!<W)1:C$U3&QB:$QL;VDT4FAY2$PP1#A#:U5'
M>D=I<55A=C5H.&U8>5<F(WA!.S!-5VQT85%2,W%Z4VU+1T9:4'%Z5#-$>7@X
M,4MS-3E*-%9136%!<65G-G%P=')V;C=Y6G%T;F54=&]B1%=R,D8Q865224A7
M3U@P+U(F(WA!.U)H26]J3&9$23=L=4%034HR6%I6,7 U,SAK5V5Q=U0R,FU-
M<TU.=W1W3&LR5FXV-$UC3G-I;%56;%)E5'A417%P0W%81&HT9TM+<U$F(WA!
M.SAX-FIP9#E,679942MJ-DYP1D1D1#!O-%$P>58U3T%H8W1557$W='E9,4]W
M;V]64VY&6%EQ-T98<U U2"M1;6QM2&UJ55DV4E(Q6%0F(WA!.TDR2#)N-DY,
M43EL-DPW-'%N6#5R*V%H3DM.0G1(<DA%43DX=S9&>'5S9CA!<V5P.2]L:49,
M>C9X<W)M*W9)8D\R5&Y03S1J:E@S63 F(WA!.RLW0W(V1C!(4TE.2#!M,C V
M2&1916]Z.4]4;F1M*VQJ:U5O+T9867$U;%9L2W-!5DEO461W46-6949E9E!+
M<C9$<34Y1E0K:G)O;#<F(WA!.U9U>2]Z4FXO049A+V1K9VA#955V33%Z-68Q
M5DQU3W(R-R]"9%%D;E0O;7!E;WA6-U1E,FUM95ID1U(T6D$X57$K<&)80R]S
M="]N<W<F(WA!.WE+6&UE;V%F9&%F9%!B6$MC2D4K-&IS464T3U-1:'-69&ER
M<U994#4V,6(Q<FQ.3VE.6310:FU)-WE%8D0O67%F>#ES5EER9U8R2W4F(WA!
M.WA6,DMU>%8V0EHK93E#=&9,<V1G-79,,CEI=&Q33U<T:DAW4TE'2W=R271X
M53)W9C O9UI#=$4K>%9Q<7%K,VY$>DYP5W5W=U-W,C@F(WA!.VM.+T=X17)'
M=G!S0U!I9C1P2E=,=3-8;%9G0G4W-V-65TU9<3=&6%EQ-T978V9L:BM83GHU
M<#%!6$XR<E(V2F).*R]L-F5Q=S,Y2D0F(WA!.R]W05-08D98=%AN5'I48656
M.4EJ<S=&55,Y9%!4<S1&031X24)X-6QF0F8R4C-0,#1P94I34U!)-U-335AD
M>5=D;4Y34V1Y4V-+2'$F(WA!.VXU5BM5:F)W+W R.%-K,'EL8DI$,5=--T=4
M-70P2'0X.$)54%)C0UA9<3=&6%EQ;#-M1%%R4%<Y36QS3&]F0RLX8V=&5VIC
M9EID9FPF(WA!.VER=U17.49V=$<Q1U=W=D4T>7AN-%=&94QQ96IQ5#%">5-%
M.#AJ961P+TPY,39&=U=K,'%9+W99>'5562]W0S=%2#9X,WA+=E=.4S F(WA!
M.WI3+TUE;7AY>'E+-G5V3S%U:S-P6"M(:4UI;#5X<75K6'5L,TIG=6MP+TI)
M4'-U4$94:VM)3$951G)'<%(V9' X,3 Q0WE#:V%(.7 F(WA!.WIS;R]R-UEQ
M.'-L:VML:V574FDP:VI&;EDY4U-A:S1&5S1Q-T9867$W1EA9<3=&6%EQ-T98
M67$W1E=F+T%*8R]L5'%(;5=73R]W0E$F(WA!.T0R;6AG,4UN4U-E;C=-5F4S
M:3,S67$Y<#$S6#E$.&UA3D9A5S!3239*>'-B0U!A;T<S2G9"83E3979Z>%,X
M53%053<S53<R5SEV6E0F(WA!.TQC4VUR364S9T%/=TA9655-;"],+W=!;'9R
M;#9,=3=1:E-R9'9J<G0V<FIF,#$Y=C5S4W(R=%965D-Q07%Q2T%$64%$27!B
M>%8R2W4F(WA!.WA6,DMU>%9)=DYV;$MX.'A74'!3,&IU-'=48EA)1S9N=U!I
M<#=J1EAH=7)A5&8V5F935U8Y1UDU-'HY1$1S>6YU1&MK2G8U4C@W86PF(WA!
M.S5E;C1,5V94-41783%9-V8V>4@Y;'8Q-'$Y9W-R+U%03D=M1F]75S5G8C=C
M8F)34G0T16163U)3>%!84$DY-V%&<')#='IB9&5(*S<F(WA!.T9(>2]A*VI$
M84AJ4&YF5E1C86@Y4E$O=7)1:U W>6XW6"]!.5!V=W%X=D%R<U9D:7)S5F1I
M<G-69&ER<U9D:7%,,'933E0Q5S=7>C F(WA!.S(R:W5R;"MK8V$Q3E!%.6=0
M8S1Q.7 X:2]K9&$R8E(S+VU9<F1822M*3E!1,6A5+SA73BLR9F)P.#AB4WEN
M>F0K64]M-D1%8D=W0U@F(WA!.T=O<4]#>$PO04A524%O3V101"M59FAJ4TAJ
M,F]A:F4V:F1Y6&0W2S Q>$MA=3=F<4$W061G34MP-S5,.&Q89FU'-SE35&Q$
M<&M2+V8F(WA!.S-(9&HO2DA8<3,V<U9E,S)6;&$R3G!&85=K66AT-%8T>'AR
M,$$O>C8U1DMT:7)S5F1I<G-69&ER<U9D:7%595IF2RMM95E,4#!,=&4F(WA!
M.TUQ5DYV8W(Y=4YJ-&5)4&-9<3A5.'EE5DY7.'8S6'!886-O1THY0S93=G!U
M4&XR4&E$:VM)2%1.53%$5$QT8G5W;F%#9&8R;%!5940F(WA!.T1O4C=(1EAP
M+VQV.#)B0S563&97:RMQ5#E0<DM!;49V.5EB<VXT:C592U<P-#AW95$O2G9M
M=4@V>E!"1S!S;W%M;U=R0EI$,3,U<E8F(WA!.U@O,E9C0UAL=FU(.&=T9717
M85128G%054EE;VEK+V-Z9$]M+W=(-WAH47=$5G9++VU,4T=+-FQP,7AA,$9E
M8F]E1E!:>%9F>'A62S@F(WA!.U9D:7)S5F1I<F%)-W-&4E-Z2%E+0E5N1E=3
M84PK6$AN5%=#<'1.3&Q32G8Y,WIJ,%DO;E8V5BMJ1EAO+VQV.$$U>"MT,#14
M95EB-'DF(WA!.VYQ8E,Q*T9E;E)P1T94.4%'3G!E9T=4>5HU3'-04VI31%0T
M>4MI1TU6;&LY-D-R=#AZ9U8U+S5O+TY(57121#(R;&AR1WIB67E6+V8F(WA!
M.W50;5!S9DIF=G<P:&<U2DIQ975&5V)E5%!Y,W4Y5TUD.7%983(P,UIK5'!*
M35!B*U94+TXY,VIG=%AR.7!A5S%P8E(R,71'<TU%4S@F(WA!.UDT,49!04U#
M5EA&6%EQ-T9867$W1EA9<3=&6%EQ-T961SAS<E,Y=#-T<G5*6C1*0E(T,T%)
M4#,T<3AY.'HO;$Y015AU9$)9>7@W:S(F(WA!.U5H*TUF-FIN-UAY3R]U8TYO
M<#4U8U<Q>&)43D)C>%!$36AO.&-I;%=".7=D.$MO=E-D9C%J4UIF53 V-VMT
M>516:U4Q4G8X05=1,54F(WA!.R]3359:>'!0-7@S4T%*<71K<W<W>E<U-$XY
M2TY52#=X9W!B6EA9+VU0-5!V;#1T9"]6,F)R2&-O5BLX+T5N-#0P;%=M.'8X
M06M(5W$F(WA!.T9R4%1R,70V4$=);6)F<CA38C1&449Z*U5(-64S1DLV54DV
M1W8W<5=64#%0:F%O9B]L4W8U968Y5RM4+T%+4TIV*V$X8E9'=V9L6BLF(WA!
M.U@Q<V=),&5%:$)U,')/+U%5<65B15EQ:3!U9DEE:$M"13)N,E)4;W-1:40O
M04A*.%=+<%9Q6#5T95<W6457:7I8<V<V1E8Y3E!P6C8F(WA!.TXO=W5':U=W
M,U=0>E4X>#-W84\P-&%F0V8Y.69&2E0S:V(O:E5$1VQ9:$Y03E!+,',X:E-Y
M=6%V235,350W:S<T5E)U:F58.5@Q;68F(WA!.S!D4'1M;6]A4$I3:V%F-GIN
M65EQ.54X<2]L:G!M;&Q,<E5I=#EF0VA64U S35HO>590,FHW=#DR0S%:=&=3
M-T9867$W1EA9<3=&6%DF(WA!.W$W1EA9<3=&6%EQ-T9867%L*W-E6#E(,6E(
M,'12=%5N<'-J;EHQ+S%81D=(,S1Q."]W0F$O2C)24S!M:C-G8V128C-/>"MI
M4E)1+U,F(WA!.V]W,FEM1F%P-54X>&%853-T:$Q'9S9Y<4]C9B]!06%C;"](
M0W%5-'$W1E9E3R]V;WAX:G5*54AG<G-"*T)X5E9B5TY764%.93-$0F4F(WA!
M.V=-<FUN-#1Q:#5B:659,6QK85$K3'-7+UAI<6YI<39/3U-2=VMA;#-B6E95
M16MN,D%X5FME:R]L,S5Q,45Q4F%',6E0*S=B;CDR0B\F(WA!.W-4.&8O0S0R
M<D]T1"]+5%(W6&I,<6MR6#!O;V935W-C45 P2&LS,VHU64Q7;6-7,7)B5W-+
M=U<P4U%W;TM*2$=O5E%0641!;%5X5C(F(WA!.TMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5DQB-WDQ-69V>51D-F9"2S4V>49&1"]W
M1$)#:F9J:7%36% U5RLF(WA!.U0U<6Q,95,S<B]V<59V.$%J9FYH=&%3*U0X
M;F9,-5 W=3=U,4AC1F\R+S0P1TYO<&(O>7!V4E K5S8U+S5*+S@P-#)T2S!0
M-5%E5VLF(WA!.V]:2C=U53EW6&I!+T)++VIJ83!M9' K6$AK-C)O4EE#6F@K
M,4TW=B]!34M4>"]$1S!P-UHV8G Q:W9'>G19<EI4<U)%:7!8-3A134,F(WA!
M.V]N1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6&AD;C5$
M+TYJ>79P3C=Q;FQD26IR;7%8,'=U=$]5,CA63&1B<3<F(WA!.VQH;FMK;6%A
M1UHS.650;6%+=VE(<&EJ9D5&568U9SAS+VY&9F%R6F%U<V=K=3E-=719:W-9
M<5="4TM#4V5'3WHY4#%&;S!J5VYQ;4XF(WA!.VXS5F=!-4%,06Q56CE8+U!U
M5S!D;75J0D]&<TDT55)D3DI+>5AC=C%U5GEY<W9Q>%=Q>#AG4&=,365!3DU6
M56]Z+WIK2D=U;4%Q<W@F(WA!.T8S87DV:3=F;S169VMT<EIR<4%Q=D@T234R
M=496,%!0-%8K,$<U04MR*UAJ*V9#<' X975"<$5&>$4Q-4Y#9$Y%>%9R84)I
M<F=F=2\F(WA!.W$V,TAR3$E9>#9T2V-+.6-653=N5"]Z;#$S.'-D6C!F6'1-
M=$@Q92]3-F="*W1X2DM%35-E:C9A47AE9W=E6&U0:FQ1;VQ+;&UR5E8F(WA!
M.V%7+S5Y0T8U83A6+S!),FPV:WA:9$YE651-8F\R8GEQ2DE6.5I1='5'16)E
M:V52<E-H>%98:VPO4'=Y,T%3,FEJ='AP5G-95T4Q;$HF(WA!.TMB-VQB+U=!
M=%DT:SEB:CE9;U<O8VXT3VQ$5E9",FYK8GI.2#59.'11879O8F$S8E=.,7$X
M=7)A0DI086E34C<R.&MM=$QL<7E*874F(WA!.UDQ66MR>3),,4%Q2UEQ<51R
M+WIK261$=5)%>7!Q:3-)841I3D\S4F)3-DQR2'E(1#9U,7E,6EDK9C<S-UA+
M9S-X5E,O5% U,$HU:3 F(WA!.UA1;FQ(,35H9#-6,')*6D=/5WIG,4M'2DI:
M,E=H02MQ5$@T64M0>30Q2#)S2W)T2E O3U)-;F]Y-FMQ=TY"3GEK=#%B5'!%
M;E0V>EHF(WA!.V]Y<W=65U=-=W9D=6Y':F=+<7-Z3CEO2W5S52\U>4)M,4MZ
M:'5Y,%=M>697;S<R-%DV84A#>4I)25I!:U%:;VUI9FAW5EAL<G9Z3S$F(WA!
M.T-644]L858K9C)N,E-R0S!Z,T1T8D-A4S=M<UHS85-+=W1O:5A:;6-F5B]8
M4V)M52]F3CA,8FMK-'%N47,O>FYU+TQV;6DQ=C-D8C8F(WA!.UEX3F],=WE7
M<TUI<CED;45S85!!,%)(*VE*0W<U=7)666IM<#-52VM-4&LS.#=,:2LP94LT
M,5,K=$Q.8E0P-RM96&=K0VM3,T1L6D8F(WA!.U,T:FM:,U%W2CA,37=&85A#
M.&%U5EIV*U@Q="M9.6IF>C)F;55,8S9F.5AI84Q56DI1.'I43$9#9U%Q<VI,
M6"LX.5=K86IK3U%:*V0F(WA!.T5#<S9X5C)+=7A6,DMU>%8O.6L]/"]X;7!'
M26UG.FEM86=E/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @
M(" @/"]R9&8Z06QT/@H@(" @(" @(" \+WAM<#I4:'5M8FYA:6QS/@H@(" @
M(" @(" \<&1F.E!R;V1U8V5R/D%D;V)E(%!$1B!L:6)R87)Y(#$P+C Q/"]P
M9&8Z4')O9'5C97(^"B @(" @(" @(#QD8SIF;W)M870^87!P;&EC871I;VXO
M<&]S='-C<FEP=#PO9&,Z9F]R;6%T/@H@(" @(" @(" \9&,Z8W)E871O<CX*
M(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^
M1V5N83PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @
M(#PO9&,Z8W)E871O<CX*(" @(" @(" @/&1C.G1I=&QE/@H@(" @(" @(" @
M(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL:2!X;6PZ;&%N9STB
M>"UD969A=6QT(CYG-S9L,#0\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z
M06QT/@H@(" @(" @(" \+V1C.G1I=&QE/@H@(" @(" @(" \9&,Z9&5S8W)I
M<'1I;VX^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \
M<F1F.FQI('AM;#IL86YG/2)X+7)E<&%I<B(^<W0P,S0N86DF(WA!.U-A="!!
M<'(@,C<@,C Q.2 Q,#HU.3HU,2!'350K,#4S,"8C>$$[4V-R:7!T('8R+C0N
M,BP@26QL=7-T<F%T;W(@=C$V+C N,"8C>$$[1W)A<&AI8R!T>7!E.B!0:64@
M0VAA<G0F(WA!.R8C>$$[XH"B(#(@0TU92R!B;&%C:R!O8FIE8W1S(&-H86YG
M960@=&\@9W)A>7-C86QE+B8C>$$[)B-X03M4:&4@9F]L;&]W:6YG(&9O;G1S
M(&%R92!P<F5S96YT(&EN('1H92!D;V-U;65N=#H@6U1E>'1&;VYT($-A;&EB
M<FE296=U;&%R72PL6U1E>'1&;VYT($-A;&EB<FE";VQD72PL6U1E>'1&;VYT
M($-A;&EB<FE296=U;&%R728C>$$[)B-X03LM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+28C>$$[<W0P,S0N86DF(WA!.U-A="!!<'(@,C<@,C Q.2 Q,3HP,3HP,R!'
M350K,#4S,"8C>$$[4V-R:7!T('8R+C0N,BP@26QL=7-T<F%T;W(@=C$V+C N
M,"8C>$$[1W)A<&AI8R!T>7!E.B!0:64@0VAA<G0F(WA!.R8C>$$[*BHJ5&AE
M(&1O8W5M96YT(&AA<R!P87-S960@<')E9FQI9VAT+BHJ*B8C>$$[)B-X03M4
M:&4@9F]L;&]W:6YG(&9O;G1S(&%R92!P<F5S96YT(&EN('1H92!D;V-U;65N
M=#H@6U1E>'1&;VYT($-A;&EB<FE296=U;&%R72PL6U1E>'1&;VYT($-A;&EB
M<FE";VQD72PL6U1E>'1&;VYT($-A;&EB<FE296=U;&%R728C>$$[)B-X03LM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+28C>$$[1FEL92!.86UE.B @(" @(" @(" @
M(" @(&<W-FPP-"YA:28C>$$[57-E<FYA;64Z(" @(" @(" @(" @("!(;W=E
M4C!#328C>$$[3&]C86P@5&EM93H@(" @(" @(" @(" @,C4M07!R+3(P,C @
M,#DZ-3(Z,#@F(WA!.T535"!4:6UE.B @(" @(" @(" @(" @,C4M07!R+3(P
M,C @,#DZ-3(Z,#@F(WA!.U-C<FEP="!697)S:6]N.B @(" @(" @(#(N-B8C
M>$$[26QL=7-T<F%T;W(@5F5R<VEO;CH@(" @,C0N,"XR)B-X03M'<F%P:&EC
M('1Y<&4Z(" @(" @(" @(%!I92!#:&%R="8C>$$[)B-X03OB@*(@,2!B;&%C
M:R!R=6QE<R!C:&%N9V5D('1O(&]V97)P<FEN="XF(WA!.R8C>$$[XH"B(#$R
M,2!B;&%C:R!T97AT(&-H87)A8W1E<G,@8VAA;F=E9"!T;R!O=F5R<')I;G0N
M)B-X03LF(WA!.U1H92!F;VQL;W=I;F<@9F]N=',@87)E('!R97-E;G0@:6X@
M=&AE(&1O8W5M96YT.B8C>$$[(" @(" @(" @($UY<FEA9%!R;RU296=U;&%R
M)B-X03L@(" @(" @(" @37ER:6%D4')O+4)O;&0F(WA!.R8C>$$[5&AE(&9O
M;&QO=VEN9R!C;VQO<G,@87)E('!R97-E;G0@:6X@=&AE(&1O8W5M96YT.B8C
M>$$[(" @(" @(" @($)L86-K)B-X03LF(WA!.RTM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+28C>$$[/"]R9&8Z;&D^
M"B @(" @(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]D8SID97-C<FEP
M=&EO;CX*(" @(" @(" @/'AM<%109SI.4&%G97,^,3PO>&UP5%!G.DY086=E
M<SX*(" @(" @(" @/'AM<%109SI(87-6:7-I8FQE5')A;G-P87)E;F-Y/D9A
M;'-E/"]X;7!44&<Z2&%S5FES:6)L951R86YS<&%R96YC>3X*(" @(" @(" @
M/'AM<%109SI(87-6:7-I8FQE3W9E<G!R:6YT/E1R=64\+WAM<%109SI(87-6
M:7-I8FQE3W9E<G!R:6YT/@H@(" @(" @(" \>&UP5%!G.DUA>%!A9V53:7IE
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T1&EM
M.G<^-C$R+C P,# P,#PO<W1$:6TZ=SX*(" @(" @(" @(" @/'-T1&EM.F@^
M-SDR+C P,# P,#PO<W1$:6TZ:#X*(" @(" @(" @(" @/'-T1&EM.G5N:70^
M4&]I;G1S/"]S=$1I;3IU;FET/@H@(" @(" @(" \+WAM<%109SI-87A086=E
M4VEZ93X*(" @(" @(" @/'AM<%109SI&;VYT<SX*(" @(" @(" @(" @/')D
M9CI"86<^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$YA;64^
M37ER:6%D4')O+5)E9W5L87(\+W-T1FYT.F9O;G1.86UE/@H@(" @(" @(" @
M(" @(" @(" \<W1&;G0Z9F]N=$9A;6EL>3Y->7)I860@4')O/"]S=$9N=#IF
M;VYT1F%M:6QY/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9A8V4^
M4')O(%)E9W5L87(\+W-T1FYT.F9O;G1&86-E/@H@(" @(" @(" @(" @(" @
M(" \<W1&;G0Z9F]N=%1Y<&4^5'EP92 Q/"]S=$9N=#IF;VYT5'EP93X*(" @
M(" @(" @(" @(" @(" @/'-T1FYT.G9E<G-I;VY3=')I;F<^,BXP,# \+W-T
M1FYT.G9E<G-I;VY3=')I;F<^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IC
M;VUP;W-I=&4^1F%L<V4\+W-T1FYT.F-O;7!O<VET93X*(" @(" @(" @(" @
M(" @(" @/'-T1FYT.F9O;G1&:6QE3F%M93Y-65))04104BY01D([($U94DE!
M1%!2+G!F;3PO<W1&;G0Z9F]N=$9I;&5.86UE/@H@(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT3F%M
M93Y->7)I8610<F\M0F]L9#PO<W1&;G0Z9F]N=$YA;64^"B @(" @(" @(" @
M(" @(" @(#QS=$9N=#IF;VYT1F%M:6QY/DUY<FEA9"!0<F\\+W-T1FYT.F9O
M;G1&86UI;'D^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%C93Y0
M<F\@0F]L9#PO<W1&;G0Z9F]N=$9A8V4^"B @(" @(" @(" @(" @(" @(#QS
M=$9N=#IF;VYT5'EP93Y4>7!E(#$\+W-T1FYT.F9O;G14>7!E/@H@(" @(" @
M(" @(" @(" @(" \<W1&;G0Z=F5R<VEO;E-T<FEN9SXR+C P,#PO<W1&;G0Z
M=F5R<VEO;E-T<FEN9SX*(" @(" @(" @(" @(" @(" @/'-T1FYT.F-O;7!O
M<VET93Y&86QS93PO<W1&;G0Z8V]M<&]S:71E/@H@(" @(" @(" @(" @(" @
M(" \<W1&;G0Z9F]N=$9I;&5.86UE/DU94DE!1%!"+E!&0CL@35E224%$4$(N
M<&9M/"]S=$9N=#IF;VYT1FEL94YA;64^"B @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" \+W)D9CI"86<^"B @(" @(" @(#PO>&UP5%!G
M.D9O;G1S/@H@(" @(" @(" \>&UP5%!G.E!L871E3F%M97,^"B @(" @(" @
M(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI/D)L86-K/"]R
M9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!4
M4&<Z4&QA=&5.86UE<SX*(" @(" @(" @/'AM<%109SI3=V%T8VA'<F]U<',^
M"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @
M/'AM<$<Z9W)O=7!.86UE/D1E9F%U;'0@4W=A=&-H($=R;W5P/"]X;7!'.F=R
M;W5P3F%M93X*(" @(" @(" @(" @(" @(" @/'AM<$<Z9W)O=7!4>7!E/C \
M+WAM<$<Z9W)O=7!4>7!E/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM<%109SI3=V%T8VA'
M<F]U<',^"B @(" @(" @(#QX;7!-33I$;V-U;65N=$E$/GAM<"YD:60Z-&9D
M,S4X-6(M,F8Y-"TW,S0X+3AA9&0M9#-A,CEF8F4T.&0Q/"]X;7!-33I$;V-U
M;65N=$E$/@H@(" @(" @(" \>&UP34TZ26YS=&%N8V5)1#YX;7 N:6ED.C1F
M9#,U.#5B+3)F.30M-S,T."TX861D+60S83(Y9F)E-#AD,3PO>&UP34TZ26YS
M=&%N8V5)1#X*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YX
M;7 N9&ED.C@P.$%".3(R03$P-D4V,3$X0T8T0C$R.3@U048V1$4P/"]X;7!-
M33I/<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I296YD:71I
M;VY#;&%S<SYD969A=6QT/"]X;7!-33I296YD:71I;VY#;&%S<SX*(" @(" @
M(" @/'AM<$U-.D1E<FEV961&<F]M(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @/'-T4F5F.FEN<W1A;F-E240^>&UP+FEI9#HX-V(X
M-C8X-RTU9C8P+39F-#8M8C8V-BTP-C)A9C<P.6)A.3D\+W-T4F5F.FEN<W1A
M;F-E240^"B @(" @(" @(" @(#QS=%)E9CID;V-U;65N=$E$/GAM<"YD:60Z
M.#=B.#8V.#<M-68V,"TV9C0V+6(V-C8M,#8R868W,#EB83DY/"]S=%)E9CID
M;V-U;65N=$E$/@H@(" @(" @(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N
M=$E$/GAM<"YD:60Z.# X04(Y,C)!,3 V138Q,3A#1C1",3(Y.#5!1C9$13 \
M+W-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F
M.G)E;F1I=&EO;D-L87-S/F1E9F%U;'0\+W-T4F5F.G)E;F1I=&EO;D-L87-S
M/@H@(" @(" @(" \+WAM<$U-.D1E<FEV961&<F]M/@H@(" @(" @(" \>&UP
M34TZ2&ES=&]R>3X*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z
M.# X04(Y,C)!,3 V138Q,3A#1C1",3(Y.#5!1C9$13 \+W-T179T.FEN<W1A
M;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,38M,#0M
M,C!4,3(Z-#$Z,3<K,#@Z,# \+W-T179T.G=H96X^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E($EL;'5S=')A=&]R($-3
M-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @
M(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D
M9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T
M179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.C1F9#,U.#5B+3)F.30M
M-S,T."TX861D+60S83(Y9F)E-#AD,3PO<W1%=G0Z:6YS=&%N8V5)1#X*(" @
M(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,"TP-"TR-50P.3HU,CHQ
M,RTP-#HP,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.G-O9G1W87)E06=E;G0^061O8F4@26QL=7-T<F%T;W(@,C0N," H5VEN9&]W
M<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @
M(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO
M>&UP34TZ2&ES=&]R>3X*(" @(" @(" @/&EL;'5S=')A=&]R.D-R96%T;W)3
M=6)4;V]L/D%D;V)E($EL;'5S=')A=&]R/"]I;&QU<W1R871O<CI#<F5A=&]R
M4W5B5&]O;#X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(#PO<F1F.E)$
M1CX*/"]X.GAM<&UE=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" */#]X<&%C
M:V5T(&5N9#TB=R(_/O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! ?_  !$( C0!U@,!$0 "$0$#$0'_Q  ?  $  00#
M 0$!            "08'" H"! 4# 0O_Q !.$   !@(" 0,"! ('!0,("04!
M @,$!08 !P@1$@D3%!4A%B(Q00HR%R,S46%VMQ@D0E*!8G&")28G-%-8D=8U
M-CA4=Y>8L;9RDJ&CP?_$ !D! 0 # 0$                ! @,$!?_$ #@1
M  (! P(#" (" @(" 00#   !$0(A,4%187'P Q*!D:&QP=$RX2+Q!!-"<E)B
M,R."HK)#4Y+_V@ , P$  A$#$0 _ -_C & , 8 P!@# & , 8 P!@$3G/KGO
MRVXV;.JFG^*/IP[?YF6"P:_'8<S?(:TM:/JNIL@G9:$_#;JPA7;.+VY@,2#\
MU?D#5I1>.E(YU"N)U0DDU8"]-*>:U3ZORM;Q\"VG #UK].<PM'<I=E[:US9.
M*][X2-9*1Y-:UN$BI8U*=#1C*U.5I:(DA@JS+2C@CJCVJ$D:P\J\98H>QQA(
M51H]/(1;M^%5#I=*3[RJCNO$SIGBM=3 >L_Q*UC2_HOWSMWT]]HZG]/7=.U)
M'4^O^6#W8D=./PDXQ]),G,Y,T!G46[8S5K]&FW$K%1=K=F11KEL1J\O=I.M/
MXTPL^RRE4G6E+IA^CU?AY$C7JB>L!4O3=C*XSB^.FWN2UXM="E-I1[2@E)"Z
MQ@=>0<HVB9>T7S:2,5;C5A@W<OF/LKM:;.M#$>LSOG<<F]9'<NOLK11WWE)6
MSQQ"U9=K7'J<:OE?3'@?4ZW-5GFHM</=8NMC3U'C)U._S$:N-L=TN!J$'-K0
MU*;V*>M=C+$PL&9U%5YF>6G&;=ZLS:)K2!1'=?>[BN^\UY.)UMJ]D14U7^(J
MV36E]![=Y6>G9L'CCPBY06=*N:DY-K;9B+H=!L[44^FV6UTE"FP;EC"OH]-:
MRG*>28/EJJQE9RFM[ZTCQ.N+_P"O*52JJ6:4GXP]?NQLF[,V;1=/:WN^W-D6
M-A5M=ZZJ<Y>+C9WQCF8P]8KL:XEY62.5N19=S[+%LJ=!JS1<.WJPI-62#ARL
MBD<99P:S5&]:+U3.<#FT[ ],KTOHC87'"LV"1@([9>^=DP5.D[P>+4 '*D,W
MEK[K*OMY(A3D3?P=;F]C?1')BMI&6^4<6J8U[E--JZXJS"3<+C;KE<N-S?\
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M;I-UW$>I(P;U\S(]00=-5EFIE@722<MU#IE(LF8P0UE05;@# & , 8 P!@#
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M3'CB%Q'JW.?^&_TMQCM]R+KJ+V!H7YS6_K))+LJ9/47;\M?ZW899LN[CT74
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M 8 P!@'A62SUNFPSVQ6V?AJS 1R?NOYJ>DF<3%M$_P!C.'SY9!LEY#^4A3*
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M^+^%7_;X1"5E#J/?@+7:*HZ!]5[)/UMZ @(/("8D8=T E'LH@XCG+94!*/W
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MFO<R2P0, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M$6RL2[<?U5CIR">/HUX0H_E.*#DXIG 2' IP$H#(K/ & , 8 P!@# & , 8
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M4%-6>8C:]7(J0G)V8=HL(J(BFB[^1D7K@P$1:LV;8BBZZRAAZ*1,AAZ[$>@
M1 "?KAWZ8D%2BQ6QN13-A9K@ (OHG6QC(R%7K2@]*)*V8Y14:V>92_* QQ!5
MKC%0% .,XH*#AIG57I3Y_4_4\M=*:-7Y?9,.0A$R$33(5--,I2)ID*!"$(0
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M946""'3UE/[3BC_D+9G^H(YE7E<OEG=_B_A5_P!OA$)64.H8 P!@# & , 8
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MHRDVX1#:2EFJ)RCY.7?E#L-Q;K*=2-KT:+AE2:<@X.K'5>&45 WB ]$(\FI
M$T5YN7,D15\X3212(WC6<>Q:;))*%XO5OZV6GFWBW+DQJR2#,_AKS"M7%FZA
M[HO)W5ED=H%NU0(J!C$^Q$ LU=(L<B+6Q1Z(% Q!.BVG&201D@HD8D=(1D54
MIKCH_A\'YK*U3M34Z>*V-J&EW2K[$JL'=J7,L[!5[(P1DH>68G$Z#ILKV @8
MI@*JW<MU2J-GK-RFD[8O$5V;M%%R@JD3!J+,V3FZ*HP!@# & , 8 P!@# &
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M+&Z I?(W1$6Z"8%0:,VY$FC)LFDU:((MTDTB:I19&13& , 8 P!@# & , 8
MP!@# ,5ZS_Z"MO+T%;_=]5[HE96Q:Y5'I-C4-G*$6E+A02#_ &32-N"1'-QJ
MC8!01)+)VB+:(F,JT(-5_%QA.ZY[?*QL:/\ G3-N]0DJLRZ<*KP;A\T9498S
M(=/64_M.*/\ D+9G^H(YE7E<OEG=_B_A5_V^$0E90ZA@# & , 8 P!@# & ,
M 8!5%(I-MV5<JMKVA5^4MEVN]@B*K4JQ"MCO):?L4\^0C8B)CFQ/S+.W[YR@
MW1+V4OFH G,0@&, -I)MX2E\D?TP_2U]/2I>G5QHB=;IEC)G<MW&.MV_;VP
MBR<_=BM%4V=7A7PD*NM2->-7CN"JY3B1.1=N+#;OB1[JV.X]KK13%WGV7WUN
M>9VO:OM*O_71=9W_ *1*96;9*5=U[S)3W&JA@%VP5,;X[DH?81Z#OVEP+_9K
MD#R*( !P43\DS6=*?/<S3:P_#0RAKMEC+,R!W'J]')XE=-%! '+100[\%2 (
M]D-T/MK$[34 !Z$#%.0F+33AFR::]UL5!D$D6GJ7\6MF[SJD)>M=SDS.KZZ8
MO5'>IBB0S.7;JF.L\L59;HID5=VU!OTV6CW9W2DG&()MX06LBF=C.WHJ2LX4
MZ_#X;<7>V*5TMW6FGUU[&MH<ATSG34(9-1,QB'(<HE.0Y1$IB'*8 ,4Q3 (&
M*( (" @( (9J9'' & 2)<".:3_CA;B4NZO'3S2]ND$_JZ(^ZX/29AP)$"6R+
M0+YG%F8I4TK)'MR"H[9)IOVJ:S]@FU?5JIE6RNH+4U0[X?4FSXQ?,I1DSDHU
MVV?QT@U;OF#]FNFY9O63M(B[5VU<HF.BX;.$%"+(+I'.FJD<IR&,4P".)L=K
M & , 8 P!@# & , 8 P#S9B8BZ]$R<].2#2*AH9@[E):3?K$;,H^.8(*.GCU
MVNH)4T6[9NDHLLH<0*0A#&$?M@&JCS=Y:R_*'9"AHM9VQU54'#MC0H-3W$1>
M%,;VG5MEFQO$?K$V5,ID$52]Q$6#>.3*#D9%R^WII[JC75]:+K2,:JN\^"P8
M3Y)48!=#3FG[SO6_PFN-?19I&=F51,JNIYIQL+%HF)\^=FW9"* RB8U,Y5'"
MXD.JJH=%DS1=2#IHU7-I7>.NO=HE*7"U-KSC-QIH?&+7K:FU)$KZ9>@W>7*X
M.6Y$I:US2:8E,Y7Z,H9I%LQ451A8=-91O&M3G$RCF0=2$@]P;;?LMC6E0N.I
MD9D%B%OG_P"HV%'/,:2X_P RDK<B>_&WC8L>J19&I&Z,BZK]5<$$R:UH(/DE
M)S*8G2KA@.T8B>?!5>"TIIF[QHM_U[\LYU5:)\W]&O@X<+NEUG3I95RY<JJ.
M'#APH=9===8YE%EEEE#&45554,8ZBAS&.<YC&,83"(YH9GRP!@# & , 8 P!
M@# & , 8 P"WFU-=1FTZ1+T^0<KQB[GXTA S[+[2=7M$2X3D*Y9XE4#$.E(0
MDLW;/4?!1,%R)JLUC"W<K$-#4J.D6IJ=+35XT>&M4^93NDMBR5[K+V/MK9"+
MV90I16F[+A4/RI-K+'HI*$F8U,P%,:NVR.5:66NN0**2D=(E;%4479N/$G*O
ME9ZXY%=/=:B]-2FE\-N:=GQ1&SZRG]IQ1_R%LS_4$<SKRN7RSL_Q?PJ_[?"(
M2LH=0P#,NI</TGNBZMOO:G(32V@Z]LYQL%GI6N[#8;FL-IVLKK)9K'6I[&M]
M1ZFV3%5*"2L;M*I1\Q?):M$DK"1V5NW&%CI&::"KK_DZ4FVHF(M.,M7X&*7X
M5M'X>_%WX;G_ ,)_.",_$_T>1_#WU(0$0C_K7Q_IOSA !$&GR??Z 1]OH!P6
ME3$J=M?(R!WEQ8O6GMC5S6T2$ALZ8L&B-#[X$:=6IAVM'06\],4?<C6.=1[8
MD@Z[JS"\-824E!!-FY=LE7:96Z*Z:116FI-3B[5WL8^Q57LL]Y#!UV=F0+\O
MR&*B)"1\?@-?G/O+X;=;KX3+_>W??7QFO^\+>"7Y\$MI9:7-P=(8F5*63,:,
MD +"G*G,&%FY L2<[H&1"28BGTP.9Z8&A2NO:$SH0;@ JB!,$RM\XXGGX P!
M@# & ;M?\.WZ7W]&%2CN?>\Z[[>Q-@0CA'C?6I9KXN*7KJ;:*-)+;#ALX("K
M>P[%C5W$72S"5(66O7+^=2,^1O<4M$WH4P]-./6YQ?Y':S_].G"R^.WV;4N:
MG(, ]&,G75;<&F6S]&-(P;KNWKQVNDVCT(YJD9R^6DUESIMD8YNV24</%W!T
MT6R*1G!U$O:]PL-)J'KCGI&[X+)*;3MUSX%S]"\GM4\ATI]*AS8K3%7>K-9:
M(?(&8/EV2:XMVUDBFJY_DNZY)G !9NU$T';83I-I9E'NU$D5,JJ*J([RB?'P
MYFJJ3QZF1&5+$+WJ)<"269";W]I2% MG;D7E-CTB+;]!9$"%,L\MM?9HE_\
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MW-?(1$1$1$1$1$1$1[$1'[B(B/W$1']1S0S/S & , 8 P!@# & , 8 P!@#
M& , Q>W(V<ZIM\7R,@T%E(=BQ:U3>44S2,H:4UU\HYXV[E;) 8SB8UC(.E9%
M54J1W*]/?6!I[A2M6I2U=G/_ /KEOX&E$5)T/+O0]JO_ !Y5XYP]S [UBG39
MZEQ)>,W"+MH[UWL=TU=-E2+-W+9>^@J@X063,9-5%9(Y5$E4S&(H0Q3E,)1
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MJJODG7:FT64%@V,0IC)#)OS'/)S;A,3 O)NEB)'!F@S11W2A08-RY,:\D@8
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MRLLX<+*N'#A519==90ZJRRRIQ456654$QU%5#F,=10YC'.<PF,(B(CFY!\L
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M^1@MEB!@$.GK*?VG%'_(6S/]01S*O*Y?+.[_ !?PJ_[?"(2LH=0P!@# & ,
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M #]P W0_<,X<'0G-T8(^I5I,NV^-L[.1S3W[5J94]^ASID\G"L,S0,C<8\#
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M!@# & , 8 P!@# .:9E"*$.D8Y52G*9,R8F*H50I@$AB&+T8#@8 $HE$# 8
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M.FHF< .0Y# )3%, &*(" @ A@'SP!@# & , 8 P!@# & , 8 P!@# & , 8
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M=N6WNY**RP& , 8!S34414(JDH=)5,Q3IJ)F,11,Y1[*<ARB!BF*( )3%$!
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M4@" *IIG[*%7;-N=O<%E5T%FRRK=PBJW71.9)9!=,Z2R2A!$ITU4U *=,Y#
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MI2MT"IG12XMA)9>%B;W\9$]=8\#M5;?FWJ5%0L-6+M(13*MNU'==,FSB7,A
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M8C & , 8 P!@# & , 8 P!@',BATCD42.=-1,P'(H0PD.0Y1[*8ABB!BF*(
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MDDU7>]79]G$-Z83C+RWQT5[+S/-JJ;;;>>LN_'B[F#.:E1@# & , 8 P!@#
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M)D?+_P /Q?+_  Z[R_9_G3S*U_B_#W1 !G:8C & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8!')Z@NVO;7KW'V$<_P!5 *,;SLXR)OLO<I&-5_"=96$/
M(I@I=5E5GKLI3)JHV*XS</)M_EUMN9/"I]ZJ=%*7R_.RC3G:<>/'33[OPQK&
M5D$# & 7@UEOC:6I 69T^S*A77K@'4K2IQLUL='EU_ $C.7]4FDGL/\ 4@0
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M/*!;4T"]=]NBP;Y5J/7[].2)#T'W'K[??)I<54OBO<58?)FN)G<8# & , 8
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MG1!NNOFKB7ISM8WY07L% ?O3R\%[JIA<2,K39R08MD2_'A-;E ")Y95U+/\
M)>37CA^,>+)L^'G'VO6^QD86$%_!C;*Q*PMXI@*(I#;Z:_":A6JKGOXK6;(5
M-"6J4FZ*45$(*XQ=?GC)![AHLI! PZ4UJK=<'8@\3+ 8 P!@# & , 8 P!@#
M & , 8 P!@%W- P![3O+3U>*3S++;,I#1<.O("M#V..,]4,'[E2:%75.'[E(
M.5K<4U/@_8E7:6[1MZ9PFY#1ZR4Z#?76EJSY]&E[K9)T"=_S!78)K'B?K]_
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M(K5YW^.D1"9<H, V5O26N(3_ !ED:RJKVXH>Q+#%I(";LR<7-M8RRM5@#O\
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MA9V\>.EE'#ITZ<J&6<.7*ZICJKKKK'.JLLH8RBBAC'.83&$1R!U\ 8 P!@#
M& , 8 P!@'JP<].5B783]:F96O3L4X([BYJ#D7D3+QKM/OVW+"28+-WC-P3L
M?!9NLFH7L?$P=X!F=2^9K]U[4?NVI-KRD/BF-[JXL:EL=N'\H.)44&AZG=_;
M$RCIX:=A6-MFW/B5U?FA1%0)3JIP[;._KE>O(GGZ?6/;7PRQJ2U2V@@+K4%N
M97U4$CN%JD+8T#L^-2(455 ?:_=N'+Z5^*@47$A(41_=J[&H]"]G43^29=*:
MT[.S]//GH[D'4,4Q#&(<HE,41*8I@$IBF*/0E, ]" @(" @( ("'0Y<'Y@#
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M0.;1=I'Y>:QI=K3PE1L1UM_?OP*WF(28KSY2,G8N0AY%(B:BC*3:+LG)4EB
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MB23P*>QJ<8\ RD44<Y\MMY?MHO!9C4E[;<(YSRP8AX(& , 8 P!@# & , 8
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M#WMY??P:4/*\>O0F-S,T(7.>FN#57;#:YLVXIQ.PXTCQ4Y"^*1+##$0CY9(
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MLYF,7%S6G)4\^T>*='=_6?36"5OY8_ODXSJ01YF0, 8 P!@# & , 8 P!@#
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MN%&Z0T1R-H%P>N_B5F4>C3;F<Y_! M8LYT63EXZ-V _'A) L;8CE#L3&ARE
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M^*UC%H$:J(*-9&)4V*U$4W4<B8,NT<M+:[^/EZ1;<GYQ;SZ]G!"1E"!@# &
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MF/0F'ZNS3*+=(O0*2C., YBI@<<T[*ON57P[/AL_#7@5J4KBNH(&A 0$0$!
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M*?LM=$;FVY S-TL4/LZ^QT]L>.E(G8,TVM<V24O$;-*^_+,[8^^:+FPHR#@
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M</:<H(KH_6YE'I9+X+)O'O$BIS2!QK55"XN5^^N9:E2^"Z@V?,Q-A@# & ,
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MDJ_,HIB/LOV)U2"!@#V7K-5K(LS*L7C993"I=UQY/=;FR<J2[X@!@$I@ 2B
M@(" " @(=" @/V$!#[" _80R"2(7EWQ14IJ\CM'6\>8]0<*G=V>NLTNQJRZI
MA,M)QZ*8?_5U90PF<-R%ZA%#") "*,4L=T=EVF*:LZ/?9?OP,JJ8NL:K;]$>
M6=!08 P!@# & , 8!'OZ@>VOIS&M\?X1UTOW%[#VB=$_W^H/8\ZNOJBL8HCV
M2(KTFO;Y-(JAF[E[;(1L]02E*F7V\:G-3V5ESU>?#"=AUUUH1;Y4# & , 8
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MWVZ^39@*4I2@4H 4I0 I2E  *4H!T   ?8  /L !]@#[!F)L?N , 8 P!@#
M& , 8 P!@&,/*_C'5.46LW=0EQ0C+5%?(DZ';11\W%>G3) 7VUQ(45EX*7!-
M)I.,"^0+(%1>($"1CX]="U-7=<Z:KK;)6I2N.AJ<;"U_;=67.P4"\P[B#M%:
M?J,)-@X#L .4"J(.FJQ?ZIY'OFQTGL<^0,=N]9+H.D#G25*8=DYNC%J+,HS
M& 9D</>85QXKW$RB8.K#K*PND/QI2O? /<Z J(6&O"L8$&-D9(%*4#&%-K,M
M4B1LD8@$8/HV*J55K#T?P^$^6;X=J:FN6OZXFTMK;95*VY38:_:_G6EAK$ZW
M!9F^:F$%$52] Y8/VQ_%Q'R;%7MN_CW::3EJN4R:J8?81Q::R;)S=%=" " @
M(=@/V$!_00_N'(!&QR:X5I3BDA?M.LD&DN?W7DY1D0(W9RAQ[46>UH.R(LY
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M2DK)/ECN7LA)2#A1V^?/'"IC*KNG;I95PX64,8ZJJASG,)C".98(R=# & ,
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MC=I.LT5$?E#X?;7QYE'7MYLA2M-LLUXGI&T7"?EK-8I9<7$E-3;YQ(R+M40
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M+QICD,,.I+GHM^OZDE4M\MS8JXV\/-.\9(LOX.B!F+FZ:@A-;"L":#FRR '
M!7;,3E("$!$*' .HN**B59-- 9-Q)ND0=FRJJ=7!;+YWZA(U5*7%[_6QE3E2
MPP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@%)W:B4W9%=?5
M*^5F&ME;D2^+N(G&*+YH8Y0,";A(%2B=J];B83M'S4Z+QHKTLU715*4X2FU=
M."&D\D+/(WTDE2&?V?C9.@JF/N.#:SM[\"JD_4WQJQ;7 @10.Q*FW86@4C%*
M!E'%F5,)4\NJ]_-?2^/(HZ-O+]]<R&F\Z^N^L[ ZJVP*K.5"P,^Q5BYZ/<1[
M@R7D8A'385B%2>LEA*86S]FHNR<D#W&ZZJ8@8=..F^49M19E'X P!@# & 9#
M:YY8\CM4 @C1MPW2-8-0*5O#2$E^)*^B0O0>"-?LR<O#(%$H 4WLL4S"4 #R
M_*40AI/*3WW?CGU)3:PV9Q43U>]ZP8(M[W1Z#?&R0%!1TR))T^;<==>0JNVB
M\M"E$P!^7V*XB!3"(B!@Z*%70M)7KUYEE6]8?H^O R\I_K":4DRI)W;6^Q:D
MY4Z ZD.>!MT8@8?YA4=*/JW(F3#[]&1AU3F_]D7]H?9O1I\[?9/^Q:KY^C)>
ML^HQP]LP)E3VXVA')^O)I9JW;(04A-^@*/G,)](^P_J*<BH!>NS" ="->Y5M
MZHMWZ=_1E\H/DEQZL@$^A[QU+(J'Z\6Z&P:J#P/+] .Q4E$WB8C^P*(%$?TZ
MR.[5L_)DRMUYHNC&V6N3 %-$3\+*E-]RFC95B^ P#^@E%JNJ ]_X=Y E;KS/
M:P2, X**IHD,HJH1),H=F.H<I"%#^\QC"!0#_$1P"C9;96N8$#&G;_284I._
M,TM:H*. G7Z^0O'Z(%Z_?OKK)A[/R9$K=>:+0V#F+Q9K)3FD]]ZP5%/OS3A;
M3'69<HA^I1;UM267\P'["0$Q. _82]Y/=J>C\;>Y'>I6OS[&/UJ]4KB-72J?
M2[+;KNHGV'M56E2Z G,'ZE35MX51L;[_ & X+^T;]2G,7H<E45/9<_U)'?IX
MOKC!BU=/64AD@61UWI*3>F, @A)72TM8P$Q^_B9:$@X^6%<!^PB4E@;^/W #
MF_7)79[OR^_T0^TV7F8:7_U1N5UT!9"'GZQKEDMY$%"E5IL+H41[ "C*6A:R
MR"*W70F<1Z[ _F BF"11\ MW*5I/-_TBKKJ?#D80739.PMCO@DM@7BV71\4Q
MCIN+18)2;.@)NP$K4)%TX(U3 !\2(MBI)$)T0A"D "A8J45@# & , 8!?;2G
M&K='(*4"/UA29*89I+E0D;,[+],J<.(^)C_4["\!-@19-(WO?3FQW4LX2*86
M<>Y, $&&TLO]\NN9*3;A$Z'&_P!+/56LC,+-N-RVVW<D/:<$A56ZB&O(AR7H
MWB2)< #JTF2-Y%]^?*E&.$Q 3UQ)8A5<S=;>++U_1HJ$LW?I^R4QLV;LVZ#1
MH@BU:M44V[9LV2(@W;MT2%310012*5-%%),I2)I)E*1,A2E*4"@ 90N?; &
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MG.'WP#YK6:MMIMK6G%@A$+&];G=,J^M*L$IMVU(!Q.Y:Q1W!7[AN0$SB=9)
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M#%*0R@% #F(03"4IC=>0E*)S"4HCT43&$  1'L#E@# /P0 P"4P 8I@$#%$
M$! 0Z$! ?L("'V$!^PA@ I2E*!2@!2E "E*4  I2@'0  !]@  ^P 'V /L&
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M8>A#L/L/VP <A%"^)R%.7LH^)R@8O93 8H]" AV4P 8H]=@8 $.A !P#E@'
MB::?E[9"$\SF4/X%*7S4-UY'-X@'D<W0>1A[,/0=C@'/ /P0 0$! ! 0$! 0
M[ 0'[" @/V$!#[" _K@'X0A$B%33(5-,A0*0A"@0A"E#H"E*4 *4H!]@
M#[ & ?B:::11*DF1,HF,<2ID*0HG.83',(%  \CF$3&-UV8PB(B(B(X *FF0
M3B0A""H?W%!*4I14/XE+YG$  3'\2E+Y&['Q*4.^@   Y  %#HH  =B/0  !
CV81,8>@_<1$1$?W$1$?N. ?N , 8 P!@# & , 8 P!@'_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
